
<html lang="en"     class="pb-page"  data-request-id="02c70780-740d-4614-8f4d-feaae2aaf054"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.7b00393;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-3;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Federica  Prati" /></meta><meta name="dc.Creator" content="Giovanni  Bottegoni" /></meta><meta name="dc.Creator" content="Maria Laura  Bolognesi" /></meta><meta name="dc.Creator" content="Andrea  Cavalli" /></meta><meta name="dc.Description" content="The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer’s disease (AD), leading to many small-molecule and biological drug candidates. One major target has been the β..." /></meta><meta name="Description" content="The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer’s disease (AD), leading to many small-molecule and biological drug candidates. One major target has been the β..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 8, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00393" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00393" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00393" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00393" /></link>
        
    
    

<title>BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00393" /></meta><meta property="og:title" content="BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0020.jpeg" /></meta><meta property="og:description" content="The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer’s disease (AD), leading to many small-molecule and biological drug candidates. One major target has been the β-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search for BACE-1 inhibitors. The lack of efficacy of verubecestat in mild-to-moderate AD raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in AD treatment. It also suggests new possibilities for discovering BACE-1-targeted compounds with more complex mechanisms of actions and improved efficacy. Herein, we review the major advances in BACE-1 drug discovery, from single-target small molecule inhibitors to multitarget compounds. We discuss these compounds as innovative tools for better understanding the complexity of AD and for identifying efficacious drug candidates to treat this devastating disease." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00393"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00393">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00393&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00393&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00393&amp;href=/doi/10.1021/acs.jmedchem.7b00393" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 619-637</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b00681" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Prati">Federica Prati</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Bottegoni">Giovanni Bottegoni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-1251-583X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Laura++Bolognesi">Maria Laura Bolognesi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Cavalli">Andrea Cavalli</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6370-1176" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, Scotland, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">CompuNet, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Heptares Therapeutics Ltd., BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, U.K.</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#2a4b444e584f4b04494b5c4b4646436a43435e04435e"><span class="__cf_email__" data-cfemail="7819161c0a1d19561b190e191414113811110c56110c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00393&amp;href=/doi/10.1021%2Facs.jmedchem.7b00393" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 619–637</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 27, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 March 2017</li><li><span class="item_label"><b>Published</b> online</span>8 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 February 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D619%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFederica%2BPrati%252C%2BGiovanni%2BBottegoni%252C%2BMaria%2BLaura%2BBolognesi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D3%26contentID%3Dacs.jmedchem.7b00393%26title%3DBACE-1%2BInhibitors%253A%2BFrom%2BRecent%2BSingle-Target%2BMolecules%2Bto%2BMultitarget%2BCompounds%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D637%26publicationDate%3DFebruary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00393"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4332</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00393" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Prati&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Bottegoni&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Laura Bolognesi&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Cavalli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;619-637&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00393&quot;},&quot;abstract&quot;:&quot;The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer’s disease (AD), leading to many small-molecule and biological drug candidates. One major target has been the β-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search for BACE-1 inhibitors. The lack of efficacy of verubecestat in mild-to-moderate AD raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in AD treatment. It also suggests new possibilities for discovering BACE-1-targeted compounds with more complex mechanisms of actions and improved efficacy. Herein, we review the major advances in BACE-1 drug discovery, from single-target small molecule inhibitors to multitarget compounds. We discuss these compounds as innovative tools for better understanding the complexity of AD and for identifying efficacious drug candidates to treat this devastating disease.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00393&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00393" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00393&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00393" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00393&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00393" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00393&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00393&amp;href=/doi/10.1021/acs.jmedchem.7b00393" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00393" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00393" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26pmid%3D28749667%26genre%3Darticle%26aulast%3DPrati%26date%3D2018%26atitle%3DBACE-1%2BInhibitors%253A%2BFrom%2BRecent%2BSingle-Target%2BMolecules%2Bto%2BMultitarget%2BCompounds%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/jmcmar.2018.61.issue-3/20180208/jmcmar.2018.61.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The amyloid hypothesis has long been the central dogma in drug discovery for Alzheimer’s disease (AD), leading to many small-molecule and biological drug candidates. One major target has been the β-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), with many big pharma companies expending great resources in the search for BACE-1 inhibitors. The lack of efficacy of verubecestat in mild-to-moderate AD raises important questions about the timing of intervention with BACE-1 inhibitors, and anti-amyloid therapies in general, in AD treatment. It also suggests new possibilities for discovering BACE-1-targeted compounds with more complex mechanisms of actions and improved efficacy. Herein, we review the major advances in BACE-1 drug discovery, from single-target small molecule inhibitors to multitarget compounds. We discuss these compounds as innovative tools for better understanding the complexity of AD and for identifying efficacious drug candidates to treat this devastating disease.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In 1992, Hardy and Higgins first outlined the amyloid cascade hypothesis, suggesting that “amyloid-β protein (Aβ) is the causative agent in Alzheimer’s disease (AD) pathology and that neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition”.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Twenty-five years later, this hypothesis, in its various incarnations, still appears to be the major inspiration for AD drug researchers. This is despite the failures of recent high-profile clinical trials and an increasing number of dissenting opinions concerning the effectiveness of this hypothesis. Indeed, several recent papers have captured the attention of the field by outlining major inconsistencies and controversies related to this hypothesis.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> These include the presence of Aβ deposition in cognitively healthy elderly people, the general discrepancies between plaque density and the severity of dementia, the lack of comprehensive nominal, functional, and structural descriptions of oligomeric Aβ assemblies, and challenges to the validity of amyloid animal models.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Nonetheless, the number of recent and ongoing clinical trials and preclinical investigations shows that many research groups are seeking to develop small molecules that can modify the generation, clearance, and/or toxicity of Aβ. These small molecule strategies compete with active and passive amyloid-based immunotherapies,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> sharing with them a long history of clinical failure.</div><div class="NLM_p">In this respect, a recent analysis of failed phase 3 amyloidocentric agents (such as γ-secretase inhibitors and Aβ-antibodies) points out how deficiencies in clinical trial design, as well as liability of the pursued compounds, ultimately compromised the success of the studies.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Particularly, while some therapeutics were very unlikely to succeed due to lack of robust preclinical data, others failed to establish adequate target engagement because of dose-limiting site effects. Therefore, these agents did not show any clinical benefit but neither allow for unequivocal testing and discarding of the mechanistic approach under investigation, as target engagement was not measured. Hence, these considerations provide sustenance to those drug developers and scientists who believe that the amyloid hypothesis has yet to be tested.</div><div class="NLM_p">Big pharma’s favorite amyloidocentric AD target is the β-site amyloid-precursor-protein-cleaving enzyme 1 (BACE-1), that is, the aspartic protease that cleaves amyloid precursor protein (APP) at the β-secretase site. JNJ-54861911,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> CNP520,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and LY3202626<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (structure not disclosed) are the three most recent BACE-1 inhibitors working their way through the trial pipeline, while verubecestat <b>1</b> (MK-8931)<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) is the most advanced BACE-1 inhibitor in clinical development. We expect other BACE-1 inhibitors to advance into clinical trials resulting from the research described herein.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Advanced Merck’s BACE-1 inhibitor <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several factors have likely contributed to the current preference for inhibiting BACE-1 rather than Aβ aggregation. First, it is particularly challenging to develop small molecule inhibitors of protein–protein interactions (PPIs).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The regions of PPIs involve large contact surfaces (1500–3000 Å), whereas the regions of protein–small-molecule interactions are only about 300–1000 Å. In addition, the PPI regions generally lack cavities, i.e., grooves or pockets into which a small molecule could dock in an energetically favorable manner. The binding energy that drives protein–protein contacts is typically distributed over a large area that lacks a defined “hotspot” for pharmacological intervention. Taken together, these inherent limitations severely restrict the druglikeness of Aβ aggregation inhibitors.</div><div class="NLM_p">Conversely and for several reasons, BACE-1 appeared (at least initially) to offer bigger opportunities and to be a more druggable target. First, effective aspartyl protease inhibitors had already been developed successfully in other therapeutic areas, such as hypertension and HIV.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Second, the first crystal structure, solved in 2000,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> seemed to support straightforward structure-based (SB) approaches. In particular, BACE-1 is a monomeric protein with a bilobal structure, which accommodates the catalytic aspartic dyad (Asp 32 and Asp 228) between the N- and C-terminal domains. The rather large active site is sheltered by a β-hairpin loop, known as a flap, which forms a large and flexible portion of the binding pocket. Spurred on by rising expectations and boosted by the discovery of different peptidomimetic inhibitors with nanomolar activity, researchers have been seeking to develop small molecule BACE-1 inhibitors ever since.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> However, progress has been hampered by the rigid prerequisites for any drug that is to treat a chronic neurodegenerative disorder and by the uncompromising nature of the BACE-1 catalytic site (see below).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Selectivity toward different aspartyl proteases could be an additional factor in the attrition rate for BACE-1 drug discovery.</div><div class="NLM_p">Thus, 2 decades of research have shed light on additional layers of complexity that may take many years to explore. Nonetheless, we will argue here that the bulk of data collected still supports BACE-1 as a major target for AD drug discovery, both now and in the future. In particular, we will consider new horizons such as the development of BACE-1 inhibitors with an expanded therapeutic profile, and the use of BACE-1 inhibitors in a more promising personalized medicine setting.</div><div class="NLM_p">Clearly, the amyloid theory is not the only pathogenic hypothesis of a complex multifactorial disease. Tau<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and prion<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> have both been proposed to trigger AD and mediate its progression. In addition, oxidative stress,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> neuroinflammatory<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and mitochondrial<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> cascades appear to explain the disease process and have been subject of considerable research and speculation.</div><div class="NLM_p">To effectively confront such multifaceted and complex nature, several lines of evidence point to multitarget compounds (often referred to as “multitarget-directed ligands” (MTDLs)), which can hit proteins in complementary pathways.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In terms of BACE-1 inhibitors, this means developing small molecules that can modulate both BACE-1 and other related targets. In principle, this could considerably enhance efficacy and produce more satisfactory clinical outcomes.</div><div class="NLM_p">In terms of personalized medicine, companion diagnostics have now entered the AD field, where they should allow clinicians to precisely assess the benefits of anti-amyloid therapy and to identify the “best patients” for a given treatment.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> For example, Merck is developing the BACE-1 inhibitor <b>1</b> in conjunction with the FDA-approved amyloid PET tracer flutemetamol. Flutemetamol will be used to identify patients who might benefit from <b>1</b> treatment and to monitor clinical outcomes.</div><div class="NLM_p last">Herein, by critically reviewing the literature and systematically discussing the progress made, we hope to address the open questions regarding the validity of BACE-1 as an AD target and to inspire the design of novel improved inhibitors. We will first review the recent advances in the design and discovery of BACE-1 inhibitors. We will then consider the major computational approaches used over the past decade to assist the design of BACE-1 inhibitors, mainly through SB approaches made possible because of the existence of BACE-1 crystallographic structures. We will conclude by reporting on MTDLs centered on BACE-1. These have the potential to become next-generation BACE-1 inhibitors with improved efficacy in treating this devastating neurological disorder.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 BACE-1 Inhibitors: An Update</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As highlighted above, the search for effective BACE-1 inhibitors for AD treatment has been a hot topic in the past few years. The many reports in the literature have been covered by some comprehensive reviews.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> Therefore, this section will focus on the most relevant medicinal chemistry investigations carried out more recently.</div><div class="NLM_p">Peptidomimetics were the first BACE-1 inhibitors to be reported. Despite their high in vitro potency, they had inadequate pharmacokinetic (PK) properties, which generally made them ineffective for treating AD. Peptidomimetics have long been a staple of BACE-1 inhibitor research programs, with recent publications demonstrating that researchers are still interested in them.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26-29)</a> However, the focus has mostly shifted to small molecule nonpeptide inhibitors.</div><div class="NLM_p">Investigations into new small molecule non-peptide inhibitors involve high-throughput, fragment-based (FB), or virtual screenings, followed by chemical optimization. The primary goal is to develop novel inhibitors that are smaller, with less of a peptide character and an improved PK profile.</div><div class="NLM_p">However, the development of nonpeptidic BACE-1 inhibitors large enough to bind with sufficient affinity to the enzymatic active site, yet small enough to exhibit satisfactory PK and sufficient lipophilicity to sustain suitable brain penetration, has proven to be very challenging.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Initially, inhibitor size reduction resulted in a decrease in BACE-1 inhibitory potency. However, SB drug design strategies, supported by crystallographic data, led to high affinity BACE-1 inhibitors with additional and specific drug–target interactions. Improved central nervous system (CNS) penetration was also achieved, through enhanced blood–brain barrier (BBB) permeability and reduced P-glycoprotein (Pgp) efflux, by properly fine-tuning compound physiochemical properties, such as polar surface area (PSA), molecular weight (MW), lipophilicity, number of rotatable bonds and hydrogen bond donors (HBD).<a onclick="showRef(event, 'ref18 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref18 ref30 ref31">(18, 30, 31)</a> Off-target effects also needed to be addressed, taking advantage of structural data and reflecting on physiochemical property balancing. Importantly, potent small molecule BACE-1 inhibitors have lately been developed to achieve satisfactory brain penetration and robust cerebral Aβ reduction with good safety margins in preclinical animal models. In summary, high level of understanding to develop efficient in vivo BACE-1 inhibitors has been obtained, and recent efforts, showing how research in the field is making strides in the right direction, are discussed below.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.1 Aminohydantoins, Aminooxazolines, Aminothiazolines, and Iminopyrimidinones</h3><div class="NLM_p">A key advance in non-peptide BACE-1 inhibitor design was the discovery of 2-amino heterocycles that engage both of the Asp moieties in the BACE-1 active site.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> Compared to initial acylguanidine inhibitors, these ligands generally enabled a better physical–chemical profile, improved brain penetrance, and in vivo efficacy.</div><div class="NLM_p">Along this line, the aminohydantoin BACE-1 inhibitor <b>2</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was recently developed by Merck. Although <b>2</b> was potent in the enzymatic assay (<i>K</i><sub>i</sub> = 22 nM), it suffered from a pronounced cell shift when tested in whole-cell assay (cell IC<sub>50</sub> = 258 nM), due to Pgp efflux. It also showed modest oral bioavailability and lowered plasma but not cortical Aβ40 levels in CRND8 mice.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Aminohydantoin <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Seeking to identify novel, highly soluble, and permeable BACE-1 inhibitors, Hunt et al. prepared a collection of small, rigid, and saturated or partially saturated cores using 2-amino heterocycles. This led to the identification of spirocyclic aminohydantoin <b>3</b> (BACE-1 IC<sub>50</sub> = 36.8 μM) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), which combines limited molecular flexibility with three-dimensionality (i.e., from aromatic to aliphatic),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> key factors for permeability and solubility, respectively. The group conducted structure–activity relationship (SAR) studies of core changes, P3 moieties, and warhead (WH) Asp-binding functional groups. This provided compounds with double-digit nanomolar enzymatic and cell-based Aβ1–40 inhibitory potencies but low selectivity with respect to the closely related aspartyl protease, cathepsin D (CatD) (IC<sub>50CatD</sub>/IC<sub>50BACE</sub> = 0.2–97). (<i>R</i>)-Enantiomers were roughly twice as potent as the corresponding racemates but did not consistently show increased affinity for CatD. Although suitable alternative Asp binding moieties to eliminate efflux were not identified (the aminohydantoin WH contributes to Pgp efflux liability as it adds two HBD and increases PSA), good BBB permeation and Aβ reduction in cerebrospinal fluid (CSF) were observed for some derivatives in vivo. More importantly, Hunt et al. demonstrated a pharmacokinetic/pharmacodynamic (PK/PD) relationship between free drug concentrations in the brain and Aβ-lowering in CSF in wild-type guinea pig and rat. Optimization of brain exposure led to the discovery of the lead compound <b>(</b><i><b>R</b></i><b>)-4</b> (BACE-1 IC<sub>50</sub> = 48 nM) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), which significantly reduced CSF Aβ in wild-type rodents and in monkey.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Spirocyclic aminohydantoins <b>3</b> and <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The group also incorporated a 7-tetrahydropyrane (7-THP) A-ring at the P2′ site of the chroman scaffold, providing a series of 1,3,4,4a,10,10a-hexahydropyrano[4,3-<i>b</i>]chromanes.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> This modification was envisaged to improve selectivity for BACE-1 versus CatD, due to differences in their active sites. They explored three different WHs (aminohydantoin, aminooxazolines, and aminothiazolines) as Asp-binding moieties, as well as SB-guided substitutions at P3 and P2′ sites to modulate potency, selectivity, efflux, and permeability (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). The aminohydantoin moiety led to the most potent analogues but with higher efflux ratios and lower permeabilities than the two alternative WH. These derivatives showed good enzymatic (10–40 nM) and cellular (5–44 nM) potencies and were 10- to 420-fold more selective for BACE-1 than for CatD. Importantly, despite the high efflux, <b>5</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) had the best coverage ratio (free brain concentration/cell IC<sub>50</sub>) of the various 7-THP chromans in mouse PK models. Furthermore, <b>5</b> significantly reduced CSF Aβ1–40 in guinea pig, rat, and cynomolgus (58%, 53%, and 63%, respectively). 2,3,4,4a,10,10a-Hexahydropyrano[3,2-<i>b</i>]chromane (8-THP chroman) derivatives showed an even better overall profile (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> As noted above, the aminohydantoin Asp binding moiety correlated with high efflux, despite being the most potent. The enzymatic (41–98 nM) and cellular (37–140 nM) potencies and CatD selectivity (430- to >2200-fold) of the aminooxazoline and aminothiazoline analogues were dramatically enhanced by methylation at the β-position of the 8-THP chroman core. Further optimization of the P3 moiety led to aminooxazoline <b>6</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), which progressed to rat PD studies. Although <b>6</b> still showed efflux liability (efflux ratio of 3.4) and had a 7-fold lower coverage ratio in rat than <b>5</b>, it showed a significant improvement in CSF Aβ1–40 reduction (69%).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Spirocyclic aminohydantoin <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Spirocyclic aminooxazoline <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other aminooxazoline derivatives have recently been reported as BACE-1 inhibitors.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36-39)</a> The aminooxazoline xanthene <b>7</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) has good BACE-1 enzymatic (2 nM) and cellular (25 nM) potency, as well as overall favorable properties. It showed robust CSF and brain Aβ-lowering activity in a rat PD model but QTc prolongation in cardiovascular models, which is consistent with in vitro activity on the cardiac hERG potassium channel (hERG <i>K</i><sub>i</sub> = 0.66 μM).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Indeed, hERG inhibition has frequently been associated with BACE-1 inhibitors. In fact, there is evidence that the increase in the p<i>K</i><sub>a</sub> and lipophilicity, which is required for efficacious BACE-1 inhibitors, increases the chance of hERG inhibition.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Hence, reducing these two parameters is a common approach for reducing hERG affinity. However, it is known that decreasing the p<i>K</i><sub>a</sub> of the Asp-binding motif generally decreases BACE-1 potency, while introduction of polarity increases PSA, which correlates with Pgp recognition. A balance of low Pgp efflux, hERG, and BACE-1 potency was achieved by introducing polarity at the P2′ site of <b>7</b> and simultaneously reducing the PSA of the P3 group.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Introducing a fluorine in position 4 of the xanthene ring also improved BACE-1 enzymatic and cellular potencies (5- to 10-fold).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The enhanced BACE-1 potency within the series was attributed to a favorable hydrogen-bond interaction between the 4-fluoro atom and NH Trp76 of BACE-1. Thus, introducing a nitrogen atom at the 3- or 4-position of the xanthene core was investigated to similarly engage NH Trp76.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> This modification boosted BACE-1 potency and reduced hERG binding affinity but elevated the Pgp efflux ratio. Optimizing the P3 and P2′ groups resulted in several compounds with improved in vitro profiles.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Spirocyclic aminooxazolines <b>7</b>–<b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The development of 3-aza-4-fluoroxanthenes was also explored.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> These lead-optimization approaches resulted in compounds with robust reductions in CSF and brain Aβ levels in a naive rat PD model. In particular, compounds <b>8</b>, <b>9</b> (AMG-8718), <b>10</b>, and <b>11</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) had excellent in vitro profiles (BACE-1 IC<sub>50</sub> = 0.3, 0.7, 0.9, 0.3 nM, respectively; cell IC<sub>50</sub> = 4, 4.4, 21.1, and 4 nM, respectively) and good in vivo PD responses in rats. These compounds exhibited modest hERG activity (<b>8</b>, hERG <i>K</i><sub>i</sub> = 3.28 μM; <b>9</b>–<b>11</b>, hERG <i>K</i><sub>i</sub> > 10 μM) and significantly reduced potential for QTc prolongation in cardiovascular safety models in dog (<b>8</b>, <b>9</b>, and <b>11</b>) and monkey (<b>10</b>).<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36-39)</a><b>10</b> and <b>11</b> also produced robust and sustained reductions in CSF and brain Aβ in a non-human primate PD model. They showed low in vivo clearance and good oral bioavailability in preclinical species.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> Unfortunately, <b>9</b>’s drug development was discontinued due to toxicity issues. It elicited retinal toxicity leading to thinning of the outer nuclear layer of the retina in a one month rat toxicity study to support first-in-human trials.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Although the origin of the toxicity was not established, it was speculated it was likely an off-target effect related to inhibition of other proteases. Mandal et al. recently reported on novel bicyclic iminopyrimidinones<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> to optimize the in vivo profile and address the off-target liabilities (cytochrome CYP3A4 and hERG inhibition) of a previous series of fused pyrrolidine iminopyrimidinone represented by <b>12</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Starting from <b>12</b>, the group improved the ancillary profile and CNS properties by truncating the P3 cyanophenyl group (to reduce lipophilicity and hERG inhibition) and optimizing the fluoropyrimidine moiety binding in the S2′–S2″ region (to modulate BACE-1 affinity and address CYP3A4 inhibition). They subsequently optimized the P1 thienyl ring to improve affinity and selectivity. This resulted in the 2,4-difluorophenyl analogue <b>13</b> (BACE-1 <i>K</i><sub>i</sub> = 5 nM, cell IC<sub>50</sub> = 14 nM) (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), which robustly lowered CSF and cortex Aβ40 in both rats and monkeys.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Iminopyrimidinones <b>12</b> and <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Importantly, by occupying the S1 and S2′–S2″ subpockets, <b>13</b> has a molecular shape that is novel among those S1–S3-binding BACE-1 inhibitors that can potently lower central Aβ in nonrodent preclinical species.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.2 Aminothiazines</h3><div class="NLM_p">The FB-derived aminothiazine <b>14</b> (LY2811376, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) developed by Eli Lilly showed well-balanced PK profiles and reduced CSF Aβ levels in different animal species.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> It was also the first molecule to demonstrate sustained brain Aβ reduction in healthy volunteers. However, clinical trials were discontinued due to preclinical retinal toxicity, potentially related to the off-target CatD inhibition.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Aminothiazines <b>14</b>–<b>22</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>14</b> exhibited only modest BACE-1 inhibitory activity (IC<sub>50</sub> = 0.24 μM). Therefore, increasing potency was considered as one strategy for widening the therapeutic window with respect to the observed toxicity. In this regard, by targeting the flap backbone of the BACE-1 active site, Wu et al. discovered the 6-dimethylisoxazole-substituted biaryl aminothiazine <b>15</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), with 34-fold improved BACE-1 inhibitory activity (IC<sub>50</sub> = 8 nM) over <b>14</b>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Despite its potency, <b>15</b> produced only modest in vivo activity in rodents, due to poor brain penetration and metabolic instability mainly related to oxidation of the pyrimidine ring. Both hurdles were overcome with the development of the pyrazine-carboxamide <b>16</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). The pyrimidyl moiety of <b>15</b> was replaced with a carboxamide, and the 5,6-difluorophenyl substituent in the S1 pocket was optimal in terms of activity and metabolic stability. Optimization of the amide side chain in the S3 pocket resulted in <b>16</b>, which exhibited potent BACE-1 inhibitory activity (IC<sub>50</sub> = 0.7 nM) and robust brain Aβ reduction in rat dose–response studies.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> An alternative approach to addressing <b>15</b>’s two major issues was to develop S3-truncated heteroaryl substituted aminothiazines.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Pyrimidine truncation boosted brain penetration (by reducing MW and PSA) and metabolic stability (by removing a metabolic soft spot). Compound <b>17</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) showed improved BBB permeability, and despite its moderate enzymatic activity (IC<sub>50</sub> = 0.15 μM), it demonstrated significant brain Aβ reduction in rodents. <b>17</b> was relatively stable in rat and mouse liver microsomes but unstable in human microsomes, due to oxidation of the methyl group(s) of the isoxazole ring. <b>17</b>’s metabolic stability was addressed by replacing the 6-dimethylisoxazole ring with a pyrimidine ring. This led to <b>18</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) with good brain permeation and metabolic stability and enhanced in vivo activity in rodents.</div><div class="NLM_p">An alternative approach to widening <b>14</b>’s therapeutic window was to improve BACE-1 selectivity versus CatD. In this respect, Butler et al. recently reported on a reductionist approach, truncating <b>14</b> to just the necessary pharmacophore, then evaluating opportunities to improve CatD selectivity using SB drug design, without impacting CNS penetration.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The group developed a series of aminothiazine-THP fused derivatives, carrying a small lateral chain to engage an induced pocket (S2′) formed by movement of the protein flap. These derivatives were efficiently selective, maintaining the desired PK profile, as exemplified by <b>19</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). The compounds displayed robust efficacy in lowering both peripheral and central Aβ loads in vivo in mice and dog models. In addition, chronic treatment in aged PS1/APP mice decreased the number and size of Aβ-derived plaques. Most importantly, a 2-week exploratory toxicology study of <b>19</b> revealed no retinal toxicity.</div><div class="NLM_p">Despite its excellent overall properties, <b>19</b>’s weak in vitro potency against BACE-1 (IC<sub>50</sub> = 1.07 μM) meant a high human dose was projected (>500 mg/day), which prevented its further investigation. A new generation of novel heterocycle-substituted analogues of <b>19</b> was designed based on structural information. Particularly, as the fluoromethyl group of <b>19</b> was found to suboptimally fill the S2′ pocket, it was postulated that positioning a heteroaryl substituent in this pocket could improve potency while maintaining the overall lipophilicity and alignment of ADME properties. This led to potent, low-clearance, CNS-penetrating BACE-1 inhibitors, represented by <b>20</b> in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> (BACE-1 IC<sub>50</sub> = 52 nM, cell IC<sub>50</sub> = 4n M).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> However, further in vitro profiling with human recombinant CYPs showed that CYP2D6 significantly contributed to <b>20</b>’s metabolism, causing drug–drug interaction (DDI) concerns.</div><div class="NLM_p">SB-guided efforts to reduce <b>20</b>’s cytochrome CYP2D6 metabolism issues resulted in highly potent derivatives, with reduced risk for DDI, central efficacy, and improved hERG therapeutic margins. In particular, due to their promising overall profiles, compounds <b>21</b> and <b>22</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) have advanced to long-term safety studies, with the results expected in due course.</div><div class="NLM_p">As noted above, Eli Lilly discovered <b>14</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and, more recently, the furo[3,4-<i>d</i>][1,3]thiazin-2-amine picolinamide LY2886721 (<b>23</b> in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), a potent BACE-1 inhibitor that reached phase 2 clinical trials to treat early AD.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Ely Lilly researchers then used a FB approach to target topologically complex polycyclic aminothiazines as BACE-1 inhibitors. Starting from the millimolar bicyclic thiazine fragment hit <b>24</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>), identified in a high concentration BACE-1 enzymatic assay, they obtained the FB-derived compounds <b>25</b> and <b>26</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>Compounds <b>25</b> and <b>26</b> showed poor potency in vitro (BACE-1 IC<sub>50</sub> = 1.83 and 2.25 μM, respectively) and in vivo (lack of Aβ brain reduction was consistent with low cerebral exposure). However, key SAR hypotheses could be tested with these compounds. These tests revealed that S3-binding could remarkably increase the potency of this series but that conformational constraint would not lead to further enhancements.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Aminothiazines <b>23</b>, <b>27</b>, and <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Aminothiazines <b>24</b>–<b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Bristol-Myers Squibb recently developed a novel series of more easily accessible furo[2,3-<i>d</i>]thiazine isosteric analogues of <b>23</b>, represented by <b>27</b> and <b>28</b> in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a> (BACE-1 IC<sub>50</sub> = 20 and 37 nM, respectively). <b>27</b> and <b>28</b> showed cellular activity comparable to that of the parent compound <b>23</b> and good in vitro permeability. However, they demonstrated low exposure and only modest reduction in Aβ brain levels in mice.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.3 Iminothiadiazinanes Dioxide</h3><div class="NLM_p">Merck recently reported on the discovery and characterization of a novel iminothiadiazinane dioxide class of BACE-1 inhibitors, represented by the advanced clinical compound <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Starting from the elaboration of initial isothiourea fragment screening hits,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> subsequent search for heterocycle isothiourea isosteres, and extensive SAR exploration around the iminothiadiazinane dioxide core, Merck developed the highly optimized inhibitor <b>1</b>. On the basis of the potent in vitro and vivo iminopyrimidinone BACE-1 inhibitor <b>29</b> (BACE-1 <i>K</i><sub>i</sub> = 1.7 nM)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and seeking to identify novel Asp-binding cores that could offer unexplored intellectual property space, the iminothiadiazinane dioxide <b>30</b> (BACE-1 <i>K</i><sub>i</sub> = 2.4 nM) was developed (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Although <b>30</b> (cell IC<sub>50</sub> = 55 nM) displayed weaker cellular potency than <b>29</b> (cell IC<sub>50</sub> = 11 nM), it was significantly more potent in vivo, probably due to the enhanced CNS penetration imparted by the iminothiadiazinane dioxide core. In an acute rat PD assay, <b>30</b> afforded robust reductions of CSF and cortex Aβ40 levels. Despite the favorable PD profiles, <b>29</b> and <b>30</b> were not developed further due to metabolic issues and modest CatD selectivity (21- and 47-fold, respectively). These two liabilities were overcome by SB optimization of the P3 and P1 binding motifs, leading to the discovery of <b>1</b> (BACE-1 <i>K</i><sub>i</sub> = 2.2 nM). Compound <b>1</b> was highly selective for BACE-1 over other aspartyl proteases, with the exception of BACE-2, and potently inhibited Aβ formation in cell-based assay (cell IC<sub>50</sub> = 2.1 nM). Compound <b>1</b> showed a good PK/PD profile in preclinical species, profoundly lowered CSF and brain Aβ levels after acute and chronic administration to rats and monkeys, and was advanced to phase 1 clinical trial to assess safety, PK, and PD in healthy volunteers and mild to moderate AD patients.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Single and multiple doses were generally well tolerated and produced reductions in Aβ levels in the CSF of both healthy human subjects and AD patients. In 2012, <b>1</b> entered into phase 2/3 clinical trial in people with mild to moderate AD (EPOCH trial), and in 2013 a phase 3 trial for prodromal AD (APECS trial) was also started. While EPOCH has been recently discontinued due to lack of efficacy, APECS will continue to address the question of timing of intervention of BACE-1 inhibition in AD (results are expected by February 2019).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Iminopyrimidinone <b>29</b> and iminothiadiazinane dioxide <b>30</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.4 Iminohydantoins</h3><div class="NLM_p">Merck recently reported SB drug design efforts around the high-throughput screening hit, spiropiperidine iminohydantoin <b>31</b> (BACE-1 IC<sub>50</sub> = 22 μM, cell IC<sub>50</sub> > 30 μM) (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> This led to compounds with more than 200-fold and 90-fold improved BACE-1 enzymatic and cell-based potency, respectively. This remarkable achievement was made possible by adding a strategically placed methyl group on the piperidine ring. This methyl group maintained the required p<i>K</i><sub>a</sub> of the <i>N</i>-piperidine nitrogen, filled a small hydrophobic pocket, and stabilized the best conformation for optimized binding to the receptor.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Importantly, derivative <b>32</b> (BACE-1 IC<sub>50</sub> = 6 nM, cell IC<sub>50</sub> = 63 nM) (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) also showed good selectivity versus CatD (IC<sub>50</sub> = 16.3 μM), and Aβ reduction in CSF in mice and monkeys.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Spiropiperidine iminohydantoins <b>31</b> and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.5 Aminoxazines</h3><div class="NLM_p">Rombouts et al. recently reported on novel 6-<i>F</i>-3-amino-1,4-oxazines for the development of BACE-1 inhibitors with improved CNS permeability.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Lead optimization efforts fine-tuned the amidine p<i>K</i><sub>a</sub> and BACE-1 primary activity, resulting in compound <b>33</b> (BACE-1 IC<sub>50</sub> = 7.6 nM; cell IC<sub>50</sub> = 8.1 nM) (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>). Compound <b>33</b> was orally bioavailable, centrally active and robustly lowered brain and CSF Aβ levels in mouse and dog models, respectively. However, brain penetration still needs to be balanced against metabolic stability and cardiovascular safety (i.e., hERG inhibition).</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Aminoxazine <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.6 Aminoquinolines</h3><div class="NLM_p">The potent SB-designed aminoquinoline derivative <b>34</b> (BACE-1 IC<sub>50</sub> = 0.8 nM) was recently developed by linking the known BACE-1 inhibitor <b>35</b> (BACE-1 <i>K</i><sub>d</sub> = 140 nM)<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> with the S3 binding fragment <b>36</b>, identified in a <sup>19</sup>F NMR second-site fragment screen (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Compound <b>34</b> exhibited a 350-fold increase in BACE-1 affinity while maintaining reasonable ligand efficiency and gaining much improved selectivity over CatD with respect to the parent compound <b>35</b>.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Aminoquinoline <b>34</b> design rationale.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.7 Macrocyclic Acyl Guanidines</h3><div class="NLM_p">The acyl guanidine chemotype is well-known in BACE-1 inhibitor development. Boy et al. recently reported on a macrocyclization strategy to improve the in vitro potency and Pgp liability of parent acyclic acyl guanidine inhibitors.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Compound <b>37</b> (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>) showed good in vitro potency (BACE-1 <i>K</i><sub>i</sub> = 3.2 nM, cell IC<sub>50</sub> = 140 nM), with robust peripheral Aβ-reduction in a wild-type mice model. However, further effort is still required to lower Pgp efflux and enhance CNS penetration, thereby achieving meaningful central exposure.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Cyclic acyl guanidine <b>37</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.8 Miscellaneous</h3><div class="NLM_p last">Recently reported in silico studies have led to the identification of new series of 4-oxo-1,4-dihydroquinoline-3-carboxamides,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> 3,5-bis-<i>N</i>-(aryl/heteroaryl)carbamoyl-4-aryl-1,4-dihydropyridines,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> allylidene hydrazinecarboximidamides,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> sulfonylaminoacetamides,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and (3<i>S</i>,4<i>S</i>)-4-aminopyrrolidine-3-ols<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> with micromolar BACE-1 inhibitory activity. These can be considered as suitable starting points for further investigation.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">3 SB Approaches to Discovering BACE-1 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">BACE-1 has been extensively characterized at the structural level. The enzyme presents three peculiar features that should be taken into account during drug discovery. First, the BACE-1 binding site is very extended (roughly 1000 Å<sup>3</sup> in size) and displays an elongated shape over 20 Å in length along the main axis.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Usually, this pocket is conveniently described as a collection of subsites, which display varying physicochemical local environments. Recently, a combination of docking studies and molecular dynamics (MD) simulations was used to investigate the selectivity of four BACE-1 inhibitors with respect to closely related proteases (BACE-2 and CatD).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Simulations showed that these compounds were too bulky to fit in the comparatively narrow binding pocket of BACE-2 and, conversely, could not establish stable interactions within the wider pocket of CatD.</div><div class="NLM_p">Flexibility is the second relevant feature to consider when designing BACE-1 inhibitors. The BACE-1 binding pocket is very flexible, as flexibility is instrumental to catalysis, and induced-fit effects are to be expected. As of today, querying the Protein Data Bank for the human BACE-1 UniProt accession code (<a href="https://P56817" class="ext-link">P56817</a>) returns 355 unique hits.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Possibly due to the abundance of crystal structures combined with its pharmacological relevance, BACE-1 is considered an ideal case study for investigating the role of receptor flexibility in docking and virtual screening.<a onclick="showRef(event, 'ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71">(69-71)</a> Cosconati and colleagues implemented an advanced ensemble docking strategy relying upon an energy-weighted set of descriptors averaged over multiple conformations of BACE-1.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Their method identified novel chemotypes displaying BACE-1 inhibitory activity in a prospective virtual screening campaign. Selected examples <b>38</b>–<b>40</b> are reported in <a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Examples of BACE-1 inhibitors (<b>38</b>–<b>43</b>) discovered employing computer-assisted drug discovery methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The third relevant structural element is the enzyme’s catalytic machinery: the aspartic dyad formed by Asp32 and Asp228 and located at the center of the binding site. Since contacting the dyad is fundamental for inhibitory activity, several studies have attempted to identify the protonation state of the aspartic acid residues conducive to tighter interactions.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73, 74)</a> Ligands interacting with the aspartic dyad by means of chemically different groups preferentially interact with different protonation states. Different protonation states alter the local electrostatic environment, and differently positioned hydrogen atoms in neutral side chains alter hydrogen bond networks. A mismatch between a certain chemotype and the dyad titration state can compromise the reliability of ligand affinity predictions. Barman and Prabhakar systematically investigated the effect of eight rearrangements of the dyad in self-docking simulations carried out on eight diverse ligands.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> For each chemotype, they identified a protonation state that returned the best results in terms of reproducing the native pose and the binding energy. Even when the bound conformation was reproduced by multiple dyad rearrangements, one often emerged as the most favorable. This confirmed the existence of a clear link between dyad protonation and ligand bound conformation. Dominguez and colleagues further extended the idea of improving docking accuracy by modulating dyad protonation, extending p<i>K</i><sub>a</sub> calculations to all titratable residues in the BACE-1 binding site.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Their results showed a small but significant improvement with respect to protocols where side chains are assigned default states. Bottegoni et al. considered five protonation states for the dyad in a virtual screening protocol, which was purposefully designed to identify multitarget fragments endowed with activity at BACE-1 and the glycogen synthase kinase 3β (GSK-3β, another known target for AD treatment).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Fragment-dyad protonation binding scores were systematically evaluated, and each compound was assigned the best generated score. Interestingly, the only fragment endowed with dual activity at both targets, <b>41</b> (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>), preferentially interacted at the BACE-1 variant displaying a dideprotonated dyad.</div><div class="NLM_p">In the above studies, protein flexibility and dyad protonation were considered almost independent issues. In Kacker et al., we combined docking, quantum-mechanical (QM) calculations, and MD to investigate the roles played by dyad protonation and protein flexibility in order to identify novel BACE-1 inhibitors by virtual ligand screening.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Our results demonstrated that the two variables had to be considered together in order to obtain significant enrichment in terms of the number of active compounds and their chemical diversity. This may explain why, until recently, computational methods, which focused on only one of these two aspects at a time, did not play a pivotal role in BACE-1 inhibitor identification.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Indeed, MD is a technique whose role in drug discovery has been steadily growing in recent years. Since the pioneering work of Park and Lee, MD has been used, either by itself or in combination with QM techniques, to investigate dyad protonation.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> More recently, constant pH MD (CpHMD) simulations produced relevant insights into the crosstalk between protonation states and protein conformations. The original CpHMD implementation includes pH as an additional thermodynamic term in classic MD.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Changes in the protonation state of titratable residues were introduced along the trajectory by a Metropolis Monte Carlo (MMC) procedure. CpHMD can be embedded within a replica exchange framework, allowing the exchange of pH between adjacent replicas.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a> This significantly improves sampling, generating much more efficiently a converged thermodynamic ensemble in both conformational and protonation spaces. Constant pH replica exchange MD (pH-REMD) was used to elucidate, at the molecular level, the role of pH in substrate and inhibitor binding.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> BACE-1 exists in multiple conformational states. At its working pH (between 2.5 and 4.5), the catalytically active conformation is the most populated. Values of pH outside this range shift the thermodynamics equilibrium toward self-inhibited, noncatalytically competent conformers. In another study, Kim and colleagues used constant pH-REMD to calculate pH-dependent binding free-energy profiles associated with selected BACE-1 inhibitors.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> They reported how free-energy-calculation errors exceeding 8 kcal/mol can be caused by incorrectly assigning the protonation state of both the catalytic dyad and other titratable residues surrounding the catalytic machinery. Constant pH-REMD was also used to retrospectively explain a puzzling affinity difference between two structurally related BACE-1 inhibitors.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Even relatively high-resolution crystallographic structures of the bound complexes could not account for the difference in potency, since the two molecules interacted with the enzyme with comparable orientations and contacting the same residues. Simulations explained how, at BACE-1’s working pH range, the structural differences between these compounds, while very subtle, were still pronounced enough to stabilize different protonation states in the dyad, altering the surrounding H-bond pattern and ultimately accounting for the different potency.</div><div class="NLM_p">In more advanced stages of drug discovery, the research focus shifts from identifying novel compounds to optimizing the identified hits. BACE-1 inhibitors have been successfully investigated using protocols that estimate the relative binding free-energy variation associated with a structural modification of a molecule.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The idea is to explore the chemical space around an interesting scaffold to identify those substituents that lead to improved affinity or, more generally, a better pharmacological profile. At this stage, using these more computationally demanding methods is acceptable because, on average, there are fewer molecules to investigate. Ciordia and colleagues used free-energy perturbation (FEP) to investigate a series of amidine-containing spirocyclic BACE-1 inhibitors.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Targeting specific subpockets at BACE-1 binding site, they first calibrated the FEP procedure on retrospective data to identify the best trade-off between sampling thoroughness and correlation with experimental values of the simulation output. The authors emphasized the importance of accomplishing such calculations within an acceptable time frame for a drug discovery campaign, particularly in an industrial setting. They then applied the tuned protocol to predict new compounds. After synthesis and biological evaluation, the predicted potencies for the synthesized spiroaminodihydropyrroles (exemplified by <b>42</b> in <a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>) were in fairly good agreement with the experimental results. In addition to computational time, FEP calculations are also limited because reliable predictions cannot be achieved for more radical modifications. To overcome this, Keränen and colleagues recently reported a “core hopping FEP+” approach that was successfully applied to a series of acylguanidine-bearing BACE-1 inhibitors (exemplified by compound <b>43</b> in <a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Comparing the computational outcome with experimental results, the match was very accurate for local substitutions and, while slightly less accurate, still encouraging when more radical scaffold modifications were attempted. Interestingly, when investigating the effect of sampling in obtaining converged calculations, multiple short runs returned more accurate results than a single, more extended trajectory.</div><div class="NLM_p last">In summary, while success stories have been episodically described and several new hit compounds have been reported, the prospective application of computer-assisted drug discovery methods to BACE-1 remains challenging. This multifaceted target severely limits the reliability of standard computational hit-discovery and optimization protocols. In line with a general and widespread trend in drug discovery,<a onclick="showRef(event, 'ref87 ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref87 ref90 ref91 ref92">(87, 90-92)</a> more complex and time-consuming methods based on MD, QM, and enhanced sampling approaches,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a>so far applied in an almost exclusively retrospective fashion, will play an increasingly important role in the prospective development of new BACE-1 inhibitors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">4 Multitarget Compounds Centered on BACE-1</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">MTDLs are (usually) small organic molecules that can simultaneously modulate more than one target. They are gaining increasing attention from the medicinal chemistry community because they can show superior therapeutic profiles relative to conventional single-target molecules, particularly for treating complex and multifactorial diseases, including neurological disorders. Indeed treating Alzheimer’s, Parkinson’s, and other neurodegenerative diseases has been one of the major focuses of multitarget drug discovery strategies in the past 20 years.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> From Melchiorre et al.’s pioneering study<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> to recent MTDLs that interfere with AD’s amyloid and tau cascades,<a onclick="showRef(event, 'ref94 ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref94 ref95 ref96">(94-96)</a> many papers have hypothesized that innovative multitarget strategies could address the complexity of neurodegenerative diseases, which remain a huge unmet medical need worldwide. However, none of these compounds have progressed beyond the preclinical phase, demonstrating that MTDLs create a big challenge in terms of both discovery and development.</div><div class="NLM_p">BACE-1 is a rather difficult target for SB design, mainly because the site is quite solvent-exposed. This requires a good compromise between hydrophobic and hydrophilic moieties in order to achieve good affinity, good residence time, and an appropriate PK profile. Additionally, experimental evidence has shown that different functional groups present on diverse BACE-1 inhibitors can stabilize the dyad in different protonation states, thus altering the dyad’s overall charge. This makes SB design of BACE-1 binders even more challenging.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> In terms of designing BACE-1-based MTDLs, it can be very demanding to identify small molecules that can inhibit BACE-1 in combination with a second (or a third) target. Indeed, it is not easy to design and optimize small molecules for two targets that are often unrelated, genetically and biologically. Furthermore, it is well-known that pharmacokinetics has been quite an issue in BACE-1 inhibitor field,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> further challenging the discovery of multitarget compounds centered on BACE-1. Finally, from the in vivo evaluation standpoint, usually multitarget compounds can be particularly complex to investigate, and systematic experimental protocols have to be defined to properly profile them, also in terms of comparison with drug combinations. For these reasons, the literature contains just a few reports of MTDLs centered on BACE-1, and these molecules have mainly been evaluated in vitro by means of biochemical and cell-based experiments. Here, we review and discuss these examples from the medicinal chemistry perspective. We first consider dual-target inhibitors modulating BACE-1 and another AD-related target. Then, we discuss multitarget compounds where more than two targets are simultaneously hit. We will discuss molecules that inhibit BACE-1 and have other “general” and often target-unrelated mechanisms, such as antioxidation, radical scavenging, and metal chelation.</div><div class="NLM_p">A comment is eventually required on the scaffold selection in multitarget drug discovery, as many compounds can show multiple mechanisms of action in vitro, mainly because of the promiscuity and wide reactivity of the chemical groups they carry. In these circumstances, there exists the actual risk that such multitarget compounds are simply promiscuous molecules, sometimes resulting in pan-assay interference compounds (PAINS) rather than in clean and rationally designed multitarget compounds.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> This issue should be carefully considered in polypharmacology-based drug discovery, and well-established protocols should be devised to properly design, discover, and develop multitarget molecules. This aspect is even more relevant for CNS-directed candidates, as the lead optimization phase should comply with a suitable drug metabolism and PK profile for CNS while preserving affinity toward two or more targets.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.1 Dual BACE-1/Acetylcholinesterase (AChE) Inhibitors</h3><div class="NLM_p">The acetylcholinesterase (AChE) enzyme was the first target within the cholinergic hypothesis to be extensively investigated in the search for novel AD drug candidates. Anti-AChE compounds are still the only drugs approved for treating AD. Despite their limited efficacy, they can alleviate symptoms in the early symptomatic phase of the disease.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> From a multitarget drug discovery standpoint, it was rather obvious that the pharmacophoric functions responsible for AChE inhibition might be combined with functional groups thought to interact with BACE-1. In 2008, Piazzi et al. reported a novel series of coumarin derivatives that were potent and balanced dual BACE-1/AChE inhibitors.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> These compounds were derived from AP2238 (<b>44</b> in <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>), one of the first ever AChE inhibitors that was rationally designed to bind both the internal and peripheral anionic sites of AChE.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> This peculiar feature allowed <b>44</b> to also interfere with AChE-induced Aβ aggregation, making it an MTDL with a rather unique mechanism of action. Starting from pharmacophore <b>44</b>, Piazzi et al. substituted one of its two methoxy groups with a halophenylalkylamidic group, obtaining rather large compounds endowed with a dual mechanism of action. Indeed, the potency against AChE was fairly well-preserved while gaining activity against BACE-1. In particular, <b>45</b> (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) showed a fairly balanced biological profile against the two targets, with an IC<sub>50</sub> of about 181 nM against AChE and 150 nM against BACE-1.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Dual binding site AchE inhibitor <b>44</b> and dual BACE-1/AChE inhibitors <b>45</b>–<b>49</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2014, seeking to identify a novel class of dual BACE-1/AChE inhibitors, the same group screened an internal library of benzophenone derivatives, with promising AChE-inhibiting profiles, for activity against BACE-1.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Most of these compounds were inactive. However, a couple showed single-digit micromolar activity against BACE-1 but with a remarkably reduced potency against AChE. This example demonstrates that discovering and, more importantly, optimizing MTDLs are likely among the biggest challenges in multitarget drug discovery. Indeed, optimizing hits against one target often significantly reduces potency against the other(s). This makes MTDL lead optimization a rather complicated and often frustrating process. Similarly, in 2015, Rampa et al. reported a series of compounds based on the indanone structure, where chemical modifications on the common core could switch from BACE-1 to AChE inhibition and vice versa. This further demonstrates the complexity of optimizing dual-target compounds against such ancestrally divergent biological targets.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p">Following the hybrid approach, Zha et al. very recently designed, synthesized, and biologically evaluated more than 20 tacrine–benzofuran compounds as dual inhibitors. Of these, <b>46</b> (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) showed subnanomolar potency against AChE and single-digit micromolar inhibition against BACE-1, further highlighting the complexity of balancing the biological profiles of multitarget inhibitors.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><div class="NLM_p">In the same year, Costanzo et al. published a promising study involving a series of donepezil derivatives as dual AChE/BACE-1 inhibitors. In addition to reporting a sustainable multistep protocol for synthesizing a set of donepezil derivatives, the authors tested the new molecules for selectivity against AChE (versus BuChE). Given donepezil’s mild activity against BACE-1, they also tested these molecules for BACE-1 inhibition. Compound <b>47</b> (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) was slightly less potent than the parent compound against AChE (<i>K</i><sub>i</sub> = 29 nM versus 10 nM of donepezil), with a promising inhibiting profile against BACE-1 (less than 20% of residual enzymatic activity at 1 μM concentration). This compound could indeed be a promising candidate for developing AChE/BACE-1 multitarget inhibitors to treat AD.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><div class="NLM_p">In 2009, Zhu et al. used a slightly different strategy to rationally design a series of BACE-1/AChE inhibitors. In particular, they rationally combined moieties responsible for AChE inhibition with those able to modulate BACE-1. This led to three series of derivatives with a dual-target mechanism of action.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Reviewing all the data published by the authors, it is interesting to note that most of the compounds showed single-target activity and that slight chemical modifications allowed them to switch from pure AChE inhibitors to pure BACE-1 inhibitors, with a few genuine dual-target compounds. Fine-tuning the single-target and dual-target activities can deepen our understanding of the SARs for each compound class. This should allow a more rational and accurate engineering of next-generation BACE-1/AChE dual-target inhibitors.</div><div class="NLM_p">For the final examples of dual BACE-1/AChE inhibitors, we mention two studies where the authors obtained compounds with rather complex mechanisms of action. These molecules modulated BACE-1, AChE, and additional targets. In 2009, Camps et al. designed and discovered a series of quinoline–chlorotacrine hybrids with a rather complex biological profile. These molecules inhibited AChE by binding at the enzyme’s internal and peripheral anionic sites.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> As such, these hybrid compounds also counteracted the AChE-induced Aβ aggregation. Surprisingly, they also inhibited BACE-1. In particular, compound <b>48</b> (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) was about 14 nM against AChE and also blocked almost 80% of BACE-1 activity at 2.5 μM concentration, pointing to an IC<sub>50</sub> in the submicromolar range. In addition, <b>48</b> inhibited both AChE-induced and spontaneous Aβ aggregation in the high micromolar range. Overall, its complex biological profile suggested <b>48</b> as a promising MTDL, acting at different key points in complementary neurodegenerative cascades of AD. Additionally, this compound crossed the BBB, despite its large size and rather high MW.</div><div class="NLM_p">In 2011, Huang et al. designed and discovered a series of quinoxaline derivatives, which also showed a complex multitarget biological profile.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> These compounds showed BACE-1 inhibition and/or AChE inhibition. Some were also histamine H<sub>3</sub> receptor antagonists. The cholinergic hypothesis provides the rationale for this additional biological activity. Blocking this presynaptic receptor can increase ACh levels in the synaptic cleft via a different mechanism than classical AChE inhibition. The activated presynaptic histamine H<sub>3</sub> receptor decreases the release of ACh from cholinergic neurons. Antagonists of this receptor can thus increase ACh levels, likely producing a synergistic effect for treating AD. Of the 17 quinoxaline analogues in the series, most showed activity against one or two targets. Only one compound (<b>49</b> in <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) modulated (i.e., inhibited and antagonized) all three selected targets. Similarly, Viayna et al. recently reported a new series of rhein–huprine hybrids with a rather complex pharmacological profile, being AChE/BACE-1 dual inhibitors and dual antiaggregating compounds for Aβ42 and tau.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><div class="NLM_p">This further highlights the complexity of discovering, optimizing, and developing MTDLs. Pragmatically speaking, we envisage that a well-designed MTDL drug discovery program will involve the rational and accurate selection of two targets, whose modulation provides a true synergistic effect against a given disease. This effect can be pharmacologically demonstrated at an early stage by using selective binders of the two selected targets. Then, the chemical design step should be conducted very carefully to allow modifications on the identified scaffold(s) that are not detrimental for either target. SB approaches could be remarkably helpful in these very early steps. A clear understanding of the SARs could help in rationally selecting modifications to achieve balanced MTDL lead candidates. There should be sufficient room (in terms of chemical tractability, size, and MW) for lead optimization so that pharmacokinetics and toxicology profiles can be carefully considered and chemical modifications made to improve the profile of the new compounds without losing affinity for either target. FB drug discovery would be particularly appropriate here. This is because fragments can intrinsically be endowed with a polypharmacological mechanism of action and because there is more room for chemical modifications on fragments than on larger leadlike compounds.</div><div class="NLM_p last">A comment is here required on the possible clinical utility of dual AChE/BACE-1 inhibitors in AD. Actually, the lack of efficacy of <b>1</b> in mild-to-moderate AD suggests that it is too late in the disease process for BACE-1 inhibition to be effective. Conversely, this patient cohort could be symptomatically treated with AChE inhibitors, despite the well-known moderate efficacy of these inhibitors in the clinical practice. Indeed, the two targets can play a role in two well-separated phases of the disease progression. We may therefore be confronted with a scenario where a dual AChE/BACE-1 could lead to a rather superfluous anticholinesterase activity in prodromal AD patients and to a clinically useless inhibition of BACE-1 in mild-to-moderate AD patients. The two drugs could conversely be used separately in different phases of the disease, with clear different mechanisms of action tackling different pathological pathways in the AD progression. The most recent clinical trials have greatly helped in better detangling the role of different pathways and molecular mechanisms in the disease progression and therapeutic treatments.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.2 Dual BACE-1/GSK-3β Inhibitors</h3><div class="NLM_p">While BACE-1 is one of the key enzymes within the amyloid cascade, GSK-3β is one of the kinases responsible for phosphorylation of the tau protein, which then detaches from microtubules to form neurofibrillary tangles. This is AD’s second key histopathological hallmark. Indeed, one strategy for treating AD could be inhibiting both enzymes, possibly producing a downstream synergistic effect. With this in mind, we recently discovered and developed a class of fragments bearing a triazinone skeleton as dual BACE-1/GSK-3β inhibitors.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94, 95)</a> In detail, exploiting a ligand-based approach, we combined the pharmacophoric functions responsible for binding to the enzymes. These were (i) the cyclic amide group that binds to kinases and (ii) the guanidine moiety that, when positively charged, binds to the aspartic dyad of BACE-1. Merging these functional groups led to a series of triazinone derivatives with a balanced micromolar affinity for the two targets. Most of the new derivatives had a very low MW. This prompted us to assess the pharmacokinetic profile of one selected compound. Compound <b>50</b> (<a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>) showed good bioavailability (66%) upon oral administration in mice, and good BBB penetration. Indeed, at the very low dose of 3 mg/kg, <b>50</b> showed a brain concentration of 0.62 μM after 30 min. Although below the in vivo target engagement levels, this represents an attractive starting point toward a promising lead optimization campaign. Interestingly, cellular data showed that this multitarget compound class also had antineuroinflammatory and neurogenic effects. This may have been due to GSK-3β modulation or the simultaneous inhibition of both targets. Subsequent in vivo data will ultimately demonstrate whether the molecule’s profile makes it suitable for progression through the drug discovery and development pipelines.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Dual BACE-1/GSK-3β triazinone inhibitor <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Taking a different approach to dual BACE-1/GSK-3β inhibitors, Di Martino et al. developed MTDLs by exploiting the versatility of the natural compound curcumin.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Using a SB approach to modify this privileged molecule, suitable moieties were mounted onto the curcumin framework to confer the new molecules with the ability to bind to both enzymes. The series of curcumin derivatives was fairly potent against BACE-1 and GSK-3β, but for most derivatives, the two actions were not properly balanced. For example, <b>51</b> (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>) showed nanomolar inhibition of BACE-1 but single-digit micromolar inhibition of GSK-3β.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Dual BACE-1/GSK-3β curcumin inhibitor <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, some of these compounds induced the NAD(P)H:quinone oxidoreductase 1 (NQO1). This enzyme is responsible for the endogenous conversion of quinones to hydroquinones. By counteracting the oxidative stress that is a common feature of AD, this could translate to a potential neuroprotective effect. Indeed, a recent longitudinal study demonstrated that air pollution from traffic could be an important risk factor for vascular dementia and AD.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Exposure to air pollution can lead to chronic oxidative stress, which is a risk factor in the pathogenesis of AD.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> NQO1 could thus be an intrinsic detoxifying and antioxidant weapon for tackling oxidative stress. Molecules that can induce this enzyme are potential antioxidant drug candidates for AD treatment. This intriguing mechanism was originally reported by some of us in 2007, when investigating the polypharmacological profile of memoquin.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> In particular, we demonstrated that the antioxidant effect of this quinone-bearing compound was due to the hydroquinone species, which could be obtained through the enzymatic activity of NQO1 in vivo. This concept was confirmed and extended in a subsequent study of memoquin in vivo. We showed that sulforaphane, a potent natural inducer of NQO1, significantly increased the antioxidant and neuroprotective effects of memoquin and other quinone-bearing compounds.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> According to the “mitochondrial dysfunction hypothesis” in AD, exploiting this detoxifying and antioxidant mechanism could be one innovative strategy for tackling AD’s pathophysiology. The curcumin-based derivatives developed by Di Martino et al. were therefore endowed with a rather complex polypharmacological profile because of their dual inhibition of BACE-1 and GSK-3β and their positive antioxidant effect as inducers of the NQO1 enzyme. It should however here be mentioned that curcumin, as well as other natural compounds, could be endowed with a highly promiscuous profile,<a onclick="showRef(event, 'ref97 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref97 ref113 ref114">(97, 113, 114)</a> and therefore further experimental evidence should be collected to clearly demonstrate that such compounds specifically modulate the intended targets rather than showing a PAINS-like profile.</div><div class="NLM_p last">In conclusion, the papers by Prati et al. and Di Martino et al. point the way to a systematic development of dual BACE-1/GSK-3β inhibitors. These two key enzymes are involved in AD’s two major pathological cascades (amyloid and tau) of AD. The resulting dual inhibitors may be endowed with pharmacological profiles that are superior to those of classic single-target molecules.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">5 Conclusions and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While submitting this paper, we learned about compound <b>1</b>’s lack of efficacy in mild-to-moderate AD.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Thus, we are again faced with profound questions concerning the amyloid hypothesis along with the timing of BACE-1 inhibition, which remains one of the critical points for properly developing novel drug candidates based on this hypothesis. We are forced to ask ourselves the following: Should we continue to develop BACE-1 inhibitors? Will it be worth the time, effort, and cost? How large is the impact of the proper patient stratification and the clinical trial design? It barely seems logical to persist in developing molecules that inevitably fail. Indeed, these questions will probably find answers in the still ongoing phase 3 clinical development of <b>1</b> in prodromal AD.</div><div class="NLM_p">At this point, there is obvious appeal in the view that AD scientists in academia and industry should learn from failures, both their own and those of others. Thus, a more appropriate question may be the following: What have we, as a community, learned in the past 20 years of discovering and optimizing BACE-1 inhibitors?</div><div class="NLM_p">First, nowadays we know how to merge the structural requirements for potency and protease selectivity with the strict need for BBB permeation, oral bioavailability, low metabolic clearance, and tolerable toxicity.</div><div class="NLM_p">Second, we have corroborated the power of FB approaches in CNS drug discovery: the case of <b>1</b> nicely exemplifies how an NMR screen can provide a weak fragment-hit that can be further optimized into a nanomolar protease inhibitor. Other examples have since followed.<a onclick="showRef(event, 'ref10 ref11 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref94 ref95">(10, 11, 94, 95)</a></div><div class="NLM_p">Third, we have successfully incorporated the concepts of personalized medicine into drug discovery and clinical trials. In the future, this could streamline the drug development process and enable targeted therapies (once developed) to be delivered appropriately. In this respect, we expect very interesting data to be produced by testing BACE-1 inhibitors in early onset familial AD patients. Indeed, they may be the ideal stratified patient population who will benefit most from a “pure” anti-amyloid therapy. From this rational stratification, we could then perhaps better understand whether BACE-1 inhibitors could be useful for nonfamilial AD patients.</div><div class="NLM_p last">Fourth, we have been reminded again of something that we already knew:<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> the unfathomable complexity of AD. Perhaps, the amyloid hypothesis is not sufficient to explain this intricate multifactorial pathogenesis of AD. A feasible solution may thus be afforded by a well-designed MTDL that can synergistically inhibit BACE-1 and modulate a second interrelated AD target. The examples discussed herein point to the power of this approach and highlight the still-undiscovered potential and the complexity of such molecules in AD drug discovery and development.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00393" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Cavalli</span> - <span class="hlFld-Affiliation affiliation">CompuNet, Istituto
Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6370-1176" title="Orcid link">http://orcid.org/0000-0002-6370-1176</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2f4e414b5d4a4e014c4e594e4343466f46465b01465b"><span class="__cf_email__" data-cfemail="6607080214030748050710070a0a0f260f0f12480f12">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Prati</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Unit,
Division of Biological Chemistry and Drug Discovery, College of Life
Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, Scotland, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Bottegoni</span> - <span class="hlFld-Affiliation affiliation">CompuNet, Istituto
Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Heptares Therapeutics Ltd., BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1251-583X" title="Orcid link">http://orcid.org/0000-0003-1251-583X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Laura Bolognesi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written with contributions from all authors. All authors have approved the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Federica Prati</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=BIO-d7e1743-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Federica Prati</b> received her Master’s degree in Chemistry and Pharmaceutical Technologies from the University of Bologna in 2010. In 2013, she was a Visiting Scholar at the University of Dundee Drug Discovery Unit (DDU), and in 2014 she was awarded the Ph.D. in Drug Discovery from the University of Genova, in collaboration with the Istituto Italiano di Tecnologia (Genova). She is presently working as Open Lab-Marie Curie fellow at the Tres Cantos medicines development campus in GlaxoSmithKline, in close partnership with the DDU of Dundee. Her research interests focus on medicinal chemistry and drug discovery. Particularly, she contributed to the development of small active molecules, through fragment-based and multitarget approaches, against cancer, tuberculosis, neurodegenerative, and neglected tropical diseases.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Giovanni Bottegoni</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=BIO-d7e1748-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Giovanni Bottegoni</b> is a scientist and an entrepreneur. He holds a Ph.D. in Pharmaceutical Sciences (University of Bologna, Italy, 2006) and a Master in healthcare management (SDA Bocconi, Italy, 2014). For 2 years, he was postdoc at The Scripps Research Institute in La Jolla, California (U.S.), and then he joined the Istituto Italiano di Tecnologia (Genova, Italy). In 2014, he cofounded BiKi Technologies and, for 2 years, was CEO of the company. He currently works as a senior scientist for Heptares Therapeutics (Welwyn Garden City, U.K.). He is the author of over 50 publications and co-inventor of several patents. In 2015, he was awarded the DCF prize for medicinal chemistry by the Medicinal Chemistry Division of the Italian Chemical Society.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Maria Laura Bolognesi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=BIO-d7e1753-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Maria Laura Bolognesi</b> is Professor of Medicinal Chemistry and Director of the Chemistry and Pharmaceutical Technologies degree program at the University of Bologna. Her research spans the design, synthesis, and pharmacological investigation of small molecules in the neurodegenerative and neglected tropical disease therapeutic areas. She has a track record of more than 140 publications in high-ranked scientific journals, including patents and patent applications, and more than 50 invited talks worldwide. She was awarded a Distinguished Visiting Professor Fellowship at the Complutense University of Madrid in 2009 and a PVE Fellowship at the University of Brasilia in 2014. She is also an Associate Editor of <i>Journal of Medicinal Chemistry</i>.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Andrea Cavalli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=BIO-d7e1761-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Andrea Cavalli</b> is Professor of Medicinal Chemistry at the University of Bologna and Research Director at the Istituto Italiano di Tecnologia, where he is also Deputy Director for Computation and Data Science. His research interests are in the field of computational drug discovery. In particular, he has developed and applied computational approaches to accelerate the discovery of druglike compounds in several therapeutic areas, including cancer, neurodegenerative diseases, and neglected tropical diseases. Prof. Cavalli is the author of more than 200 publications in high-ranked journals, is inventor of several PCT international patents, and has delivered numerous invited lectures and seminars. In 2003, he was awarded the “Farmindustria Prize for Pharmaceutical Research”. He is cofounder of the high-tech startup company BiKi Technologies.</p></figure></div><div class="ack" id="ACK-d7e1766-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the University of Bologna and the Italian Institute of Technology for financial support. We thank Grace Fox for copyediting and proofreading.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> Abbreviations Used</h2><tr><td class="NLM_term">CatD</td><td class="NLM_def"><p class="first last">cathepsin D</p></td></tr><tr><td class="NLM_term">CpHMD</td><td class="NLM_def"><p class="first last">constant pH molecular dynamics</p></td></tr><tr><td class="NLM_term">FB</td><td class="NLM_def"><p class="first last">fragment-based</p></td></tr><tr><td class="NLM_term">FEP</td><td class="NLM_def"><p class="first last">free-energy perturbation</p></td></tr><tr><td class="NLM_term">GSK-3β</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3β</p></td></tr><tr><td class="NLM_term">MMC</td><td class="NLM_def"><p class="first last">Metropolis Monte Carlo</p></td></tr><tr><td class="NLM_term">MTDL</td><td class="NLM_def"><p class="first last">multitarget-directed ligand</p></td></tr><tr><td class="NLM_term">NQO1</td><td class="NLM_def"><p class="first last">NAD(P)H:quinone oxidoreductase 1</p></td></tr><tr><td class="NLM_term">pH-REMD</td><td class="NLM_def"><p class="first last">pH replica exchange molecular dynamics</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">QM</td><td class="NLM_def"><p class="first last">quantum mechanical</p></td></tr><tr><td class="NLM_term">SB</td><td class="NLM_def"><p class="first last">structure-based</p></td></tr><tr><td class="NLM_term">7-THP</td><td class="NLM_def"><p class="first last">7-tetrahydropyran</p></td></tr><tr><td class="NLM_term">8-THP</td><td class="NLM_def"><p class="first last">8-tetrahydropyran</p></td></tr><tr><td class="NLM_term">WH</td><td class="NLM_def"><p class="first last">warhead</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 115 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lj7owtzBV9eng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Morris, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vissel, B.</span><span> </span><span class="NLM_article-title">Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">Acta Neuropathol. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="refDoi"> DOI: 10.1186/PREACCEPT-1342777270140958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1186%2FPREACCEPT-1342777270140958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=25231068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A280%3ADC%252BC2M7it1Cgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=135&author=G.+P.+Morrisauthor=I.+A.+Clarkauthor=B.+Vissel&title=Inconsistencies+and+controversies+surrounding+the+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2FPREACCEPT-1342777270140958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Morris Gary P; Clark Ian A; Vissel Bryce</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The amyloid hypothesis has driven drug development strategies for Alzheimer's disease for over 20 years.  We review why accumulation of amyloid-beta (Aβ) oligomers is generally considered causal for synaptic loss and neurodegeneration in AD.  We elaborate on and update arguments for and against the amyloid hypothesis with new data and interpretations, and consider why the amyloid hypothesis may be failing therapeutically.  We note several unresolved issues in the field including the presence of Aβ deposition in cognitively normal individuals, the weak correlation between plaque load and cognition, questions regarding the biochemical nature, presence and role of Aβ oligomeric assemblies in vivo, the bias of pre-clinical AD models toward the amyloid hypothesis and the poorly explained pathological heterogeneity and comorbidities associated with AD.  We also illustrate how extensive data cited in support of the amyloid hypothesis, including genetic links to disease, can be interpreted independently of a role for Aβ in AD.  We conclude it is essential to expand our view of pathogenesis beyond Aβ and tau pathology and suggest several future directions for AD research, which we argue will be critical to understanding AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR74FIGjSHtAvx2phytoz6_fW6udTcc2ea2SW_fEwdKTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7it1Cgtw%253D%253D&md5=5588d9e21d74eda10e7978d7f6856357</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2FPREACCEPT-1342777270140958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252FPREACCEPT-1342777270140958%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BP.%26aulast%3DClark%26aufirst%3DI.%2BA.%26aulast%3DVissel%26aufirst%3DB.%26atitle%3DInconsistencies%2520and%2520controversies%2520surrounding%2520the%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%2520Commun.%26date%3D2014%26volume%3D2%26spage%3D135%26doi%3D10.1186%2FPREACCEPT-1342777270140958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Herrup, K.</span><span> </span><span class="NLM_article-title">The case for rejecting the amyloid cascade hypothesis</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">794</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span><span class="refDoi"> DOI: 10.1038/nn.4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1038%2Fnn.4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=26007212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=794-799&author=K.+Herrup&title=The+case+for+rejecting+the+amyloid+cascade+hypothesis&doi=10.1038%2Fnn.4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The case for rejecting the amyloid cascade hypothesis</span></div><div class="casAuthors">Herrup, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">794-799</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a biol. complex neurodegenerative dementia.  Nearly 20 years ago, with the combination of observations from biochem., neuropathol. and genetics, a compelling hypothesis known as the amyloid cascade hypothesis was formulated.  The core of this hypothesis is that it is pathol. accumulations of amyloid-β, a peptide fragment of a membrane protein called amyloid precursor protein, that act as the root cause of AD and initiate its pathogenesis.  Yet, with the passage of time, growing amts. of data have accumulated that are inconsistent with the basically linear structure of this hypothesis.  And while there is fear in the field over the consequences of rejecting it outright, clinging to an inaccurate disease model is the option we should fear most.  This Perspective explores the proposition that we are over-reliant on amyloid to define and diagnose AD and that the time has come to face our fears and reject the amyloid cascade hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIDjilDJZlrVg90H21EOLACvtfcHk0lj7owtzBV9eng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7bN&md5=e7513943fd2fa3fe7c6d9e1cb3f859b2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnn.4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4017%26sid%3Dliteratum%253Aachs%26aulast%3DHerrup%26aufirst%3DK.%26atitle%3DThe%2520case%2520for%2520rejecting%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D794%26epage%3D799%26doi%3D10.1038%2Fnn.4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kepp, K. P.</span><span> </span><span class="NLM_article-title">Ten challenges of the amyloid hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span><span class="refDoi"> DOI: 10.3233/JAD-160550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.3233%2FJAD-160550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=27662304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A280%3ADC%252BC2svjt1OnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2017&pages=447-457&author=K.+P.+Kepp&title=Ten+challenges+of+the+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-160550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease</span></div><div class="casAuthors">Kepp Kasper Planeta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">447-457</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The inability to effectively halt or cure Alzheimer's disease (AD), exacerbated by the recent failures of high-profile clinical trials, emphasizes the urgent need to understand the complex biochemistry of this major neurodegenerative disease.  In this paper, ten central, current challenges of the major paradigm in the field, the amyloid hypothesis, are sharply formulated.  These challenges together show that new approaches are necessary that address data heterogeneity, increase focus on the proteome level, use available human patient data more actively, account for the aging phenotype as a background model of the disease, unify our understanding of the interplay between genetic and non-genetic risk factors, and combine into one framework both the familial and sporadic forms of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAInuhTpciTLqxQ2mb9Pu8fW6udTcc2eb3S50UDw_p87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svjt1OnsQ%253D%253D&md5=4fd6780f6a2b98c2d278001667c3a1dd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3233%2FJAD-160550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-160550%26sid%3Dliteratum%253Aachs%26aulast%3DKepp%26aufirst%3DK.%2BP.%26atitle%3DTen%2520challenges%2520of%2520the%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2017%26volume%3D55%26spage%3D447%26epage%3D457%26doi%3D10.3233%2FJAD-160550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lemere, C. A.</span><span> </span><span class="NLM_article-title">Immunotherapy for Alzheimer’s disease: hoops and hurdles</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="refDoi"> DOI: 10.1186/1750-1326-8-36</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1186%2F1750-1326-8-36" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=24148220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVyhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=36&author=C.+A.+Lemere&title=Immunotherapy+for+Alzheimer%E2%80%99s+disease%3A+hoops+and+hurdles&doi=10.1186%2F1750-1326-8-36"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy for Alzheimer's disease: hoops and hurdles</span></div><div class="casAuthors">Lemere, Cynthia A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36/1-36/6, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia, afflicting more than 30 million people worldwide.  Currently, there is no cure or way to prevent this devastating disease.  Extracellular plaques, contg. various forms of amyloid-β protein (Aβ), and intracellular neurofibrillary tangles (NFTs), composed of hyper-phosphorylated tau protein, are two major pathol. hallmarks of the AD brain.  Aggregation, deposition and N-terminal modification of Aβ protein and tau phosphorylation and aggregation are thought to precede the onset of cognitive decline, which is better correlated with tangle formation and neuron loss.  Active and passive vaccines against various forms of Aβ have shown promise in pre-clin. animal models.  However, translating these results safely and effectively into humans has been challenging.  Recent clin. trials showed little or no cognitive efficacy, possibly due to the fact that the aforementioned neurodegenerative processes most likely pre-existed in the patients well before the start of immunotherapy.  Efforts are now underway to treat individuals at risk for AD prior to or in the earliest stages of cognitive decline with the hope of preventing or delaying the onset of the disease.  In addn., efforts to immunize against tau and other AD-related targets are underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD87mWhmrsprVg90H21EOLACvtfcHk0lh5yfavy-5vMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVyhs7s%253D&md5=9004fbde56ff73a61c29c1032ef75acd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-8-36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-8-36%26sid%3Dliteratum%253Aachs%26aulast%3DLemere%26aufirst%3DC.%2BA.%26atitle%3DImmunotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520hoops%2520and%2520hurdles%26jtitle%3DMol.%2520Neurodegener.%26date%3D2013%26volume%3D8%26spage%3D36%26doi%3D10.1186%2F1750-1326-8-36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1002/ana.24188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fana.24188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=24853080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=185-205&author=E.+Karranauthor=J.+Hardy&title=A+critique+of+the+drug+discovery+and+phase+3+clinical+programs+targeting+the+amyloid+hypothesis+for+Alzheimer+disease&doi=10.1002%2Fana.24188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span></div><div class="casAuthors">Karran, Eric; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-205</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Review of a critique of the drug discovery and phase 3 clin. programs targeting the amyloid hypothesis for Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQE-UU2jSXbVg90H21EOLACvtfcHk0lh5yfavy-5vMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K&md5=64287890331df95f3e2594ef711cdc27</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fana.24188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24188%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DA%2520critique%2520of%2520the%2520drug%2520discovery%2520and%2520phase%25203%2520clinical%2520programs%2520targeting%2520the%2520amyloid%2520hypothesis%2520for%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D76%26spage%3D185%26epage%3D205%26doi%3D10.1002%2Fana.24188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><a href="http://www.alzforum.org/therapeutics/jnj-54861911" class="extLink">http://www.alzforum.org/therapeutics/jnj-54861911</a> (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fjnj-54861911+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><a href="http://www.alzforum.org/therapeutics/cnp520" class="extLink">http://www.alzforum.org/therapeutics/cnp520</a>. (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fcnp520.+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><a href="http://www.alzforum.org/therapeutics/ly3202626-0" class="extLink">http://www.alzforum.org/therapeutics/ly3202626-0</a> (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fly3202626-0+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockendorf, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleijn, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palcza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M. S.</span><span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer’s disease patients</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">363ra150</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&author=M.+E.+Kennedyauthor=A.+W.+Stamfordauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+F.+Dockendorfauthor=M.+Eganauthor=L.+Ereshefskyauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=S.+Jheeauthor=H.+J.+Kleijnauthor=R.+Kuvelkarauthor=W.+Liauthor=B.+A.+Mattsonauthor=H.+Meiauthor=J.+Palczaauthor=J.+D.+Scottauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=J.+A.+Stoneauthor=E.+M.+Parkerauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+beta-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520beta-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunskill, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossiter, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-Abeta-site smyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10435</span><span class="NLM_x">–</span> <span class="NLM_lpage">10450</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-Abeta-site+smyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-Abeta-site%2520smyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Nie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M. Y.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of amyloid beta peptide aggregation as a potential therapeutic strategy for Alzheimer’s disease</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1038/aps.2011.14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1038%2Faps.2011.14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=21499284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=545-551&author=Q.+Nieauthor=X.+G.+Duauthor=M.+Y.+Geng&title=Small+molecule+inhibitors+of+amyloid+beta+peptide+aggregation+as+a+potential+therapeutic+strategy+for+Alzheimer%E2%80%99s+disease&doi=10.1038%2Faps.2011.14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease</span></div><div class="casAuthors">Nie, Qin; Du, Xiao-guang; Geng, Mei-yu</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-551</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyloid β (Aβ) peptides have long been viewed as a potential target for Alzheimer's disease (AD).  Aggregation of Aβ peptides in the brain tissue is believed to be an exclusively pathol. process.  Therefore, blocking the initial stages of Aβ peptide aggregation with small mols. could hold considerable promise as the starting point for the development of new therapies for AD.  Recent rapid progresses in our understanding of toxic amyloid assembly provide a fresh impetus for this interesting approach.  Here, we discuss the problems, challenges and new concepts in targeting Aβ peptides.  Acta Pharmacologica Sinica (2011) 32: 545-551; doi: 10.1038/aps.2011.14; published online 18 Apr 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrROzsHwdwhHbVg90H21EOLACvtfcHk0ljBUS7HtBQObg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtb4%253D&md5=243954abf169e75b7ed55f3096afb34b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.14%26sid%3Dliteratum%253Aachs%26aulast%3DNie%26aufirst%3DQ.%26aulast%3DDu%26aufirst%3DX.%2BG.%26aulast%3DGeng%26aufirst%3DM.%2BY.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520amyloid%2520beta%2520peptide%2520aggregation%2520as%2520a%2520potential%2520therapeutic%2520strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2011%26volume%3D32%26spage%3D545%26epage%3D551%26doi%3D10.1038%2Faps.2011.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenerton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, P.</span><span> </span><span class="NLM_article-title">Development of protease inhibitors for protozoan infections</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span><span class="refDoi"> DOI: 10.1097/QCO.0b013e328315cca9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1097%2FQCO.0b013e328315cca9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=18978536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWltbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=668-672&author=J.+H.+McKerrowauthor=P.+J.+Rosenthalauthor=R.+Swenertonauthor=P.+Doyle&title=Development+of+protease+inhibitors+for+protozoan+infections&doi=10.1097%2FQCO.0b013e328315cca9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development of protease inhibitors for protozoan infections</span></div><div class="casAuthors">McKerrow, James H.; Rosenthal, Philip J.; Swenerton, Ryan; Doyle, Patricia</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">668-672</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: To highlight the promise of parasite proteases as targets for development of new antiparasitic chemotherapy.  Proteolytic enzymes play key roles in the life cycle of protozoan parasites or the pathogenesis of diseases they produce.  These roles include processing of host or parasite surface proteins for invasion of host cells, digestion of host proteins for nutrition, and inactivation of host immune defense mediators.  Recent findings: Drug development for other markets has shown that proteases are druggable targets, and protease inhibitors are now licensed or in clin. development to treat hypertension, diabetes, thrombosis, osteoporosis, infectious diseases, and cancer.  Several protease targets have been validated by genetic or chem. knockout in protozoan parasites.  Many other parasite proteases appear promising as targets, but require more work for validation, or to identify viable drug leads.  Because homologous proteases function as key enzymes in several parasites, targeting these proteases may allow development of a single compd., or a set of similar compds., that target multiple diseases including malaria, trypanosomiasis, leishmaniasis, toxoplasmosis, cryptosporidiosis, and amebiasis.  Summary: Proteases have been validated as targets in a no. of parasitic infections.  Proteases are druggable targets as evidenced by effective antiprotease drugs for the treatment of many human diseases including hypertension and AIDS.  Future drug development targeting parasite proteases will be aided by the strong foundation of biochem., structural, and computational databases already published or available online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJj2JMKZMoibVg90H21EOLACvtfcHk0ljBUS7HtBQObg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWltbzO&md5=a285ec4c4c5d12e5665db5ee280259c2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e328315cca9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e328315cca9%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DSwenerton%26aufirst%3DR.%26aulast%3DDoyle%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520protease%2520inhibitors%2520for%2520protozoan%2520infections%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D21%26spage%3D668%26epage%3D672%26doi%3D10.1097%2FQCO.0b013e328315cca9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1126/science.290.5489.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1126%2Fscience.290.5489.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=11021803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Chtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=150-153&author=L.+Hongauthor=G.+Koelschauthor=X.+Linauthor=S.+Wuauthor=S.+Terzyanauthor=A.+K.+Ghoshauthor=X.+C.+Zhangauthor=J.+Tang&title=Structure+of+the+protease+domain+of+memapsin+2+%28beta-secretase%29+complexed+with+inhibitor&doi=10.1126%2Fscience.290.5489.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor</span></div><div class="casAuthors">Hong, Lin; Koelsch, Gerald; Lin, Xinli; Wu, Shili; Terzyan, Simon; Ghosh, Arun K.; Zhang, Xuenjun C.; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">5489</span>),
    <span class="NLM_cas:pages">150-153</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Memapsin 2 (β-secretase) is a membrane-assocd. aspartic protease involved in the prodn. of β-amyloid peptide in Alzheimer's disease and is a major target for drug design.  We detd. the crystal structure of the protease domain of human memapsin 2 complexed to an eight-residue inhibitor at 1.9 angstrom resoln.  The active site of memapsin 2 is more open and less hydrophobic than that of other human aspartic proteases.  The subsite locations from S4 to S2' are well defined.  A kink of the inhibitor chain at P2' and the change of chain direction of P3' and P4' may be mimicked to provide inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtz4LHUXVGBrVg90H21EOLACvtfcHk0limtLLw-k-1ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Chtrs%253D&md5=c5d15af5ae58e6c3f46da1b22f7d4df9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.290.5489.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.290.5489.150%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520protease%2520domain%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520complexed%2520with%2520inhibitor%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D150%26epage%3D153%26doi%3D10.1126%2Fscience.290.5489.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Developing beta-secretase inhibitors for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07476.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1111%2Fj.1471-4159.2011.07476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22122681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=71-83&issue=Suppl.+1&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=J.+Tang&title=Developing+beta-secretase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2011.07476.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Developing β-secretase inhibitors for treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Secretase (memapsin 2; BACE-1) is the first protease in the processing of amyloid precursor protein leading to the prodn. of amyloid-β (Aβ) in the brain.  It is believed that high levels of brain Aβ are responsible for the pathogenesis of Alzheimer's disease (AD).  Therefore, β-secretase is a major therapeutic target for the development of inhibitor drugs.  During the past decade, steady progress has been made in the evolution of β-secretase inhibitors toward better drug properties.  Recent inhibitors are potent, selective and have been shown to penetrate the blood-brain barrier to inhibit Aβ levels in the brains of exptl. animals.  Moreover, continuous administration of a β-secretase inhibitor was shown to rescue age-related cognitive decline in transgenic AD mice.  A small no. of β-secretase inhibitors have also entered early phase clin. trials.  These developments offer some optimism for the clin. development of a disease-modifying drug for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvY0fxn2hBubVg90H21EOLACvtfcHk0limtLLw-k-1ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D&md5=186d6ccadd1c207ecd7aaa9cb7584684</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07476.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DDeveloping%2520beta-secretase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl.%25201%26spage%3D71%26epage%3D83%26doi%3D10.1111%2Fj.1471-4159.2011.07476.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osswald, H. L.</span><span> </span><span class="NLM_article-title">BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6765</span><span class="NLM_x">–</span> <span class="NLM_lpage">6813</span><span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28beta-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0lihThwI6BYjvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528beta-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Structure-based design of beta-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4156</span><span class="NLM_x">–</span> <span class="NLM_lpage">4180</span><span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+beta-site+APP+cleaving+enzyme+1+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yuan, Jing; Venkatraman, Shankar; Zheng, Yajun; McKeever, Brian M.; Dillard, Lawrence W.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4156-4180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis asserts that excess prodn. or reduced clearance of the amyloid-β (Aβ) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease dementia.  The Aβ hypothesis has identified BACE1 as a therapeutic target to treat Alzheimer's and led to medicinal chem. efforts to design its inhibitors both in the pharmaceutical industry and in academia.  This review summarizes two distinct categories of inhibitors designed based on conformational states of "closed" and "open" forms of the enzyme.  In each category the inhibitors are classified based on the core catalytic interaction group or the aspartyl binding motif (ABM).  This review covers the description of inhibitors in each ABM class with X-ray crystal structures of key compds., their binding modes, related structure-activity data highlighting potency advances, and addnl. properties such as selectivity profile, P-gp efflux, pharmacokinetic, and pharmacodynamic data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLs7KN_eIzbVg90H21EOLACvtfcHk0lihThwI6BYjvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D&md5=b703f57572b737b47658d86f5b730087</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520beta-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">The structural evolution of beta-secretase inhibitors: a focus on the development of small-molecule inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1787</span><span class="NLM_x">–</span> <span class="NLM_lpage">1807</span><span class="refDoi"> DOI: 10.2174/15680266113139990137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.2174%2F15680266113139990137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=23931442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1787-1807&author=S.+Butiniauthor=S.+Brogiauthor=E.+Novellinoauthor=G.+Campianiauthor=A.+K.+Ghoshauthor=M.+Brindisiauthor=S.+Gemma&title=The+structural+evolution+of+beta-secretase+inhibitors%3A+a+focus+on+the+development+of+small-molecule+inhibitors&doi=10.2174%2F15680266113139990137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Structural Evolution of β-Secretase Inhibitors: A Focus on the Development of Small-Molecule Inhibitors</span></div><div class="casAuthors">Butini, Stefania; Brogi, Simone; Novellino, Ettore; Campiani, Giuseppe; Ghosh, Arun K.; Brindisi, Margherita; Gemma, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1787-1807</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Effective treatment of Alzheimer's disease (AD) remains a crit. unmet need in medicine.  The lack of useful treatment for AD led to an intense search for novel therapies based on the amyloid hypothesis, which states that amyloid β-42 (Aβ 42) plays an early and crucial role in all cases of AD. β-Secretase (also known as BACE-1 β-site APP-cleaving enzyme, Asp-2 or memapsin-2) is an aspartyl protease representing the rate limiting step in the generation of Aβ peptide fragments, therefore it could represent an important target in the steady hunt for a disease-modifying treatment.  Generally, β-secretase inhibitors are grouped into two families: peptidomimetic and nonpeptidomimetic inhibitors.  However, irresp. of the class, serious challenges with respect to blood-brain barrier (BBB) penetration and selectivity still remain.  Discovering a small mol. inhibitor of β-secretase represents an unnerving challenge but, due to its significant potential as a therapeutic target, growing efforts in this task are evident from both academic and industrial labs.  In this frame, the rising availability of crystal structures of β-secretase-inhibitor complexes represents an invaluable opportunity for optimization.  Nevertheless, beyond the inhibitory activity, the major issue of the current research approaches is about problems assocd. with BBB penetration and pharmacokinetic properties.  This review follows the structural evolution of the early β-secretase inhibitors and gives a snap-shot of the hottest chem. templates in the literature of the last five years, showing research progress in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9SkCa5mjCv7Vg90H21EOLACvtfcHk0lgwxd5RRPCzuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsLrI&md5=05e8126a28f1d7560530a0a67304864f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990137%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DThe%2520structural%2520evolution%2520of%2520beta-secretase%2520inhibitors%253A%2520a%2520focus%2520on%2520the%2520development%2520of%2520small-molecule%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1787%26epage%3D1807%26doi%3D10.2174%2F15680266113139990137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau in Alzheimer’s disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span><span class="refDoi"> DOI: 10.1016/S0962-8924(98)01368-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2FS0962-8924%2898%2901368-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=9854307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADyaK1MXmsV2i" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=425-427&author=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Tau+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0962-8924%2898%2901368-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Tau in Alzheimer's disease</span></div><div class="casAuthors">Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">425-427</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 38 refs.  Neurofibrillar protein aggregates contg. tau are one of the major hallmarks of Alzheimer's disease (AD).  In normal cells, tau stabilizes axonal microtubules, which are the tracks for intracellular traffic.  In AD, tau becomes abnormally phosphorylated, aggregates into paired helical filaments and loses its ability to maintain the microtubule tracks.  There is renewed interest in tau as a causative factor in neurodegenerative disease based on recently discovered mutations in the gene encoding tau.  This article discusses how changes in tau protein could lead to retraction of neuronal processes and thus cell death and argues that tau pathol., rather than β-amyloid, might be the most reliable indicative factor for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1ZpMyBcDM27Vg90H21EOLACvtfcHk0lgwxd5RRPCzuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsV2i&md5=659158d82f69a5be7952ce8983ffb953</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2898%2901368-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252898%252901368-3%26sid%3Dliteratum%253Aachs%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1998%26volume%3D8%26spage%3D425%26epage%3D427%26doi%3D10.1016%2FS0962-8924%2898%2901368-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Games played by rogue proteins in prion disorders and Alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span><span class="refDoi"> DOI: 10.1126/science.1087348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1126%2Fscience.1087348" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=814-818&author=A.+Aguzziauthor=C.+Haass&title=Games+played+by+rogue+proteins+in+prion+disorders+and+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fscience.1087348"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087348%26sid%3Dliteratum%253Aachs%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DGames%2520played%2520by%2520rogue%2520proteins%2520in%2520prion%2520disorders%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D814%26epage%3D818%26doi%3D10.1126%2Fscience.1087348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the two-hit hypothesis</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.1016/S1474-4422(04)00707-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2FS1474-4422%2804%2900707-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=15039034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFyisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=219-226&author=X.+Zhuauthor=A.+K.+Rainaauthor=G.+Perryauthor=M.+A.+Smith&title=Alzheimer%E2%80%99s+disease%3A+the+two-hit+hypothesis&doi=10.1016%2FS1474-4422%2804%2900707-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: the two-hit hypothesis</span></div><div class="casAuthors">Zhu, Xiongwei; Raina, Arun K.; Perry, George; Smith, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-226</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">A review.  There are many lines of evidence showing that oxidative stress and aberrant mitogenic changes have important roles in the pathogenesis of Alzheimer's disease (AD).  However, although both oxidative stress and cell cycle-related abnormalities are early events, occurring before any cytopathol., the relation between these two events, and their role in pathophysiol. was, until recently, unclear.  However, on the basis of studies of mitogenic and oxidative stress signaling pathways in AD, we proposed a "two-hit hypothesis" which states that although either oxidative stress or abnormalities in mitotic signaling can independently serve as initiators, both processes are necessary to propagate disease pathogenesis.  In this paper, we summarize evidence for oxidative stress and abnormal mitotic alterations in AD and explain the two-hit hypothesis by describing how both mechanisms are necessary and invariant features of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq75S_m11G58bVg90H21EOLACvtfcHk0ljPTYUWmLyOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFyisbo%253D&md5=d4bddb80814d4cb7e7f12e6a4759016f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2804%2900707-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252804%252900707-0%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DRaina%26aufirst%3DA.%2BK.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520two-hit%2520hypothesis%26jtitle%3DLancet%2520Neurol.%26date%3D2004%26volume%3D3%26spage%3D219%26epage%3D226%26doi%3D10.1016%2FS1474-4422%2804%2900707-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wyss-Coray, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J.</span><span> </span><span class="NLM_article-title">Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006346</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1101%2Fcshperspect.a006346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22315714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFKlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006346&author=T.+Wyss-Corayauthor=J.+Rogers&title=Inflammation+in+Alzheimer+disease-a+brief+review+of+the+basic+science+and+clinical+literature&doi=10.1101%2Fcshperspect.a006346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature</span></div><div class="casAuthors">Wyss-Coray, Tony; Rogers, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a006346/1-a006346/23</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Biochem. and neuropathol. studies of brains from individuals with Alzheimer disease (AD) provide clear evidence for an activation of inflammatory pathways, and longterm use of anti-inflammatory drugs is linked with reduced risk to develop the disease.  As cause and effect relationships between inflammation and AD are being worked out, there is a realization that some components of this complex mol. and cellular machinery are most likely promoting pathol. processes leading to AD, whereas other components serve to do the opposite.  The challenge will be to find ways of fine tuning inflammation to delay, prevent, or treat AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOJegLfCJvkbVg90H21EOLACvtfcHk0ljPTYUWmLyOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFKlsL4%253D&md5=6ee844f83faf56a1c48324bc3df95aa7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006346%26sid%3Dliteratum%253Aachs%26aulast%3DWyss-Coray%26aufirst%3DT.%26aulast%3DRogers%26aufirst%3DJ.%26atitle%3DInflammation%2520in%2520Alzheimer%2520disease-a%2520brief%2520review%2520of%2520the%2520basic%2520science%2520and%2520clinical%2520literature%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006346%26doi%3D10.1101%2Fcshperspect.a006346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Swerdlow, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. M.</span><span> </span><span class="NLM_article-title">A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease</span> <span class="citation_source-journal">Med. Hypotheses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.1016/j.mehy.2003.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.mehy.2003.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=15193340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVehs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2004&pages=8-20&author=R.+H.+Swerdlowauthor=S.+M.+Khan&title=A+%E2%80%9Cmitochondrial+cascade+hypothesis%E2%80%9D+for+sporadic+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.mehy.2003.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease</span></div><div class="casAuthors">Swerdlow, Russell H.; Khan, Shaharyar M.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-20</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) includes etiol. heterogeneous disorders characterized by senile or presenile dementia, extracellular amyloid protein aggregations contg. an insol. amyloid precursor protein deriv., and intracytoplasmic tau protein aggregations.  Recent studies also show excess neuronal aneuploidy, programmed cell death (PCD), and mitochondrial dysfunction.  The leading AD mol. paradigm, the "amyloid cascade hypothesis", is based on studies of rare autosomal dominant variants and does not specify what initiates the common late-onset, sporadic form.  The authors propose for late-onset, sporadic AD a "mitochondrial cascade hypothesis" that comprehensively reconciles seemingly disparate histopathol. and pathophysiol. features.  In the authors' model, the inherited, gene-detd. make-up of an individual's electron transport chain sets basal rates of reactive oxygen species (ROS) prodn., which dets. the pace at which acquired mitochondrial damage accumulates.  Oxidative mitochondrial DNA, RNA, lipid, and protein damage amplifies ROS prodn. and triggers three events: (1) a reset response in which cells respond to elevated ROS by generating the β-sheet protein, beta amyloid, which further perturbs mitochondrial function, (2) a removal response in which compromised cells are purged via PCD mechanisms, and (3) a replace response in which neuronal progenitors unsuccessfully attempt to re-enter the cell cycle, with resultant aneuploidy, tau phosphorylation, and neurofibrillary tangle formation.  In addn. to defining a role for aging in AD pathogenesis, the mitochondrial cascade hypothesis also allows and accounts for histopathol. overlap between the sporadic, late-onset and autosomal dominant, early onset forms of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon6w28KOkDx7Vg90H21EOLACvtfcHk0lh6q6RKDvBxNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVehs7g%253D&md5=8912554c61664823010da53c8f64fe0f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2003.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2003.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DSwerdlow%26aufirst%3DR.%2BH.%26aulast%3DKhan%26aufirst%3DS.%2BM.%26atitle%3DA%2520%25E2%2580%259Cmitochondrial%2520cascade%2520hypothesis%25E2%2580%259D%2520for%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Hypotheses%26date%3D2004%26volume%3D63%26spage%3D8%26epage%3D20%26doi%3D10.1016%2Fj.mehy.2003.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lh6q6RKDvBxNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassi, E.</span><span> </span><span class="NLM_article-title">From companion diagnostics to theranostics: a new avenue for Alzheimer’s disease?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7759</span><span class="NLM_x">–</span> <span class="NLM_lpage">7770</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7759-7770&author=M.+L.+Bolognesiauthor=A.+Gandiniauthor=F.+Pratiauthor=E.+Uliassi&title=From+companion+diagnostics+to+theranostics%3A+a+new+avenue+for+Alzheimer%E2%80%99s+disease%3F&doi=10.1021%2Facs.jmedchem.6b00151"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00151%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DUliassi%26aufirst%3DE.%26atitle%3DFrom%2520companion%2520diagnostics%2520to%2520theranostics%253A%2520a%2520new%2520avenue%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7759%26epage%3D7770%26doi%3D10.1021%2Facs.jmedchem.6b00151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabellieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maramai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kshirsagar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guarino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustiniano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">A stereoselective approach to peptidomimetic BACE1 inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.ejmech.2013.09.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=233-247&author=S.+Butiniauthor=E.+Gabellieriauthor=M.+Brindisiauthor=S.+Giovaniauthor=S.+Maramaiauthor=G.+Kshirsagarauthor=E.+Guarinoauthor=S.+Brogiauthor=V.+La+Pietraauthor=M.+Giustinianoauthor=L.+Marinelliauthor=E.+Novellinoauthor=G.+Campianiauthor=A.+Cappelliauthor=S.+Gemma&title=A+stereoselective+approach+to+peptidomimetic+BACE1+inhibitors&doi=10.1016%2Fj.ejmech.2013.09.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DGiovani%26aufirst%3DS.%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DKshirsagar%26aufirst%3DG.%26aulast%3DGuarino%26aufirst%3DE.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DGiustiniano%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DA%2520stereoselective%2520approach%2520to%2520peptidomimetic%2520BACE1%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D233%26epage%3D247%26doi%3D10.1016%2Fj.ejmech.2013.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Vila-Real, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maycock, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iranzo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simplicio, A. L.</span><span> </span><span class="NLM_article-title">Peptidomimetic beta-secretase inhibitors comprising a sequence of amyloid-beta peptide for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5408</span><span class="NLM_x">–</span> <span class="NLM_lpage">5418</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00658</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00658" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5408-5418&author=H.+Vila-Realauthor=H.+Coelhoauthor=J.+Rochaauthor=A.+Fernandesauthor=M.+R.+Venturaauthor=C.+D.+Maycockauthor=O.+Iranzoauthor=A.+L.+Simplicio&title=Peptidomimetic+beta-secretase+inhibitors+comprising+a+sequence+of+amyloid-beta+peptide+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.5b00658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00658%26sid%3Dliteratum%253Aachs%26aulast%3DVila-Real%26aufirst%3DH.%26aulast%3DCoelho%26aufirst%3DH.%26aulast%3DRocha%26aufirst%3DJ.%26aulast%3DFernandes%26aufirst%3DA.%26aulast%3DVentura%26aufirst%3DM.%2BR.%26aulast%3DMaycock%26aufirst%3DC.%2BD.%26aulast%3DIranzo%26aufirst%3DO.%26aulast%3DSimplicio%26aufirst%3DA.%2BL.%26atitle%3DPeptidomimetic%2520beta-secretase%2520inhibitors%2520comprising%2520a%2520sequence%2520of%2520amyloid-beta%2520peptide%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5408%26epage%3D5418%26doi%3D10.1021%2Facs.jmedchem.5b00658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teruya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akaji, K.</span><span> </span><span class="NLM_article-title">Evaluation of transition-state mimics in a superior BACE1 cleavage sequence as peptide-mimetic BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5626</span><span class="NLM_x">–</span> <span class="NLM_lpage">5640</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2015.07.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5626-5640&author=Y.+Hattoriauthor=K.+Kobayashiauthor=A.+Deguchiauthor=Y.+Noharaauthor=T.+Akiyamaauthor=K.+Teruyaauthor=A.+Sanjohauthor=A.+Nakagawaauthor=E.+Yamashitaauthor=K.+Akaji&title=Evaluation+of+transition-state+mimics+in+a+superior+BACE1+cleavage+sequence+as+peptide-mimetic+BACE1+inhibitors&doi=10.1016%2Fj.bmc.2015.07.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DDeguchi%26aufirst%3DA.%26aulast%3DNohara%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTeruya%26aufirst%3DK.%26aulast%3DSanjoh%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DA.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DAkaji%26aufirst%3DK.%26atitle%3DEvaluation%2520of%2520transition-state%2520mimics%2520in%2520a%2520superior%2520BACE1%2520cleavage%2520sequence%2520as%2520peptide-mimetic%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5626%26epage%3D5640%26doi%3D10.1016%2Fj.bmc.2015.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devasamudram, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilcer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesecar, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure-based design, synthesis and biological evaluation of novel beta-secretase inhibitors containing a pyrazole or thiazole moiety as the P3 ligand</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2014.11.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=668-672&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=Y.+C.+Yenauthor=X.+Xuauthor=X.+Huangauthor=T.+Devasamudramauthor=G.+Bilcerauthor=H.+Leiauthor=G.+Koelschauthor=A.+D.+Mesecarauthor=J.+Tang&title=Structure-based+design%2C+synthesis+and+biological+evaluation+of+novel+beta-secretase+inhibitors+containing+a+pyrazole+or+thiazole+moiety+as+the+P3+ligand&doi=10.1016%2Fj.bmcl.2014.11.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.087%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DYen%26aufirst%3DY.%2BC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDevasamudram%26aufirst%3DT.%26aulast%3DBilcer%26aufirst%3DG.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520beta-secretase%2520inhibitors%2520containing%2520a%2520pyrazole%2520or%2520thiazole%2520moiety%2520as%2520the%2520P3%2520ligand%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D668%26epage%3D672%26doi%3D10.1016%2Fj.bmcl.2014.11.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0lgTWNwhjSeqbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgiDspcNk2-lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Discovery of potent iminoheterocycle BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5455</span><span class="NLM_x">–</span> <span class="NLM_lpage">5459</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2014.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=25455483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVenu7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5455-5459&author=J.+P.+Caldwellauthor=R.+D.+Mazzolaauthor=J.+Durkinauthor=J.+Chenauthor=X.+Chenauthor=L.+Favreauauthor=M.+Kennedyauthor=R.+Kuvelkarauthor=J.+Leeauthor=N.+McHughauthor=B.+McKittrickauthor=P.+Orthauthor=A.+Stamfordauthor=C.+Stricklandauthor=J.+Voigtauthor=L.+Wangauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhu&title=Discovery+of+potent+iminoheterocycle+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent iminoheterocycle BACE1 inhibitors</span></div><div class="casAuthors">Caldwell, John P.; Mazzola, Robert D.; Durkin, James; Chen, Joseph; Chen, Xia; Favreau, Leonard; Kennedy, Matthew; Kuvelkar, Reshma; Lee, Julie; McHugh, Nansie; McKittrick, Brian; Orth, Peter; Stamford, Andrew; Strickland, Corey; Voigt, Johannes; Wang, Liyang; Zhang, Lili; Zhang, Qi; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5455-5459</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis of a series of iminoheterocycles and their structure-activity relationships (SAR) as inhibitors of the aspartyl protease BACE1 will be detailed.  An effort to access the S3 subsite directly from the S1 subsite initially yielded compds. with sub-micromolar potency.  A subset of compds. from this effort unexpectedly occupied a different binding site and displayed excellent BACE1 affinities.  Select compds. from this subset acutely lowered Aβ40 levels upon s.c. and oral administration to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwTVeMzYRYrLVg90H21EOLACvtfcHk0lgiDspcNk2-lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVenu7bF&md5=613faa1b5a7af6093d75fd022ad83f64</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMcHugh%26aufirst%3DN.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520potent%2520iminoheterocycle%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5455%26epage%3D5459%26doi%3D10.1016%2Fj.bmcl.2014.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span> </span><span class="NLM_article-title">Spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid beta in a higher species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3379</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span><span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+from+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+beta+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520beta%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span> </span><span class="NLM_article-title">Discovery of 7-tetrahydropyran-2-yl chromans: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid beta-protein (Abeta) in the central nervous system</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span><span class="refDoi"> DOI: 10.1021/jm401635n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401635n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=878-902&author=A.+A.+Thomasauthor=K.+W.+Huntauthor=M.+Volgrafauthor=R.+J.+Wattsauthor=X.+Liuauthor=G.+Vigersauthor=D.+Smithauthor=D.+Sammondauthor=T.+P.+Tangauthor=S.+P.+Rhodesauthor=A.+T.+Metcalfauthor=K.+D.+Brownauthor=J.+N.+Ottenauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Doauthor=D.+Dutcherauthor=S.+Ranaauthor=R.+K.+DeLisleauthor=K.+Regalauthor=A.+D.+Wrightauthor=R.+Gronebergauthor=K.+Scearce-Levieauthor=M.+Siuauthor=H.+E.+Purkeyauthor=J.+P.+Lyssikatosauthor=I.+W.+Gunawardana&title=Discovery+of+7-tetrahydropyran-2-yl+chromans%3A+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors+that+reduce+amyloid+beta-protein+%28Abeta%29+in+the+central+nervous+system&doi=10.1021%2Fjm401635n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm401635n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401635n%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DBrown%26aufirst%3DK.%2BD.%26aulast%3DOtten%26aufirst%3DJ.%2BN.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26atitle%3DDiscovery%2520of%25207-tetrahydropyran-2-yl%2520chromans%253A%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520that%2520reduce%2520amyloid%2520beta-protein%2520%2528Abeta%2529%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D878%26epage%3D902%26doi%3D10.1021%2Fjm401635n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newhouse, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10112</span><span class="NLM_x">–</span> <span class="NLM_lpage">10129</span><span class="refDoi"> DOI: 10.1021/jm5015132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5015132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10112-10129&author=A.+A.+Thomasauthor=K.+W.+Huntauthor=B.+Newhouseauthor=R.+J.+Wattsauthor=X.+Liuauthor=G.+Vigersauthor=D.+Smithauthor=S.+P.+Rhodesauthor=K.+D.+Brownauthor=J.+N.+Ottenauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=S.+Ranaauthor=R.+K.+DeLisleauthor=K.+Regalauthor=A.+D.+Wrightauthor=R.+Gronebergauthor=J.+Liaoauthor=K.+Scearce-Levieauthor=M.+Siuauthor=H.+E.+Purkeyauthor=J.+P.+Lyssikatos&title=8-Tetrahydropyran-2-yl+chromans%3A+highly+selective+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors&doi=10.1021%2Fjm5015132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors</span></div><div class="casAuthors">Thomas, Allen A.; Hunt, Kevin W.; Newhouse, Brad; Watts, Ryan J.; Liu, Xingrong; Vigers, Guy; Smith, Darin; Rhodes, Susan P.; Brown, Karin D.; Otten, Jennifer N.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Rana, Sumeet; DeLisle, Robert K.; Regal, Kelly; Wright, Albion D.; Groneberg, Robert; Liao, Jiangpeng; Scearce-Levie, Kimberly; Siu, Michael; Purkey, Hans E.; Lyssikatos, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10112-10129</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hexahydropyrano[3,2-b]chromenes such as I were prepd. as inhibitors of β-site amyloid cleaving enzyme 1 (BACE1) selective for BACE1 over cathepsin D (CatD).  Three different Asp-binding moieties were examd. (spirocyclic acyl guanidines, spirocyclic aminooxazolines, and spirocyclic aminothiazolines) in order to modulate potency, selectivity, efflux, and permeability; changes to the aryl substituents of the pyranochromene moiety and substitution of a ring junction proton with a Me group were also studied.  In particular, spirocyclic aminooxazoline and aminothiazoline inhibitors with Me substituents possessed excellent cellular potency (37-137 nM) for inhibiting BACE1 and high selectivity (435 to >2000-fold) for BACE1 vs CatD.  These efforts led to nonracemic I, which demonstrated a 69% redn. in rat CSF Aβ1-40 at a dosage of 60 mg/kg (PO).  The complexes of four hexahydropyrano[3,2-b]chromenes bound to BACE-1 were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKJ3ssfyhPHrVg90H21EOLACvtfcHk0ljWmL70ci4ARQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqurnK&md5=827f89cabdaa149283d04f030a3d5568</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm5015132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5015132%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DNewhouse%26aufirst%3DB.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DBrown%26aufirst%3DK.%2BD.%26aulast%3DOtten%26aufirst%3DJ.%2BN.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3D8-Tetrahydropyran-2-yl%2520chromans%253A%2520highly%2520selective%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10112%26epage%3D10129%26doi%3D10.1021%2Fjm5015132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derakhchan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Human, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span> </span><span class="NLM_article-title">Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene beta-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9810</span><span class="refDoi"> DOI: 10.1021/jm501266w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501266w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9796-9810&author=O.+Epsteinauthor=M.+C.+Bryanauthor=A.+C.+Chengauthor=K.+Derakhchanauthor=T.+A.+Dineenauthor=D.+Hickmanauthor=Z.+Huaauthor=J.+B.+Humanauthor=C.+Kreimanauthor=I.+E.+Marxauthor=M.+M.+Weissauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=X.+M.+Zhengauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Lead+optimization+and+modulation+of+hERG+activity+in+a+series+of+aminooxazoline+xanthene+beta-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors&doi=10.1021%2Fjm501266w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501266w%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DBryan%26aufirst%3DM.%2BC.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDerakhchan%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHua%26aufirst%3DZ.%26aulast%3DHuman%26aufirst%3DJ.%2BB.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DLead%2520optimization%2520and%2520modulation%2520of%2520hERG%2520activity%2520in%2520a%2520series%2520of%2520aminooxazoline%2520xanthene%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9796%26epage%3D9810%26doi%3D10.1021%2Fjm501266w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derakhchan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span> </span><span class="NLM_article-title">Inhibitors of beta-site amyloid precursor protein cleaving enzyme (BACE1): identification of (S)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[ 2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9811</span><span class="NLM_x">–</span> <span class="NLM_lpage">9831</span><span class="refDoi"> DOI: 10.1021/jm5012676</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012676" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9811-9831&author=T.+A.+Dineenauthor=K.+Chenauthor=A.+C.+Chengauthor=K.+Derakhchanauthor=O.+Epsteinauthor=J.+Esmayauthor=D.+Hickmanauthor=C.+E.+Kreimanauthor=I.+E.+Marxauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=M.+M.+Weissauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29%3A+identification+of+%28S%29-7-%282-fluoropyridin-3-yl%29-3-%28%283-methyloxetan-3-yl%29ethynyl%29-5%E2%80%B2H-spiro%5Bchromeno%5B+2%2C3-b%5Dpyridine-5%2C4%E2%80%B2-oxazol%5D-2%E2%80%B2-amine+%28AMG-8718%29&doi=10.1021%2Fjm5012676"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012676%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDerakhchan%26aufirst%3DK.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKreiman%26aufirst%3DC.%2BE.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DInhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%253A%2520identification%2520of%2520%2528S%2529-7-%25282-fluoropyridin-3-yl%2529-3-%2528%25283-methyloxetan-3-yl%2529ethynyl%2529-5%25E2%2580%25B2H-spiro%255Bchromeno%255B%25202%252C3-b%255Dpyridine-5%252C4%25E2%2580%25B2-oxazol%255D-2%25E2%2580%25B2-amine%2520%2528AMG-8718%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9811%26epage%3D9831%26doi%3D10.1021%2Fjm5012676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amegadzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minatti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Human, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everds, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonderfecht, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span> </span><span class="NLM_article-title">Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious beta-secretase inhibitors for the potential treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2014.12.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=767-774&author=J.+J.+Chenauthor=Q.+Liuauthor=C.+Yuanauthor=V.+Goreauthor=P.+Lopezauthor=V.+Maauthor=A.+Amegadzieauthor=W.+Qianauthor=T.+C.+Juddauthor=A.+E.+Minattiauthor=J.+Brownauthor=Y.+Chengauthor=M.+Xueauthor=W.+Zhongauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=J.+Humanauthor=C.+Kreimanauthor=I.+Marxauthor=M.+M.+Weissauthor=S.+A.+Hitchcockauthor=T.+S.+Powersauthor=K.+Chenauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=A.+C.+Chengauthor=M.+D.+Bartbergerauthor=D.+Hickmanauthor=J.+A.+Wernerauthor=H.+M.+Vargasauthor=N.+E.+Everdsauthor=S.+L.+Vonderfechtauthor=R.+T.+Dunnauthor=S.+Woodauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Development+of+2-aminooxazoline+3-azaxanthenes+as+orally+efficacious+beta-secretase+inhibitors+for+the+potential+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2014.12.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.092%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DGore%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DV.%26aulast%3DAmegadzie%26aufirst%3DA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DHuman%26aufirst%3DJ.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DMarx%26aufirst%3DI.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DWerner%26aufirst%3DJ.%2BA.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DEverds%26aufirst%3DN.%2BE.%26aulast%3DVonderfecht%26aufirst%3DS.%2BL.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DDevelopment%2520of%25202-aminooxazoline%25203-azaxanthenes%2520as%2520orally%2520efficacious%2520beta-secretase%2520inhibitors%2520for%2520the%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.bmcl.2014.12.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minatti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">An orally available BACE1 inhibitor that affords robust CNS Abeta reduction without cardiovascular liabilities</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.1021/ml500458t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=210-215&author=Y.+Chengauthor=J.+Brownauthor=T.+C.+Juddauthor=P.+Lopezauthor=W.+Qianauthor=T.+S.+Powersauthor=J.+J.+Chenauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=R.+T.+Dunnauthor=O.+Epsteinauthor=R.+T.+Fremeauauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=Y.+Luoauthor=A.+E.+Minattiauthor=V.+F.+Patelauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=X.+M.+Zhengauthor=S.+Wood&title=An+orally+available+BACE1+inhibitor+that+affords+robust+CNS+Abeta+reduction+without+cardiovascular+liabilities&doi=10.1021%2Fml500458t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities</span></div><div class="casAuthors">Cheng, Yuan; Brown, James; Judd, Ted C.; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S.; Chen, Jian Jeffrey; Bartberger, Michael D.; Chen, Kui; Dunn, Robert T.; Epstein, Oleg; Fremeau, Robert T.; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A.; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F.; Vargas, Hugo M.; Wahl, Robert C.; Weiss, Matthew M.; Wen, Paul H.; White, Ryan D.; Whittington, Douglas A.; Zheng, Xiao Mei; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-215</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibition to prevent Aβ peptide formation is considered to be a potential route to a disease-modifying treatment for Alzheimer's disease.  Previous efforts in our lab. using a combined structure- and property-based approach have resulted in the identification of aminooxazoline xanthenes as potent BACE1 inhibitors.  Herein, we report further optimization leading to the discovery of inhibitor 15 as an orally available and highly efficacious BACE1 inhibitor that robustly reduces CSF and brain Aβ levels in both rats and nonhuman primates.  In addn., compd. 15 exhibited low activity on the hERG ion channel and was well tolerated in an integrated cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH-0fLNUlbrVg90H21EOLACvtfcHk0ljXi-4vo1PFXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI&md5=bd8e5a33d06a51646873c4c43d01b003</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500458t%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DAn%2520orally%2520available%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520Abeta%2520reduction%2520without%2520cardiovascular%2520liabilities%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D210%26epage%3D215%26doi%3D10.1021%2Fml500458t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span><span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0ljXi-4vo1PFXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Fielden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamison, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueblood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afshari, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot-Dunn, R.</span><span> </span><span class="NLM_article-title">Retinal toxicity induced by a novel beta-secretase inhibitor in the sprague-dawley rat</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span><span class="refDoi"> DOI: 10.1177/0192623314553804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1177%2F0192623314553804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=25361751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCqu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=581-592&author=M.+R.+Fieldenauthor=J.+Wernerauthor=J.+A.+Jamisonauthor=A.+Coppiauthor=D.+Hickmanauthor=R.+T.+Dunnauthor=E.+Truebloodauthor=L.+Zhouauthor=C.+A.+Afshariauthor=R.+Lightfoot-Dunn&title=Retinal+toxicity+induced+by+a+novel+beta-secretase+inhibitor+in+the+sprague-dawley+rat&doi=10.1177%2F0192623314553804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Retinal toxicity induced by a novel β-secretase inhibitor in the sprague-dawley rat</span></div><div class="casAuthors">Fielden, Mark R.; Werner, Jonathan; Jamison, Jeff A.; Coppi, Aldo; Hickman, Dean; Dunn, Robert T., II; Trueblood, Esther; Zhou, Lei; Afshari, Cynthia A.; Lightfoot-Dunn, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">581-592</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">β-Secretase 1 (BACE1) represents an attractive target for the treatment of Alzheimer's disease.  In the course of development of a novel small mol. BACE1 inhibitor (AMG-8718), retinal thinning was obsd. in a 1-mo toxicity study in the rat.  To further understand the lesion, an investigational study was conducted whereby rats were treated daily with AMG-8718 for 1 mo followed by a 2-mo treatment-free phase.  The earliest detectable change in the retina was an increase in autofluorescent granules in the retinal pigment epithelium (RPE) on day 5; however, there were no treatment-related light microscopic changes obsd. in the neuroretina and no changes obsd. by fundus autofluorescence or routine ophthalmoscopic examn. after 28 days of dosing.  Following 2 mo of recovery, there was significant retinal thinning attributed to loss of photoreceptor nuclei from the outer nuclear layer.  Electroretinog. changes were obsd. as early as day 14, before any microscopic evidence of photoreceptor loss.  BACE1 knockout rats were generated and found to have normal retinal morphol. indicating that the retinal toxicity induced by AMG-8718 was likely off-target.  These results suggest that AMG-8718 impairs phagolysosomal function in the rat RPE, which leads to photoreceptor dysfunction and ultimately loss of photoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfyBfTezUdUrVg90H21EOLACvtfcHk0lhonGJXe5Aq4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCqu7fP&md5=d6f4af801e795995739478385f5e36fd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1177%2F0192623314553804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623314553804%26sid%3Dliteratum%253Aachs%26aulast%3DFielden%26aufirst%3DM.%2BR.%26aulast%3DWerner%26aufirst%3DJ.%26aulast%3DJamison%26aufirst%3DJ.%2BA.%26aulast%3DCoppi%26aufirst%3DA.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DTrueblood%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DAfshari%26aufirst%3DC.%2BA.%26aulast%3DLightfoot-Dunn%26aufirst%3DR.%26atitle%3DRetinal%2520toxicity%2520induced%2520by%2520a%2520novel%2520beta-secretase%2520inhibitor%2520in%2520the%2520sprague-dawley%2520rat%26jtitle%3DToxicol.%2520Pathol.%26date%3D2015%26volume%3D43%26spage%3D581%26epage%3D592%26doi%3D10.1177%2F0192623314553804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michener, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure-based design of an iminoheterocyclic beta-site amyloid precursor protein cleaving enzyme (BACE) inhibitor that lowers central Abeta in nonhuman primates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3231</span><span class="NLM_x">–</span> <span class="NLM_lpage">3248</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01995</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3231-3248&author=M.+Mandalauthor=Y.+Wuauthor=J.+Misiaszekauthor=G.+Liauthor=A.+Buevichauthor=J.+P.+Caldwellauthor=X.+Liuauthor=R.+D.+Mazzolaauthor=P.+Orthauthor=C.+Stricklandauthor=J.+Voigtauthor=H.+Wangauthor=Z.+Zhuauthor=X.+Chenauthor=M.+Grzelakauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=P.+T.+Leachauthor=G.+Terracinaauthor=L.+Zhangauthor=Q.+Zhangauthor=M.+S.+Michenerauthor=B.+Smithauthor=K.+Coxauthor=D.+Grotzauthor=L.+Favreauauthor=K.+Mitraauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=M.+E.+Kennedyauthor=E.+M.+Parkerauthor=J.+N.+Cummingauthor=A.+W.+Stamford&title=Structure-based+design+of+an+iminoheterocyclic+beta-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE%29+inhibitor+that+lowers+central+Abeta+in+nonhuman+primates&doi=10.1021%2Facs.jmedchem.5b01995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLeach%26aufirst%3DP.%2BT.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DMichener%26aufirst%3DM.%2BS.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DGrotz%26aufirst%3DD.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure-based%2520design%2520of%2520an%2520iminoheterocyclic%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE%2529%2520inhibitor%2520that%2520lowers%2520central%2520Abeta%2520in%2520nonhuman%2520primates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3231%26epage%3D3248%26doi%3D10.1021%2Facs.jmedchem.5b01995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span><span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0ljqnxT05RtnlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-beta+in+humans+with+an+orally+available%2C+non-peptidic+beta-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0ljxEJIW9j8BIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-beta%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520beta-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Abeta reduction in rodents</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.+J.+Wuauthor=J.+Guernonauthor=F.+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+Abeta+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520Abeta%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckelbauer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Discovery of S3-truncated, C-6 heteroaryl substituted aminothiazine beta-site APP cleaving enzyme-1 (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8593</span><span class="NLM_x">–</span> <span class="NLM_lpage">8600</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8593-8600&author=Y.+J.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=L.+Marcinauthor=M.+Higginsauthor=R.+Rajamaniauthor=J.+Muckelbauerauthor=H.+Lewisauthor=C.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Discovery+of+S3-truncated%2C+C-6+heteroaryl+substituted+aminothiazine+beta-site+APP+cleaving+enzyme-1+%28BACE1%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b01012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMarcin%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DMuckelbauer%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DDiscovery%2520of%2520S3-truncated%252C%2520C-6%2520heteroaryl%2520substituted%2520aminothiazine%2520beta-site%2520APP%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8593%26epage%3D8600%26doi%3D10.1021%2Facs.jmedchem.6b01012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2678</span><span class="NLM_x">–</span> <span class="NLM_lpage">2702</span><span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0lhRtB3tMrv50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundesmann, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henegar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChapelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikochik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3223</span><span class="NLM_x">–</span> <span class="NLM_lpage">3252</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug-drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors</span></div><div class="casAuthors">Brodney, Michael A.; Beck, Elizabeth M.; Butler, Christopher R.; Barreiro, Gabriela; Johnson, Eric F.; Riddell, David; Parris, Kevin; Nolan, Charles E.; Fan, Ying; Atchison, Kevin; Gonzales, Cathleen; Robshaw, Ashley E.; Doran, Shawn D.; Bundesmann, Mark W.; Buzon, Leanne; Dutra, Jason; Henegar, Kevin; LaChapelle, Erik; Hou, Xinjun; Rogers, Bruce N.; Pandit, Jayvardhan; Lira, Ricardo; Martinez-Alsina, Luis; Mikochik, Peter; Murray, John C.; Ogilvie, Kevin; Price, Loren; Sakya, Subas M.; Yu, Aijia; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3223-3252</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, the first generation of β-secretase (BACE1) inhibitors advanced into clin. development for the treatment of Alzheimer's disease (AD).  However, the alignment of drug-like properties and selectivity remains a major challenge.  Herein, we describe the discovery of a novel class of potent, low clearance, CNS penetrant BACE1 inhibitors represented by thioamidine 5.  Further profiling suggested that a high fraction of the metab. (>95%) was due to CYP2D6, increasing the potential risk for victim-based drug-drug interactions (DDI) and variable exposure in the clinic due to the polymorphic nature of this enzyme.  To guide future design, we solved crystal structures of CYP2D6 complexes with substrate 5 and its corresponding metabolic product pyrazole 6, which provided insight into the binding mode and movements between substrate/inhibitor complexes.  Guided by the BACE1 and CYP2D6 crystal structures, we designed and synthesized analogs with reduced risk for DDI, central efficacy, and improved hERG therapeutic margins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRdq_8px-VLVg90H21EOLACvtfcHk0lhRtB3tMrv50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D&md5=ed44904d0e55c74417a6874c1454683c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug-drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borders, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevorkyan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komjathy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Abeta pharmacodynamic responses in mice, dogs, and humans</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1210</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+Abeta+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lgts9uoGoM3OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520Abeta%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borders, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudziak, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimkowski, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia Losada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span> </span><span class="NLM_article-title">Preparation and biological evaluation of conformationally constrained BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3260</span><span class="NLM_x">–</span> <span class="NLM_lpage">3268</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2015.04.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3260-3268&author=L.+L.+Winneroskiauthor=M.+A.+Schifflerauthor=J.+A.+Ericksonauthor=P.+C.+Mayauthor=S.+A.+Monkauthor=D.+E.+Timmauthor=J.+E.+Audiaauthor=J.+P.+Beckauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+D.+Boyerauthor=R.+A.+Brierauthor=K.+J.+Hudziakauthor=V.+J.+Klimkowskiauthor=P.+Garcia+Losadaauthor=B.+M.+Mathesauthor=S.+L.+Stoutauthor=B.+M.+Watsonauthor=D.+J.+Mergott&title=Preparation+and+biological+evaluation+of+conformationally+constrained+BACE1+inhibitors&doi=10.1016%2Fj.bmc.2015.04.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.062%26sid%3Dliteratum%253Aachs%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DSchiffler%26aufirst%3DM.%2BA.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBeck%26aufirst%3DJ.%2BP.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBoyer%26aufirst%3DR.%2BD.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DHudziak%26aufirst%3DK.%2BJ.%26aulast%3DKlimkowski%26aufirst%3DV.%2BJ.%26aulast%3DGarcia%2BLosada%26aufirst%3DP.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DPreparation%2520and%2520biological%2520evaluation%2520of%2520conformationally%2520constrained%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3260%26epage%3D3268%26doi%3D10.1016%2Fj.bmc.2015.04.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckelbauer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Discovery of furo[2,3-d][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5729</span><span class="NLM_x">–</span> <span class="NLM_lpage">5731</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2016.10.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5729-5731&author=Y.+J.+Wuauthor=J.+Guernonauthor=R.+Rajamaniauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+Muckelbauerauthor=C.+Changauthor=D.+Camacauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Discovery+of+furo%5B2%2C3-d%5D%5B1%2C3%5Dthiazinamines+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors&doi=10.1016%2Fj.bmcl.2016.10.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.055%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMuckelbauer%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DDiscovery%2520of%2520furo%255B2%252C3-d%255D%255B1%252C3%255Dthiazinamines%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5729%26epage%3D5731%26doi%3D10.1016%2Fj.bmcl.2016.10.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wang, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nechuta, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D. F.</span><span> </span><span class="NLM_article-title">Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span><span class="refDoi"> DOI: 10.1021/jm901472u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901472u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=942-950&author=Y.+S.+Wangauthor=C.+Stricklandauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=B.+M.+Beyerauthor=M.+M.+Seniorauthor=E.+M.+Smithauthor=T.+L.+Nechutaauthor=V.+S.+Madisonauthor=M.+Czarnieckiauthor=B.+A.+McKittrickauthor=A.+W.+Stamfordauthor=E.+M.+Parkerauthor=J.+C.+Hunterauthor=W.+J.+Greenleeauthor=D.+F.+Wyss&title=Application+of+fragment-based+NMR+screening%2C+X-ray+crystallography%2C+structure-based+design%2C+and+focused+chemical+library+design+to+identify+novel+microM+leads+for+the+development+of+nM+BACE-1+%28beta-site+APP+cleaving+enzyme+1%29+inhibitors&doi=10.1021%2Fjm901472u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm901472u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901472u%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DSenior%26aufirst%3DM.%2BM.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DNechuta%26aufirst%3DT.%2BL.%26aulast%3DMadison%26aufirst%3DV.%2BS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DWyss%26aufirst%3DD.%2BF.%26atitle%3DApplication%2520of%2520fragment-based%2520NMR%2520screening%252C%2520X-ray%2520crystallography%252C%2520structure-based%2520design%252C%2520and%2520focused%2520chemical%2520library%2520design%2520to%2520identify%2520novel%2520microM%2520leads%2520for%2520the%2520development%2520of%2520nM%2520BACE-1%2520%2528beta-site%2520APP%2520cleaving%2520enzyme%25201%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D942%26epage%3D950%26doi%3D10.1021%2Fjm901472u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 Inhibitor that affords robust CNS Abeta reduction</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span><span class="refDoi"> DOI: 10.1021/ml3001165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWhtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+Inhibitor+that+affords+robust+CNS+Abeta+reduction&doi=10.1021%2Fml3001165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction</span></div><div class="casAuthors">Stamford, Andrew W.; Scott, Jack D.; Li, Sarah W.; Babu, Suresh; Tadesse, Dawit; Hunter, Rachael; Wu, Yusheng; Misiaszek, Jeffrey; Cumming, Jared N.; Gilbert, Eric J.; Huang, Chunli; McKittrick, Brian A.; Hong, Liwu; Guo, Tao; Zhu, Zhaoning; Strickland, Corey; Orth, Peter; Voigt, Johannes H.; Kennedy, Matthew E.; Chen, Xia; Kuvelkar, Reshma; Hodgson, Robert; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Parker, Eric M.; Greenlee, William J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">897-902</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of BACE1 to prevent brain Aβ peptide formation is a potential disease-modifying approach to the treatment of Alzheimer's disease.  Despite over a decade of drug discovery efforts, the identification of brain-penetrant BACE1 inhibitors that substantially lower CNS Aβ levels following systemic administration remains challenging.  In this report we describe structure-based optimization of a series of brain-penetrant BACE1 inhibitors derived from an iminopyrimidinone scaffold.  Application of structure-based design in tandem with control of physicochem. properties culminated in the discovery of compd. 16, which potently reduced cortex and CSF Aβ40 levels when administered orally to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplHonEJedFZbVg90H21EOLACvtfcHk0lhkKf8c5cO98g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWhtLvL&md5=8f743636119e48ed25d0f8c97d963440</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520Inhibitor%2520that%2520affords%2520robust%2520CNS%2520Abeta%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D897%26epage%3D902%26doi%3D10.1021%2Fml3001165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span>Merck Pulls Plug on Phase 2/3 BACE Inhibitor Trial. <a href="http://www.alzforum.org/news/research-news/merck-pulls-plug-phase-23-bace-inhibitor-trial" class="extLink">http://www.alzforum.org/news/research-news/merck-pulls-plug-phase-23-bace-inhibitor-trial</a>. (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+Pulls+Plug+on+Phase+2%2F3+BACE+Inhibitor+Trial.+http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fresearch-news%2Fmerck-pulls-plug-phase-23-bace-inhibitor-trial.+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levorse, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6259</span><span class="NLM_x">–</span> <span class="NLM_lpage">6262</span><span class="refDoi"> DOI: 10.1021/jm800914n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800914n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6259-6262&author=J.+C.+Barrowauthor=S.+R.+Staufferauthor=K.+E.+Rittleauthor=P.+L.+Ngoauthor=Z.+Yangauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=S.+Munshiauthor=G.+B.+McGaugheyauthor=M.+K.+Hollowayauthor=A.+J.+Simonauthor=E.+A.+Priceauthor=S.+Sankaranarayananauthor=D.+Colussiauthor=K.+Tugushevaauthor=M.+T.+Laiauthor=A.+S.+Espesethauthor=M.+Xuauthor=Q.+Huangauthor=A.+Wolfeauthor=B.+Pietrakauthor=P.+Zuckauthor=D.+A.+Levorseauthor=D.+Hazudaauthor=J.+P.+Vacca&title=Discovery+and+X-ray+crystallographic+analysis+of+a+spiropiperidine+iminohydantoin+inhibitor+of+beta-secretase&doi=10.1021%2Fjm800914n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm800914n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800914n%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DLevorse%26aufirst%3DD.%2BA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520X-ray%2520crystallographic%2520analysis%2520of%2520a%2520spiropiperidine%2520iminohydantoin%2520inhibitor%2520of%2520beta-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6259%26epage%3D6262%26doi%3D10.1021%2Fjm800914n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Egbertson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McWherter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahr, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugabook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri-Michener, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span> </span><span class="NLM_article-title">Methyl-substitution of an iminohydantoin spiropiperidine beta-secretase (BACE-1) inhibitor has a profound effect on its potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4812</span><span class="NLM_x">–</span> <span class="NLM_lpage">4819</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.06.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4812-4819&author=M.+Egbertsonauthor=G.+B.+McGaugheyauthor=S.+M.+Pitzenbergerauthor=S.+R.+Staufferauthor=C.+A.+Coburnauthor=S.+J.+Stachelauthor=W.+Yangauthor=J.+C.+Barrowauthor=L.+A.+Neilsonauthor=M.+McWherterauthor=D.+Perlowauthor=B.+Fahrauthor=S.+Munshiauthor=T.+J.+Allisonauthor=K.+Hollowayauthor=H.+G.+Selnickauthor=Z.+Yangauthor=J.+Swestockauthor=A.+J.+Simonauthor=S.+Sankaranarayananauthor=D.+Colussiauthor=K.+Tugushevaauthor=M.+T.+Laiauthor=B.+Pietrakauthor=S.+Haugabookauthor=L.+Jinauthor=I.+W.+Chenauthor=M.+Holahanauthor=M.+Stranieri-Michenerauthor=J.+J.+Cookauthor=J.+Vaccaauthor=S.+L.+Graham&title=Methyl-substitution+of+an+iminohydantoin+spiropiperidine+beta-secretase+%28BACE-1%29+inhibitor+has+a+profound+effect+on+its+potency&doi=10.1016%2Fj.bmcl.2015.06.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.082%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DPitzenberger%26aufirst%3DS.%2BM.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DNeilson%26aufirst%3DL.%2BA.%26aulast%3DMcWherter%26aufirst%3DM.%26aulast%3DPerlow%26aufirst%3DD.%26aulast%3DFahr%26aufirst%3DB.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DHolloway%26aufirst%3DK.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DHaugabook%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DStranieri-Michener%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26atitle%3DMethyl-substitution%2520of%2520an%2520iminohydantoin%2520spiropiperidine%2520beta-secretase%2520%2528BACE-1%2529%2520inhibitor%2520has%2520a%2520profound%2520effect%2520on%2520its%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4812%26epage%3D4819%26doi%3D10.1016%2Fj.bmcl.2015.06.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Rombouts, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Lamenca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso de Diego, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">1,4-Oxazine beta-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8216</span><span class="NLM_x">–</span> <span class="NLM_lpage">8235</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Martinez-Lamencaauthor=M.+Van+Goolauthor=A.+Garcia-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+beta-secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0ljjX-rLO6LATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520beta-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.,  St</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span><span class="refDoi"> DOI: 10.1021/jm200544q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29&doi=10.1021%2Fjm200544q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0ljjX-rLO6LATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857%26doi%3D10.1021%2Fjm200544q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Jordan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span> </span><span class="NLM_article-title">Fragment-linking approach using (19)F NMR spectroscopy to obtain highly potent and selective inhibitors of beta-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3732</span><span class="NLM_x">–</span> <span class="NLM_lpage">3749</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01917</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01917" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFeitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3732-3749&author=J.+B.+Jordanauthor=D.+A.+Whittingtonauthor=M.+D.+Bartbergerauthor=E.+A.+Sickmierauthor=K.+Chenauthor=Y.+Chengauthor=T.+Judd&title=Fragment-linking+approach+using+%2819%29F+NMR+spectroscopy+to+obtain+highly+potent+and+selective+inhibitors+of+beta-secretase&doi=10.1021%2Facs.jmedchem.5b01917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Linking Approach Using 19F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase</span></div><div class="casAuthors">Jordan, John B.; Whittington, Douglas A.; Bartberger, Michael D.; Sickmier, E. Allen; Chen, Kui; Cheng, Yuan; Judd, Ted</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3732-3749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery (FBDD) has become a widely used tool in small-mol. drug discovery efforts.  One of the most commonly used biophys. methods in detecting weak binding of fragments is NMR (NMR) spectroscopy.  In particular, FBDD performed with 19F NMR-based methods has been shown to provide several advantages over 1H NMR using traditional magnetization-transfer and/or two-dimensional methods.  Here, we demonstrate the utility and power of 19F-based fragment screening by detailing the identification of a second-site fragment through 19F NMR screening that binds to a specific pocket of the aspartic acid protease, β-secretase (BACE-1).  The identification of this second-site fragment allowed the undertaking of a fragment-linking approach, which ultimately yielded a mol. exhibiting a more than 360-fold increase in potency while maintaining reasonable ligand efficiency and gaining much improved selectivity over cathepsin-D (CatD).  X-ray crystallog. studies of the mols. demonstrated that the linked fragments exhibited binding modes consistent with those predicted from the targeted screening approach, through-space NMR data, and mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq95M4k5aaQurVg90H21EOLACvtfcHk0ljdfH043CIqpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFeitr8%253D&md5=6bd6021938c555d8c7083549e4b49a2e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01917%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DJ.%2BB.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%26atitle%3DFragment-linking%2520approach%2520using%2520%252819%2529F%2520NMR%2520spectroscopy%2520to%2520obtain%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520beta-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3732%26epage%3D3749%26doi%3D10.1021%2Facs.jmedchem.5b01917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Boy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.,  3rd</span><span> </span><span class="NLM_article-title">Macrocyclic prolinyl acyl guanidines as inhibitors of beta-secretase (BACE)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5040</span><span class="NLM_x">–</span> <span class="NLM_lpage">5047</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.10.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5040-5047&author=K.+M.+Boyauthor=J.+M.+Guernonauthor=Y.+J.+Wuauthor=Y.+Zhangauthor=J.+Shiauthor=W.+Zhaiauthor=S.+Zhuauthor=S.+W.+Gerritzauthor=J.+H.+Toynauthor=J.+E.+Meredithauthor=D.+M.+Bartenauthor=C.+R.+Burtonauthor=C.+F.+Albrightauthor=A.+C.+Goodauthor=J.+E.+Graceauthor=K.+A.+Lentzauthor=R.+E.+Olsonauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Macrocyclic+prolinyl+acyl+guanidines+as+inhibitors+of+beta-secretase+%28BACE%29&doi=10.1016%2Fj.bmcl.2015.10.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DBoy%26aufirst%3DK.%2BM.%26aulast%3DGuernon%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DZhai%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DGerritz%26aufirst%3DS.%2BW.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DMacrocyclic%2520prolinyl%2520acyl%2520guanidines%2520as%2520inhibitors%2520of%2520beta-secretase%2520%2528BACE%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5040%26epage%3D5047%26doi%3D10.1016%2Fj.bmcl.2015.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, P.</span><span> </span><span class="NLM_article-title">4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.ejmech.2014.04.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=413-421&author=P.+Liuauthor=Y.+Niuauthor=C.+Wangauthor=Q.+Sunauthor=Y.+Zhaiauthor=J.+Yuauthor=J.+Sunauthor=F.+Xuauthor=G.+Yanauthor=W.+Huangauthor=L.+Liangauthor=P.+Xu&title=4-Oxo-1%2C4-dihydro-quinoline-3-carboxamides+as+BACE-1+inhibitors%3A+synthesis%2C+biological+evaluation+and+docking+studies&doi=10.1016%2Fj.ejmech.2014.04.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DNiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DP.%26atitle%3D4-Oxo-1%252C4-dihydro-quinoline-3-carboxamides%2520as%2520BACE-1%2520inhibitors%253A%2520synthesis%252C%2520biological%2520evaluation%2520and%2520docking%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D413%26epage%3D421%26doi%3D10.1016%2Fj.ejmech.2014.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Razzaghi-Asl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firuzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmateenejad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javidnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edraki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miri, R.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6893</span><span class="NLM_x">–</span> <span class="NLM_lpage">6909</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2013.09.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6893-6909&author=N.+Razzaghi-Aslauthor=O.+Firuziauthor=B.+Hemmateenejadauthor=K.+Javidniaauthor=N.+Edrakiauthor=R.+Miri&title=Design+and+synthesis+of+novel+3%2C5-bis-N-%28aryl%2Fheteroaryl%29+carbamoyl-4-aryl-1%2C4-dihydropyridines+as+small+molecule+BACE-1+inhibitors&doi=10.1016%2Fj.bmc.2013.09.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DRazzaghi-Asl%26aufirst%3DN.%26aulast%3DFiruzi%26aufirst%3DO.%26aulast%3DHemmateenejad%26aufirst%3DB.%26aulast%3DJavidnia%26aufirst%3DK.%26aulast%3DEdraki%26aufirst%3DN.%26aulast%3DMiri%26aufirst%3DR.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%25203%252C5-bis-N-%2528aryl%252Fheteroaryl%2529%2520carbamoyl-4-aryl-1%252C4-dihydropyridines%2520as%2520small%2520molecule%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6893%26epage%3D6909%26doi%3D10.1016%2Fj.bmc.2013.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Jain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwa, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohilla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, H. R.</span><span> </span><span class="NLM_article-title">Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.11.044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=33-37&author=P.+Jainauthor=P.+K.+Wadhwaauthor=S.+Rohillaauthor=H.+R.+Jadhav&title=Rational+design%2C+synthesis+and+in+vitro+evaluation+of+allylidene+hydrazinecarboximidamide+derivatives+as+BACE-1+inhibitors&doi=10.1016%2Fj.bmcl.2015.11.044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DP.%26aulast%3DWadhwa%26aufirst%3DP.%2BK.%26aulast%3DRohilla%26aufirst%3DS.%26aulast%3DJadhav%26aufirst%3DH.%2BR.%26atitle%3DRational%2520design%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520allylidene%2520hydrazinecarboximidamide%2520derivatives%2520as%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D33%26epage%3D37%26doi%3D10.1016%2Fj.bmcl.2015.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Jain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwa, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunapati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, H. R.</span><span> </span><span class="NLM_article-title">Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2567</span><span class="NLM_x">–</span> <span class="NLM_lpage">2575</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2016.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=27102162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmtlegur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2567-2575&author=P.+Jainauthor=P.+K.+Wadhwaauthor=S.+Gunapatiauthor=H.+R.+Jadhav&title=Design%2C+synthesis+and+in+vitro+evaluation+studies+of+sulfonyl-amino-acetamides+as+small+molecule+BACE-1+inhibitors&doi=10.1016%2Fj.bmc.2016.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors</span></div><div class="casAuthors">Jain, Priti; Wadhwa, Pankaj K.; Gunapati, Sinduri; Jadhav, Hemant R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2567-2575</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of a series of sulfonyl-amino-acetamides as BACE-1 (β-secretase) inhibitors for the treatment of Alzheimer's disease is reported.  The derivs. were designed based on the docking simulation study, synthesized and assessed for BACE-1 inhibition in vitro.  The designed ligands revealed desired binding interactions with the catalytic aspartate dyad and occupancy of S1 and S2' active site regions.  These in silico results correlated well with in vitro activity.  Out of 33 compds. synthesized, 12 compds. showed significant inhibition at 10 μM concn.  The most active compd. I had IC50 of 7.90 μM against BACE-1, which was concomitant with results of in silico docking study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfyzGhzRcSZbVg90H21EOLACvtfcHk0likQ3QnHdl9VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmtlegur4%253D&md5=a56bc59e8476f0e13d82632052654e06</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DP.%26aulast%3DWadhwa%26aufirst%3DP.%2BK.%26aulast%3DGunapati%26aufirst%3DS.%26aulast%3DJadhav%26aufirst%3DH.%2BR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520studies%2520of%2520sulfonyl-amino-acetamides%2520as%2520small%2520molecule%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2567%26epage%3D2575%26doi%3D10.1016%2Fj.bmc.2016.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">De Tran, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bepary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H. J.</span><span> </span><span class="NLM_article-title">Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.11.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=51-54&author=Q.+De+Tranauthor=S.+Beparyauthor=G.+H.+Leeauthor=H.+Choauthor=W.+K.+Parkauthor=H.+J.+Lim&title=Synthesis+of+%283S%2C4S%29-4-aminopyrrolidine-3-ol+derivatives+and+biological+evaluation+for+their+BACE1+inhibitory+activities&doi=10.1016%2Fj.bmcl.2015.11.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BTran%26aufirst%3DQ.%26aulast%3DBepary%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DW.%2BK.%26aulast%3DLim%26aufirst%3DH.%2BJ.%26atitle%3DSynthesis%2520of%2520%25283S%252C4S%2529-4-aminopyrrolidine-3-ol%2520derivatives%2520and%2520biological%2520evaluation%2520for%2520their%2520BACE1%2520inhibitory%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D51%26epage%3D54%26doi%3D10.1016%2Fj.bmcl.2015.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Kacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Computational methods in the discovery and design of BACE-1 inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6095</span><span class="NLM_x">–</span> <span class="NLM_lpage">6111</span><span class="refDoi"> DOI: 10.2174/0929867311209066095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.2174%2F0929867311209066095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=23072352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1yrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=6095-6111&author=P.+Kackerauthor=G.+Bottegoniauthor=A.+Cavalli&title=Computational+methods+in+the+discovery+and+design+of+BACE-1+inhibitors&doi=10.2174%2F0929867311209066095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Computational methods in the discovery and design of BACE-1 inhibitors</span></div><div class="casAuthors">Kacker, P.; Bottegoni, G.; Cavalli, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">6095-6111</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  BACE-1 is a membrane assocd. aspartyl protease and is one of the enzymes responsible for the hydrolysis of the amyloid precursor protein.  Due to its central role in the generation of the amyloid-β peptide, it is considered as a primary drug target for Alzheimer's disease.  BACE-1 has been the focus of many drug discovery programs aimed at identifying inhibitors that effectively block this enzyme and trigger the sought therapeutic effects.  Thanks to the availability of a large no. of crystal structures of the catalytic domain of this enzyme, computational methods, ranging from mol. dynamics simulations, quantum mech. calcns. and ligand docking, have played a fundamental role in almost every hit discovery and hit optimization campaign performed on this target.  The present article reviews the latest computational modeling and drug discovery efforts that have been carried out on this target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi36YRvXfbJrVg90H21EOLACvtfcHk0lhC84rQenv2aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1yrsw%253D%253D&md5=73247b810fb9e673d360309ba68f6dc2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.2174%2F0929867311209066095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311209066095%26sid%3Dliteratum%253Aachs%26aulast%3DKacker%26aufirst%3DP.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DComputational%2520methods%2520in%2520the%2520discovery%2520and%2520design%2520of%2520BACE-1%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D6095%26epage%3D6111%26doi%3D10.2174%2F0929867311209066095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Hernández-Rodríguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa-Basurto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutiérrez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitorica, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosales-Hernández, M. C.</span><span> </span><span class="NLM_article-title">Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.ejmech.2016.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=27639619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFams7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=1142-1154&author=M.+Hern%C3%A1ndez-Rodr%C3%ADguezauthor=J.+Correa-Basurtoauthor=A.+Guti%C3%A9rrezauthor=J.+Vitoricaauthor=M.+C.+Rosales-Hern%C3%A1ndez&title=Asp32+and+Asp228+determine+the+selective+inhibition+of+BACE1+as+shown+by+docking+and+molecular+dynamics+simulations&doi=10.1016%2Fj.ejmech.2016.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations</span></div><div class="casAuthors">Hernandez-Rodriguez, Maricarmen; Correa-Basurto, Jose; Gutierrez, Antonia; Vitorica, Javier; Rosales-Hernandez, Martha C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1142-1154</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Inhibition of β-site amyloid-β-protein precursor cleaving enzyme 1 (BACE1) represents a promising approach for the treatment of Alzheimer's disease (AD).  However, the development of a selective BACE1 inhibitor is difficult due to its highly flexible catalytic site and homol. to other aspartic proteases, including BACE2 and Cathepsin D (CTSD).  Aiming to better understand the structural factors responsible for selective BACE1 inhibition, the authors performed alignment studies, mol. dynamics (MD) simulations and docking studies to explore the recognition of four selective BACE1 inhibitors by aspartyl proteases.  The results show that selective BACE1 inhibition may be due to the formation of strong electrostatic interactions with Asp32 and Asp228 and a large no. of hydrogen bonds, π-π and Van der Waals interactions with the amino acid residues located inside the catalytic cavity, which has different vol. and shape compared to BACE2 and CTSD.  Hindrance effects avoid the accommodation of ligands in the small catalytic site of BACE2, resulting in a lower affinity and the high cavity of CTSD results in the formation of a small no. of interactions with the ligands, although they show a similar binding mode with BACE1.  These results might help to rationalize the design of selective BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr79HaKwP_JxLVg90H21EOLACvtfcHk0lhC84rQenv2aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFams7nL&md5=4be6466e1222ef971bca4e3b5bd7affe</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez-Rodr%25C3%25ADguez%26aufirst%3DM.%26aulast%3DCorrea-Basurto%26aufirst%3DJ.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DA.%26aulast%3DVitorica%26aufirst%3DJ.%26aulast%3DRosales-Hern%25C3%25A1ndez%26aufirst%3DM.%2BC.%26atitle%3DAsp32%2520and%2520Asp228%2520determine%2520the%2520selective%2520inhibition%2520of%2520BACE1%2520as%2520shown%2520by%2520docking%2520and%2520molecular%2520dynamics%2520simulations%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D1142%26epage%3D1154%26doi%3D10.1016%2Fj.ejmech.2016.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span>Protein Data Bank. <a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a> (accessed February 1,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Data+Bank.+www.rcsb.org+%28accessed+February+1%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totrov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span> </span><span class="NLM_article-title">Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1021/jm8009958</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8009958" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=397-406&author=G.+Bottegoniauthor=I.+Kufarevaauthor=M.+Totrovauthor=R.+Abagyan&title=Four-dimensional+docking%3A+a+fast+and+accurate+account+of+discrete+receptor+flexibility+in+ligand+docking&doi=10.1021%2Fjm8009958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm8009958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8009958%26sid%3Dliteratum%253Aachs%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DFour-dimensional%2520docking%253A%2520a%2520fast%2520and%2520accurate%2520account%2520of%2520discrete%2520receptor%2520flexibility%2520in%2520ligand%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D397%26epage%3D406%26doi%3D10.1021%2Fjm8009958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Craig, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essex, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, K.</span><span> </span><span class="NLM_article-title">Ensemble docking into multiple crystallographically derived protein structures: an evaluation based on the statistical analysis of enrichments</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span><span class="refDoi"> DOI: 10.1021/ci900407c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci900407c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVChtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=511-524&author=I.+R.+Craigauthor=J.+W.+Essexauthor=K.+Spiegel&title=Ensemble+docking+into+multiple+crystallographically+derived+protein+structures%3A+an+evaluation+based+on+the+statistical+analysis+of+enrichments&doi=10.1021%2Fci900407c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Ensemble Docking into Multiple Crystallographically Derived Protein Structures: An Evaluation Based on the Statistical Analysis of Enrichments</span></div><div class="casAuthors">Craig, Ian R.; Essex, Jonathan W.; Spiegel, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-524</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Docking into multiple receptor conformations ("ensemble docking") has been proposed, and employed, in the hope that it may account for receptor flexibility in virtual screening and thus provide higher enrichments than docking into single rigid receptor structures.  The statistical analyses presented in this paper provide quant. evidence that in some cases docking into a crystallog. derived conformational ensemble does indeed yield better enrichment than docking into any of the individual members of the ensemble.  However, these "successful" ensembles account for only a minority of those examd. and it would not have been possible to prospectively predict their identity using only protein structural information.  A more frequently obsd. outcome is that the ensemble enrichment is higher than the mean of the enrichments provided by its individual members.  An addnl. and promising finding is that, if a set of known active compds. is available, an approach based on induced-fit docking appears to be a reliable way to construct ensembles which provide relatively high enrichments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsZjWjOe3d4rVg90H21EOLACvtfcHk0lgVM8TWYu6F8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVChtr8%253D&md5=4d83a7d8b4f4ad1b961a85e6b9e0ccb2</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fci900407c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900407c%26sid%3Dliteratum%253Aachs%26aulast%3DCraig%26aufirst%3DI.%2BR.%26aulast%3DEssex%26aufirst%3DJ.%2BW.%26aulast%3DSpiegel%26aufirst%3DK.%26atitle%3DEnsemble%2520docking%2520into%2520multiple%2520crystallographically%2520derived%2520protein%2520structures%253A%2520an%2520evaluation%2520based%2520on%2520the%2520statistical%2520analysis%2520of%2520enrichments%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D511%26epage%3D524%26doi%3D10.1021%2Fci900407c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Limongelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span> </span><span class="NLM_article-title">Ensemble-docking approach on BACE-1: pharmacophore perception and guidelines for drug design</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1002/cmdc.200600314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fcmdc.200600314" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=667-678&author=V.+Limongelliauthor=L.+Marinelliauthor=S.+Cosconatiauthor=H.+A.+Braunauthor=B.+Schmidtauthor=E.+Novellino&title=Ensemble-docking+approach+on+BACE-1%3A+pharmacophore+perception+and+guidelines+for+drug+design&doi=10.1002%2Fcmdc.200600314"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600314%26sid%3Dliteratum%253Aachs%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DBraun%26aufirst%3DH.%2BA.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DNovellino%26aufirst%3DE.%26atitle%3DEnsemble-docking%2520approach%2520on%2520BACE-1%253A%2520pharmacophore%2520perception%2520and%2520guidelines%2520for%2520drug%2520design%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D667%26epage%3D678%26doi%3D10.1002%2Fcmdc.200600314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Leva, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Protein flexibility in virtual screening: the BACE-1 case study</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2697</span><span class="NLM_x">–</span> <span class="NLM_lpage">2704</span><span class="refDoi"> DOI: 10.1021/ci300390h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300390h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2nsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2697-2704&author=S.+Cosconatiauthor=L.+Marinelliauthor=F.+S.+Di+Levaauthor=V.+La+Pietraauthor=A.+De+Simoneauthor=F.+Manciniauthor=V.+Andrisanoauthor=E.+Novellinoauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=Protein+flexibility+in+virtual+screening%3A+the+BACE-1+case+study&doi=10.1021%2Fci300390h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Flexibility in Virtual Screening: The BACE-1 Case Study</span></div><div class="casAuthors">Cosconati, Sandro; Marinelli, Luciana; Di Leva, Francesco Saverio; La Pietra, Valeria; De Simone, Angela; Mancini, Francesca; Andrisano, Vincenza; Novellino, Ettore; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2697-2704</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Simulating protein flexibility is a major issue in the docking-based drug-design process for which a single methodol. soln. does not exist.  In our search of new anti-Alzheimer ligands, we were faced with the challenge of including receptor plasticity in a virtual screening campaign aimed at finding new β-secretase inhibitors.  To this aim, we incorporated protein flexibility in our simulations by using an ensemble of static x-ray enzyme structures to screen the National Cancer Institute database.  A unified description of the protein motion was also generated by computing and combining a set of grid maps using an energy weighting scheme.  Such a description was used in an energy-weighted virtual screening expt. on the same mol. database.  Assessment of the enrichment factors from these two virtual screening approaches demonstrated comparable predictive powers, with the energy-weighted method being faster than the ensemble method.  The in vitro evaluation demonstrated that out of the 32 tested ligands, 17 featured the predicted enzyme inhibiting property.  Such an impressive success rate (53.1%) demonstrates the enhanced power of the two methodologies and suggests that energy-weighted virtual screening is a more than valid alternative to ensemble virtual screening given its reduced computational demands and comparable performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot7N2e88apQrVg90H21EOLACvtfcHk0ljvkqs163Ibdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2nsLfJ&md5=531464b7df392cc788caf01e9c7f6c48</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fci300390h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300390h%26sid%3Dliteratum%253Aachs%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DDi%2BLeva%26aufirst%3DF.%2BS.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DProtein%2520flexibility%2520in%2520virtual%2520screening%253A%2520the%2520BACE-1%2520case%2520study%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D2697%26epage%3D2704%26doi%3D10.1021%2Fci300390h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Dominguez, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopeit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villaverde, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otero, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nystrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraznenok, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, F.</span><span> </span><span class="NLM_article-title">Effect of the protonation state of the titratable residues on the inhibitor affinity to BACE-1</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7263</span><span class="refDoi"> DOI: 10.1021/bi100637n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi100637n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslKjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=7255-7263&author=J.+L.+Dominguezauthor=T.+Christopeitauthor=M.+C.+Villaverdeauthor=T.+Gossasauthor=J.+M.+Oteroauthor=S.+Nystromauthor=V.+Baraznenokauthor=E.+Lindstromauthor=U.+H.+Danielsonauthor=F.+Sussman&title=Effect+of+the+protonation+state+of+the+titratable+residues+on+the+inhibitor+affinity+to+BACE-1&doi=10.1021%2Fbi100637n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the Protonation State of the Titratable Residues on the Inhibitor Affinity to BACE-1</span></div><div class="casAuthors">Dominguez, Jose L.; Christopeit, Tony; Villaverde, M. Carmen; Gossas, Thomas; Otero, Jose M.; Nystrom, Susanne; Baraznenok, Vera; Lindstrom, Erik; Danielson, U. Helena; Sussman, Fredy</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7255-7263</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE-1 is one of the aspartic proteases involved in the cleavage of β amyloid peptide, an initial step in the formation of amyloid plaques whose toxicity induces neuron death in Alzheimer's disease patients.  One of the central issues in the search of novel BACE-1 inhibitors is the optimum pH for the binding of inhibitors to the enzyme.  It is known that the enzyme has optimal catalytic activity at acidic pH, while cell active inhibitors may bind optimally at higher pH.  In this work we det. the effect of the pH on the affinities of a set of inhibitors, with a variety of chem. motifs, for the ectodomain region of BACE-1 by a surface plasmon resonance (SPR) biosensor based assay.  In order to understand the mol. interactions that underlie the diverse optimum pH for the binding of the various inhibitors as obsd. exptl., we have calcd. the titrn. curves for a set of BACE-1 ligand complexes.  The results indicate that the pKa values of the titratable residues of the protein depend on the nature of the ligand involved, in disagreement with previous work.  The enzyme-inhibitor structures with the resulting protonation states at pH values 4.5 and 7.4 served as the starting point for the prediction of the pH-dependent binding ranking.  Our calcns. reproduced the entire affinity ranking obsd. upon pH increase and most of the binding trends among inhibitors, esp. at low pH.  Finally, our cell-based assays indicate a possible correlation between high inhibitor affinity at both acidic and neutral pH values, with optimal cell response, a result that may open new venues for the search of potent BACE-1 inhibitors that are active at the cellular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprMAi9258abLVg90H21EOLACvtfcHk0ljvkqs163Ibdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslKjsro%253D&md5=17d462cc2666acaa43f6e48f3d757847</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fbi100637n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi100637n%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DJ.%2BL.%26aulast%3DChristopeit%26aufirst%3DT.%26aulast%3DVillaverde%26aufirst%3DM.%2BC.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DOtero%26aufirst%3DJ.%2BM.%26aulast%3DNystrom%26aufirst%3DS.%26aulast%3DBaraznenok%26aufirst%3DV.%26aulast%3DLindstrom%26aufirst%3DE.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSussman%26aufirst%3DF.%26atitle%3DEffect%2520of%2520the%2520protonation%2520state%2520of%2520the%2520titratable%2520residues%2520on%2520the%2520inhibitor%2520affinity%2520to%2520BACE-1%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D7255%26epage%3D7263%26doi%3D10.1021%2Fbi100637n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Polgar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Virtual screening for beta-secretase (BACE1) inhibitors reveals the importance of protonation states at Asp32 and Asp228</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3749</span><span class="NLM_x">–</span> <span class="NLM_lpage">3755</span><span class="refDoi"> DOI: 10.1021/jm049133b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049133b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3749-3755&author=T.+Polgarauthor=G.+M.+Keseru&title=Virtual+screening+for+beta-secretase+%28BACE1%29+inhibitors+reveals+the+importance+of+protonation+states+at+Asp32+and+Asp228&doi=10.1021%2Fjm049133b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm049133b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049133b%26sid%3Dliteratum%253Aachs%26aulast%3DPolgar%26aufirst%3DT.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DVirtual%2520screening%2520for%2520beta-secretase%2520%2528BACE1%2529%2520inhibitors%2520reveals%2520the%2520importance%2520of%2520protonation%2520states%2520at%2520Asp32%2520and%2520Asp228%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3749%26epage%3D3755%26doi%3D10.1021%2Fjm049133b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Barman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, R.</span><span> </span><span class="NLM_article-title">Protonation states of the catalytic dyad of beta-secretase (BACE1) in the presence of chemically diverse inhibitors: a molecular docking study</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span><span class="refDoi"> DOI: 10.1021/ci200611t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200611t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1OqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1275-1287&author=A.+Barmanauthor=R.+Prabhakar&title=Protonation+states+of+the+catalytic+dyad+of+beta-secretase+%28BACE1%29+in+the+presence+of+chemically+diverse+inhibitors%3A+a+molecular+docking+study&doi=10.1021%2Fci200611t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Protonation States of the Catalytic Dyad of β-Secretase (BACE1) in the Presence of Chemically Diverse Inhibitors: A Molecular Docking Study</span></div><div class="casAuthors">Barman, Arghya; Prabhakar, Rajeev</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1275-1287</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this mol. docking study, the protonation states of the catalytic Asp dyad of the beta-secretase (BACE1) enzyme in the presence of eight chem. diverse inhibitors have been predicted.  BACE1 catalyzes the rate-detg. step in the generation of Alzheimer amyloid beta peptides and is widely considered as a promising therapeutic target.  All the inhibitors were redocked into their corresponding x-ray structures using a combination of eight different protonation states of the Asp dyad for each inhibitor.  Five inhibitors were primarily found to favor two different monoprotonated states, and the remaining three favor a dideprotonated state.  In addn., five of them exhibited secondary preference for a diprotonated state.  These results show that the knowledge of a single protonation state of the Asp dyad is not sufficient to search for the novel inhibitors of BACE1 and the most plausible state for each inhibitor must be detd. prior to conducting in-silico screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ324QbyXbT7Vg90H21EOLACvtfcHk0ljvTtx3n-_ARg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1OqtL0%253D&md5=6a18e71bfe8af60e73b8a4e4775f317f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fci200611t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200611t%26sid%3Dliteratum%253Aachs%26aulast%3DBarman%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DR.%26atitle%3DProtonation%2520states%2520of%2520the%2520catalytic%2520dyad%2520of%2520beta-secretase%2520%2528BACE1%2529%2520in%2520the%2520presence%2520of%2520chemically%2520diverse%2520inhibitors%253A%2520a%2520molecular%2520docking%2520study%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1275%26epage%3D1287%26doi%3D10.1021%2Fci200611t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Dominguez, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villaverde, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, F.</span><span> </span><span class="NLM_article-title">Effect of pH and ligand charge state on BACE-1 fragment docking performance</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span><span class="refDoi"> DOI: 10.1007/s10822-013-9653-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1007%2Fs10822-013-9653-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=403-417&author=J.+L.+Dominguezauthor=M.+C.+Villaverdeauthor=F.+Sussman&title=Effect+of+pH+and+ligand+charge+state+on+BACE-1+fragment+docking+performance&doi=10.1007%2Fs10822-013-9653-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9653-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9653-7%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DJ.%2BL.%26aulast%3DVillaverde%26aufirst%3DM.%2BC.%26aulast%3DSussman%26aufirst%3DF.%26atitle%3DEffect%2520of%2520pH%2520and%2520ligand%2520charge%2520state%2520on%2520BACE-1%2520fragment%2520docking%2520performance%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D403%26epage%3D417%26doi%3D10.1007%2Fs10822-013-9653-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veronesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Development and application of a virtual screening protocol for the identification of multitarget fragments</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span><span class="refDoi"> DOI: 10.1002/cmdc.201500521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fcmdc.201500521" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1259-1263&author=G.+Bottegoniauthor=M.+Veronesiauthor=P.+Bisignanoauthor=P.+Kackerauthor=A.+D.+Faviaauthor=A.+Cavalli&title=Development+and+application+of+a+virtual+screening+protocol+for+the+identification+of+multitarget+fragments&doi=10.1002%2Fcmdc.201500521"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500521%26sid%3Dliteratum%253Aachs%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DKacker%26aufirst%3DP.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DDevelopment%2520and%2520application%2520of%2520a%2520virtual%2520screening%2520protocol%2520for%2520the%2520identification%2520of%2520multitarget%2520fragments%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1259%26epage%3D1263%26doi%3D10.1002%2Fcmdc.201500521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Kacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Combining dyad protonation and active site plasticity in BACE-1 structure-based drug design</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1085</span><span class="refDoi"> DOI: 10.1021/ci200366z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200366z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVOjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1079-1085&author=P.+Kackerauthor=M.+Masettiauthor=M.+Mangoldauthor=G.+Bottegoniauthor=A.+Cavalli&title=Combining+dyad+protonation+and+active+site+plasticity+in+BACE-1+structure-based+drug+design&doi=10.1021%2Fci200366z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Dyad Protonation and Active Site Plasticity in BACE-1 Structure-Based Drug Design</span></div><div class="casAuthors">Kacker, Puneet; Masetti, Matteo; Mangold, Martina; Bottegoni, Giovanni; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1079-1085</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ability of the BACE-1 catalytic dyad to adopt multiple protonation states and the conformational flexibility of the active site have hampered the reliability of computational screening campaigns carried out on this drug target for Alzheimer's disease.  Here, we propose a protocol that, for the first time, combining quantum mech. calcns., mol. dynamics, and conformational ensemble virtual ligand screening addresses these issues simultaneously.  The encouraging results prefigure this approach as a valuable tool for future drug discovery campaigns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKRhdkbh-ZUbVg90H21EOLACvtfcHk0lhppy3Zo86XQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVOjtro%253D&md5=6e718d38ed3c4fa24820b33161183b78</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fci200366z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200366z%26sid%3Dliteratum%253Aachs%26aulast%3DKacker%26aufirst%3DP.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DMangold%26aufirst%3DM.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DCombining%2520dyad%2520protonation%2520and%2520active%2520site%2520plasticity%2520in%2520BACE-1%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1079%26epage%3D1085%26doi%3D10.1021%2Fci200366z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.1002/med.20132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fmed.20132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=18651582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=295-338&author=R.+Silvestri&title=Boom+in+the+development+of+non-peptidic+beta-secretase+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fmed.20132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-338</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  β-Amyloid cleaving enzyme-1 (BACE1) has become a significant target for the therapy of Alzheimer's disease.  After the discovery of the first non-peptidomimetic β-secretase inhibitors by Takeda Chems. in 2001, several research teams focused on SAR development of these agents.  The non-peptidic BACE1 inhibitors may potentially overcome the classical problems assocd. with the peptide structure of first generation, such as blood-brain barrier crossing, poor oral bioavailability and susceptibility to P-glycoprotein transport.  In the past 6 years a boom in research of non-peptidic BACE1 inhibitors has disseminated findings over hundreds of publications and patents.  The rapidly growing literature has been reviewed with particular emphasis on literature of pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpbmzl8ONz3LVg90H21EOLACvtfcHk0lhppy3Zo86XQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D&md5=1e92f25f055def1c1c56b3650f4cc40a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2Fmed.20132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20132%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DBoom%2520in%2520the%2520development%2520of%2520non-peptidic%2520beta-secretase%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D295%26epage%3D338%26doi%3D10.1002%2Fmed.20132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span> </span><span class="NLM_article-title">Determination of the active site protonation state of beta-secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">16416</span><span class="NLM_x">–</span> <span class="NLM_lpage">16422</span><span class="refDoi"> DOI: 10.1021/ja0304493</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0304493" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=16416-16422&author=H.+Parkauthor=S.+Lee&title=Determination+of+the+active+site+protonation+state+of+beta-secretase+from+molecular+dynamics+simulation+and+docking+experiment%3A+implications+for+structure-based+inhibitor+design&doi=10.1021%2Fja0304493"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fja0304493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0304493%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DDetermination%2520of%2520the%2520active%2520site%2520protonation%2520state%2520of%2520beta-secretase%2520from%2520molecular%2520dynamics%2520simulation%2520and%2520docking%2520experiment%253A%2520implications%2520for%2520structure-based%2520inhibitor%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D16416%26epage%3D16422%26doi%3D10.1021%2Fja0304493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Mongan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span> </span><span class="NLM_article-title">Constant pH molecular dynamics in generalized Born implicit solvent</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2038</span><span class="NLM_x">–</span> <span class="NLM_lpage">2048</span><span class="refDoi"> DOI: 10.1002/jcc.20139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fjcc.20139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=15481090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVylsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=2038-2048&author=J.+Monganauthor=D.+A.+Caseauthor=J.+A.+McCammon&title=Constant+pH+molecular+dynamics+in+generalized+Born+implicit+solvent&doi=10.1002%2Fjcc.20139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Constant pH molecular dynamics in generalized Born implicit solvent</span></div><div class="casAuthors">Mongan, John; Case, David A.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2038-2048</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A new method is proposed for const. pH mol. dynamics (MD), employing generalized Born (GB) electrostatics.  Protonation states are modeled with different charge sets, and titrating residues sample a Boltzmann distribution of protonation states as the simulation progresses, using Monte Carlo sampling based on GB-derived energies.  The method is applied to four different crystal structures of hen egg-white lysozyme (HEWL).  PKa predictions derived from the simulations have root-mean-square (RMS) error of 0.82 relative to exptl. values.  Similarity of results between the four crystal structures shows the method to be independent of starting crystal structure; this is in contrast to most electrostatics-only models.  A strong correlation between conformation and protonation state is noted and quant. analyzed, emphasizing the importance of sampling protonation states in conjunction with dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25O2HS8zlebVg90H21EOLACvtfcHk0lgQLBK1DPNIkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVylsb0%253D&md5=d59be32638bb1c3def2cefdf594df47b</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20139%26sid%3Dliteratum%253Aachs%26aulast%3DMongan%26aufirst%3DJ.%26aulast%3DCase%26aufirst%3DD.%2BA.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DConstant%2520pH%2520molecular%2520dynamics%2520in%2520generalized%2520Born%2520implicit%2520solvent%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D2038%26epage%3D2048%26doi%3D10.1002%2Fjcc.20139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Itoh, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damjanović, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, B. R.</span><span> </span><span class="NLM_article-title">pH replica-exchange method based on discrete protonation states</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">3420</span><span class="NLM_x">–</span> <span class="NLM_lpage">3436</span><span class="refDoi"> DOI: 10.1002/prot.23176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fprot.23176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22002801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVektrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=3420-3436&author=S.+G.+Itohauthor=A.+Damjanovi%C4%87author=B.+R.+Brooks&title=pH+replica-exchange+method+based+on+discrete+protonation+states&doi=10.1002%2Fprot.23176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">pH replica-exchange method based on discrete protonation states</span></div><div class="casAuthors">Itoh, Satoru G.; Damjanovic, Ana; Brooks, Bernard R.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3420-3436</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The authors propose a new algorithm for obtaining proton titrn. curves of ionizable residues.  The algorithm is a pH replica-exchange method (PHREM), which is based on the const. pH algorithm of J. Mongan et al. (2004).  In the original replica-exchange method, simulations of different replicas are performed at different temps., and the temps. are exchanged between the replicas.  In the authors' PHREM, simulations of different replicas are performed at different pH values, and the pHs are exchanged between the replicas.  The PHREM was applied to a blocked amino acid and to two protein systems (snake cardiotoxin and turkey ovomucoid third domain), in conjunction with a generalized Born implicit solvent.  The performance and accuracy of this algorithm and the original const. pH method (PHMD) were compared.  For a single set of simulations at different pHs, the use of PHREM yields more accurate Hill coeffs. of titratable residues.  By performing multiple sets of const. pH simulations started with different initial states, the accuracy of predicted pKa values and Hill coeffs. obtained with PHREM and PHMD methods becomes comparable.  However, the PHREM algorithm exhibits better samplings of the protonation states of titratable residues and less scatter of the titrn. points and thus better precision of measured pKa values and Hill coeffs.  In addn., PHREM exhibits faster convergence of individual simulations than the original const. pH algorithm.  Proteins 2011; © 2011 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFZWUDme4fTrVg90H21EOLACvtfcHk0lg_rPpQfsKUAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVektrvM&md5=35718b888a8b98b999af0d4a34c824bf</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fprot.23176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.23176%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DS.%2BG.%26aulast%3DDamjanovi%25C4%2587%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26atitle%3DpH%2520replica-exchange%2520method%2520based%2520on%2520discrete%2520protonation%2520states%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2011%26volume%3D79%26spage%3D3420%26epage%3D3436%26doi%3D10.1002%2Fprot.23176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Swails, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roitberg, A. E.</span><span> </span><span class="NLM_article-title">Enhancing conformation and protonation state sampling of hen egg white lysozyme using pH replica exchange molecular dynamics</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">4393</span><span class="NLM_x">–</span> <span class="NLM_lpage">4404</span><span class="refDoi"> DOI: 10.1021/ct300512h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300512h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OksL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=4393-4404&author=J.+M.+Swailsauthor=A.+E.+Roitberg&title=Enhancing+conformation+and+protonation+state+sampling+of+hen+egg+white+lysozyme+using+pH+replica+exchange+molecular+dynamics&doi=10.1021%2Fct300512h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Conformation and Protonation State Sampling of Hen Egg White Lysozyme Using pH Replica Exchange Molecular Dynamics</span></div><div class="casAuthors">Swails, Jason M.; Roitberg, Adrian E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4393-4404</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We evaluate the efficiency of the pH replica exchange mol. dynamics (pH-REMD) method proposed by Itoh et al. (Proteins 2011, 79, 3420-3436) by using it to predict the pKa values of the titratable residues in hen egg white lysozyme (HEWL).  PKa values predicted using pH-REMD converge significantly faster than those calcd. using const. pH mol. dynamics (CpHMD).  Furthermore, increasing the frequency between exchange attempts in pH-REMD simulations improves protonation and conformational state sampling.  By enabling the simulation to sample both conformational and protonation states more rapidly, pH-REMD simulations provide valuable insight into the pH-dependence of HEWL that the CpHMD simulations failed to capture.  We present an efficient and highly scalable implementation of pH-REMD as an attractive enhancement to traditional CpHMD methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqclVg3r5a-ubVg90H21EOLACvtfcHk0liWR39K8MhRsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OksL3E&md5=ed9dd8ac07eaa488cd069c226091bef3</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fct300512h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300512h%26sid%3Dliteratum%253Aachs%26aulast%3DSwails%26aufirst%3DJ.%2BM.%26aulast%3DRoitberg%26aufirst%3DA.%2BE.%26atitle%3DEnhancing%2520conformation%2520and%2520protonation%2520state%2520sampling%2520of%2520hen%2520egg%2520white%2520lysozyme%2520using%2520pH%2520replica%2520exchange%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D4393%26epage%3D4404%26doi%3D10.1021%2Fct300512h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Ellis, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">pH-dependent population shift regulates BACE1 activity and inhibition</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">9543</span><span class="NLM_x">–</span> <span class="NLM_lpage">9546</span><span class="refDoi"> DOI: 10.1021/jacs.5b05891</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b05891" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyqsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=9543-9546&author=C.+R.+Ellisauthor=J.+Shen&title=pH-dependent+population+shift+regulates+BACE1+activity+and+inhibition&doi=10.1021%2Fjacs.5b05891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Dependent Population Shift Regulates BACE1 Activity and Inhibition</span></div><div class="casAuthors">Ellis, Christopher R.; Shen, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9543-9546</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1, a major therapeutic target for treatment of Alzheimer's disease, functions within a narrow pH range.  Despite tremendous effort and progress in the development of BACE1 inhibitors, details of the underlying pH-dependent regulatory mechanism remain unclear.  Here the authors elucidate the pH-dependent conformational mechanism that regulates BACE1 activity using continuous const.-pH mol. dynamics (MD).  The simulations reveal that BACE1 mainly occupies three conformational states and that the relative populations of the states shift according to pH.  At intermediate pH, when the catalytic dyad is monoprotonated, a binding-competent state is highly populated, while at low and high pH a Tyr-inhibited state is dominant.  The authors' data provide strong evidence supporting conformational selection as a major mechanism for substrate and peptide-inhibitor binding.  These new insights, while consistent with expt., greatly extend the knowledge of BACE1 and have implications for further optimization of inhibitors and understanding potential side effects of targeting BACE1.  Finally, the work highlights the importance of properly modeling protonation states in MD simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCblGrLaicdLVg90H21EOLACvtfcHk0liWR39K8MhRsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyqsL%252FM&md5=a7d2efc129a95da28e647bcaad8c857e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b05891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b05891%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DC.%2BR.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DpH-dependent%2520population%2520shift%2520regulates%2520BACE1%2520activity%2520and%2520inhibition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D9543%26epage%3D9546%26doi%3D10.1021%2Fjacs.5b05891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Kim, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blachly, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span> </span><span class="NLM_article-title">Conformational dynamics and binding free energies of inhibitors of BACE-1: from the perspective of protonation equilibria</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1004341</span><span class="refDoi"> DOI: 10.1371/journal.pcbi.1004341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1371%2Fjournal.pcbi.1004341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1004341&author=M.+O.+Kimauthor=P.+G.+Blachlyauthor=J.+A.+McCammon&title=Conformational+dynamics+and+binding+free+energies+of+inhibitors+of+BACE-1%3A+from+the+perspective+of+protonation+equilibria&doi=10.1371%2Fjournal.pcbi.1004341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1004341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1004341%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BO.%26aulast%3DBlachly%26aufirst%3DP.%2BG.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DConformational%2520dynamics%2520and%2520binding%2520free%2520energies%2520of%2520inhibitors%2520of%2520BACE-1%253A%2520from%2520the%2520perspective%2520of%2520protonation%2520equilibria%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3De1004341%26doi%3D10.1371%2Fjournal.pcbi.1004341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Ellis, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Constant pH molecular dynamics reveals pH-modulated binding of two small-molecule BACE1 inhibitors</span> <span class="citation_source-journal">J. Phys. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">944</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span><span class="refDoi"> DOI: 10.1021/acs.jpclett.6b00137</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jpclett.6b00137" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFOltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=944-949&author=C.+R.+Ellisauthor=C.-C.+Tsaiauthor=X.+Houauthor=J.+Shen&title=Constant+pH+molecular+dynamics+reveals+pH-modulated+binding+of+two+small-molecule+BACE1+inhibitors&doi=10.1021%2Facs.jpclett.6b00137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Constant pH Molecular Dynamics Reveals pH-Modulated Binding of Two Small-Molecule BACE1 Inhibitors</span></div><div class="casAuthors">Ellis, Christopher R.; Tsai, Cheng-Chieh; Hou, Xinjun; Shen, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">944-949</span>CODEN:
                <span class="NLM_cas:coden">JPCLCD</span>;
        ISSN:<span class="NLM_cas:issn">1948-7185</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeting β-secretase (BACE1) with small-mol. inhibitors offers a promising route for treatment of Alzheimer's disease.  However, the intricate pH dependence of BACE1 function and inhibitor efficacy has posed major challenges for structure-based drug design.  Here we investigate two structurally similar BACE1 inhibitors that have dramatically different inhibitory activity using continuous const. pH mol. dynamics (CpHMD).  At high pH, both inhibitors are stably bound to BACE1; however, within the enzyme active pH range, only the iminopyrimidinone-based inhibitor remains bound, while the aminothiazine-based inhibitor becomes partially dissocd. following the loss of hydrogen bonding with the active site and change of the 10s loop conformation.  The drastically lower activity of the second inhibitor is due to the protonation of a catalytic aspartate and the lack of a propyne tail.  This work demonstrates that CpHMD can be used for screening pH-dependent binding profiles of small-mol. inhibitors, providing a new tool for structure-based drug design and optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvwJYDdO8MHrVg90H21EOLACvtfcHk0lgvtsXAiWldeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFOltrY%253D&md5=7305c7884d26f2c841c2bd47e5c8032d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facs.jpclett.6b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jpclett.6b00137%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DC.%2BR.%26aulast%3DTsai%26aufirst%3DC.-C.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DConstant%2520pH%2520molecular%2520dynamics%2520reveals%2520pH-modulated%2520binding%2520of%2520two%2520small-molecule%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Phys.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D944%26epage%3D949%26doi%3D10.1021%2Facs.jpclett.6b00137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Chodera, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirts, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pande, V. S.</span><span> </span><span class="NLM_article-title">Alchemical free energy methods for drug discovery: progress and challenges</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1016/j.sbi.2011.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.sbi.2011.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=21349700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Kisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=150-160&author=J.+D.+Choderaauthor=D.+L.+Mobleyauthor=M.+R.+Shirtsauthor=R.+W.+Dixonauthor=K.+Bransonauthor=V.+S.+Pande&title=Alchemical+free+energy+methods+for+drug+discovery%3A+progress+and+challenges&doi=10.1016%2Fj.sbi.2011.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Alchemical free energy methods for drug discovery: Progress and challenges</span></div><div class="casAuthors">Chodera, John D.; Mobley, David L.; Shirts, Michael R.; Dixon, Richard W.; Branson, Kim; Pande, Vijay S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-160</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Improved rational drug design methods are needed to lower the cost and increase the success rate of drug discovery and development.  Alchem. binding free energy calcns., one potential tool for rational design, have progressed rapidly over the past decade, but still fall short of providing robust tools for pharmaceutical engineering.  Recent studies, esp. on model receptor systems, have clarified many of the challenges that must be overcome for robust predictions of binding affinity to be useful in rational design.  In this review, inspired by a recent joint academic/industry meeting organized by the authors, we discuss these challenges and suggest a no. of promising approaches for overcoming them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobUBHsGUCIWLVg90H21EOLACvtfcHk0lgvtsXAiWldeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Kisrk%253D&md5=fa17c0982d921cd1c32cd095fd34420e</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2011.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2011.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DChodera%26aufirst%3DJ.%2BD.%26aulast%3DMobley%26aufirst%3DD.%2BL.%26aulast%3DShirts%26aufirst%3DM.%2BR.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DBranson%26aufirst%3DK.%26aulast%3DPande%26aufirst%3DV.%2BS.%26atitle%3DAlchemical%2520free%2520energy%2520methods%2520for%2520drug%2520discovery%253A%2520progress%2520and%2520challenges%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D150%26epage%3D160%26doi%3D10.1016%2Fj.sbi.2011.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Ciordia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Benito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Application of free energy perturbation for the design of BACE1 inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1871</span><span class="refDoi"> DOI: 10.1021/acs.jcim.6b00220</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00220" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12mu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1856-1871&author=M.+Ciordiaauthor=L.+P%C3%A9rez-Benitoauthor=F.+Delgadoauthor=A.+A.+Trabancoauthor=G.+Tresadern&title=Application+of+free+energy+perturbation+for+the+design+of+BACE1+inhibitors&doi=10.1021%2Facs.jcim.6b00220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Free Energy Perturbation for the Design of BACE1 Inhibitors</span></div><div class="casAuthors">Ciordia, Myriam; Perez-Benito, Laura; Delgado, Francisca; Trabanco, Andres A.; Tresadern, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1856-1871</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel spiroaminodihydropyrroles probing for optimized interactions at the P3 pocket of β-secretase 1 (BACE1) were designed with the use of free energy perturbation (FEP) calcns.  The resulting mols. showed pIC50 potencies in enzymic BACE1 inhibition assays ranging from approx. 5 to 7.  Good correlation was obsd. between the predicted activity from the FEP calcns. and exptl. activity.  Simulations run with a default 5 ns approach delivered a mean unsigned error (MUE) between prediction and expt. of 0.58 and 0.91 kcal/mol for retrospective and prospective applications, resp.  With longer simulations of 10 and 20 ns, the MUE was in both cases 0.57 kcal/mol for the retrospective application, and 0.69 and 0.59 kcal/mol for the prospective application.  Other considerations that impact the quality of the calcns. are discussed.  This work provides an example of the value of FEP as a computational tool for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqpi-OiII-FrVg90H21EOLACvtfcHk0ljox9moNWcV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12mu7%252FK&md5=b7577a89492867fc334cb1ec937a4eb6</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00220%26sid%3Dliteratum%253Aachs%26aulast%3DCiordia%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez-Benito%26aufirst%3DL.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DApplication%2520of%2520free%2520energy%2520perturbation%2520for%2520the%2520design%2520of%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2016%26volume%3D56%26spage%3D1856%26epage%3D1871%26doi%3D10.1021%2Facs.jcim.6b00220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Keranen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Benito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciordia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbrecher, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Vlijmen, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Acylguanidine beta secretase 1 inhibitors: a combined experimental and free energy perturbation study</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1439</span><span class="NLM_x">–</span> <span class="NLM_lpage">1453</span><span class="refDoi"> DOI: 10.1021/acs.jctc.6b01141</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.6b01141" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1ehsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1439-1453&author=H.+Keranenauthor=L.+Perez-Benitoauthor=M.+Ciordiaauthor=F.+Delgadoauthor=T.+B.+Steinbrecherauthor=D.+Oehlrichauthor=H.+W.+van+Vlijmenauthor=A.+A.+Trabancoauthor=G.+Tresadern&title=Acylguanidine+beta+secretase+1+inhibitors%3A+a+combined+experimental+and+free+energy+perturbation+study&doi=10.1021%2Facs.jctc.6b01141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Acylguanidine Beta Secretase 1 Inhibitors: A Combined Experimental and Free Energy Perturbation Study</span></div><div class="casAuthors">Keranen, Henrik; Perez-Benito, Laura; Ciordia, Myriam; Delgado, Francisca; Steinbrecher, Thomas B.; Oehlrich, Daniel; van Vlijmen, Herman W. T.; Trabanco, Andres A.; Tresadern, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1439-1453</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acylguanidine beta secretase 1 (BACE1) inhibitors with modified scaffold and P3 pocket substituent was synthesized and studied with Free Energy Perturbation (FEP) calcns.  The resulting mols. showed potencies in enzymic BACE1 inhibition assays up to 1 nM.  The correlation between the predicted activity from the FEP calcns. and the exptl. activity was good for the P3 pocket substituents.  The av. mean unsigned error (MUE) between prediction and expt. was 0.68±0.17 kcal/mol for the default 5 ns lambda window simulation time improving to 0.35±0.13 kcal/mol for 40 ns.  FEP calcns. for the P2' pocket substituents on the same acylguanidine scaffold also showed good agreement with expt. and the results remained stable with repeated simulations and increased simulation time.  It proved more difficult to use FEP calcns. to study the scaffold modification from increasing 5 to 6 and 7 membered-rings.  Although prediction and expt. were in agreement for short 2 ns simulations, as the simulation time increased the results diverged.  This was improved by the use of a newly developed 'Core Hopping FEP+' approach, which also showed improved stability in repeat calcns.  The origins of these differences along with the value of repeat and longer simulation times are discussed.  This work provides a further example of the use of FEP as a computational tool for mol. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmHZjygsk_PbVg90H21EOLACvtfcHk0ljox9moNWcV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1ehsrg%253D&md5=987ab8fc475670d0ba19aa086519a4ba</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.6b01141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.6b01141%26sid%3Dliteratum%253Aachs%26aulast%3DKeranen%26aufirst%3DH.%26aulast%3DPerez-Benito%26aufirst%3DL.%26aulast%3DCiordia%26aufirst%3DM.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DSteinbrecher%26aufirst%3DT.%2BB.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3Dvan%2BVlijmen%26aufirst%3DH.%2BW.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DAcylguanidine%2520beta%2520secretase%25201%2520inhibitors%253A%2520a%2520combined%2520experimental%2520and%2520free%2520energy%2520perturbation%2520study%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2017%26volume%3D13%26spage%3D1439%26epage%3D1453%26doi%3D10.1021%2Facs.jctc.6b01141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">De Vivo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Role of molecular dynamics and related methods in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4035</span><span class="NLM_x">–</span> <span class="NLM_lpage">4061</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4035-4061&author=M.+De+Vivoauthor=M.+Masettiauthor=G.+Bottegoniauthor=A.+Cavalli&title=Role+of+molecular+dynamics+and+related+methods+in+drug+discovery&doi=10.1021%2Facs.jmedchem.5b01684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Molecular Dynamics and Related Methods in Drug Discovery</span></div><div class="casAuthors">De Vivo, Marco; Masetti, Matteo; Bottegoni, Giovanni; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4035-4061</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. dynamics (MD) and related methods are close to becoming routine computational tools for drug discovery.  Their main advantage is in explicitly treating structural flexibility and entropic effects.  This allows a more accurate est. of the thermodn. and kinetics assocd. with drug-target recognition and binding, as better algorithms and hardware architectures increase their use.  Here, we review the theor. background of MD and enhanced sampling methods, focusing on free-energy perturbation, metadynamics, steered MD, and other methods most consistently used to study drug-target binding.  We discuss unbiased MD simulations that nowadays allow the observation of unsupervised ligand-target binding, assessing how these approaches help optimizing target affinity and drug residence time toward improved drug efficacy.  Further issues discussed include allosteric modulation and the role of water mols. in ligand binding and optimization.  We conclude by calling for more prospective studies to attest to these methods' utility in discovering novel drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQb_02a7Nmh7Vg90H21EOLACvtfcHk0ljox9moNWcV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWksLs%253D&md5=b3d8a4fb5705a3555c2bb2a962420396</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01684%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DRole%2520of%2520molecular%2520dynamics%2520and%2520related%2520methods%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4035%26epage%3D4061%26doi%3D10.1021%2Facs.jmedchem.5b01684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krilov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupyan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbrecher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span> </span><span class="NLM_article-title">Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">2695</span><span class="NLM_x">–</span> <span class="NLM_lpage">2703</span><span class="refDoi"> DOI: 10.1021/ja512751q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja512751q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2iuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=2695-2703&author=L.+Wangauthor=Y.+Wuauthor=Y.+Dengauthor=B.+Kimauthor=L.+Pierceauthor=G.+Krilovauthor=D.+Lupyanauthor=S.+Robinsonauthor=M.+K.+Dahlgrenauthor=J.+Greenwoodauthor=D.+L.+Romeroauthor=C.+Masseauthor=J.+L.+Knightauthor=T.+Steinbrecherauthor=T.+Beumingauthor=W.+Dammauthor=E.+Harderauthor=W.+Shermanauthor=M.+Brewerauthor=R.+Westerauthor=M.+Murckoauthor=L.+Fryeauthor=R.+Faridauthor=T.+Linauthor=D.+L.+Mobleyauthor=W.+L.+Jorgensenauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=R.+Abel&title=Accurate+and+reliable+prediction+of+relative+ligand+binding+potency+in+prospective+drug+discovery+by+way+of+a+modern+free-energy+calculation+protocol+and+force+field&doi=10.1021%2Fja512751q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field</span></div><div class="casAuthors">Wang, Lingle; Wu, Yujie; Deng, Yuqing; Kim, Byungchan; Pierce, Levi; Krilov, Goran; Lupyan, Dmitry; Robinson, Shaughnessy; Dahlgren, Markus K.; Greenwood, Jeremy; Romero, Donna L.; Masse, Craig; Knight, Jennifer L.; Steinbrecher, Thomas; Beuming, Thijs; Damm, Wolfgang; Harder, Ed; Sherman, Woody; Brewer, Mark; Wester, Ron; Murcko, Mark; Frye, Leah; Farid, Ramy; Lin, Teng; Mobley, David L.; Jorgensen, William L.; Berne, Bruce J.; Friesner, Richard A.; Abel, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2695-2703</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designing tight-binding ligands is a primary objective of small-mol. drug discovery.  Over the past few decades, free-energy calcns. have benefited from improved force fields and sampling algorithms, as well as the advent of low-cost parallel computing.  However, it has proven to be challenging to reliably achieve the level of accuracy that would be needed to guide lead optimization (∼5× in binding affinity) for a wide range of ligands and protein targets.  Not surprisingly, widespread com. application of free-energy simulations has been limited due to the lack of large-scale validation coupled with the tech. challenges traditionally assocd. with running these types of calcns.  Here, we report an approach that achieves an unprecedented level of accuracy across a broad range of target classes and ligands, with retrospective results encompassing 200 ligands and a wide variety of chem. perturbations, many of which involve significant changes in ligand chem. structures.  In addn., we have applied the method in prospective drug discovery projects and found a significant improvement in the quality of the compds. synthesized that have been predicted to be potent.  Compds. predicted to be potent by this approach have a substantial redn. in false positives relative to compds. synthesized on the basis of other computational or medicinal chem. approaches.  Furthermore, the results are consistent with those obtained from our retrospective studies, demonstrating the robustness and broad range of applicability of this approach, which can be used to drive decisions in lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9UtXEyLPpLVg90H21EOLACvtfcHk0lijKQGxPy-aog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2iuro%253D&md5=37a4f4a6c085f47ed531342643b6c33b</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fja512751q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja512751q%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DPierce%26aufirst%3DL.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DGreenwood%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DD.%2BL.%26aulast%3DMasse%26aufirst%3DC.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DSteinbrecher%26aufirst%3DT.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DBrewer%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DR.%26aulast%3DMurcko%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DL.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DMobley%26aufirst%3DD.%2BL.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DAbel%26aufirst%3DR.%26atitle%3DAccurate%2520and%2520reliable%2520prediction%2520of%2520relative%2520ligand%2520binding%2520potency%2520in%2520prospective%2520drug%2520discovery%2520by%2520way%2520of%2520a%2520modern%2520free-energy%2520calculation%2520protocol%2520and%2520force%2520field%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D2695%26epage%3D2703%26doi%3D10.1021%2Fja512751q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitaleri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saladino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gervasio, F. L.</span><span> </span><span class="NLM_article-title">Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span><span class="refDoi"> DOI: 10.1021/ar500356n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar500356n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2nt7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=277-285&author=A.+Cavalliauthor=A.+Spitaleriauthor=G.+Saladinoauthor=F.+L.+Gervasio&title=Investigating+drug-target+association+and+dissociation+mechanisms+using+metadynamics-based+algorithms&doi=10.1021%2Far500356n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating Drug-Target Association and Dissociation Mechanisms Using Metadynamics-Based Algorithms</span></div><div class="casAuthors">Cavalli, Andrea; Spitaleri, Andrea; Saladino, Giorgio; Gervasio, Francesco L.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Account highlights recent advances and discusses major challenges in the field of drug-target recognition, binding, and unbinding studied using metadynamics-based approaches, with particular emphasis on their role in structure-based design.  Computational chem. has significantly contributed to drug design and optimization in an extremely broad range of areas, including prediction of target druggability and drug likeness, de novo design, fragment screening, ligand docking, estn. of binding affinity, and modulation of ADMET (absorption, distribution, metab., excretion, toxicity) properties.  Computationally driven drug discovery must continuously adapt to keep pace with the evolving knowledge of the factors that modulate the pharmacol. action of drugs.  There is thus an urgent need for novel computational approaches that integrate the vast amt. of complex information currently available for small (bio)org. compds., biol. relevant targets and their complexes, while also accounting accurately for the thermodn. and kinetics of drug-target assocn., the intrinsic dynamical behavior of biomol. systems, and the complexity of protein-protein networks.  Understanding the mechanism of drug binding to and unbinding from biol. targets is fundamental for optimizing lead compds. and designing novel biol. active ones.  One major challenge is the accurate description of the conformational complexity prior to and upon formation of drug-target complexes.  Recently, enhanced sampling methods, including metadynamics and related approaches, have been successfully applied to investigate complex mechanisms of drugs binding to flexible targets.  Metadynamics is a family of enhanced sampling techniques aimed at enhancing the rare events and reconstructing the underlying free energy landscape as a function of a set of order parameters, usually referred to as collective variables.  Studies of drug binding mechanisms have predicted the most probable assocn. and dissocn. pathways and the related binding free energy profile.  In addn., the availability of an efficient open-source implementation, running on cost-effective GPU (i.e., graphical processor unit) architectures, has considerably decreased the learning curve and the computational costs of the methods, and increased their adoption by the community.  Here, we review the recent contributions of metadynamics and other enhanced sampling methods to the field of drug-target recognition and binding.  We discuss how metadynamics has been used to search for transition states, to predict binding and unbinding paths, to treat conformational flexibility, and to compute free energy profiles.  We highlight the importance of such predictions in drug discovery.  Major challenges in the field and possible solns. will finally be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-_m41iVArELVg90H21EOLACvtfcHk0lg7U1CLEuSh2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2nt7zL&md5=e3b79a23aca3a58914eb0bbf4d73306e</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Far500356n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far500356n%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DSpitaleri%26aufirst%3DA.%26aulast%3DSaladino%26aufirst%3DG.%26aulast%3DGervasio%26aufirst%3DF.%2BL.%26atitle%3DInvestigating%2520drug-target%2520association%2520and%2520dissociation%2520mechanisms%2520using%2520metadynamics-based%2520algorithms%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26spage%3D277%26epage%3D285%26doi%3D10.1021%2Far500356n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4186</span><span class="NLM_x">–</span> <span class="NLM_lpage">4189</span><span class="refDoi"> DOI: 10.1021/jm9810452</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9810452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4186-4189&author=C.+Melchiorreauthor=V.+Andrisanoauthor=M.+L.+Bolognesiauthor=R.+Budriesiauthor=A.+Cavalliauthor=V.+Cavriniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatini&title=Acetylcholinesterase+noncovalent+inhibitors+based+on+a+polyamine+backbone+for+potential+use+against+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm9810452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fjm9810452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9810452%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520noncovalent%2520inhibitors%2520based%2520on%2520a%2520polyamine%2520backbone%2520for%2520potential%2520use%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4186%26epage%3D4189%26doi%3D10.1021%2Fjm9810452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massenzio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Multitarget drug discovery for Alzheimer’s disease: triazinones as BACE-1 and GSK-3beta inhibitors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1002/anie.201410456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fanie.201410456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1578-1582&author=F.+Pratiauthor=A.+De+Simoneauthor=P.+Bisignanoauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=A.+D.+Faviaauthor=G.+Bottegoniauthor=A.+Martinezauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=Multitarget+drug+discovery+for+Alzheimer%E2%80%99s+disease%3A+triazinones+as+BACE-1+and+GSK-3beta+inhibitors&doi=10.1002%2Fanie.201410456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410456%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DMultitarget%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520triazinones%2520as%2520BACE-1%2520and%2520GSK-3beta%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1578%26epage%3D1582%26doi%3D10.1002%2Fanie.201410456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massenzio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatino, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the first dual BACE-1/GSK-3beta fragment hits against Alzheimer’s disease</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1665</span><span class="NLM_x">–</span> <span class="NLM_lpage">1682</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00121</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00121" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKkt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1665-1682&author=F.+Pratiauthor=A.+De+Simoneauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=S.+M.+Bertozziauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=P.+Sabatinoauthor=G.+Bottegoniauthor=A.+Martinezauthor=A.+Cavalliauthor=M.+L.+Bolognesi&title=3%2C4-Dihydro-1%2C3%2C5-triazin-2%281H%29-ones+as+the+first+dual+BACE-1%2FGSK-3beta+fragment+hits+against+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.5b00121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease</span></div><div class="casAuthors">Prati, Federica; De Simone, Angela; Armirotti, Andrea; Summa, Maria; Pizzirani, Daniela; Scarpelli, Rita; Bertozzi, Sine Mandrup; Perez, Daniel I.; Andrisano, Vincenza; Perez-Castillo, Ana; Monti, Barbara; Massenzio, Francesca; Polito, Letizia; Racchi, Marco; Sabatino, Piera; Bottegoni, Giovanni; Martinez, Ana; Cavalli, Andrea; Bolognesi, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1665-1682</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the main obstacles toward the discovery of effective anti-Alzheimer drugs is the multifactorial nature of its etiopathol.  Therefore, the use of multitarget-directed ligands has emerged as particularly suitable.  Such ligands, able to modulate different neurodegenerative pathways, for example, amyloid and tau cascades, as well as cognitive and neurogenic functions, are fostered to come.  In this respect, we report herein on the first class of BACE-1/GSK-3β dual inhibitors based on a 3,4-dihydro-1,3,5-triazin-2(1H)-one skeleton, whose hit compd. 1 showed interesting properties in a preliminary investigation.  Notably, compd. 2, endowed with well-balanced potencies against the two isolated enzymes (IC50 of 16 and 7 μM against BACE-1 and GSK-3β, resp.), displayed effective neuroprotective and neurogenic activities and no neurotoxicity in cell-based assays.  It also showed good brain permeability in a pharmacokinetic assessment in mice.  Overall, triazinone derivs., thanks to the simultaneous modulation of multiple points of the diseased network, might emerge as suitable candidates to be tested in in vivo Alzheimer's disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9gpkNszZOQ7Vg90H21EOLACvtfcHk0lg7U1CLEuSh2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKkt73O&md5=5d02342f3164a73e41eb17c4f87fb4fa</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00121%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DSabatino%26aufirst%3DP.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3D3%252C4-Dihydro-1%252C3%252C5-triazin-2%25281H%2529-ones%2520as%2520the%2520first%2520dual%2520BACE-1%252FGSK-3beta%2520fragment%2520hits%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1665%26epage%3D1682%26doi%3D10.1021%2Facschemneuro.5b00121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Di Martino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span> </span><span class="NLM_article-title">Versatility of the curcumin scaffold: discovery of potent and balanced dual BACE-1 and GSK-3beta inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00894</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00894" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=531-544&author=R.+M.+Di+Martinoauthor=A.+De+Simoneauthor=V.+Andrisanoauthor=P.+Bisignanoauthor=A.+Bisiauthor=S.+Gobbiauthor=A.+Rampaauthor=R.+Fatoauthor=C.+Bergaminiauthor=D.+I.+Perezauthor=A.+Martinezauthor=G.+Bottegoniauthor=A.+Cavalliauthor=F.+Belluti&title=Versatility+of+the+curcumin+scaffold%3A+discovery+of+potent+and+balanced+dual+BACE-1+and+GSK-3beta+inhibitors&doi=10.1021%2Facs.jmedchem.5b00894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors</span></div><div class="casAuthors">Di Martino, Rita Maria Concetta; De Simone, Angela; Andrisano, Vincenza; Bisignano, Paola; Bisi, Alessandra; Gobbi, Silvia; Rampa, Angela; Fato, Romana; Bergamini, Christian; Perez, Daniel I.; Martinez, Ana; Bottegoni, Giovanni; Cavalli, Andrea; Belluti, Federica</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">531-544</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multitarget approach has gained increasing acceptance as a useful tool to address complex and multifactorial maladies such as Alzheimer's disease (AD).  The concurrent inhibition of the validated AD targets β-secretase (BACE-1) and glycogen synthase kinase-3β (GSK-3β) by attacking both β-amyloid and tau protein cascades has been identified as a promising AD therapeutic strategy.  In our study, curcumin was identified as a lead compd. for the simultaneous inhibition of both targets; therefore, synthetic efforts were dedicated to obtaining a small library of novel curcumin-based analogs, and a no. of potent and balanced dual-target inhibitors were obtained.  In particular, 2, 6, and 7 emerged as promising drug candidates endowed with neuroprotective potential and brain permeability.  Notably, for some new compds. the sym. diketo and the β-keto-enol tautomeric forms were purposely isolated and tested in vitro, allowing us to gain insight into the key requirements for BACE-1 and GSK-3β inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw1HaZGRzvJbVg90H21EOLACvtfcHk0lgxQnIjyX8LEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrsLrJ&md5=349916a940c9cc8d87ca817c689756f1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00894%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMartino%26aufirst%3DR.%2BM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DFato%26aufirst%3DR.%26aulast%3DBergamini%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26atitle%3DVersatility%2520of%2520the%2520curcumin%2520scaffold%253A%2520discovery%2520of%2520potent%2520and%2520balanced%2520dual%2520BACE-1%2520and%2520GSK-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D531%26epage%3D544%26doi%3D10.1021%2Facs.jmedchem.5b00894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">Feeling nature’s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span><span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=616-628&author=J.+B.+Baell&title=Feeling+nature%E2%80%99s+PAINS%3A+natural+products%2C+natural+product+drugs%2C+and+pan+assay+interference+compounds+%28PAINS%29&doi=10.1021%2Facs.jnatprod.5b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-628</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We have previously reported on classes of compds. that can interfere with bioassays via a no. of different mechanisms and termed such compds. Pan Assay INterference compds., or PAINS.  These compds. were defined on the basis of high-throughput data derived from vendor-supplied synthetics.  The question therefore arises whether the concept of PAINS is relevant to compds. of natural origin.  Here, it is shown that this is indeed the case, but that the context of the biol. readout is an important factor that must be brought into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFy3lN9vzSbVg90H21EOLACvtfcHk0lgxQnIjyX8LEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D&md5=199b040b1f6f3d636521879acae0114d</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00947%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DFeeling%2520nature%25E2%2580%2599s%2520PAINS%253A%2520natural%2520products%252C%2520natural%2520product%2520drugs%252C%2520and%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D616%26epage%3D628%26doi%3D10.1021%2Facs.jnatprod.5b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Leinonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koponen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartikainen, S.</span><span> </span><span class="NLM_article-title">Systematic review: representativeness of participants in RCTs of acetylcholinesterase inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0124500</span><span class="refDoi"> DOI: 10.1371/journal.pone.0124500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1371%2Fjournal.pone.0124500" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0124500&author=A.+Leinonenauthor=M.+Koponenauthor=S.+Hartikainen&title=Systematic+review%3A+representativeness+of+participants+in+RCTs+of+acetylcholinesterase+inhibitors&doi=10.1371%2Fjournal.pone.0124500"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0124500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0124500%26sid%3Dliteratum%253Aachs%26aulast%3DLeinonen%26aufirst%3DA.%26aulast%3DKoponen%26aufirst%3DM.%26aulast%3DHartikainen%26aufirst%3DS.%26atitle%3DSystematic%2520review%253A%2520representativeness%2520of%2520participants%2520in%2520RCTs%2520of%2520acetylcholinesterase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0124500%26doi%3D10.1371%2Fjournal.pone.0124500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colizzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2007.09.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=17998161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1WgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=423-426&author=L.+Piazziauthor=A.+Cavalliauthor=F.+Colizziauthor=F.+Bellutiauthor=M.+Bartoliniauthor=F.+Manciniauthor=M.+Recanatiniauthor=V.+Andrisanoauthor=A.+Rampa&title=Multi-target-directed+coumarin+derivatives%3A+hAChE+and+BACE1+inhibitors+as+potential+anti-Alzheimer+compounds&doi=10.1016%2Fj.bmcl.2007.09.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds</span></div><div class="casAuthors">Piazzi, Lorna; Cavalli, Andrea; Colizzi, Francesco; Belluti, Federica; Bartolini, Manuela; Mancini, Francesca; Recanatini, Maurizio; Andrisano, Vincenza; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">423-426</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The complex etiol. of Alzheimer's disease (AD) prompts scientists to develop multifunctional compds. to combat causes and symptoms of such neurodegeneration.  A series of compds., e.g., I, has been designed, synthesized, and tested by introducing halophenylalkylamidic functions on the scaffold of AP2238 (II), which is a dual binding site acetylcholinesterase inhibitor.  The inhibitory activity was successfully extended to the beta-site amyloid precursor protein cleavage enzyme, leading to the discovery of a potent inhibitor of this enzyme and affording multifunctional compds. for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQZP5TwhQKrVg90H21EOLACvtfcHk0liQreVByJnDNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1WgtA%253D%253D&md5=f97fcfe0199fced046a876d98ed481bc</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.100%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DColizzi%26aufirst%3DF.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DMulti-target-directed%2520coumarin%2520derivatives%253A%2520hAChE%2520and%2520BACE1%2520inhibitors%2520as%2520potential%2520anti-Alzheimer%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D423%26epage%3D426%26doi%3D10.1016%2Fj.bmcl.2007.09.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer’s disease therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2282</span><span class="refDoi"> DOI: 10.1021/jm0340602</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0340602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2279-2282&author=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Cavalliauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=P.+Valentiauthor=M.+Recanatini&title=3-%284-%5B%5BBenzyl%28methyl%29amino%5Dmethyl%5Dphenyl%29-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+inhibits+both+acetylcholinesterase+and+acetylcholinesterase-induced+beta-amyloid+aggregation%3A+a+dual+function+lead+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1021%2Fjm0340602"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm0340602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340602%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3D3-%25284-%255B%255BBenzyl%2528methyl%2529amino%255Dmethyl%255Dphenyl%2529-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520inhibits%2520both%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%253A%2520a%2520dual%2520function%2520lead%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2279%26epage%3D2282%26doi%3D10.1021%2Fjm0340602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djemil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.ejmech.2014.03.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=157-166&author=F.+Bellutiauthor=A.+De+Simoneauthor=A.+Tarozziauthor=M.+Bartoliniauthor=A.+Djemilauthor=A.+Bisiauthor=S.+Gobbiauthor=S.+Montanariauthor=A.+Cavalliauthor=V.+Andrisanoauthor=G.+Bottegoniauthor=A.+Rampa&title=Fluorinated+benzophenone+derivatives%3A+balanced+multipotent+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2014.03.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDjemil%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DMontanari%26aufirst%3DS.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFluorinated%2520benzophenone%2520derivatives%253A%2520balanced%2520multipotent%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D78%26spage%3D157%26epage%3D166%26doi%3D10.1016%2Fj.ejmech.2014.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Martino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span> </span><span class="NLM_article-title">From AChE to BACE1 inhibitors: the role of the amine on the indanone scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2804</span><span class="NLM_x">–</span> <span class="NLM_lpage">2808</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.05.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2804-2808&author=A.+Rampaauthor=F.+Manciniauthor=A.+De+Simoneauthor=F.+Falchiauthor=F.+Bellutiauthor=R.+M.+Di+Martinoauthor=S.+Gobbiauthor=V.+Andrisanoauthor=A.+Tarozziauthor=M.+Bartoliniauthor=A.+Cavalliauthor=A.+Bisi&title=From+AChE+to+BACE1+inhibitors%3A+the+role+of+the+amine+on+the+indanone+scaffold&doi=10.1016%2Fj.bmcl.2015.05.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DFalchi%26aufirst%3DF.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DDi%2BMartino%26aufirst%3DR.%2BM.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26atitle%3DFrom%2520AChE%2520to%2520BACE1%2520inhibitors%253A%2520the%2520role%2520of%2520the%2520amine%2520on%2520the%2520indanone%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2804%26epage%3D2808%26doi%3D10.1016%2Fj.bmcl.2015.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Zha, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesaresi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span> </span><span class="NLM_article-title">Novel tacrine-benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer’s disease: design, synthesis, biological evaluation, and X-ray crystallography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01119</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01119" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=114-131&author=X.+Zhaauthor=D.+Lambaauthor=L.+Zhangauthor=Y.+Louauthor=C.+Xuauthor=D.+Kangauthor=L.+Chenauthor=Y.+Xuauthor=L.+Zhangauthor=A.+De+Simoneauthor=S.+Samezauthor=A.+Pesaresiauthor=J.+Stojanauthor=M.+G.+Lopezauthor=J.+Egeaauthor=V.+Andrisanoauthor=M.+Bartolini&title=Novel+tacrine-benzofuran+hybrids+as+potent+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+design%2C+synthesis%2C+biological+evaluation%2C+and+X-ray+crystallography&doi=10.1021%2Facs.jmedchem.5b01119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography</span></div><div class="casAuthors">Zha, Xiaoming; Lamba, Doriano; Zhang, Lili; Lou, Yinghan; Xu, Changxu; Kang, Di; Chen, Li; Xu, Yungen; Zhang, Luyong; De Simone, Angela; Samez, Sarah; Pesaresi, Alessandro; Stojan, Jure; Lopez, Manuela G.; Egea, Javier; Andrisano, Vincenza; Bartolini, Manuela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-131</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Twenty-six new tacrine-benzofuran hybrids, I [R = H, OMe, X = (CH2)m, Y= (CH2)n, m = 1-3, n = 6, 7], II [R = H, OMe, X = CH2, Y = (CH2)6; R = OMe, X = (CH2)2, Y = (CH2)6; R = H, X = (CH2)m, m = 1, 2, Y = (CH2)7; R = H, X = (CH2)2, Y = (CH2)7; R = OMe, X = (CH2)3, Y = (CH2)7] and III [R = H, OMe, X = CH2, Y = (CH2)6; R = OMe, X = (CH2)m, m = 2, 3, Y = (CH2)6; R = H, X = (CH2)m, m = 1-3, Y = (CH2)7; R = OMe, X = (CH2)3, Y = (CH2)7] were designed, synthesized, and evaluated in vitro on key mol. targets for Alzheimer's disease.  Most hybrids exhibited good inhibitory activities on cholinesterases and β-amyloid self-aggregation.  Selected compds. displayed significant inhibition of human β-secretase-1 (hBACE-1).  Among the 26 hybrids, II [R = H, X = (CH2)2, Y = (CH2)7] (IV) showed the most interesting profile as a subnanomolar selective inhibitor of human acetylcholinesterase (hAChE) (IC50 = 0.86 nM) and a good inhibitor of both β-amyloid aggregation (hAChE- and self-induced, 61.3% and 58.4%, resp.) and hBACE-1 activity (IC50 = 1.35 μM).  Kinetic studies showed that IV acted as a slow, tight-binding, mixed-type inhibitor, while X-ray crystallog. studies highlighted the ability of IV to induce large-scale structural changes in the active-site gorge of Torpedo californica AChE (TcAChE), with significant implications for structure-based drug design.  In vivo studies confirmed that IV significantly ameliorates performances of scopolamine-treated ICR mice.  Finally, IV administration did not exhibit significant hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdWlshOsJO7Vg90H21EOLACvtfcHk0lixv5v9TjBV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsr%252FJ&md5=809e7be0412644a990920590f8a31125</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01119%26sid%3Dliteratum%253Aachs%26aulast%3DZha%26aufirst%3DX.%26aulast%3DLamba%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DSamez%26aufirst%3DS.%26aulast%3DPesaresi%26aufirst%3DA.%26aulast%3DStojan%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26atitle%3DNovel%2520tacrine-benzofuran%2520hybrids%2520as%2520potent%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520design%252C%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520X-ray%2520crystallography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D114%26epage%3D131%26doi%3D10.1021%2Facs.jmedchem.5b01119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Costanzo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cariati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desiderio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgammato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamberti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masullo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliverio, M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of donepezil-like compounds as AChE and BACE-1 inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=470-475&author=P.+Costanzoauthor=L.+Cariatiauthor=D.+Desiderioauthor=R.+Sgammatoauthor=A.+Lambertiauthor=R.+Arconeauthor=R.+Salernoauthor=M.+Nardiauthor=M.+Masulloauthor=M.+Oliverio&title=Design%2C+synthesis%2C+and+evaluation+of+donepezil-like+compounds+as+AChE+and+BACE-1+inhibitors&doi=10.1021%2Facsmedchemlett.5b00483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors</span></div><div class="casAuthors">Costanzo, Paola; Cariati, Luca; Desiderio, Doriana; Sgammato, Roberta; Lamberti, Anna; Arcone, Rosaria; Salerno, Raffaele; Nardi, Monica; Masullo, Mariorosario; Oliverio, Manuela</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">470-475</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylmethylpiperidinylmethyleneindanone donepezil analogs I (R, R1, R2 = H, HO, MeO; R3 = Ph, 3-MeOC6H4, 1,3-benzodioxole-5-yl) were prepd. as dual acetylcholinesterase (AChE) and β-secretase (BACE-1) inhibitors for potential use in the treatment of Alzheimer's disease.  I were prepd. by a green synthesis by Friedel-Crafts reaction of arylpropanoic acids in the presence of triflic acid using microwave irradn. followed by diastereoselective aldol condensation using Amberlyst A-26 as base and ultrasound as the energy source at 40-50°; for selected compds., demethylation was performed using iodocyclohexane in DMF.  The selectivities of I for inhibition of acetylcholinesterase over butyrylcholinesterase and their toxicities to neuroblastoma cells were detd.  I (R = H; R1 = R2 = MeO; R3 = Ph) and I (R = R1 = H; R2 = MeO; R3 = Ph) were identified as potential new lead compds. for a dual therapeutic strategy against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWJM9pEJTfmbVg90H21EOLACvtfcHk0lixv5v9TjBV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCks7o%253D&md5=994095d9e45508b6c6494d6f482bd217</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00483%26sid%3Dliteratum%253Aachs%26aulast%3DCostanzo%26aufirst%3DP.%26aulast%3DCariati%26aufirst%3DL.%26aulast%3DDesiderio%26aufirst%3DD.%26aulast%3DSgammato%26aufirst%3DR.%26aulast%3DLamberti%26aufirst%3DA.%26aulast%3DArcone%26aufirst%3DR.%26aulast%3DSalerno%26aufirst%3DR.%26aulast%3DNardi%26aufirst%3DM.%26aulast%3DMasullo%26aufirst%3DM.%26aulast%3DOliverio%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520donepezil-like%2520compounds%2520as%2520AChE%2520and%2520BACE-1%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D470%26epage%3D475%26doi%3D10.1021%2Facsmedchemlett.5b00483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1600</span><span class="NLM_x">–</span> <span class="NLM_lpage">1613</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.12.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2008.12.067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1600-1613&author=Y.+Zhuauthor=K.+Xiaoauthor=L.+Maauthor=B.+Xiongauthor=Y.+Fuauthor=H.+Yuauthor=W.+Wangauthor=X.+Wangauthor=D.+Huauthor=H.+Pengauthor=J.+Liauthor=Q.+Gongauthor=Q.+Chaiauthor=X.+Tangauthor=H.+Zhangauthor=J.+Liauthor=J.+Shen&title=Design%2C+synthesis+and+biological+evaluation+of+novel+dual+inhibitors+of+acetylcholinesterase+and+beta-secretase&doi=10.1016%2Fj.bmc.2008.12.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.12.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.12.067%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DChai%26aufirst%3DQ.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520beta-secretase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D1600%26epage%3D1613%26doi%3D10.1016%2Fj.bmc.2008.12.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dafni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5365</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span><span class="refDoi"> DOI: 10.1021/jm900859q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Munoz-Torreroauthor=L.+Ramirezauthor=E.+Gomezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodriguez-Francoauthor=O.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline-6-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+beta-amyloid-directed+anti-Alzheimer+compounds&doi=10.1021%2Fjm900859q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DRamirez%26aufirst%3DL.%26aulast%3DGomez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline-6-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520beta-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379%26doi%3D10.1021%2Fjm900859q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span> </span><span class="NLM_article-title">Searching for the multi-target-directed ligands against Alzheimer’s disease: discovery of quinoxaline-based hybrid compounds with AChE, H(3)R and BACE 1 inhibitory activities</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7158</span><span class="NLM_x">–</span> <span class="NLM_lpage">7167</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.09.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2011.09.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=7158-7167&author=W.+Huangauthor=L.+Tangauthor=Y.+Shiauthor=S.+Huangauthor=L.+Xuauthor=R.+Shengauthor=P.+Wuauthor=J.+Liauthor=N.+Zhouauthor=Y.+Hu&title=Searching+for+the+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease%3A+discovery+of+quinoxaline-based+hybrid+compounds+with+AChE%2C+H%283%29R+and+BACE+1+inhibitory+activities&doi=10.1016%2Fj.bmc.2011.09.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.09.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.09.061%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DSearching%2520for%2520the%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520discovery%2520of%2520quinoxaline-based%2520hybrid%2520compounds%2520with%2520AChE%252C%2520H%25283%2529R%2520and%2520BACE%25201%2520inhibitory%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D7158%26epage%3D7167%26doi%3D10.1016%2Fj.bmc.2011.09.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia-Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juarez-Jimenez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabateauthor=J.+Juarez-Jimenezauthor=B.+Perezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Munoz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lg066LjhL6STQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DJuarez-Jimenez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Oudin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolfsson, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modig, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolfsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L. G.</span><span> </span><span class="NLM_article-title">Traffic-related air pollution and dementia incidence in northern sweden: a longitudinal study</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1289/ehp.1408322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1289%2Fehp.1408322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtFyhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=306-312&author=A.+Oudinauthor=B.+Forsbergauthor=A.+N.+Adolfssonauthor=N.+Lindauthor=L.+Modigauthor=M.+Nordinauthor=S.+Nordinauthor=R.+Adolfssonauthor=L.+G.+Nilsson&title=Traffic-related+air+pollution+and+dementia+incidence+in+northern+sweden%3A+a+longitudinal+study&doi=10.1289%2Fehp.1408322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Traffic-related air pollution and dementia incidence in northern Sweden: a longitudinal study</span></div><div class="casAuthors">Oudin, Anna; Forsberg, Bertil; Adolfsson, Annelie Nordin; Lind, Nina; Modig, Lars; Nordin, Maria; Nordin, Steven; Adolfsson, Rolf; Nilsson, Lars-Goeran</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Health Perspectives</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-312</span>CODEN:
                <span class="NLM_cas:coden">EVHPAZ</span>;
        ISSN:<span class="NLM_cas:issn">1552-9924</span>.
    
            (<span class="NLM_cas:orgname">U. S. Department of Health and Human Services, National Institutes of Health</span>)
        </div><div class="casAbstract">Background: Exposure to ambient air pollution is suspected to cause cognitive effects, but a prospective cohort is needed to study exposure to air pollution at the home address and the incidence of dementia.  Objectives: We aimed to assess the assocn. between long-term exposure to traffic-related air pollution and dementia incidence in a major city in northern Sweden.  Methods: Data on dementia incidence over a 15-yr period were obtained from the longitudinal Betula study.  Traffic air pollution exposure was assessed using a land-use regression model with a spatial resoln. of 50 m × 50 m.  Annual mean nitrogen oxide levels at the residential address of the participants at baseline (the start of follow-up) were used as markers for long-term exposure to air pollution.  Results: Out of 1,806 participants at baseline, 191 were diagnosed with Alzheimer's disease during follow-up, and 111 were diagnosed with vascular dementia.  Participants in the group with the highest exposure were more likely than those in the group with the lowest exposure to be diagnosed with dementia (Alzheimer's disease or vascular dementia), with a hazard ratio (HR) of 1.43 (95% CI: 0.998, 2.05 for the highest vs. the lowest quartile).  The ests. were similar for Alzheimer's disease (HR 1.38) and vascular dementia (HR 1.47).  The HR for dementia assocd. with the third quartile vs. the lowest quartile was 1.48 (95% CI: 1.03, 2.11).  A subanal. that excluded a younger sample that had been retested after only 5 years of follow-up suggested stronger assocns. with exposure than were present in the full cohort (HR = 1.71; 95% CI: 1.08, 2.73 for the highest vs. the lowest quartile).  Conclusions: If the assocns. we obsd. are causal, then air pollution from traffic might be an important risk factor for vascular dementia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGXyUJFPkxI7Vg90H21EOLACvtfcHk0ljQqalQMKRr2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtFyhsro%253D&md5=a6c7f631f214658c7fbdeb9a6cec55f9</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1289%2Fehp.1408322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.1408322%26sid%3Dliteratum%253Aachs%26aulast%3DOudin%26aufirst%3DA.%26aulast%3DForsberg%26aufirst%3DB.%26aulast%3DAdolfsson%26aufirst%3DA.%2BN.%26aulast%3DLind%26aufirst%3DN.%26aulast%3DModig%26aufirst%3DL.%26aulast%3DNordin%26aufirst%3DM.%26aulast%3DNordin%26aufirst%3DS.%26aulast%3DAdolfsson%26aufirst%3DR.%26aulast%3DNilsson%26aufirst%3DL.%2BG.%26atitle%3DTraffic-related%2520air%2520pollution%2520and%2520dementia%2520incidence%2520in%2520northern%2520sweden%253A%2520a%2520longitudinal%2520study%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2016%26volume%3D124%26spage%3D306%26epage%3D312%26doi%3D10.1289%2Fehp.1408322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Moulton, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span> </span><span class="NLM_article-title">Air pollution, oxidative stress, and Alzheimer’s disease</span> <span class="citation_source-journal">J. Environ. Public Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">472751</span><span class="refDoi"> DOI: 10.1155/2012/472751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1155%2F2012%2F472751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22523504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A280%3ADC%252BC38rntVaktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=472751&author=P.+V.+Moultonauthor=W.+Yang&title=Air+pollution%2C+oxidative+stress%2C+and+Alzheimer%E2%80%99s+disease&doi=10.1155%2F2012%2F472751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Air pollution, oxidative stress, and Alzheimer's disease</span></div><div class="casAuthors">Moulton Paula Valencia; Yang Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of environmental and public health</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">472751</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the most common form of dementia affecting millions of people worldwide and will continue to affect millions more with population aging on the rise.  AD causality is multifactorial.  Known causal factors include genetic predisposition, age, and sex.  Environmental toxins such as air pollution (AP) have also been implicated in AD causation.  Exposure to AP can lead to chronic oxidative stress (OS), which is involved in the pathogenesis of AD.  Whereas AP plays a role in AD pathology, the epidemiological evidence for this association is limited.  Given the significant prevalence of AP exposure combined with increased population aging, epidemiological evidence for this link is important to consider.  In this paper, we examine the existing evidence supporting the relationship between AP, OS, and AD and provide recommendations for future research on the population level, which will provide evidence in support of public health interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3_M1KFAjW5IkFb3mqPUYDfW6udTcc2eZYrMEOehxx9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rntVaktw%253D%253D&md5=bcdeacb748355673d975ae93fa56300f</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1155%2F2012%2F472751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F472751%26sid%3Dliteratum%253Aachs%26aulast%3DMoulton%26aufirst%3DP.%2BV.%26aulast%3DYang%26aufirst%3DW.%26atitle%3DAir%2520pollution%252C%2520oxidative%2520stress%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Environ.%2520Public%2520Health%26date%3D2012%26volume%3D2012%26spage%3D472751%26doi%3D10.1155%2F2012%2F472751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">A small molecule targeting the multifactorial nature of Alzheimer’s disease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span><span class="refDoi"> DOI: 10.1002/anie.200700256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fanie.200700256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvFOns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3689-3692&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=S.+Capsoniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Margottiauthor=A.+Cattaneoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=A+small+molecule+targeting+the+multifactorial+nature+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fanie.200700256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule targeting the multifactorial nature of Alzheimer's disease</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Capsoni, Simona; Andrisano, Vincenza; Bartolini, Manuela; Margotti, Elisa; Cattaneo, Antonino; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3689-3692</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sights set on a cure: Memoquin (1) affects several mechanisms relevant to Alzheimer's disease (AD): the formation of reactive oxygen species, the processing and aggregation of amyloid β (Aβ) peptides, and acetylcholinesterase activity.  In animal models, 1 causes a remarkable decrease in the formation of AD neuro-degenerative hallmarks and a significant reversal of behavioral deficits.  HAChE, BACE-1, and NQO1 are enzymes targeted by 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDjj0kTvqp_bVg90H21EOLACvtfcHk0ljQqalQMKRr2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvFOns78%253D&md5=249751815672fbdb88d73debf79518ed</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Fanie.200700256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200700256%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMargotti%26aufirst%3DE.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DA%2520small%2520molecule%2520targeting%2520the%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3689%26epage%3D3692%26doi%3D10.1002%2Fanie.200700256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Capurro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busquet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56870</span><span class="refDoi"> DOI: 10.1371/journal.pone.0056870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1371%2Fjournal.pone.0056870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=23441223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFShsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56870&author=V.+Capurroauthor=P.+Busquetauthor=J.+P.+Lopesauthor=R.+Bertorelliauthor=G.+Tarozzoauthor=M.+L.+Bolognesiauthor=D.+Piomelliauthor=A.+Reggianiauthor=A.+Cavalli&title=Pharmacological+characterization+of+memoquin%2C+a+multi-target+compound+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0056870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of Memoquin, a multi-target compound for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Capurro, Valeria; Busquet, Perrine; Lopes, Joao Pedro; Bertorelli, Rosalia; Tarozzo, Glauco; Bolognesi, Maria Laura; Piomelli, Daniele; Reggiani, Angelo; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e56870</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by progressive loss of cognitive function, dementia and altered behavior.  Over 30 million people worldwide suffer from AD and available therapies are still palliative rather than curative.  Recently, Memoquin (MQ), a quinone-bearing polyamine compd., has emerged as a promising anti-AD lead candidate, mainly thanks to its multi-target profile.  MQ acts as an acetylcholinesterase and β-secretase-1 inhibitor, and also possesses anti-amyloid and anti-oxidant properties.  Despite this potential interest, in vivo behavioral studies with MQ have been limited.  Here, we report on in vivo studies with MQ (acute and sub-chronic treatments; 7-15 mg/kg per os) carried out using two different mouse models: i) scopolamine- and ii) beta-amyloid peptide- (Aβ-) induced amnesia.  Several aspects related to memory were examd. using the T-maze, the Morris water maze, the novel object recognition, and the passive avoidance tasks.  At the dose of 15 mg/kg, MQ was able to rescue all tested aspects of cognitive impairment including spatial, episodic, aversive, short and long-term memory in both scopolamine- and Aβ-induced amnesia models.  Furthermore, when tested in primary cortical neurons, MQ was able to fully prevent the Aβ-induced neurotoxicity mediated by oxidative stress.  The results support the effectiveness of MQ as a cognitive enhancer, and highlight the value of a multi-target strategy to address the complex nature of cognitive dysfunction in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9fRuR1K2KrrVg90H21EOLACvtfcHk0lhE95OhRdAWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFShsr8%253D&md5=8873f950c61e58ae5ad2e66f4c40e584</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0056870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0056870%26sid%3Dliteratum%253Aachs%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DLopes%26aufirst%3DJ.%2BP.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DPharmacological%2520characterization%2520of%2520memoquin%252C%2520a%2520multi-target%2520compound%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56870%26doi%3D10.1371%2Fjournal.pone.0056870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhE95OhRdAWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Nelson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauli, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, M. A.</span><span> </span><span class="NLM_article-title">The essential medicinal chemistry of curcumin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1620</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00975</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00975" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1620-1637&author=K.+M.+Nelsonauthor=J.+L.+Dahlinauthor=J.+Bissonauthor=J.+Grahamauthor=G.+F.+Pauliauthor=M.+A.+Walters&title=The+essential+medicinal+chemistry+of+curcumin&doi=10.1021%2Facs.jmedchem.6b00975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">The Essential Medicinal Chemistry of Curcumin</span></div><div class="casAuthors">Nelson, Kathryn M.; Dahlin, Jayme L.; Bisson, Jonathan; Graham, James; Pauli, Guido F.; Walters, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1620-1637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Curcumin is a constituent (3-5%) of the traditional medicine known as turmeric.  Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation.  Curcumin has recently been classified as both a PAINS (pan-assay interference compds.) and an IMPS (invalid metabolic panaceas) candidate.  The likely false activity of curcumin in vitro and in vivo has resulted in >120 clin. trials of curcuminoids against several diseases.  No double-blinded, placebo controlled clin. trial of curcumin has been successful.  This Perspective reviews the essential medicinal chem. of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compd. and, therefore, a highly improbable lead.  Based on this in-depth evaluation, potential new directions for research on curcuminoids are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSvgRUG-0XoLVg90H21EOLACvtfcHk0lipmwamx7l-xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsFKjsA%253D%253D&md5=dfb16371e0ef27d4111628203c6acc09</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00975%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DK.%2BM.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DBisson%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DJ.%26aulast%3DPauli%26aufirst%3DG.%2BF.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26atitle%3DThe%2520essential%2520medicinal%2520chemistry%2520of%2520curcumin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1620%26epage%3D1637%26doi%3D10.1021%2Facs.jmedchem.6b00975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span>Alzheimer’s Drug Fails in Another Crushing Disappointment. <a href="https://www.scientificamerican.com/article/alzheimer-rsquo-s-drug-fails-in-another-crushing-disappointment/" class="extLink">https://www.scientificamerican.com/article/alzheimer-rsquo-s-drug-fails-in-another-crushing-disappointment/</a>. (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Drug+Fails+in+Another+Crushing+Disappointment.+https%3A%2F%2Fwww.scientificamerican.com%2Farticle%2Falzheimer-rsquo-s-drug-fails-in-another-crushing-disappointment%2F.+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Richard W. Barnhart, Amelie Dion, Steven Guinness, Alan Happe, Cheryl M. Hayward, Jeffrey Kohrt, Teresa Makowski, Mark Maloney, Jade D. Nelson, Asaad Nematalla, J. Christopher McWilliams, Zhihui Peng, Jeffrey Raggon, John Sagal, Gerald A. Weisenburger, Denghui Bao, Miguel Gonzalez, Jiangping Lu, Mark D. McLaws, Jian Tao, <span class="NLM_string-name hlFld-ContribAuthor">Baolin Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor—Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (6)
                                     , 1440-1453. <a href="https://doi.org/10.1021/acs.oprd.1c00126" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00126%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Bof%252Ba%252BSecond%252BGeneration%252B%2525CE%2525B2-Amyloid-Cleaving%252BEnzyme%252BInhibitor%2525E2%252580%252594Improving%252Bthe%252BRobustness%252Bof%252Ba%252BHalogen-Metal%252BExchange%252BUsing%252BContinuous%252BStirred-Tank%252BReactors%26aulast%3DLi%26aufirst%3DBryan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12042021%26date%3D24052021%26volume%3D25%26issue%3D6%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mohammad Aslam, Sonaimuthu Mohandoss, Palanisamy Subramanian, SangGuan You, Won-Guen Yang, Sung Hong Kim, <span class="NLM_string-name hlFld-ContribAuthor">Yong Rok Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Indium-Catalyzed Aromative Spiro Coupling of Quinones with Oxindoles for Highly Functionalized Xanthenes as Efficient Fluorophores. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (4)
                                     , 1383-1387. <a href="https://doi.org/10.1021/acs.orglett.1c00042" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00042%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIndium-Catalyzed%252BAromative%252BSpiro%252BCoupling%252Bof%252BQuinones%252Bwith%252BOxindoles%252Bfor%252BHighly%252BFunctionalized%252BXanthenes%252Bas%252BEfficient%252BFluorophores%26aulast%3DAslam%26aufirst%3DMohammad%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D06012021%26date%3D02022021%26volume%3D23%26issue%3D4%26spage%3D1383%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Angela De Simone, Vincenzo Tumiatti, Vincenza Andrisano, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Milelli</span>. </span><span class="cited-content_cbyCitation_article-title">Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 26-41. <a href="https://doi.org/10.1021/acs.jmedchem.0c00931" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%25253A%252BA%252BNew%252BGold%252BRush%252Bin%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BMultitarget%252BDrug%252BDiscovery%25253F%26aulast%3DDe%2BSimone%26aufirst%3DAngela%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D01062020%26date%3D21122020%26volume%3D64%26issue%3D1%26spage%3D26%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kaifu Gao, Duc Duy Nguyen, Meihua Tu, <span class="NLM_string-name hlFld-ContribAuthor">Guo-Wei Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Generative Network Complex for the Automated Generation of Drug-like Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (12)
                                     , 5682-5698. <a href="https://doi.org/10.1021/acs.jcim.0c00599" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00599%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DGenerative%252BNetwork%252BComplex%252Bfor%252Bthe%252BAutomated%252BGeneration%252Bof%252BDrug-like%252BMolecules%26aulast%3DGao%26aufirst%3DKaifu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30052020%26date%3D07082020%26date%3D20072020%26volume%3D60%26issue%3D12%26spage%3D5682%26epage%3D5698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hongtao Du, Xinlian Liu, Jusen Xie, <span class="NLM_string-name hlFld-ContribAuthor">Fang Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Deoxyvasicinone–Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 2397-2407. <a href="https://doi.org/10.1021/acschemneuro.8b00699" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00699%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BDeoxyvasicinone%2525E2%252580%252593Donepezil%252BHybrids%252Bas%252BPotential%252BMultitarget%252BDrug%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DDu%26aufirst%3DHongtao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13122018%26date%3D05022019%26date%3D18022019%26date%3D05022019%26volume%3D10%26issue%3D5%26spage%3D2397%26epage%3D2407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria E. Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7640-7656. <a href="https://doi.org/10.1021/acs.jmedchem.8b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau-Centric%252BMultitarget%252BApproach%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDevelopment%252Bof%252BFirst-in-Class%252BDual%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252Band%252BTau-Aggregation%252BInhibitors%26aulast%3DGandini%26aufirst%3DAnnachiara%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17042018%26date%3D24082018%26date%3D04082018%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Leeson</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6421-6467. <a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMapping%252Bthe%252BEfficiency%252Band%252BPhysicochemical%252BTrajectories%252Bof%252BSuccessful%252BOptimizations%26aulast%3DYoung%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03022018%26date%3D25042018%26date%3D05042018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sandra Karch, Johannes Broichhagen, Julia Schneider, Daniel Böning, Stephanie Hartmann, Benjamin Schmid, Philipp Tripal, Ralf Palmisano, Christian Alzheimer, Kai Johnsson, <span class="NLM_string-name hlFld-ContribAuthor">Tobias Huth</span>. </span><span class="cited-content_cbyCitation_article-title">A New Fluorogenic Small-Molecule Labeling Tool for Surface Diffusion Analysis and Advanced Fluorescence Imaging of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Based on Silicone Rhodamine: SiR-BACE1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 6121-6139. <a href="https://doi.org/10.1021/acs.jmedchem.8b00387" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00387</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00387%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNew%252BFluorogenic%252BSmall-Molecule%252BLabeling%252BTool%252Bfor%252BSurface%252BDiffusion%252BAnalysis%252Band%252BAdvanced%252BFluorescence%252BImaging%252Bof%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein-Cleaving%252BEnzyme%252B1%252BBased%252Bon%252BSilicone%252BRhodamine%25253A%252BSiR-BACE1%26aulast%3DKarch%26aufirst%3DSandra%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04042018%26date%3D10072018%26date%3D25062018%26volume%3D61%26issue%3D14%26spage%3D6121%26epage%3D6139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sneha R. Sagar, Devendra Pratap Singh, Nirupa B. Panchal, Rajesh D. Das, Dhaivat H. Pandya, Vasudevan Sudarsanam, Manish Nivsarkar, <span class="NLM_string-name hlFld-ContribAuthor">Kamala K. Vasu</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazolyl-thiadiazines as Beta Site Amyloid Precursor Protein Cleaving Enzyme-1 (BACE-1) Inhibitors and Anti-inflammatory Agents: Multitarget-Directed Ligands for the Efficient Management of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 1663-1679. <a href="https://doi.org/10.1021/acschemneuro.8b00063" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00063%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DThiazolyl-thiadiazines%252Bas%252BBeta%252BSite%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme-1%252B%252528BACE-1%252529%252BInhibitors%252Band%252BAnti-inflammatory%252BAgents%25253A%252BMultitarget-Directed%252BLigands%252Bfor%252Bthe%252BEfficient%252BManagement%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DSagar%26aufirst%3DSneha%2BR.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09022018%26date%3D26042018%26date%3D10052018%26date%3D26042018%26volume%3D9%26issue%3D7%26spage%3D1663%26epage%3D1679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nibedita Pradhan, Koushik Debnath, Suman Mandal, Nihar R. Jana, <span class="NLM_string-name hlFld-ContribAuthor">Nikhil R. Jana</span>. </span><span class="cited-content_cbyCitation_article-title">Antiamyloidogenic Chemical/Biochemical-Based Designed Nanoparticle as Artificial Chaperone for Efficient Inhibition of Protein Aggregation. </span><span class="cited-content_cbyCitation_journal-name">Biomacromolecules</span><span> <strong>2018,</strong> <em>19 </em>
                                    (6)
                                     , 1721-1731. <a href="https://doi.org/10.1021/acs.biomac.8b00671" title="DOI URL">https://doi.org/10.1021/acs.biomac.8b00671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biomac.8b00671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biomac.8b00671%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomacromolecules%26atitle%3DAntiamyloidogenic%252BChemical%25252FBiochemical-Based%252BDesigned%252BNanoparticle%252Bas%252BArtificial%252BChaperone%252Bfor%252BEfficient%252BInhibition%252Bof%252BProtein%252BAggregation%26aulast%3DPradhan%26aufirst%3DNibedita%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25042018%26date%3D18052018%26date%3D09052018%26volume%3D19%26issue%3D6%26spage%3D1721%26epage%3D1731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">João P.S.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Hélio M.T.  Albuquerque</span>, <span class="hlFld-ContribAuthor ">Susana M.  Cardoso</span>, <span class="hlFld-ContribAuthor ">Artur M.S.  Silva</span>, <span class="hlFld-ContribAuthor ">Vera L.M.  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113492. <a href="https://doi.org/10.1016/j.ejmech.2021.113492" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113492%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-target%252Bcompounds%252Bfor%252BAlzheimer%252527s%252Bdisease%25253A%252BNatural%252Band%252Bsynthetic%252BAChE%252Band%252BBACE-1%252Bdual-inhibitors%252Band%252Btheir%252Bstructure-activity%252Brelationship%252B%252528SAR%252529%26aulast%3DFerreira%26aufirst%3DJo%25C3%25A3o%2BP.S.%26date%3D2021%26volume%3D221%26spage%3D113492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adriana Ferreira Lopes  Vilela</span>, <span class="hlFld-ContribAuthor ">Vitor Eduardo  Narciso dos Reis</span>, <span class="hlFld-ContribAuthor ">Carmen Lúcia  Cardoso</span>. </span><span class="cited-content_cbyCitation_article-title">Co-Immobilized Capillary Enzyme Reactor Based on Beta-Secretase1 and Acetylcholinesterase: A Model for Dual-Ligand Screening. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.708374" title="DOI URL">https://doi.org/10.3389/fchem.2021.708374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.708374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.708374%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DCo-Immobilized%252BCapillary%252BEnzyme%252BReactor%252BBased%252Bon%252BBeta-Secretase1%252Band%252BAcetylcholinesterase%25253A%252BA%252BModel%252Bfor%252BDual-Ligand%252BScreening%26aulast%3DVilela%26aufirst%3DAdriana%2BFerreira%2BLopes%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanay  Dalvi</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Dewangan</span>, <span class="hlFld-ContribAuthor ">Gopal  Agarwal</span>, <span class="hlFld-ContribAuthor ">Dattatray  Shinde Suchita</span>, <span class="hlFld-ContribAuthor ">Alok  Jain</span>, <span class="hlFld-ContribAuthor ">Akshay  Srivastava</span>, <span class="hlFld-ContribAuthor ">Bichismita  Sahu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in-vitro evaluation of fluorinated triazoles as multi-target directed ligands for Alzheimer disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>42 </em>, 127999. <a href="https://doi.org/10.1016/j.bmcl.2021.127999" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127999%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin-vitro%252Bevaluation%252Bof%252Bfluorinated%252Btriazoles%252Bas%252Bmulti-target%252Bdirected%252Bligands%252Bfor%252BAlzheimer%252Bdisease%26aulast%3DDalvi%26aufirst%3DTanay%26date%3D2021%26volume%3D42%26spage%3D127999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Paula  Zaręba</span>, <span class="hlFld-ContribAuthor ">Dorota  Łażewska</span>, <span class="hlFld-ContribAuthor ">Dorota  Stary</span>, <span class="hlFld-ContribAuthor ">David  Reiner-Link</span>, <span class="hlFld-ContribAuthor ">Annika  Frank</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Szczepan  Mogilski</span>, <span class="hlFld-ContribAuthor ">Maria  Kaleta</span>, <span class="hlFld-ContribAuthor ">Agata  Doroz-Płonka</span>, <span class="hlFld-ContribAuthor ">Annamaria  Lubelska</span>, <span class="hlFld-ContribAuthor ">Ewelina  Honkisz-Orzechowska</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Olejarz-Maciej</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Handzlik</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>, <span class="hlFld-ContribAuthor ">Marek  Bajda</span>. </span><span class="cited-content_cbyCitation_article-title">Cyanobiphenyls: novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>7 </em>, 105129. <a href="https://doi.org/10.1016/j.bioorg.2021.105129" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105129%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCyanobiphenyls%25253A%252Bnovel%252BH3%252Breceptor%252Bligands%252Bwith%252Bcholinesterase%252Band%252BMAO%252BB%252Binhibitory%252Bactivity%252Bas%252Bmultitarget%252Bcompounds%252Bfor%252Bpotential%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DGody%25C5%2584%26aufirst%3DJustyna%26date%3D2021%26volume%3D7%26spage%3D105129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Devin  Kepchia</span>, <span class="hlFld-ContribAuthor ">Antonio  Currais</span>, <span class="hlFld-ContribAuthor ">Richard  Dargusch</span>, <span class="hlFld-ContribAuthor ">Kim  Finley</span>, <span class="hlFld-ContribAuthor ">David  Schubert</span>, <span class="hlFld-ContribAuthor ">Pamela  Maher</span>. </span><span class="cited-content_cbyCitation_article-title">Geroprotective effects of Alzheimer’s disease drug candidates. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 3269-3289. <a href="https://doi.org/10.18632/aging.202631" title="DOI URL">https://doi.org/10.18632/aging.202631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.202631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.202631%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DGeroprotective%252Beffects%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bdrug%252Bcandidates%26aulast%3DKepchia%26aufirst%3DDevin%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D3269%26epage%3D3289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renata P.  Sakata</span>, <span class="hlFld-ContribAuthor ">Giorgio  Antoniolli</span>, <span class="hlFld-ContribAuthor ">Marcelo  Lancellotti</span>, <span class="hlFld-ContribAuthor ">Daniel Fabio  Kawano</span>, <span class="hlFld-ContribAuthor ">Euzébio  Guimarães Barbosa</span>, <span class="hlFld-ContribAuthor ">Wanda P.  Almeida</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2′-Aminochalcone: A multi-target approach to find drug candidates to treat Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>103 </em>, 104201. <a href="https://doi.org/10.1016/j.bioorg.2020.104201" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104201%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2%2525E2%252580%2525B2-Aminochalcone%25253A%252BA%252Bmulti-target%252Bapproach%252Bto%252Bfind%252Bdrug%252Bcandidates%252Bto%252Btreat%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSakata%26aufirst%3DRenata%2BP.%26date%3D2020%26volume%3D103%26spage%3D104201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yutong  Zhou</span>, <span class="hlFld-ContribAuthor ">Feiyan  Zhu</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Meng  Zheng</span>, <span class="hlFld-ContribAuthor ">Yibin  Wang</span>, <span class="hlFld-ContribAuthor ">Dongya  Zhang</span>, <span class="hlFld-ContribAuthor ">Yasutaka  Anraku</span>, <span class="hlFld-ContribAuthor ">Yan  Zou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Haigang  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaobin  Pang</span>, <span class="hlFld-ContribAuthor ">Wei  Tao</span>, <span class="hlFld-ContribAuthor ">Olga  Shimoni</span>, <span class="hlFld-ContribAuthor ">Ashley I.  Bush</span>, <span class="hlFld-ContribAuthor ">Xue  Xue</span>, <span class="hlFld-ContribAuthor ">Bingyang  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Science Advances</span><span> <strong>2020,</strong> <em>6 </em>
                                    (41)
                                     , eabc7031. <a href="https://doi.org/10.1126/sciadv.abc7031" title="DOI URL">https://doi.org/10.1126/sciadv.abc7031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/sciadv.abc7031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fsciadv.abc7031%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Advances%26atitle%3DBlood-brain%252Bbarrier%2525E2%252580%252593penetrating%252BsiRNA%252Bnanomedicine%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btherapy%26aulast%3DZhou%26aufirst%3DYutong%26date%3D2020%26date%3D2020%26volume%3D6%26issue%3D41%26spage%3Deabc7031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Cheng</span>, <span class="hlFld-ContribAuthor ">Nan  Zheng</span>, <span class="hlFld-ContribAuthor ">Deyang  Sun</span>, <span class="hlFld-ContribAuthor ">Weishuo  Fang</span>, <span class="hlFld-ContribAuthor ">Lingling  Zheng</span>, <span class="hlFld-ContribAuthor ">Weihong  Song</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Compound YS-5-23 Exhibits Neuroprotective Effect by Reducing β-Site Amyloid Precursor Protein Cleaving Enzyme 1’s Expression and H2O2-Induced Cytotoxicity in SH-SY5Y Cells. </span><span class="cited-content_cbyCitation_journal-name">Neurochemical Research</span><span> <strong>2020,</strong> <em>45 </em>
                                    (9)
                                     , 2113-2127. <a href="https://doi.org/10.1007/s11064-020-03073-4" title="DOI URL">https://doi.org/10.1007/s11064-020-03073-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11064-020-03073-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11064-020-03073-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemical%2520Research%26atitle%3DA%252BNovel%252BCompound%252BYS-5-23%252BExhibits%252BNeuroprotective%252BEffect%252Bby%252BReducing%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%2525E2%252580%252599s%252BExpression%252Band%252BH2O2-Induced%252BCytotoxicity%252Bin%252BSH-SY5Y%252BCells%26aulast%3DCheng%26aufirst%3DChen%26date%3D2020%26date%3D2020%26volume%3D45%26issue%3D9%26spage%3D2113%26epage%3D2127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ondrej  Benek</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>. </span><span class="cited-content_cbyCitation_article-title">A Perspective on Multi-target Drugs for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2020,</strong> <em>41 </em>
                                    (7)
                                     , 434-445. <a href="https://doi.org/10.1016/j.tips.2020.04.008" title="DOI URL">https://doi.org/10.1016/j.tips.2020.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DA%252BPerspective%252Bon%252BMulti-target%252BDrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBenek%26aufirst%3DOndrej%26date%3D2020%26volume%3D41%26issue%3D7%26spage%3D434%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Sahab  Uddin</span>, <span class="hlFld-ContribAuthor ">Md. Tanvir  Kabir</span>, <span class="hlFld-ContribAuthor ">Philippe  Jeandet</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Ghulam Md  Ashraf</span>, <span class="hlFld-ContribAuthor ">Asma  Perveen</span>, <span class="hlFld-ContribAuthor ">May N.  Bin-Jumah</span>, <span class="hlFld-ContribAuthor ">Shaker A.  Mousa</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Abdel-Daim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2020,</strong> <em>2020 </em>, 1-19. <a href="https://doi.org/10.1155/2020/7039138" title="DOI URL">https://doi.org/10.1155/2020/7039138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/7039138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F7039138%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DNovel%252BAnti-Alzheimer%2525E2%252580%252599s%252BTherapeutic%252BMolecules%252BTargeting%252BAmyloid%252BPrecursor%252BProtein%252BProcessing%26aulast%3DUddin%26aufirst%3DMd.%2BSahab%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Basciu</span>, <span class="hlFld-ContribAuthor ">Panagiotis I.  Koukos</span>, <span class="hlFld-ContribAuthor ">Giuliano  Malloci</span>, <span class="hlFld-ContribAuthor ">Alexandre M. J. J.  Bonvin</span>, <span class="hlFld-ContribAuthor ">Attilio V.  Vargiu</span>. </span><span class="cited-content_cbyCitation_article-title">Coupling enhanced sampling of the apo-receptor with template-based ligand conformers selection: performance in pose prediction in the D3R Grand Challenge 4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2020,</strong> <em>34 </em>
                                    (2)
                                     , 149-162. <a href="https://doi.org/10.1007/s10822-019-00244-6" title="DOI URL">https://doi.org/10.1007/s10822-019-00244-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-019-00244-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-019-00244-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DCoupling%252Benhanced%252Bsampling%252Bof%252Bthe%252Bapo-receptor%252Bwith%252Btemplate-based%252Bligand%252Bconformers%252Bselection%25253A%252Bperformance%252Bin%252Bpose%252Bprediction%252Bin%252Bthe%252BD3R%252BGrand%252BChallenge%252B4%26aulast%3DBasciu%26aufirst%3DAndrea%26date%3D2020%26date%3D2019%26volume%3D34%26issue%3D2%26spage%3D149%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Kadukova</span>, <span class="hlFld-ContribAuthor ">Vladimir  Chupin</span>, <span class="hlFld-ContribAuthor ">Sergei  Grudinin</span>. </span><span class="cited-content_cbyCitation_article-title">Docking rigid macrocycles using Convex-PL, AutoDock Vina, and RDKit in the D3R Grand Challenge 4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2020,</strong> <em>34 </em>
                                    (2)
                                     , 191-200. <a href="https://doi.org/10.1007/s10822-019-00263-3" title="DOI URL">https://doi.org/10.1007/s10822-019-00263-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-019-00263-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-019-00263-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DDocking%252Brigid%252Bmacrocycles%252Busing%252BConvex-PL%25252C%252BAutoDock%252BVina%25252C%252Band%252BRDKit%252Bin%252Bthe%252BD3R%252BGrand%252BChallenge%252B4%26aulast%3DKadukova%26aufirst%3DMaria%26date%3D2020%26date%3D2019%26volume%3D34%26issue%3D2%26spage%3D191%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sílvia  Chaves</span>, <span class="hlFld-ContribAuthor ">Simonetta  Resta</span>, <span class="hlFld-ContribAuthor ">Federica  Rinaldo</span>, <span class="hlFld-ContribAuthor ">Marina  Costa</span>, <span class="hlFld-ContribAuthor ">Romane  Josselin</span>, <span class="hlFld-ContribAuthor ">Karolina  Gwizdala</span>, <span class="hlFld-ContribAuthor ">Luca  Piemontese</span>, <span class="hlFld-ContribAuthor ">Vito  Capriati</span>, <span class="hlFld-ContribAuthor ">A. Raquel  Pereira-Santos</span>, <span class="hlFld-ContribAuthor ">Sandra M.  Cardoso</span>, <span class="hlFld-ContribAuthor ">M. Amélia  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 985. <a href="https://doi.org/10.3390/molecules25040985" title="DOI URL">https://doi.org/10.3390/molecules25040985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25040985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25040985%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BEvaluation%252Bof%252BHydroxybenzimidazole-Donepezil%252BAnalogues%252Bas%252BMultitarget-Directed%252BLigands%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DChaves%26aufirst%3DS%25C3%25ADlvia%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nour M.  Moussa‐Pacha</span>, <span class="hlFld-ContribAuthor ">Shifaa M.  Abdin</span>, <span class="hlFld-ContribAuthor ">Hany A.  Omar</span>, <span class="hlFld-ContribAuthor ">Hasan  Alniss</span>, <span class="hlFld-ContribAuthor ">Taleb H.  Al‐Tel</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 339-384. <a href="https://doi.org/10.1002/med.21622" title="DOI URL">https://doi.org/10.1002/med.21622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21622%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DBACE1%252Binhibitors%25253A%252BCurrent%252Bstatus%252Band%252Bfuture%252Bdirections%252Bin%252Btreating%252BAlzheimer%252527s%252Bdisease%26aulast%3DMoussa%25E2%2580%2590Pacha%26aufirst%3DNour%2BM.%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D339%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhidong  Xu</span>, <span class="hlFld-ContribAuthor ">Caihong  Miao</span>, <span class="hlFld-ContribAuthor ">Fugui  Dong</span>, <span class="hlFld-ContribAuthor ">Limeng  Jia</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Liu</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis of a carbon-11 labeled tetrahydrobenzisoxazole derivative as a new PET probe for γ-secretase imaging in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2020,</strong> <em>155 </em>, 108915. <a href="https://doi.org/10.1016/j.apradiso.2019.108915" title="DOI URL">https://doi.org/10.1016/j.apradiso.2019.108915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2019.108915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2019.108915%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DRadiosynthesis%252Bof%252Ba%252Bcarbon-11%252Blabeled%252Btetrahydrobenzisoxazole%252Bderivative%252Bas%252Ba%252Bnew%252BPET%252Bprobe%252Bfor%252B%2525CE%2525B3-secretase%252Bimaging%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DXu%26aufirst%3DZhidong%26date%3D2020%26volume%3D155%26spage%3D108915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriela Dumitrita  Stanciu</span>, <span class="hlFld-ContribAuthor ">Andrei  Luca</span>, <span class="hlFld-ContribAuthor ">Razvan Nicolae  Rusu</span>, <span class="hlFld-ContribAuthor ">Veronica  Bild</span>, <span class="hlFld-ContribAuthor ">Sorin Ioan  Beschea Chiriac</span>, <span class="hlFld-ContribAuthor ">Carmen  Solcan</span>, <span class="hlFld-ContribAuthor ">Walther  Bild</span>, <span class="hlFld-ContribAuthor ">Daniela Carmen  Ababei</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     , 40. <a href="https://doi.org/10.3390/biom10010040" title="DOI URL">https://doi.org/10.3390/biom10010040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10010040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10010040%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%252BPharmacotherapy%252Bin%252BRelation%252Bto%252BCholinergic%252BSystem%252BInvolvement%26aulast%3DStanciu%26aufirst%3DGabriela%2BDumitrita%26date%3D2020%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Blaikie</span>, <span class="hlFld-ContribAuthor ">Graeme  Kay</span>, <span class="hlFld-ContribAuthor ">Paul  Kong Thoo Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 2052-2072. <a href="https://doi.org/10.1039/C9MD00337A" title="DOI URL">https://doi.org/10.1039/C9MD00337A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00337A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00337A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DCurrent%252Band%252Bemerging%252Btherapeutic%252Btargets%252Bof%252Balzheimer%252527s%252Bdisease%252Bfor%252Bthe%252Bdesign%252Bof%252Bmulti-target%252Bdirected%252Bligands%26aulast%3DBlaikie%26aufirst%3DLaura%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D12%26spage%3D2052%26epage%3D2072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Woong-Hee  Shin</span>, <span class="hlFld-ContribAuthor ">Daisuke  Kihara</span>. </span><span class="cited-content_cbyCitation_article-title">Predicting binding poses and affinity ranking in D3R Grand Challenge using PL-PatchSurfer2.0. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2019,</strong> <em>33 </em>
                                    (12)
                                     , 1083-1094. <a href="https://doi.org/10.1007/s10822-019-00222-y" title="DOI URL">https://doi.org/10.1007/s10822-019-00222-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-019-00222-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-019-00222-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DPredicting%252Bbinding%252Bposes%252Band%252Baffinity%252Branking%252Bin%252BD3R%252BGrand%252BChallenge%252Busing%252BPL-PatchSurfer2.0%26aulast%3DShin%26aufirst%3DWoong-Hee%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D12%26spage%3D1083%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junjie  Zou</span>, <span class="hlFld-ContribAuthor ">Chuan  Tian</span>, <span class="hlFld-ContribAuthor ">Carlos  Simmerling</span>. </span><span class="cited-content_cbyCitation_article-title">Blinded prediction of protein–ligand binding affinity using Amber thermodynamic integration for the 2018 D3R grand challenge 4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2019,</strong> <em>33 </em>
                                    (12)
                                     , 1021-1029. <a href="https://doi.org/10.1007/s10822-019-00223-x" title="DOI URL">https://doi.org/10.1007/s10822-019-00223-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-019-00223-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-019-00223-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DBlinded%252Bprediction%252Bof%252Bprotein%2525E2%252580%252593ligand%252Bbinding%252Baffinity%252Busing%252BAmber%252Bthermodynamic%252Bintegration%252Bfor%252Bthe%252B2018%252BD3R%252Bgrand%252Bchallenge%252B4%26aulast%3DZou%26aufirst%3DJunjie%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D12%26spage%3D1021%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Vanda</span>, <span class="hlFld-ContribAuthor ">Paweł  Zajdel</span>, <span class="hlFld-ContribAuthor ">Miroslav  Soural</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111569. <a href="https://doi.org/10.1016/j.ejmech.2019.111569" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111569%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImidazopyridine-based%252Bselective%252Band%252Bmultifunctional%252Bligands%252Bof%252Bbiological%252Btargets%252Bassociated%252Bwith%252Bpsychiatric%252Band%252Bneurodegenerative%252Bdiseases%26aulast%3DVanda%26aufirst%3DDavid%26date%3D2019%26volume%3D181%26spage%3D111569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viktoriya  Ivasiv</span>, <span class="hlFld-ContribAuthor ">Claudia  Albertini</span>, <span class="hlFld-ContribAuthor ">Ana E.  Gonçalves</span>, <span class="hlFld-ContribAuthor ">Michele  Rossi</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1694-1711. <a href="https://doi.org/10.2174/1568026619666190619115735" title="DOI URL">https://doi.org/10.2174/1568026619666190619115735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190619115735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190619115735%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252BHybridization%252Bas%252Ba%252BTool%252Bfor%252BDesigning%252BMultitarget%252BDrug%252BCandidates%252Bfor%252BComplex%252BDiseases%26aulast%3DIvasiv%26aufirst%3DViktoriya%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1694%26epage%3D1711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan F.  González</span>, <span class="hlFld-ContribAuthor ">Andrés R.  Alcántara</span>, <span class="hlFld-ContribAuthor ">Antonio L.  Doadrio</span>, <span class="hlFld-ContribAuthor ">Jose María  Sánchez-Montero</span>. </span><span class="cited-content_cbyCitation_article-title">Developments with multi-target drugs for Alzheimer’s disease: an overview of the current discovery approaches. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , 879-891. <a href="https://doi.org/10.1080/17460441.2019.1623201" title="DOI URL">https://doi.org/10.1080/17460441.2019.1623201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1623201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1623201%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DDevelopments%252Bwith%252Bmulti-target%252Bdrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Ban%252Boverview%252Bof%252Bthe%252Bcurrent%252Bdiscovery%252Bapproaches%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DJuan%2BF.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3D879%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changxing  Qi</span>, <span class="hlFld-ContribAuthor ">Qun  Zhou</span>, <span class="hlFld-ContribAuthor ">Weixi  Gao</span>, <span class="hlFld-ContribAuthor ">Mengting  Liu</span>, <span class="hlFld-ContribAuthor ">Chunmei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Nian  Li</span>, <span class="hlFld-ContribAuthor ">Yongji  Lai</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Dongyan  Li</span>, <span class="hlFld-ContribAuthor ">Zhengxi  Hu</span>, <span class="hlFld-ContribAuthor ">Hucheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Yonghui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-BACE1 and anti-AchE activities of undescribed spiro-dioxolane-containing meroterpenoids from the endophytic fungus Aspergillus terreus Thom. </span><span class="cited-content_cbyCitation_journal-name">Phytochemistry</span><span> <strong>2019,</strong> <em>165 </em>, 112041. <a href="https://doi.org/10.1016/j.phytochem.2019.05.014" title="DOI URL">https://doi.org/10.1016/j.phytochem.2019.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phytochem.2019.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phytochem.2019.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytochemistry%26atitle%3DAnti-BACE1%252Band%252Banti-AchE%252Bactivities%252Bof%252Bundescribed%252Bspiro-dioxolane-containing%252Bmeroterpenoids%252Bfrom%252Bthe%252Bendophytic%252Bfungus%252BAspergillus%252Bterreus%252BThom%26aulast%3DQi%26aufirst%3DChangxing%26date%3D2019%26volume%3D165%26spage%3D112041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Jiarui  Li</span>, <span class="hlFld-ContribAuthor ">Tiantian  Sun</span>, <span class="hlFld-ContribAuthor ">Chao  Cai</span>, <span class="hlFld-ContribAuthor ">Meng  Shao</span>, <span class="hlFld-ContribAuthor ">Guangli  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Concise chemoenzymatic synthesis of heparan sulfate analogues as potent BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Polymers</span><span> <strong>2019,</strong> <em>217 </em>, 232-239. <a href="https://doi.org/10.1016/j.carbpol.2019.04.047" title="DOI URL">https://doi.org/10.1016/j.carbpol.2019.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carbpol.2019.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carbpol.2019.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Polymers%26atitle%3DConcise%252Bchemoenzymatic%252Bsynthesis%252Bof%252Bheparan%252Bsulfate%252Banalogues%252Bas%252Bpotent%252BBACE-1%252Binhibitors%26aulast%3DLi%26aufirst%3DJun%26date%3D2019%26volume%3D217%26spage%3D232%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target design strategies for the improved treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 228-247. <a href="https://doi.org/10.1016/j.ejmech.2019.05.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMulti-target%252Bdesign%252Bstrategies%252Bfor%252Bthe%252Bimproved%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DZhang%26aufirst%3DPengfei%26date%3D2019%26volume%3D176%26spage%3D228%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mukesh Ghanshyam  Chaubey</span>, <span class="hlFld-ContribAuthor ">Stuti Nareshkumar  Patel</span>, <span class="hlFld-ContribAuthor ">Rajesh Prasad  Rastogi</span>, <span class="hlFld-ContribAuthor ">Prabhakar Lal  Srivastava</span>, <span class="hlFld-ContribAuthor ">Arun Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Datta  Madamwar</span>, <span class="hlFld-ContribAuthor ">Niraj Kumar  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of cyanobacterial pigment protein phycoerythrin: in silico and in vitro study of BACE1 interaction and in vivo Aβ reduction. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2019,</strong> <em>134 </em>, 368-378. <a href="https://doi.org/10.1016/j.ijbiomac.2019.05.006" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2019.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2019.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2019.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DTherapeutic%252Bpotential%252Bof%252Bcyanobacterial%252Bpigment%252Bprotein%252Bphycoerythrin%25253A%252Bin%252Bsilico%252Band%252Bin%252Bvitro%252Bstudy%252Bof%252BBACE1%252Binteraction%252Band%252Bin%252Bvivo%252BA%2525CE%2525B2%252Breduction%26aulast%3DChaubey%26aufirst%3DMukesh%2BGhanshyam%26date%3D2019%26volume%3D134%26spage%3D368%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacopo  Meldolesi</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer’s disease: Key developments support promising perspectives for therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>146 </em>, 104316. <a href="https://doi.org/10.1016/j.phrs.2019.104316" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104316%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BKey%252Bdevelopments%252Bsupport%252Bpromising%252Bperspectives%252Bfor%252Btherapy%26aulast%3DMeldolesi%26aufirst%3DJacopo%26date%3D2019%26volume%3D146%26spage%3D104316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lídia  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Célia  Faustino</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Strategies Targeting Amyloid-β in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Alzheimer Research</span><span> <strong>2019,</strong> <em>16 </em>
                                    (5)
                                     , 418-452. <a href="https://doi.org/10.2174/1567205016666190321163438" title="DOI URL">https://doi.org/10.2174/1567205016666190321163438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1567205016666190321163438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1567205016666190321163438%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Alzheimer%2520Research%26atitle%3DTherapeutic%252BStrategies%252BTargeting%252BAmyloid-%2525CE%2525B2%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPinheiro%26aufirst%3DL%25C3%25ADdia%26date%3D2019%26volume%3D16%26issue%3D5%26spage%3D418%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 761-777. <a href="https://doi.org/10.1016/j.bmcl.2018.12.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bevolutions%252Bin%252Bthe%252BBACE1%252Binhibitor%252Bfield%252Bfrom%252B2014%252Bto%252B2018%26aulast%3DHsiao%26aufirst%3DChien-Chi%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D761%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Maia</span>, <span class="hlFld-ContribAuthor ">Emília  Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     , 41. <a href="https://doi.org/10.3390/ph12010041" title="DOI URL">https://doi.org/10.3390/ph12010041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12010041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12010041%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DBACE-1%252Band%252B%2525CE%2525B3-Secretase%252Bas%252BTherapeutic%252BTargets%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMaia%26aufirst%3DMiguel%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Belluti</span>, <span class="hlFld-ContribAuthor ">Giulia  Orteca</span>, <span class="hlFld-ContribAuthor ">Valentina  Semeghini</span>, <span class="hlFld-ContribAuthor ">Giovanna  Rigillo</span>, <span class="hlFld-ContribAuthor ">Francesca  Parenti</span>, <span class="hlFld-ContribAuthor ">Erika  Ferrari</span>, <span class="hlFld-ContribAuthor ">Carol  Imbriano</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (1)
                                     , 28. <a href="https://doi.org/10.3390/ijms20010028" title="DOI URL">https://doi.org/10.3390/ijms20010028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20010028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20010028%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPotent%252BAnti-Cancer%252BProperties%252Bof%252BPhthalimide-Based%252BCurcumin%252BDerivatives%252Bon%252BProstate%252BTumor%252BCells%26aulast%3DBelluti%26aufirst%3DSilvia%26date%3D2019%26date%3D2018%26volume%3D20%26issue%3D1%26spage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">MostafaM.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">MoustafaT.  Gabr</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget therapeutic strategies for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Neural Regeneration Research</span><span> <strong>2019,</strong> <em>14 </em>
                                    (3)
                                     , 437. <a href="https://doi.org/10.4103/1673-5374.245463" title="DOI URL">https://doi.org/10.4103/1673-5374.245463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/1673-5374.245463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F1673-5374.245463%26sid%3Dliteratum%253Aachs%26jtitle%3DNeural%2520Regeneration%2520Research%26atitle%3DMultitarget%252Btherapeutic%252Bstrategies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DIbrahim%26aufirst%3DMostafaM.%26date%3D2019%26volume%3D14%26issue%3D3%26spage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santiago  Lascano</span>, <span class="hlFld-ContribAuthor ">Marie  Lopez</span>, <span class="hlFld-ContribAuthor ">Paola B.  Arimondo</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Products and Chemical Biology Tools: Alternatives to Target Epigenetic Mechanisms in Cancers. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2018,</strong> <em>18 </em>
                                    (12)
                                     , 1854-1876. <a href="https://doi.org/10.1002/tcr.201800133" title="DOI URL">https://doi.org/10.1002/tcr.201800133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.201800133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.201800133%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DNatural%252BProducts%252Band%252BChemical%252BBiology%252BTools%25253A%252BAlternatives%252Bto%252BTarget%252BEpigenetic%252BMechanisms%252Bin%252BCancers%26aulast%3DLascano%26aufirst%3DSantiago%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D12%26spage%3D1854%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moustafa T.  Gabr</span>, <span class="hlFld-ContribAuthor ">Mohammed S.  Abdel-Raziq</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>80 </em>, 245-252. <a href="https://doi.org/10.1016/j.bioorg.2018.06.031" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.06.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.06.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.06.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bdonepezil%252Banalogues%252Bas%252Bdual%252BAChE%252Band%252BBACE-1%252Binhibitors%26aulast%3DGabr%26aufirst%3DMoustafa%2BT.%26date%3D2018%26volume%3D80%26spage%3D245%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Martínez</span>, <span class="hlFld-ContribAuthor ">Mai  Zahran</span>, <span class="hlFld-ContribAuthor ">Miguel  Gomez</span>, <span class="hlFld-ContribAuthor ">Coreen  Cooper</span>, <span class="hlFld-ContribAuthor ">Johnny  Guevara</span>, <span class="hlFld-ContribAuthor ">Erik  Ekengard</span>, <span class="hlFld-ContribAuthor ">Ebbe  Nordlander</span>, <span class="hlFld-ContribAuthor ">Ralph  Alcendor</span>, <span class="hlFld-ContribAuthor ">Sarah  Hambleton</span>. </span><span class="cited-content_cbyCitation_article-title">Novel multi-target compounds in the quest for new chemotherapies against Alzheimer’s disease: An experimental and theoretical study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (17)
                                     , 4823-4840. <a href="https://doi.org/10.1016/j.bmc.2018.08.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.08.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.08.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bmulti-target%252Bcompounds%252Bin%252Bthe%252Bquest%252Bfor%252Bnew%252Bchemotherapies%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BAn%252Bexperimental%252Band%252Btheoretical%252Bstudy%26aulast%3DMart%25C3%25ADnez%26aufirst%3DAlberto%26date%3D2018%26volume%3D26%26issue%3D17%26spage%3D4823%26epage%3D4840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moustafa T.  Gabr</span>, <span class="hlFld-ContribAuthor ">Mohammed S.  Abdel-Raziq</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (17)
                                     , 2910-2913. <a href="https://doi.org/10.1016/j.bmcl.2018.07.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.07.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.07.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bstructurally%252Brigid%252Bdonepezil%252Banalogues%252Bas%252Bdual%252BAChE%252Band%252BBACE-1%252Binhibitors%26aulast%3DGabr%26aufirst%3DMoustafa%2BT.%26date%3D2018%26volume%3D28%26issue%3D17%26spage%3D2910%26epage%3D2913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Katarina  Spilovska</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Rafael  Dolezal</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>. </span><span class="cited-content_cbyCitation_article-title">Amyloid Beta Hypothesis: Attention to β- and γ-Secretase Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,<a href="https://doi.org/10.5772/intechopen.75629" title="DOI URL">https://doi.org/10.5772/intechopen.75629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.75629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.75629%26sid%3Dliteratum%253Aachs%26atitle%3DAmyloid%252BBeta%252BHypothesis%25253A%252BAttention%252Bto%252B%2525CE%2525B2-%252Band%252B%2525CE%2525B3-Secretase%252BModulators%26aulast%3DKorabecny%26aufirst%3DJan%26date%3D2018%26date%3D2018%26pub%3DInTech%26atitle%3DAlzheimer%252527s%252BDisease%252B-%252BThe%252B21st%252BCentury%252BChallenge%26aulast%3DDorszewska%26aufirst%3DJolanta%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorleta  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Raquel L.  Arribas</span>, <span class="hlFld-ContribAuthor ">Lucia  Viejo</span>, <span class="hlFld-ContribAuthor ">Rocio  Lajarin-Cuesta</span>, <span class="hlFld-ContribAuthor ">Cristobal  de los Rios</span>. </span><span class="cited-content_cbyCitation_article-title">Substituent effect of N-benzylated gramine derivatives that prevent the PP2A inhibition and dissipate the neuronal Ca2+ overload, as a multitarget strategy for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (9)
                                     , 2551-2560. <a href="https://doi.org/10.1016/j.bmc.2018.04.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSubstituent%252Beffect%252Bof%252BN-benzylated%252Bgramine%252Bderivatives%252Bthat%252Bprevent%252Bthe%252BPP2A%252Binhibition%252Band%252Bdissipate%252Bthe%252Bneuronal%252BCa2%25252B%252Boverload%25252C%252Bas%252Ba%252Bmultitarget%252Bstrategy%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DGonzalez%26aufirst%3DDorleta%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2551%26epage%3D2560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danielle M.  Raymond</span>, <span class="hlFld-ContribAuthor ">Bradley L.  Nilsson</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent peptide assemblies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2018,</strong> <em>47 </em>
                                    (10)
                                     , 3659-3720. <a href="https://doi.org/10.1039/C8CS00115D" title="DOI URL">https://doi.org/10.1039/C8CS00115D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CS00115D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CS00115D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DMulticomponent%252Bpeptide%252Bassemblies%26aulast%3DRaymond%26aufirst%3DDanielle%2BM.%26date%3D2018%26date%3D2018%26volume%3D47%26issue%3D10%26spage%3D3659%26epage%3D3720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosanna  Caliandro</span>, <span class="hlFld-ContribAuthor ">Alessandro  Pesaresi</span>, <span class="hlFld-ContribAuthor ">Luca  Cariati</span>, <span class="hlFld-ContribAuthor ">Antonio  Procopio</span>, <span class="hlFld-ContribAuthor ">Manuela  Oliverio</span>, <span class="hlFld-ContribAuthor ">Doriano  Lamba</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetic and structural studies on the interactions of
              Torpedo californica
              acetylcholinesterase with two donepezil-like rigid analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 794-803. <a href="https://doi.org/10.1080/14756366.2018.1458030" title="DOI URL">https://doi.org/10.1080/14756366.2018.1458030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1458030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1458030%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DKinetic%252Band%252Bstructural%252Bstudies%252Bon%252Bthe%252Binteractions%252Bof%252BTorpedo%252Bcalifornica%252Bacetylcholinesterase%252Bwith%252Btwo%252Bdonepezil-like%252Brigid%252Banalogues%26aulast%3DCaliandro%26aufirst%3DRosanna%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D794%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Advanced Merck’s BACE-1 inhibitor <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Aminohydantoin <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Spirocyclic aminohydantoins <b>3</b> and <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Spirocyclic aminohydantoin <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Spirocyclic aminooxazoline <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Spirocyclic aminooxazolines <b>7</b>–<b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Iminopyrimidinones <b>12</b> and <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Aminothiazines <b>14</b>–<b>22</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Aminothiazines <b>23</b>, <b>27</b>, and <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Aminothiazines <b>24</b>–<b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Iminopyrimidinone <b>29</b> and iminothiadiazinane dioxide <b>30</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Spiropiperidine iminohydantoins <b>31</b> and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Aminoxazine <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Aminoquinoline <b>34</b> design rationale.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Cyclic acyl guanidine <b>37</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Examples of BACE-1 inhibitors (<b>38</b>–<b>43</b>) discovered employing computer-assisted drug discovery methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Dual binding site AchE inhibitor <b>44</b> and dual BACE-1/AChE inhibitors <b>45</b>–<b>49</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Dual BACE-1/GSK-3β triazinone inhibitor <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/medium/jm-2017-00393z_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Dual BACE-1/GSK-3β curcumin inhibitor <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00393/20180201/images/large/jm-2017-00393z_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00393&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 115 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lhVFyzkj4Kvug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Morris, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vissel, B.</span><span> </span><span class="NLM_article-title">Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">Acta Neuropathol. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="refDoi"> DOI: 10.1186/PREACCEPT-1342777270140958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1186%2FPREACCEPT-1342777270140958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=25231068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A280%3ADC%252BC2M7it1Cgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=135&author=G.+P.+Morrisauthor=I.+A.+Clarkauthor=B.+Vissel&title=Inconsistencies+and+controversies+surrounding+the+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.1186%2FPREACCEPT-1342777270140958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Morris Gary P; Clark Ian A; Vissel Bryce</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The amyloid hypothesis has driven drug development strategies for Alzheimer's disease for over 20 years.  We review why accumulation of amyloid-beta (Aβ) oligomers is generally considered causal for synaptic loss and neurodegeneration in AD.  We elaborate on and update arguments for and against the amyloid hypothesis with new data and interpretations, and consider why the amyloid hypothesis may be failing therapeutically.  We note several unresolved issues in the field including the presence of Aβ deposition in cognitively normal individuals, the weak correlation between plaque load and cognition, questions regarding the biochemical nature, presence and role of Aβ oligomeric assemblies in vivo, the bias of pre-clinical AD models toward the amyloid hypothesis and the poorly explained pathological heterogeneity and comorbidities associated with AD.  We also illustrate how extensive data cited in support of the amyloid hypothesis, including genetic links to disease, can be interpreted independently of a role for Aβ in AD.  We conclude it is essential to expand our view of pathogenesis beyond Aβ and tau pathology and suggest several future directions for AD research, which we argue will be critical to understanding AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR74FIGjSHtAvx2phytoz6_fW6udTcc2eZg0Y-vBHMqU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7it1Cgtw%253D%253D&md5=5588d9e21d74eda10e7978d7f6856357</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2FPREACCEPT-1342777270140958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252FPREACCEPT-1342777270140958%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BP.%26aulast%3DClark%26aufirst%3DI.%2BA.%26aulast%3DVissel%26aufirst%3DB.%26atitle%3DInconsistencies%2520and%2520controversies%2520surrounding%2520the%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%2520Commun.%26date%3D2014%26volume%3D2%26spage%3D135%26doi%3D10.1186%2FPREACCEPT-1342777270140958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Herrup, K.</span><span> </span><span class="NLM_article-title">The case for rejecting the amyloid cascade hypothesis</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">794</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span><span class="refDoi"> DOI: 10.1038/nn.4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1038%2Fnn.4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=26007212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=794-799&author=K.+Herrup&title=The+case+for+rejecting+the+amyloid+cascade+hypothesis&doi=10.1038%2Fnn.4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The case for rejecting the amyloid cascade hypothesis</span></div><div class="casAuthors">Herrup, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">794-799</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a biol. complex neurodegenerative dementia.  Nearly 20 years ago, with the combination of observations from biochem., neuropathol. and genetics, a compelling hypothesis known as the amyloid cascade hypothesis was formulated.  The core of this hypothesis is that it is pathol. accumulations of amyloid-β, a peptide fragment of a membrane protein called amyloid precursor protein, that act as the root cause of AD and initiate its pathogenesis.  Yet, with the passage of time, growing amts. of data have accumulated that are inconsistent with the basically linear structure of this hypothesis.  And while there is fear in the field over the consequences of rejecting it outright, clinging to an inaccurate disease model is the option we should fear most.  This Perspective explores the proposition that we are over-reliant on amyloid to define and diagnose AD and that the time has come to face our fears and reject the amyloid cascade hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIDjilDJZlrVg90H21EOLACvtfcHk0lgFd2_DaUiEvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7bN&md5=e7513943fd2fa3fe7c6d9e1cb3f859b2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnn.4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4017%26sid%3Dliteratum%253Aachs%26aulast%3DHerrup%26aufirst%3DK.%26atitle%3DThe%2520case%2520for%2520rejecting%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D794%26epage%3D799%26doi%3D10.1038%2Fnn.4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kepp, K. P.</span><span> </span><span class="NLM_article-title">Ten challenges of the amyloid hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span><span class="refDoi"> DOI: 10.3233/JAD-160550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.3233%2FJAD-160550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=27662304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A280%3ADC%252BC2svjt1OnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2017&pages=447-457&author=K.+P.+Kepp&title=Ten+challenges+of+the+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-160550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease</span></div><div class="casAuthors">Kepp Kasper Planeta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">447-457</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The inability to effectively halt or cure Alzheimer's disease (AD), exacerbated by the recent failures of high-profile clinical trials, emphasizes the urgent need to understand the complex biochemistry of this major neurodegenerative disease.  In this paper, ten central, current challenges of the major paradigm in the field, the amyloid hypothesis, are sharply formulated.  These challenges together show that new approaches are necessary that address data heterogeneity, increase focus on the proteome level, use available human patient data more actively, account for the aging phenotype as a background model of the disease, unify our understanding of the interplay between genetic and non-genetic risk factors, and combine into one framework both the familial and sporadic forms of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAInuhTpciTLqxQ2mb9Pu8fW6udTcc2eYACkwtQT6dx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svjt1OnsQ%253D%253D&md5=4fd6780f6a2b98c2d278001667c3a1dd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3233%2FJAD-160550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-160550%26sid%3Dliteratum%253Aachs%26aulast%3DKepp%26aufirst%3DK.%2BP.%26atitle%3DTen%2520challenges%2520of%2520the%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2017%26volume%3D55%26spage%3D447%26epage%3D457%26doi%3D10.3233%2FJAD-160550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lemere, C. A.</span><span> </span><span class="NLM_article-title">Immunotherapy for Alzheimer’s disease: hoops and hurdles</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="refDoi"> DOI: 10.1186/1750-1326-8-36</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1186%2F1750-1326-8-36" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=24148220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVyhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=36&author=C.+A.+Lemere&title=Immunotherapy+for+Alzheimer%E2%80%99s+disease%3A+hoops+and+hurdles&doi=10.1186%2F1750-1326-8-36"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy for Alzheimer's disease: hoops and hurdles</span></div><div class="casAuthors">Lemere, Cynthia A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36/1-36/6, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia, afflicting more than 30 million people worldwide.  Currently, there is no cure or way to prevent this devastating disease.  Extracellular plaques, contg. various forms of amyloid-β protein (Aβ), and intracellular neurofibrillary tangles (NFTs), composed of hyper-phosphorylated tau protein, are two major pathol. hallmarks of the AD brain.  Aggregation, deposition and N-terminal modification of Aβ protein and tau phosphorylation and aggregation are thought to precede the onset of cognitive decline, which is better correlated with tangle formation and neuron loss.  Active and passive vaccines against various forms of Aβ have shown promise in pre-clin. animal models.  However, translating these results safely and effectively into humans has been challenging.  Recent clin. trials showed little or no cognitive efficacy, possibly due to the fact that the aforementioned neurodegenerative processes most likely pre-existed in the patients well before the start of immunotherapy.  Efforts are now underway to treat individuals at risk for AD prior to or in the earliest stages of cognitive decline with the hope of preventing or delaying the onset of the disease.  In addn., efforts to immunize against tau and other AD-related targets are underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD87mWhmrsprVg90H21EOLACvtfcHk0lgFd2_DaUiEvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVyhs7s%253D&md5=9004fbde56ff73a61c29c1032ef75acd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-8-36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-8-36%26sid%3Dliteratum%253Aachs%26aulast%3DLemere%26aufirst%3DC.%2BA.%26atitle%3DImmunotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520hoops%2520and%2520hurdles%26jtitle%3DMol.%2520Neurodegener.%26date%3D2013%26volume%3D8%26spage%3D36%26doi%3D10.1186%2F1750-1326-8-36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1002/ana.24188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fana.24188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=24853080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=185-205&author=E.+Karranauthor=J.+Hardy&title=A+critique+of+the+drug+discovery+and+phase+3+clinical+programs+targeting+the+amyloid+hypothesis+for+Alzheimer+disease&doi=10.1002%2Fana.24188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span></div><div class="casAuthors">Karran, Eric; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-205</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Review of a critique of the drug discovery and phase 3 clin. programs targeting the amyloid hypothesis for Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQE-UU2jSXbVg90H21EOLACvtfcHk0lg2aVQZiw6JjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K&md5=64287890331df95f3e2594ef711cdc27</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fana.24188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24188%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DA%2520critique%2520of%2520the%2520drug%2520discovery%2520and%2520phase%25203%2520clinical%2520programs%2520targeting%2520the%2520amyloid%2520hypothesis%2520for%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D76%26spage%3D185%26epage%3D205%26doi%3D10.1002%2Fana.24188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><a href="http://www.alzforum.org/therapeutics/jnj-54861911" class="extLink">http://www.alzforum.org/therapeutics/jnj-54861911</a> (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fjnj-54861911+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><a href="http://www.alzforum.org/therapeutics/cnp520" class="extLink">http://www.alzforum.org/therapeutics/cnp520</a>. (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fcnp520.+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><a href="http://www.alzforum.org/therapeutics/ly3202626-0" class="extLink">http://www.alzforum.org/therapeutics/ly3202626-0</a> (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fly3202626-0+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockendorf, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleijn, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palcza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M. S.</span><span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer’s disease patients</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">363ra150</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&author=M.+E.+Kennedyauthor=A.+W.+Stamfordauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+F.+Dockendorfauthor=M.+Eganauthor=L.+Ereshefskyauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=S.+Jheeauthor=H.+J.+Kleijnauthor=R.+Kuvelkarauthor=W.+Liauthor=B.+A.+Mattsonauthor=H.+Meiauthor=J.+Palczaauthor=J.+D.+Scottauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=J.+A.+Stoneauthor=E.+M.+Parkerauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+beta-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520beta-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunskill, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossiter, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-Abeta-site smyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10435</span><span class="NLM_x">–</span> <span class="NLM_lpage">10450</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-Abeta-site+smyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-Abeta-site%2520smyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Nie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M. Y.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of amyloid beta peptide aggregation as a potential therapeutic strategy for Alzheimer’s disease</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1038/aps.2011.14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1038%2Faps.2011.14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=21499284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=545-551&author=Q.+Nieauthor=X.+G.+Duauthor=M.+Y.+Geng&title=Small+molecule+inhibitors+of+amyloid+beta+peptide+aggregation+as+a+potential+therapeutic+strategy+for+Alzheimer%E2%80%99s+disease&doi=10.1038%2Faps.2011.14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease</span></div><div class="casAuthors">Nie, Qin; Du, Xiao-guang; Geng, Mei-yu</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-551</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyloid β (Aβ) peptides have long been viewed as a potential target for Alzheimer's disease (AD).  Aggregation of Aβ peptides in the brain tissue is believed to be an exclusively pathol. process.  Therefore, blocking the initial stages of Aβ peptide aggregation with small mols. could hold considerable promise as the starting point for the development of new therapies for AD.  Recent rapid progresses in our understanding of toxic amyloid assembly provide a fresh impetus for this interesting approach.  Here, we discuss the problems, challenges and new concepts in targeting Aβ peptides.  Acta Pharmacologica Sinica (2011) 32: 545-551; doi: 10.1038/aps.2011.14; published online 18 Apr 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrROzsHwdwhHbVg90H21EOLACvtfcHk0lhINVziTNoOyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKgtb4%253D&md5=243954abf169e75b7ed55f3096afb34b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.14%26sid%3Dliteratum%253Aachs%26aulast%3DNie%26aufirst%3DQ.%26aulast%3DDu%26aufirst%3DX.%2BG.%26aulast%3DGeng%26aufirst%3DM.%2BY.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520amyloid%2520beta%2520peptide%2520aggregation%2520as%2520a%2520potential%2520therapeutic%2520strategy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2011%26volume%3D32%26spage%3D545%26epage%3D551%26doi%3D10.1038%2Faps.2011.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenerton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, P.</span><span> </span><span class="NLM_article-title">Development of protease inhibitors for protozoan infections</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span><span class="refDoi"> DOI: 10.1097/QCO.0b013e328315cca9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1097%2FQCO.0b013e328315cca9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=18978536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWltbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=668-672&author=J.+H.+McKerrowauthor=P.+J.+Rosenthalauthor=R.+Swenertonauthor=P.+Doyle&title=Development+of+protease+inhibitors+for+protozoan+infections&doi=10.1097%2FQCO.0b013e328315cca9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development of protease inhibitors for protozoan infections</span></div><div class="casAuthors">McKerrow, James H.; Rosenthal, Philip J.; Swenerton, Ryan; Doyle, Patricia</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">668-672</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: To highlight the promise of parasite proteases as targets for development of new antiparasitic chemotherapy.  Proteolytic enzymes play key roles in the life cycle of protozoan parasites or the pathogenesis of diseases they produce.  These roles include processing of host or parasite surface proteins for invasion of host cells, digestion of host proteins for nutrition, and inactivation of host immune defense mediators.  Recent findings: Drug development for other markets has shown that proteases are druggable targets, and protease inhibitors are now licensed or in clin. development to treat hypertension, diabetes, thrombosis, osteoporosis, infectious diseases, and cancer.  Several protease targets have been validated by genetic or chem. knockout in protozoan parasites.  Many other parasite proteases appear promising as targets, but require more work for validation, or to identify viable drug leads.  Because homologous proteases function as key enzymes in several parasites, targeting these proteases may allow development of a single compd., or a set of similar compds., that target multiple diseases including malaria, trypanosomiasis, leishmaniasis, toxoplasmosis, cryptosporidiosis, and amebiasis.  Summary: Proteases have been validated as targets in a no. of parasitic infections.  Proteases are druggable targets as evidenced by effective antiprotease drugs for the treatment of many human diseases including hypertension and AIDS.  Future drug development targeting parasite proteases will be aided by the strong foundation of biochem., structural, and computational databases already published or available online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJj2JMKZMoibVg90H21EOLACvtfcHk0ljOUnqjAPD3sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWltbzO&md5=a285ec4c4c5d12e5665db5ee280259c2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e328315cca9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e328315cca9%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DSwenerton%26aufirst%3DR.%26aulast%3DDoyle%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520protease%2520inhibitors%2520for%2520protozoan%2520infections%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D21%26spage%3D668%26epage%3D672%26doi%3D10.1097%2FQCO.0b013e328315cca9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1126/science.290.5489.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1126%2Fscience.290.5489.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=11021803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Chtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=150-153&author=L.+Hongauthor=G.+Koelschauthor=X.+Linauthor=S.+Wuauthor=S.+Terzyanauthor=A.+K.+Ghoshauthor=X.+C.+Zhangauthor=J.+Tang&title=Structure+of+the+protease+domain+of+memapsin+2+%28beta-secretase%29+complexed+with+inhibitor&doi=10.1126%2Fscience.290.5489.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor</span></div><div class="casAuthors">Hong, Lin; Koelsch, Gerald; Lin, Xinli; Wu, Shili; Terzyan, Simon; Ghosh, Arun K.; Zhang, Xuenjun C.; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">5489</span>),
    <span class="NLM_cas:pages">150-153</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Memapsin 2 (β-secretase) is a membrane-assocd. aspartic protease involved in the prodn. of β-amyloid peptide in Alzheimer's disease and is a major target for drug design.  We detd. the crystal structure of the protease domain of human memapsin 2 complexed to an eight-residue inhibitor at 1.9 angstrom resoln.  The active site of memapsin 2 is more open and less hydrophobic than that of other human aspartic proteases.  The subsite locations from S4 to S2' are well defined.  A kink of the inhibitor chain at P2' and the change of chain direction of P3' and P4' may be mimicked to provide inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtz4LHUXVGBrVg90H21EOLACvtfcHk0ljOUnqjAPD3sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Chtrs%253D&md5=c5d15af5ae58e6c3f46da1b22f7d4df9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.290.5489.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.290.5489.150%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520protease%2520domain%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520complexed%2520with%2520inhibitor%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D150%26epage%3D153%26doi%3D10.1126%2Fscience.290.5489.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Developing beta-secretase inhibitors for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2011.07476.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1111%2Fj.1471-4159.2011.07476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22122681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=71-83&issue=Suppl.+1&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=J.+Tang&title=Developing+beta-secretase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2011.07476.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Developing β-secretase inhibitors for treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Secretase (memapsin 2; BACE-1) is the first protease in the processing of amyloid precursor protein leading to the prodn. of amyloid-β (Aβ) in the brain.  It is believed that high levels of brain Aβ are responsible for the pathogenesis of Alzheimer's disease (AD).  Therefore, β-secretase is a major therapeutic target for the development of inhibitor drugs.  During the past decade, steady progress has been made in the evolution of β-secretase inhibitors toward better drug properties.  Recent inhibitors are potent, selective and have been shown to penetrate the blood-brain barrier to inhibit Aβ levels in the brains of exptl. animals.  Moreover, continuous administration of a β-secretase inhibitor was shown to rescue age-related cognitive decline in transgenic AD mice.  A small no. of β-secretase inhibitors have also entered early phase clin. trials.  These developments offer some optimism for the clin. development of a disease-modifying drug for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvY0fxn2hBubVg90H21EOLACvtfcHk0lhMbjKE2JRUlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D&md5=186d6ccadd1c207ecd7aaa9cb7584684</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07476.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DDeveloping%2520beta-secretase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl.%25201%26spage%3D71%26epage%3D83%26doi%3D10.1111%2Fj.1471-4159.2011.07476.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osswald, H. L.</span><span> </span><span class="NLM_article-title">BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6765</span><span class="NLM_x">–</span> <span class="NLM_lpage">6813</span><span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28beta-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0lhMbjKE2JRUlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528beta-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Structure-based design of beta-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4156</span><span class="NLM_x">–</span> <span class="NLM_lpage">4180</span><span class="refDoi"> DOI: 10.1021/jm301659n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-based+design+of+beta-site+APP+cleaving+enzyme+1+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm301659n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Yuan, Jing; Venkatraman, Shankar; Zheng, Yajun; McKeever, Brian M.; Dillard, Lawrence W.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4156-4180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The amyloid hypothesis asserts that excess prodn. or reduced clearance of the amyloid-β (Aβ) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease dementia.  The Aβ hypothesis has identified BACE1 as a therapeutic target to treat Alzheimer's and led to medicinal chem. efforts to design its inhibitors both in the pharmaceutical industry and in academia.  This review summarizes two distinct categories of inhibitors designed based on conformational states of "closed" and "open" forms of the enzyme.  In each category the inhibitors are classified based on the core catalytic interaction group or the aspartyl binding motif (ABM).  This review covers the description of inhibitors in each ABM class with X-ray crystal structures of key compds., their binding modes, related structure-activity data highlighting potency advances, and addnl. properties such as selectivity profile, P-gp efflux, pharmacokinetic, and pharmacodynamic data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLs7KN_eIzbVg90H21EOLACvtfcHk0lhMbjKE2JRUlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKgtr0%253D&md5=b703f57572b737b47658d86f5b730087</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-based%2520design%2520of%2520beta-site%2520APP%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180%26doi%3D10.1021%2Fjm301659n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">The structural evolution of beta-secretase inhibitors: a focus on the development of small-molecule inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1787</span><span class="NLM_x">–</span> <span class="NLM_lpage">1807</span><span class="refDoi"> DOI: 10.2174/15680266113139990137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.2174%2F15680266113139990137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=23931442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1787-1807&author=S.+Butiniauthor=S.+Brogiauthor=E.+Novellinoauthor=G.+Campianiauthor=A.+K.+Ghoshauthor=M.+Brindisiauthor=S.+Gemma&title=The+structural+evolution+of+beta-secretase+inhibitors%3A+a+focus+on+the+development+of+small-molecule+inhibitors&doi=10.2174%2F15680266113139990137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Structural Evolution of β-Secretase Inhibitors: A Focus on the Development of Small-Molecule Inhibitors</span></div><div class="casAuthors">Butini, Stefania; Brogi, Simone; Novellino, Ettore; Campiani, Giuseppe; Ghosh, Arun K.; Brindisi, Margherita; Gemma, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1787-1807</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Effective treatment of Alzheimer's disease (AD) remains a crit. unmet need in medicine.  The lack of useful treatment for AD led to an intense search for novel therapies based on the amyloid hypothesis, which states that amyloid β-42 (Aβ 42) plays an early and crucial role in all cases of AD. β-Secretase (also known as BACE-1 β-site APP-cleaving enzyme, Asp-2 or memapsin-2) is an aspartyl protease representing the rate limiting step in the generation of Aβ peptide fragments, therefore it could represent an important target in the steady hunt for a disease-modifying treatment.  Generally, β-secretase inhibitors are grouped into two families: peptidomimetic and nonpeptidomimetic inhibitors.  However, irresp. of the class, serious challenges with respect to blood-brain barrier (BBB) penetration and selectivity still remain.  Discovering a small mol. inhibitor of β-secretase represents an unnerving challenge but, due to its significant potential as a therapeutic target, growing efforts in this task are evident from both academic and industrial labs.  In this frame, the rising availability of crystal structures of β-secretase-inhibitor complexes represents an invaluable opportunity for optimization.  Nevertheless, beyond the inhibitory activity, the major issue of the current research approaches is about problems assocd. with BBB penetration and pharmacokinetic properties.  This review follows the structural evolution of the early β-secretase inhibitors and gives a snap-shot of the hottest chem. templates in the literature of the last five years, showing research progress in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9SkCa5mjCv7Vg90H21EOLACvtfcHk0liEeKvxdToQLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsLrI&md5=05e8126a28f1d7560530a0a67304864f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990137%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DThe%2520structural%2520evolution%2520of%2520beta-secretase%2520inhibitors%253A%2520a%2520focus%2520on%2520the%2520development%2520of%2520small-molecule%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1787%26epage%3D1807%26doi%3D10.2174%2F15680266113139990137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Tau in Alzheimer’s disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span><span class="refDoi"> DOI: 10.1016/S0962-8924(98)01368-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2FS0962-8924%2898%2901368-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=9854307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADyaK1MXmsV2i" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=425-427&author=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Tau+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0962-8924%2898%2901368-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Tau in Alzheimer's disease</span></div><div class="casAuthors">Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">425-427</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 38 refs.  Neurofibrillar protein aggregates contg. tau are one of the major hallmarks of Alzheimer's disease (AD).  In normal cells, tau stabilizes axonal microtubules, which are the tracks for intracellular traffic.  In AD, tau becomes abnormally phosphorylated, aggregates into paired helical filaments and loses its ability to maintain the microtubule tracks.  There is renewed interest in tau as a causative factor in neurodegenerative disease based on recently discovered mutations in the gene encoding tau.  This article discusses how changes in tau protein could lead to retraction of neuronal processes and thus cell death and argues that tau pathol., rather than β-amyloid, might be the most reliable indicative factor for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1ZpMyBcDM27Vg90H21EOLACvtfcHk0liEeKvxdToQLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsV2i&md5=659158d82f69a5be7952ce8983ffb953</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2898%2901368-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252898%252901368-3%26sid%3Dliteratum%253Aachs%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DTau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1998%26volume%3D8%26spage%3D425%26epage%3D427%26doi%3D10.1016%2FS0962-8924%2898%2901368-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Games played by rogue proteins in prion disorders and Alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span><span class="refDoi"> DOI: 10.1126/science.1087348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1126%2Fscience.1087348" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=814-818&author=A.+Aguzziauthor=C.+Haass&title=Games+played+by+rogue+proteins+in+prion+disorders+and+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fscience.1087348"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087348%26sid%3Dliteratum%253Aachs%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DGames%2520played%2520by%2520rogue%2520proteins%2520in%2520prion%2520disorders%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D814%26epage%3D818%26doi%3D10.1126%2Fscience.1087348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the two-hit hypothesis</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span><span class="refDoi"> DOI: 10.1016/S1474-4422(04)00707-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2FS1474-4422%2804%2900707-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=15039034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFyisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=219-226&author=X.+Zhuauthor=A.+K.+Rainaauthor=G.+Perryauthor=M.+A.+Smith&title=Alzheimer%E2%80%99s+disease%3A+the+two-hit+hypothesis&doi=10.1016%2FS1474-4422%2804%2900707-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: the two-hit hypothesis</span></div><div class="casAuthors">Zhu, Xiongwei; Raina, Arun K.; Perry, George; Smith, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-226</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">A review.  There are many lines of evidence showing that oxidative stress and aberrant mitogenic changes have important roles in the pathogenesis of Alzheimer's disease (AD).  However, although both oxidative stress and cell cycle-related abnormalities are early events, occurring before any cytopathol., the relation between these two events, and their role in pathophysiol. was, until recently, unclear.  However, on the basis of studies of mitogenic and oxidative stress signaling pathways in AD, we proposed a "two-hit hypothesis" which states that although either oxidative stress or abnormalities in mitotic signaling can independently serve as initiators, both processes are necessary to propagate disease pathogenesis.  In this paper, we summarize evidence for oxidative stress and abnormal mitotic alterations in AD and explain the two-hit hypothesis by describing how both mechanisms are necessary and invariant features of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq75S_m11G58bVg90H21EOLACvtfcHk0liEYuUchayAGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFyisbo%253D&md5=d4bddb80814d4cb7e7f12e6a4759016f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2804%2900707-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252804%252900707-0%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DRaina%26aufirst%3DA.%2BK.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520two-hit%2520hypothesis%26jtitle%3DLancet%2520Neurol.%26date%3D2004%26volume%3D3%26spage%3D219%26epage%3D226%26doi%3D10.1016%2FS1474-4422%2804%2900707-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wyss-Coray, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J.</span><span> </span><span class="NLM_article-title">Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006346</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1101%2Fcshperspect.a006346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22315714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFKlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006346&author=T.+Wyss-Corayauthor=J.+Rogers&title=Inflammation+in+Alzheimer+disease-a+brief+review+of+the+basic+science+and+clinical+literature&doi=10.1101%2Fcshperspect.a006346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature</span></div><div class="casAuthors">Wyss-Coray, Tony; Rogers, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a006346/1-a006346/23</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Biochem. and neuropathol. studies of brains from individuals with Alzheimer disease (AD) provide clear evidence for an activation of inflammatory pathways, and longterm use of anti-inflammatory drugs is linked with reduced risk to develop the disease.  As cause and effect relationships between inflammation and AD are being worked out, there is a realization that some components of this complex mol. and cellular machinery are most likely promoting pathol. processes leading to AD, whereas other components serve to do the opposite.  The challenge will be to find ways of fine tuning inflammation to delay, prevent, or treat AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOJegLfCJvkbVg90H21EOLACvtfcHk0liEYuUchayAGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFKlsL4%253D&md5=6ee844f83faf56a1c48324bc3df95aa7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006346%26sid%3Dliteratum%253Aachs%26aulast%3DWyss-Coray%26aufirst%3DT.%26aulast%3DRogers%26aufirst%3DJ.%26atitle%3DInflammation%2520in%2520Alzheimer%2520disease-a%2520brief%2520review%2520of%2520the%2520basic%2520science%2520and%2520clinical%2520literature%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006346%26doi%3D10.1101%2Fcshperspect.a006346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Swerdlow, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. M.</span><span> </span><span class="NLM_article-title">A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease</span> <span class="citation_source-journal">Med. Hypotheses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.1016/j.mehy.2003.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.mehy.2003.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=15193340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVehs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2004&pages=8-20&author=R.+H.+Swerdlowauthor=S.+M.+Khan&title=A+%E2%80%9Cmitochondrial+cascade+hypothesis%E2%80%9D+for+sporadic+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.mehy.2003.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease</span></div><div class="casAuthors">Swerdlow, Russell H.; Khan, Shaharyar M.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-20</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) includes etiol. heterogeneous disorders characterized by senile or presenile dementia, extracellular amyloid protein aggregations contg. an insol. amyloid precursor protein deriv., and intracytoplasmic tau protein aggregations.  Recent studies also show excess neuronal aneuploidy, programmed cell death (PCD), and mitochondrial dysfunction.  The leading AD mol. paradigm, the "amyloid cascade hypothesis", is based on studies of rare autosomal dominant variants and does not specify what initiates the common late-onset, sporadic form.  The authors propose for late-onset, sporadic AD a "mitochondrial cascade hypothesis" that comprehensively reconciles seemingly disparate histopathol. and pathophysiol. features.  In the authors' model, the inherited, gene-detd. make-up of an individual's electron transport chain sets basal rates of reactive oxygen species (ROS) prodn., which dets. the pace at which acquired mitochondrial damage accumulates.  Oxidative mitochondrial DNA, RNA, lipid, and protein damage amplifies ROS prodn. and triggers three events: (1) a reset response in which cells respond to elevated ROS by generating the β-sheet protein, beta amyloid, which further perturbs mitochondrial function, (2) a removal response in which compromised cells are purged via PCD mechanisms, and (3) a replace response in which neuronal progenitors unsuccessfully attempt to re-enter the cell cycle, with resultant aneuploidy, tau phosphorylation, and neurofibrillary tangle formation.  In addn. to defining a role for aging in AD pathogenesis, the mitochondrial cascade hypothesis also allows and accounts for histopathol. overlap between the sporadic, late-onset and autosomal dominant, early onset forms of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon6w28KOkDx7Vg90H21EOLACvtfcHk0lhFV4apcnKNQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVehs7g%253D&md5=8912554c61664823010da53c8f64fe0f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2003.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2003.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DSwerdlow%26aufirst%3DR.%2BH.%26aulast%3DKhan%26aufirst%3DS.%2BM.%26atitle%3DA%2520%25E2%2580%259Cmitochondrial%2520cascade%2520hypothesis%25E2%2580%259D%2520for%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Hypotheses%26date%3D2004%26volume%3D63%26spage%3D8%26epage%3D20%26doi%3D10.1016%2Fj.mehy.2003.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lhFV4apcnKNQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassi, E.</span><span> </span><span class="NLM_article-title">From companion diagnostics to theranostics: a new avenue for Alzheimer’s disease?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7759</span><span class="NLM_x">–</span> <span class="NLM_lpage">7770</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7759-7770&author=M.+L.+Bolognesiauthor=A.+Gandiniauthor=F.+Pratiauthor=E.+Uliassi&title=From+companion+diagnostics+to+theranostics%3A+a+new+avenue+for+Alzheimer%E2%80%99s+disease%3F&doi=10.1021%2Facs.jmedchem.6b00151"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00151%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DUliassi%26aufirst%3DE.%26atitle%3DFrom%2520companion%2520diagnostics%2520to%2520theranostics%253A%2520a%2520new%2520avenue%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7759%26epage%3D7770%26doi%3D10.1021%2Facs.jmedchem.6b00151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabellieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maramai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kshirsagar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guarino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustiniano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">A stereoselective approach to peptidomimetic BACE1 inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.ejmech.2013.09.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=233-247&author=S.+Butiniauthor=E.+Gabellieriauthor=M.+Brindisiauthor=S.+Giovaniauthor=S.+Maramaiauthor=G.+Kshirsagarauthor=E.+Guarinoauthor=S.+Brogiauthor=V.+La+Pietraauthor=M.+Giustinianoauthor=L.+Marinelliauthor=E.+Novellinoauthor=G.+Campianiauthor=A.+Cappelliauthor=S.+Gemma&title=A+stereoselective+approach+to+peptidomimetic+BACE1+inhibitors&doi=10.1016%2Fj.ejmech.2013.09.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DGiovani%26aufirst%3DS.%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DKshirsagar%26aufirst%3DG.%26aulast%3DGuarino%26aufirst%3DE.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DGiustiniano%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DA%2520stereoselective%2520approach%2520to%2520peptidomimetic%2520BACE1%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D233%26epage%3D247%26doi%3D10.1016%2Fj.ejmech.2013.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Vila-Real, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maycock, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iranzo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simplicio, A. L.</span><span> </span><span class="NLM_article-title">Peptidomimetic beta-secretase inhibitors comprising a sequence of amyloid-beta peptide for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5408</span><span class="NLM_x">–</span> <span class="NLM_lpage">5418</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00658</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00658" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5408-5418&author=H.+Vila-Realauthor=H.+Coelhoauthor=J.+Rochaauthor=A.+Fernandesauthor=M.+R.+Venturaauthor=C.+D.+Maycockauthor=O.+Iranzoauthor=A.+L.+Simplicio&title=Peptidomimetic+beta-secretase+inhibitors+comprising+a+sequence+of+amyloid-beta+peptide+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.5b00658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00658%26sid%3Dliteratum%253Aachs%26aulast%3DVila-Real%26aufirst%3DH.%26aulast%3DCoelho%26aufirst%3DH.%26aulast%3DRocha%26aufirst%3DJ.%26aulast%3DFernandes%26aufirst%3DA.%26aulast%3DVentura%26aufirst%3DM.%2BR.%26aulast%3DMaycock%26aufirst%3DC.%2BD.%26aulast%3DIranzo%26aufirst%3DO.%26aulast%3DSimplicio%26aufirst%3DA.%2BL.%26atitle%3DPeptidomimetic%2520beta-secretase%2520inhibitors%2520comprising%2520a%2520sequence%2520of%2520amyloid-beta%2520peptide%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5408%26epage%3D5418%26doi%3D10.1021%2Facs.jmedchem.5b00658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teruya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akaji, K.</span><span> </span><span class="NLM_article-title">Evaluation of transition-state mimics in a superior BACE1 cleavage sequence as peptide-mimetic BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5626</span><span class="NLM_x">–</span> <span class="NLM_lpage">5640</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2015.07.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5626-5640&author=Y.+Hattoriauthor=K.+Kobayashiauthor=A.+Deguchiauthor=Y.+Noharaauthor=T.+Akiyamaauthor=K.+Teruyaauthor=A.+Sanjohauthor=A.+Nakagawaauthor=E.+Yamashitaauthor=K.+Akaji&title=Evaluation+of+transition-state+mimics+in+a+superior+BACE1+cleavage+sequence+as+peptide-mimetic+BACE1+inhibitors&doi=10.1016%2Fj.bmc.2015.07.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DDeguchi%26aufirst%3DA.%26aulast%3DNohara%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTeruya%26aufirst%3DK.%26aulast%3DSanjoh%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DA.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DAkaji%26aufirst%3DK.%26atitle%3DEvaluation%2520of%2520transition-state%2520mimics%2520in%2520a%2520superior%2520BACE1%2520cleavage%2520sequence%2520as%2520peptide-mimetic%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5626%26epage%3D5640%26doi%3D10.1016%2Fj.bmc.2015.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devasamudram, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilcer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesecar, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure-based design, synthesis and biological evaluation of novel beta-secretase inhibitors containing a pyrazole or thiazole moiety as the P3 ligand</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2014.11.087" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=668-672&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=Y.+C.+Yenauthor=X.+Xuauthor=X.+Huangauthor=T.+Devasamudramauthor=G.+Bilcerauthor=H.+Leiauthor=G.+Koelschauthor=A.+D.+Mesecarauthor=J.+Tang&title=Structure-based+design%2C+synthesis+and+biological+evaluation+of+novel+beta-secretase+inhibitors+containing+a+pyrazole+or+thiazole+moiety+as+the+P3+ligand&doi=10.1016%2Fj.bmcl.2014.11.087"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.087%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DYen%26aufirst%3DY.%2BC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDevasamudram%26aufirst%3DT.%26aulast%3DBilcer%26aufirst%3DG.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520beta-secretase%2520inhibitors%2520containing%2520a%2520pyrazole%2520or%2520thiazole%2520moiety%2520as%2520the%2520P3%2520ligand%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D668%26epage%3D672%26doi%3D10.1016%2Fj.bmcl.2014.11.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0lgU_f7Ntq-bYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgU_f7Ntq-bYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Discovery of potent iminoheterocycle BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5455</span><span class="NLM_x">–</span> <span class="NLM_lpage">5459</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2014.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=25455483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVenu7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5455-5459&author=J.+P.+Caldwellauthor=R.+D.+Mazzolaauthor=J.+Durkinauthor=J.+Chenauthor=X.+Chenauthor=L.+Favreauauthor=M.+Kennedyauthor=R.+Kuvelkarauthor=J.+Leeauthor=N.+McHughauthor=B.+McKittrickauthor=P.+Orthauthor=A.+Stamfordauthor=C.+Stricklandauthor=J.+Voigtauthor=L.+Wangauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhu&title=Discovery+of+potent+iminoheterocycle+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent iminoheterocycle BACE1 inhibitors</span></div><div class="casAuthors">Caldwell, John P.; Mazzola, Robert D.; Durkin, James; Chen, Joseph; Chen, Xia; Favreau, Leonard; Kennedy, Matthew; Kuvelkar, Reshma; Lee, Julie; McHugh, Nansie; McKittrick, Brian; Orth, Peter; Stamford, Andrew; Strickland, Corey; Voigt, Johannes; Wang, Liyang; Zhang, Lili; Zhang, Qi; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5455-5459</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis of a series of iminoheterocycles and their structure-activity relationships (SAR) as inhibitors of the aspartyl protease BACE1 will be detailed.  An effort to access the S3 subsite directly from the S1 subsite initially yielded compds. with sub-micromolar potency.  A subset of compds. from this effort unexpectedly occupied a different binding site and displayed excellent BACE1 affinities.  Select compds. from this subset acutely lowered Aβ40 levels upon s.c. and oral administration to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwTVeMzYRYrLVg90H21EOLACvtfcHk0lgsU7mh94GTEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVenu7bF&md5=613faa1b5a7af6093d75fd022ad83f64</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMcHugh%26aufirst%3DN.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%2520potent%2520iminoheterocycle%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5455%26epage%3D5459%26doi%3D10.1016%2Fj.bmcl.2014.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span> </span><span class="NLM_article-title">Spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid beta in a higher species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3379</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span><span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+from+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+beta+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520beta%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span> </span><span class="NLM_article-title">Discovery of 7-tetrahydropyran-2-yl chromans: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid beta-protein (Abeta) in the central nervous system</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span><span class="refDoi"> DOI: 10.1021/jm401635n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401635n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=878-902&author=A.+A.+Thomasauthor=K.+W.+Huntauthor=M.+Volgrafauthor=R.+J.+Wattsauthor=X.+Liuauthor=G.+Vigersauthor=D.+Smithauthor=D.+Sammondauthor=T.+P.+Tangauthor=S.+P.+Rhodesauthor=A.+T.+Metcalfauthor=K.+D.+Brownauthor=J.+N.+Ottenauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Doauthor=D.+Dutcherauthor=S.+Ranaauthor=R.+K.+DeLisleauthor=K.+Regalauthor=A.+D.+Wrightauthor=R.+Gronebergauthor=K.+Scearce-Levieauthor=M.+Siuauthor=H.+E.+Purkeyauthor=J.+P.+Lyssikatosauthor=I.+W.+Gunawardana&title=Discovery+of+7-tetrahydropyran-2-yl+chromans%3A+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors+that+reduce+amyloid+beta-protein+%28Abeta%29+in+the+central+nervous+system&doi=10.1021%2Fjm401635n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm401635n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401635n%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DBrown%26aufirst%3DK.%2BD.%26aulast%3DOtten%26aufirst%3DJ.%2BN.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26atitle%3DDiscovery%2520of%25207-tetrahydropyran-2-yl%2520chromans%253A%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520that%2520reduce%2520amyloid%2520beta-protein%2520%2528Abeta%2529%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D878%26epage%3D902%26doi%3D10.1021%2Fjm401635n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newhouse, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10112</span><span class="NLM_x">–</span> <span class="NLM_lpage">10129</span><span class="refDoi"> DOI: 10.1021/jm5015132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5015132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10112-10129&author=A.+A.+Thomasauthor=K.+W.+Huntauthor=B.+Newhouseauthor=R.+J.+Wattsauthor=X.+Liuauthor=G.+Vigersauthor=D.+Smithauthor=S.+P.+Rhodesauthor=K.+D.+Brownauthor=J.+N.+Ottenauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=S.+Ranaauthor=R.+K.+DeLisleauthor=K.+Regalauthor=A.+D.+Wrightauthor=R.+Gronebergauthor=J.+Liaoauthor=K.+Scearce-Levieauthor=M.+Siuauthor=H.+E.+Purkeyauthor=J.+P.+Lyssikatos&title=8-Tetrahydropyran-2-yl+chromans%3A+highly+selective+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors&doi=10.1021%2Fjm5015132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors</span></div><div class="casAuthors">Thomas, Allen A.; Hunt, Kevin W.; Newhouse, Brad; Watts, Ryan J.; Liu, Xingrong; Vigers, Guy; Smith, Darin; Rhodes, Susan P.; Brown, Karin D.; Otten, Jennifer N.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Rana, Sumeet; DeLisle, Robert K.; Regal, Kelly; Wright, Albion D.; Groneberg, Robert; Liao, Jiangpeng; Scearce-Levie, Kimberly; Siu, Michael; Purkey, Hans E.; Lyssikatos, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10112-10129</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hexahydropyrano[3,2-b]chromenes such as I were prepd. as inhibitors of β-site amyloid cleaving enzyme 1 (BACE1) selective for BACE1 over cathepsin D (CatD).  Three different Asp-binding moieties were examd. (spirocyclic acyl guanidines, spirocyclic aminooxazolines, and spirocyclic aminothiazolines) in order to modulate potency, selectivity, efflux, and permeability; changes to the aryl substituents of the pyranochromene moiety and substitution of a ring junction proton with a Me group were also studied.  In particular, spirocyclic aminooxazoline and aminothiazoline inhibitors with Me substituents possessed excellent cellular potency (37-137 nM) for inhibiting BACE1 and high selectivity (435 to >2000-fold) for BACE1 vs CatD.  These efforts led to nonracemic I, which demonstrated a 69% redn. in rat CSF Aβ1-40 at a dosage of 60 mg/kg (PO).  The complexes of four hexahydropyrano[3,2-b]chromenes bound to BACE-1 were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKJ3ssfyhPHrVg90H21EOLACvtfcHk0lhXDjczusJQfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqurnK&md5=827f89cabdaa149283d04f030a3d5568</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm5015132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5015132%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DNewhouse%26aufirst%3DB.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DBrown%26aufirst%3DK.%2BD.%26aulast%3DOtten%26aufirst%3DJ.%2BN.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3D8-Tetrahydropyran-2-yl%2520chromans%253A%2520highly%2520selective%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10112%26epage%3D10129%26doi%3D10.1021%2Fjm5015132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derakhchan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Human, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span> </span><span class="NLM_article-title">Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene beta-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9810</span><span class="refDoi"> DOI: 10.1021/jm501266w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501266w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9796-9810&author=O.+Epsteinauthor=M.+C.+Bryanauthor=A.+C.+Chengauthor=K.+Derakhchanauthor=T.+A.+Dineenauthor=D.+Hickmanauthor=Z.+Huaauthor=J.+B.+Humanauthor=C.+Kreimanauthor=I.+E.+Marxauthor=M.+M.+Weissauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=X.+M.+Zhengauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Lead+optimization+and+modulation+of+hERG+activity+in+a+series+of+aminooxazoline+xanthene+beta-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors&doi=10.1021%2Fjm501266w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501266w%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DBryan%26aufirst%3DM.%2BC.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDerakhchan%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHua%26aufirst%3DZ.%26aulast%3DHuman%26aufirst%3DJ.%2BB.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DLead%2520optimization%2520and%2520modulation%2520of%2520hERG%2520activity%2520in%2520a%2520series%2520of%2520aminooxazoline%2520xanthene%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9796%26epage%3D9810%26doi%3D10.1021%2Fjm501266w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derakhchan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span> </span><span class="NLM_article-title">Inhibitors of beta-site amyloid precursor protein cleaving enzyme (BACE1): identification of (S)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[ 2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9811</span><span class="NLM_x">–</span> <span class="NLM_lpage">9831</span><span class="refDoi"> DOI: 10.1021/jm5012676</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012676" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9811-9831&author=T.+A.+Dineenauthor=K.+Chenauthor=A.+C.+Chengauthor=K.+Derakhchanauthor=O.+Epsteinauthor=J.+Esmayauthor=D.+Hickmanauthor=C.+E.+Kreimanauthor=I.+E.+Marxauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=M.+M.+Weissauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29%3A+identification+of+%28S%29-7-%282-fluoropyridin-3-yl%29-3-%28%283-methyloxetan-3-yl%29ethynyl%29-5%E2%80%B2H-spiro%5Bchromeno%5B+2%2C3-b%5Dpyridine-5%2C4%E2%80%B2-oxazol%5D-2%E2%80%B2-amine+%28AMG-8718%29&doi=10.1021%2Fjm5012676"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012676%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDerakhchan%26aufirst%3DK.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKreiman%26aufirst%3DC.%2BE.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DInhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%253A%2520identification%2520of%2520%2528S%2529-7-%25282-fluoropyridin-3-yl%2529-3-%2528%25283-methyloxetan-3-yl%2529ethynyl%2529-5%25E2%2580%25B2H-spiro%255Bchromeno%255B%25202%252C3-b%255Dpyridine-5%252C4%25E2%2580%25B2-oxazol%255D-2%25E2%2580%25B2-amine%2520%2528AMG-8718%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9811%26epage%3D9831%26doi%3D10.1021%2Fjm5012676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amegadzie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minatti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Human, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everds, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonderfecht, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span> </span><span class="NLM_article-title">Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious beta-secretase inhibitors for the potential treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2014.12.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=767-774&author=J.+J.+Chenauthor=Q.+Liuauthor=C.+Yuanauthor=V.+Goreauthor=P.+Lopezauthor=V.+Maauthor=A.+Amegadzieauthor=W.+Qianauthor=T.+C.+Juddauthor=A.+E.+Minattiauthor=J.+Brownauthor=Y.+Chengauthor=M.+Xueauthor=W.+Zhongauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=J.+Humanauthor=C.+Kreimanauthor=I.+Marxauthor=M.+M.+Weissauthor=S.+A.+Hitchcockauthor=T.+S.+Powersauthor=K.+Chenauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=A.+C.+Chengauthor=M.+D.+Bartbergerauthor=D.+Hickmanauthor=J.+A.+Wernerauthor=H.+M.+Vargasauthor=N.+E.+Everdsauthor=S.+L.+Vonderfechtauthor=R.+T.+Dunnauthor=S.+Woodauthor=R.+T.+Fremeauauthor=R.+D.+Whiteauthor=V.+F.+Patel&title=Development+of+2-aminooxazoline+3-azaxanthenes+as+orally+efficacious+beta-secretase+inhibitors+for+the+potential+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2014.12.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.092%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DGore%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DV.%26aulast%3DAmegadzie%26aufirst%3DA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DHuman%26aufirst%3DJ.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DMarx%26aufirst%3DI.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DWerner%26aufirst%3DJ.%2BA.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DEverds%26aufirst%3DN.%2BE.%26aulast%3DVonderfecht%26aufirst%3DS.%2BL.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26atitle%3DDevelopment%2520of%25202-aminooxazoline%25203-azaxanthenes%2520as%2520orally%2520efficacious%2520beta-secretase%2520inhibitors%2520for%2520the%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.bmcl.2014.12.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minatti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">An orally available BACE1 inhibitor that affords robust CNS Abeta reduction without cardiovascular liabilities</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.1021/ml500458t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=210-215&author=Y.+Chengauthor=J.+Brownauthor=T.+C.+Juddauthor=P.+Lopezauthor=W.+Qianauthor=T.+S.+Powersauthor=J.+J.+Chenauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=R.+T.+Dunnauthor=O.+Epsteinauthor=R.+T.+Fremeauauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=Y.+Luoauthor=A.+E.+Minattiauthor=V.+F.+Patelauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=X.+M.+Zhengauthor=S.+Wood&title=An+orally+available+BACE1+inhibitor+that+affords+robust+CNS+Abeta+reduction+without+cardiovascular+liabilities&doi=10.1021%2Fml500458t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities</span></div><div class="casAuthors">Cheng, Yuan; Brown, James; Judd, Ted C.; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S.; Chen, Jian Jeffrey; Bartberger, Michael D.; Chen, Kui; Dunn, Robert T.; Epstein, Oleg; Fremeau, Robert T.; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A.; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F.; Vargas, Hugo M.; Wahl, Robert C.; Weiss, Matthew M.; Wen, Paul H.; White, Ryan D.; Whittington, Douglas A.; Zheng, Xiao Mei; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-215</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibition to prevent Aβ peptide formation is considered to be a potential route to a disease-modifying treatment for Alzheimer's disease.  Previous efforts in our lab. using a combined structure- and property-based approach have resulted in the identification of aminooxazoline xanthenes as potent BACE1 inhibitors.  Herein, we report further optimization leading to the discovery of inhibitor 15 as an orally available and highly efficacious BACE1 inhibitor that robustly reduces CSF and brain Aβ levels in both rats and nonhuman primates.  In addn., compd. 15 exhibited low activity on the hERG ion channel and was well tolerated in an integrated cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH-0fLNUlbrVg90H21EOLACvtfcHk0liG6m8q_h82mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI&md5=bd8e5a33d06a51646873c4c43d01b003</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500458t%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DAn%2520orally%2520available%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520Abeta%2520reduction%2520without%2520cardiovascular%2520liabilities%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D210%26epage%3D215%26doi%3D10.1021%2Fml500458t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span><span class="refDoi"> DOI: 10.1021/jm701122q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb&doi=10.1021%2Fjm701122q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lgXCFdLPLJULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834%26doi%3D10.1021%2Fjm701122q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Fielden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamison, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueblood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afshari, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot-Dunn, R.</span><span> </span><span class="NLM_article-title">Retinal toxicity induced by a novel beta-secretase inhibitor in the sprague-dawley rat</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span><span class="refDoi"> DOI: 10.1177/0192623314553804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1177%2F0192623314553804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=25361751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCqu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=581-592&author=M.+R.+Fieldenauthor=J.+Wernerauthor=J.+A.+Jamisonauthor=A.+Coppiauthor=D.+Hickmanauthor=R.+T.+Dunnauthor=E.+Truebloodauthor=L.+Zhouauthor=C.+A.+Afshariauthor=R.+Lightfoot-Dunn&title=Retinal+toxicity+induced+by+a+novel+beta-secretase+inhibitor+in+the+sprague-dawley+rat&doi=10.1177%2F0192623314553804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Retinal toxicity induced by a novel β-secretase inhibitor in the sprague-dawley rat</span></div><div class="casAuthors">Fielden, Mark R.; Werner, Jonathan; Jamison, Jeff A.; Coppi, Aldo; Hickman, Dean; Dunn, Robert T., II; Trueblood, Esther; Zhou, Lei; Afshari, Cynthia A.; Lightfoot-Dunn, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">581-592</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">β-Secretase 1 (BACE1) represents an attractive target for the treatment of Alzheimer's disease.  In the course of development of a novel small mol. BACE1 inhibitor (AMG-8718), retinal thinning was obsd. in a 1-mo toxicity study in the rat.  To further understand the lesion, an investigational study was conducted whereby rats were treated daily with AMG-8718 for 1 mo followed by a 2-mo treatment-free phase.  The earliest detectable change in the retina was an increase in autofluorescent granules in the retinal pigment epithelium (RPE) on day 5; however, there were no treatment-related light microscopic changes obsd. in the neuroretina and no changes obsd. by fundus autofluorescence or routine ophthalmoscopic examn. after 28 days of dosing.  Following 2 mo of recovery, there was significant retinal thinning attributed to loss of photoreceptor nuclei from the outer nuclear layer.  Electroretinog. changes were obsd. as early as day 14, before any microscopic evidence of photoreceptor loss.  BACE1 knockout rats were generated and found to have normal retinal morphol. indicating that the retinal toxicity induced by AMG-8718 was likely off-target.  These results suggest that AMG-8718 impairs phagolysosomal function in the rat RPE, which leads to photoreceptor dysfunction and ultimately loss of photoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfyBfTezUdUrVg90H21EOLACvtfcHk0lgXCFdLPLJULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCqu7fP&md5=d6f4af801e795995739478385f5e36fd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1177%2F0192623314553804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623314553804%26sid%3Dliteratum%253Aachs%26aulast%3DFielden%26aufirst%3DM.%2BR.%26aulast%3DWerner%26aufirst%3DJ.%26aulast%3DJamison%26aufirst%3DJ.%2BA.%26aulast%3DCoppi%26aufirst%3DA.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DTrueblood%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DAfshari%26aufirst%3DC.%2BA.%26aulast%3DLightfoot-Dunn%26aufirst%3DR.%26atitle%3DRetinal%2520toxicity%2520induced%2520by%2520a%2520novel%2520beta-secretase%2520inhibitor%2520in%2520the%2520sprague-dawley%2520rat%26jtitle%3DToxicol.%2520Pathol.%26date%3D2015%26volume%3D43%26spage%3D581%26epage%3D592%26doi%3D10.1177%2F0192623314553804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michener, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure-based design of an iminoheterocyclic beta-site amyloid precursor protein cleaving enzyme (BACE) inhibitor that lowers central Abeta in nonhuman primates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3231</span><span class="NLM_x">–</span> <span class="NLM_lpage">3248</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01995</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3231-3248&author=M.+Mandalauthor=Y.+Wuauthor=J.+Misiaszekauthor=G.+Liauthor=A.+Buevichauthor=J.+P.+Caldwellauthor=X.+Liuauthor=R.+D.+Mazzolaauthor=P.+Orthauthor=C.+Stricklandauthor=J.+Voigtauthor=H.+Wangauthor=Z.+Zhuauthor=X.+Chenauthor=M.+Grzelakauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=P.+T.+Leachauthor=G.+Terracinaauthor=L.+Zhangauthor=Q.+Zhangauthor=M.+S.+Michenerauthor=B.+Smithauthor=K.+Coxauthor=D.+Grotzauthor=L.+Favreauauthor=K.+Mitraauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=M.+E.+Kennedyauthor=E.+M.+Parkerauthor=J.+N.+Cummingauthor=A.+W.+Stamford&title=Structure-based+design+of+an+iminoheterocyclic+beta-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE%29+inhibitor+that+lowers+central+Abeta+in+nonhuman+primates&doi=10.1021%2Facs.jmedchem.5b01995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLeach%26aufirst%3DP.%2BT.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DMichener%26aufirst%3DM.%2BS.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DGrotz%26aufirst%3DD.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure-based%2520design%2520of%2520an%2520iminoheterocyclic%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE%2529%2520inhibitor%2520that%2520lowers%2520central%2520Abeta%2520in%2520nonhuman%2520primates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3231%26epage%3D3248%26doi%3D10.1021%2Facs.jmedchem.5b01995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span><span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0ljSF67klWT91w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-beta+in+humans+with+an+orally+available%2C+non-peptidic+beta-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0liafKj1CdFaBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-beta%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520beta-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Targeting the BACE1 active site flap leads to a potent inhibitor that elicits robust brain Abeta reduction in rodents</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00432</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00432" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=271-276&author=Y.+J.+Wuauthor=J.+Guernonauthor=F.+Yangauthor=L.+Snyderauthor=J.+Shiauthor=A.+McClureauthor=R.+Rajamaniauthor=H.+Parkauthor=A.+Ngauthor=H.+Lewisauthor=C.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Targeting+the+BACE1+active+site+flap+leads+to+a+potent+inhibitor+that+elicits+robust+brain+Abeta+reduction+in+rodents&doi=10.1021%2Facsmedchemlett.5b00432"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00432%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DTargeting%2520the%2520BACE1%2520active%2520site%2520flap%2520leads%2520to%2520a%2520potent%2520inhibitor%2520that%2520elicits%2520robust%2520brain%2520Abeta%2520reduction%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D271%26epage%3D276%26doi%3D10.1021%2Facsmedchemlett.5b00432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckelbauer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Discovery of S3-truncated, C-6 heteroaryl substituted aminothiazine beta-site APP cleaving enzyme-1 (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8593</span><span class="NLM_x">–</span> <span class="NLM_lpage">8600</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8593-8600&author=Y.+J.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=L.+Marcinauthor=M.+Higginsauthor=R.+Rajamaniauthor=J.+Muckelbauerauthor=H.+Lewisauthor=C.+Changauthor=D.+Camacauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Discovery+of+S3-truncated%2C+C-6+heteroaryl+substituted+aminothiazine+beta-site+APP+cleaving+enzyme-1+%28BACE1%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b01012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMarcin%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DMuckelbauer%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DDiscovery%2520of%2520S3-truncated%252C%2520C-6%2520heteroaryl%2520substituted%2520aminothiazine%2520beta-site%2520APP%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8593%26epage%3D8600%26doi%3D10.1021%2Facs.jmedchem.6b01012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2678</span><span class="NLM_x">–</span> <span class="NLM_lpage">2702</span><span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0ljTYm9cuswYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundesmann, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henegar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChapelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikochik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3223</span><span class="NLM_x">–</span> <span class="NLM_lpage">3252</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug-drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors</span></div><div class="casAuthors">Brodney, Michael A.; Beck, Elizabeth M.; Butler, Christopher R.; Barreiro, Gabriela; Johnson, Eric F.; Riddell, David; Parris, Kevin; Nolan, Charles E.; Fan, Ying; Atchison, Kevin; Gonzales, Cathleen; Robshaw, Ashley E.; Doran, Shawn D.; Bundesmann, Mark W.; Buzon, Leanne; Dutra, Jason; Henegar, Kevin; LaChapelle, Erik; Hou, Xinjun; Rogers, Bruce N.; Pandit, Jayvardhan; Lira, Ricardo; Martinez-Alsina, Luis; Mikochik, Peter; Murray, John C.; Ogilvie, Kevin; Price, Loren; Sakya, Subas M.; Yu, Aijia; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3223-3252</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, the first generation of β-secretase (BACE1) inhibitors advanced into clin. development for the treatment of Alzheimer's disease (AD).  However, the alignment of drug-like properties and selectivity remains a major challenge.  Herein, we describe the discovery of a novel class of potent, low clearance, CNS penetrant BACE1 inhibitors represented by thioamidine 5.  Further profiling suggested that a high fraction of the metab. (>95%) was due to CYP2D6, increasing the potential risk for victim-based drug-drug interactions (DDI) and variable exposure in the clinic due to the polymorphic nature of this enzyme.  To guide future design, we solved crystal structures of CYP2D6 complexes with substrate 5 and its corresponding metabolic product pyrazole 6, which provided insight into the binding mode and movements between substrate/inhibitor complexes.  Guided by the BACE1 and CYP2D6 crystal structures, we designed and synthesized analogs with reduced risk for DDI, central efficacy, and improved hERG therapeutic margins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRdq_8px-VLVg90H21EOLACvtfcHk0ljTYm9cuswYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksFynsL4%253D&md5=ed44904d0e55c74417a6874c1454683c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug-drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borders, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevorkyan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komjathy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Abeta pharmacodynamic responses in mice, dogs, and humans</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1210</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+Abeta+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lhgtOvC1CgXYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520Abeta%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borders, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudziak, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimkowski, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia Losada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span> </span><span class="NLM_article-title">Preparation and biological evaluation of conformationally constrained BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3260</span><span class="NLM_x">–</span> <span class="NLM_lpage">3268</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2015.04.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3260-3268&author=L.+L.+Winneroskiauthor=M.+A.+Schifflerauthor=J.+A.+Ericksonauthor=P.+C.+Mayauthor=S.+A.+Monkauthor=D.+E.+Timmauthor=J.+E.+Audiaauthor=J.+P.+Beckauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+D.+Boyerauthor=R.+A.+Brierauthor=K.+J.+Hudziakauthor=V.+J.+Klimkowskiauthor=P.+Garcia+Losadaauthor=B.+M.+Mathesauthor=S.+L.+Stoutauthor=B.+M.+Watsonauthor=D.+J.+Mergott&title=Preparation+and+biological+evaluation+of+conformationally+constrained+BACE1+inhibitors&doi=10.1016%2Fj.bmc.2015.04.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.062%26sid%3Dliteratum%253Aachs%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DSchiffler%26aufirst%3DM.%2BA.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBeck%26aufirst%3DJ.%2BP.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBoyer%26aufirst%3DR.%2BD.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DHudziak%26aufirst%3DK.%2BJ.%26aulast%3DKlimkowski%26aufirst%3DV.%2BJ.%26aulast%3DGarcia%2BLosada%26aufirst%3DP.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DPreparation%2520and%2520biological%2520evaluation%2520of%2520conformationally%2520constrained%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3260%26epage%3D3268%26doi%3D10.1016%2Fj.bmc.2015.04.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlijanian, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckelbauer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.</span><span> </span><span class="NLM_article-title">Discovery of furo[2,3-d][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5729</span><span class="NLM_x">–</span> <span class="NLM_lpage">5731</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2016.10.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5729-5731&author=Y.+J.+Wuauthor=J.+Guernonauthor=R.+Rajamaniauthor=J.+H.+Toynauthor=M.+K.+Ahlijanianauthor=C.+F.+Albrightauthor=J.+Muckelbauerauthor=C.+Changauthor=D.+Camacauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Discovery+of+furo%5B2%2C3-d%5D%5B1%2C3%5Dthiazinamines+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors&doi=10.1016%2Fj.bmcl.2016.10.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.055%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DAhlijanian%26aufirst%3DM.%2BK.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMuckelbauer%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DDiscovery%2520of%2520furo%255B2%252C3-d%255D%255B1%252C3%255Dthiazinamines%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5729%26epage%3D5731%26doi%3D10.1016%2Fj.bmcl.2016.10.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wang, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nechuta, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D. F.</span><span> </span><span class="NLM_article-title">Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span><span class="refDoi"> DOI: 10.1021/jm901472u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901472u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=942-950&author=Y.+S.+Wangauthor=C.+Stricklandauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=B.+M.+Beyerauthor=M.+M.+Seniorauthor=E.+M.+Smithauthor=T.+L.+Nechutaauthor=V.+S.+Madisonauthor=M.+Czarnieckiauthor=B.+A.+McKittrickauthor=A.+W.+Stamfordauthor=E.+M.+Parkerauthor=J.+C.+Hunterauthor=W.+J.+Greenleeauthor=D.+F.+Wyss&title=Application+of+fragment-based+NMR+screening%2C+X-ray+crystallography%2C+structure-based+design%2C+and+focused+chemical+library+design+to+identify+novel+microM+leads+for+the+development+of+nM+BACE-1+%28beta-site+APP+cleaving+enzyme+1%29+inhibitors&doi=10.1021%2Fjm901472u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm901472u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901472u%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DSenior%26aufirst%3DM.%2BM.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DNechuta%26aufirst%3DT.%2BL.%26aulast%3DMadison%26aufirst%3DV.%2BS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DWyss%26aufirst%3DD.%2BF.%26atitle%3DApplication%2520of%2520fragment-based%2520NMR%2520screening%252C%2520X-ray%2520crystallography%252C%2520structure-based%2520design%252C%2520and%2520focused%2520chemical%2520library%2520design%2520to%2520identify%2520novel%2520microM%2520leads%2520for%2520the%2520development%2520of%2520nM%2520BACE-1%2520%2528beta-site%2520APP%2520cleaving%2520enzyme%25201%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D942%26epage%3D950%26doi%3D10.1021%2Fjm901472u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 Inhibitor that affords robust CNS Abeta reduction</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span><span class="refDoi"> DOI: 10.1021/ml3001165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWhtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+Inhibitor+that+affords+robust+CNS+Abeta+reduction&doi=10.1021%2Fml3001165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction</span></div><div class="casAuthors">Stamford, Andrew W.; Scott, Jack D.; Li, Sarah W.; Babu, Suresh; Tadesse, Dawit; Hunter, Rachael; Wu, Yusheng; Misiaszek, Jeffrey; Cumming, Jared N.; Gilbert, Eric J.; Huang, Chunli; McKittrick, Brian A.; Hong, Liwu; Guo, Tao; Zhu, Zhaoning; Strickland, Corey; Orth, Peter; Voigt, Johannes H.; Kennedy, Matthew E.; Chen, Xia; Kuvelkar, Reshma; Hodgson, Robert; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Parker, Eric M.; Greenlee, William J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">897-902</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of BACE1 to prevent brain Aβ peptide formation is a potential disease-modifying approach to the treatment of Alzheimer's disease.  Despite over a decade of drug discovery efforts, the identification of brain-penetrant BACE1 inhibitors that substantially lower CNS Aβ levels following systemic administration remains challenging.  In this report we describe structure-based optimization of a series of brain-penetrant BACE1 inhibitors derived from an iminopyrimidinone scaffold.  Application of structure-based design in tandem with control of physicochem. properties culminated in the discovery of compd. 16, which potently reduced cortex and CSF Aβ40 levels when administered orally to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplHonEJedFZbVg90H21EOLACvtfcHk0ljgLjfWoe89fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWhtLvL&md5=8f743636119e48ed25d0f8c97d963440</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520Inhibitor%2520that%2520affords%2520robust%2520CNS%2520Abeta%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D897%26epage%3D902%26doi%3D10.1021%2Fml3001165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span>Merck Pulls Plug on Phase 2/3 BACE Inhibitor Trial. <a href="http://www.alzforum.org/news/research-news/merck-pulls-plug-phase-23-bace-inhibitor-trial" class="extLink">http://www.alzforum.org/news/research-news/merck-pulls-plug-phase-23-bace-inhibitor-trial</a>. (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+Pulls+Plug+on+Phase+2%2F3+BACE+Inhibitor+Trial.+http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fresearch-news%2Fmerck-pulls-plug-phase-23-bace-inhibitor-trial.+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levorse, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6259</span><span class="NLM_x">–</span> <span class="NLM_lpage">6262</span><span class="refDoi"> DOI: 10.1021/jm800914n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800914n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6259-6262&author=J.+C.+Barrowauthor=S.+R.+Staufferauthor=K.+E.+Rittleauthor=P.+L.+Ngoauthor=Z.+Yangauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=S.+Munshiauthor=G.+B.+McGaugheyauthor=M.+K.+Hollowayauthor=A.+J.+Simonauthor=E.+A.+Priceauthor=S.+Sankaranarayananauthor=D.+Colussiauthor=K.+Tugushevaauthor=M.+T.+Laiauthor=A.+S.+Espesethauthor=M.+Xuauthor=Q.+Huangauthor=A.+Wolfeauthor=B.+Pietrakauthor=P.+Zuckauthor=D.+A.+Levorseauthor=D.+Hazudaauthor=J.+P.+Vacca&title=Discovery+and+X-ray+crystallographic+analysis+of+a+spiropiperidine+iminohydantoin+inhibitor+of+beta-secretase&doi=10.1021%2Fjm800914n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm800914n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800914n%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DLevorse%26aufirst%3DD.%2BA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520X-ray%2520crystallographic%2520analysis%2520of%2520a%2520spiropiperidine%2520iminohydantoin%2520inhibitor%2520of%2520beta-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6259%26epage%3D6262%26doi%3D10.1021%2Fjm800914n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Egbertson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McWherter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahr, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugabook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranieri-Michener, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span> </span><span class="NLM_article-title">Methyl-substitution of an iminohydantoin spiropiperidine beta-secretase (BACE-1) inhibitor has a profound effect on its potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4812</span><span class="NLM_x">–</span> <span class="NLM_lpage">4819</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.06.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4812-4819&author=M.+Egbertsonauthor=G.+B.+McGaugheyauthor=S.+M.+Pitzenbergerauthor=S.+R.+Staufferauthor=C.+A.+Coburnauthor=S.+J.+Stachelauthor=W.+Yangauthor=J.+C.+Barrowauthor=L.+A.+Neilsonauthor=M.+McWherterauthor=D.+Perlowauthor=B.+Fahrauthor=S.+Munshiauthor=T.+J.+Allisonauthor=K.+Hollowayauthor=H.+G.+Selnickauthor=Z.+Yangauthor=J.+Swestockauthor=A.+J.+Simonauthor=S.+Sankaranarayananauthor=D.+Colussiauthor=K.+Tugushevaauthor=M.+T.+Laiauthor=B.+Pietrakauthor=S.+Haugabookauthor=L.+Jinauthor=I.+W.+Chenauthor=M.+Holahanauthor=M.+Stranieri-Michenerauthor=J.+J.+Cookauthor=J.+Vaccaauthor=S.+L.+Graham&title=Methyl-substitution+of+an+iminohydantoin+spiropiperidine+beta-secretase+%28BACE-1%29+inhibitor+has+a+profound+effect+on+its+potency&doi=10.1016%2Fj.bmcl.2015.06.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.082%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DPitzenberger%26aufirst%3DS.%2BM.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DNeilson%26aufirst%3DL.%2BA.%26aulast%3DMcWherter%26aufirst%3DM.%26aulast%3DPerlow%26aufirst%3DD.%26aulast%3DFahr%26aufirst%3DB.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DHolloway%26aufirst%3DK.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DHaugabook%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DStranieri-Michener%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DVacca%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26atitle%3DMethyl-substitution%2520of%2520an%2520iminohydantoin%2520spiropiperidine%2520beta-secretase%2520%2528BACE-1%2529%2520inhibitor%2520has%2520a%2520profound%2520effect%2520on%2520its%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4812%26epage%3D4819%26doi%3D10.1016%2Fj.bmcl.2015.06.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Rombouts, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Lamenca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso de Diego, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">1,4-Oxazine beta-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8216</span><span class="NLM_x">–</span> <span class="NLM_lpage">8235</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Martinez-Lamencaauthor=M.+Van+Goolauthor=A.+Garcia-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+beta-secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0ljSZxLOUO4jpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520beta-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.,  St</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span><span class="refDoi"> DOI: 10.1021/jm200544q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29&doi=10.1021%2Fjm200544q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0ljSZxLOUO4jpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857%26doi%3D10.1021%2Fjm200544q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Jordan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span> </span><span class="NLM_article-title">Fragment-linking approach using (19)F NMR spectroscopy to obtain highly potent and selective inhibitors of beta-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3732</span><span class="NLM_x">–</span> <span class="NLM_lpage">3749</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01917</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01917" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFeitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3732-3749&author=J.+B.+Jordanauthor=D.+A.+Whittingtonauthor=M.+D.+Bartbergerauthor=E.+A.+Sickmierauthor=K.+Chenauthor=Y.+Chengauthor=T.+Judd&title=Fragment-linking+approach+using+%2819%29F+NMR+spectroscopy+to+obtain+highly+potent+and+selective+inhibitors+of+beta-secretase&doi=10.1021%2Facs.jmedchem.5b01917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Linking Approach Using 19F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase</span></div><div class="casAuthors">Jordan, John B.; Whittington, Douglas A.; Bartberger, Michael D.; Sickmier, E. Allen; Chen, Kui; Cheng, Yuan; Judd, Ted</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3732-3749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery (FBDD) has become a widely used tool in small-mol. drug discovery efforts.  One of the most commonly used biophys. methods in detecting weak binding of fragments is NMR (NMR) spectroscopy.  In particular, FBDD performed with 19F NMR-based methods has been shown to provide several advantages over 1H NMR using traditional magnetization-transfer and/or two-dimensional methods.  Here, we demonstrate the utility and power of 19F-based fragment screening by detailing the identification of a second-site fragment through 19F NMR screening that binds to a specific pocket of the aspartic acid protease, β-secretase (BACE-1).  The identification of this second-site fragment allowed the undertaking of a fragment-linking approach, which ultimately yielded a mol. exhibiting a more than 360-fold increase in potency while maintaining reasonable ligand efficiency and gaining much improved selectivity over cathepsin-D (CatD).  X-ray crystallog. studies of the mols. demonstrated that the linked fragments exhibited binding modes consistent with those predicted from the targeted screening approach, through-space NMR data, and mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq95M4k5aaQurVg90H21EOLACvtfcHk0ljSZxLOUO4jpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFeitr8%253D&md5=6bd6021938c555d8c7083549e4b49a2e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01917%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DJ.%2BB.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%26atitle%3DFragment-linking%2520approach%2520using%2520%252819%2529F%2520NMR%2520spectroscopy%2520to%2520obtain%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520beta-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3732%26epage%3D3749%26doi%3D10.1021%2Facs.jmedchem.5b01917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Boy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.,  3rd</span><span> </span><span class="NLM_article-title">Macrocyclic prolinyl acyl guanidines as inhibitors of beta-secretase (BACE)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5040</span><span class="NLM_x">–</span> <span class="NLM_lpage">5047</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.10.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5040-5047&author=K.+M.+Boyauthor=J.+M.+Guernonauthor=Y.+J.+Wuauthor=Y.+Zhangauthor=J.+Shiauthor=W.+Zhaiauthor=S.+Zhuauthor=S.+W.+Gerritzauthor=J.+H.+Toynauthor=J.+E.+Meredithauthor=D.+M.+Bartenauthor=C.+R.+Burtonauthor=C.+F.+Albrightauthor=A.+C.+Goodauthor=J.+E.+Graceauthor=K.+A.+Lentzauthor=R.+E.+Olsonauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Macrocyclic+prolinyl+acyl+guanidines+as+inhibitors+of+beta-secretase+%28BACE%29&doi=10.1016%2Fj.bmcl.2015.10.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DBoy%26aufirst%3DK.%2BM.%26aulast%3DGuernon%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DZhai%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DGerritz%26aufirst%3DS.%2BW.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DMacrocyclic%2520prolinyl%2520acyl%2520guanidines%2520as%2520inhibitors%2520of%2520beta-secretase%2520%2528BACE%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5040%26epage%3D5047%26doi%3D10.1016%2Fj.bmcl.2015.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, P.</span><span> </span><span class="NLM_article-title">4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.ejmech.2014.04.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=413-421&author=P.+Liuauthor=Y.+Niuauthor=C.+Wangauthor=Q.+Sunauthor=Y.+Zhaiauthor=J.+Yuauthor=J.+Sunauthor=F.+Xuauthor=G.+Yanauthor=W.+Huangauthor=L.+Liangauthor=P.+Xu&title=4-Oxo-1%2C4-dihydro-quinoline-3-carboxamides+as+BACE-1+inhibitors%3A+synthesis%2C+biological+evaluation+and+docking+studies&doi=10.1016%2Fj.ejmech.2014.04.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DNiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DP.%26atitle%3D4-Oxo-1%252C4-dihydro-quinoline-3-carboxamides%2520as%2520BACE-1%2520inhibitors%253A%2520synthesis%252C%2520biological%2520evaluation%2520and%2520docking%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D413%26epage%3D421%26doi%3D10.1016%2Fj.ejmech.2014.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Razzaghi-Asl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firuzi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmateenejad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javidnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edraki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miri, R.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6893</span><span class="NLM_x">–</span> <span class="NLM_lpage">6909</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2013.09.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6893-6909&author=N.+Razzaghi-Aslauthor=O.+Firuziauthor=B.+Hemmateenejadauthor=K.+Javidniaauthor=N.+Edrakiauthor=R.+Miri&title=Design+and+synthesis+of+novel+3%2C5-bis-N-%28aryl%2Fheteroaryl%29+carbamoyl-4-aryl-1%2C4-dihydropyridines+as+small+molecule+BACE-1+inhibitors&doi=10.1016%2Fj.bmc.2013.09.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DRazzaghi-Asl%26aufirst%3DN.%26aulast%3DFiruzi%26aufirst%3DO.%26aulast%3DHemmateenejad%26aufirst%3DB.%26aulast%3DJavidnia%26aufirst%3DK.%26aulast%3DEdraki%26aufirst%3DN.%26aulast%3DMiri%26aufirst%3DR.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%25203%252C5-bis-N-%2528aryl%252Fheteroaryl%2529%2520carbamoyl-4-aryl-1%252C4-dihydropyridines%2520as%2520small%2520molecule%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6893%26epage%3D6909%26doi%3D10.1016%2Fj.bmc.2013.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Jain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwa, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohilla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, H. R.</span><span> </span><span class="NLM_article-title">Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.11.044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=33-37&author=P.+Jainauthor=P.+K.+Wadhwaauthor=S.+Rohillaauthor=H.+R.+Jadhav&title=Rational+design%2C+synthesis+and+in+vitro+evaluation+of+allylidene+hydrazinecarboximidamide+derivatives+as+BACE-1+inhibitors&doi=10.1016%2Fj.bmcl.2015.11.044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DP.%26aulast%3DWadhwa%26aufirst%3DP.%2BK.%26aulast%3DRohilla%26aufirst%3DS.%26aulast%3DJadhav%26aufirst%3DH.%2BR.%26atitle%3DRational%2520design%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520allylidene%2520hydrazinecarboximidamide%2520derivatives%2520as%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D33%26epage%3D37%26doi%3D10.1016%2Fj.bmcl.2015.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Jain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwa, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunapati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, H. R.</span><span> </span><span class="NLM_article-title">Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2567</span><span class="NLM_x">–</span> <span class="NLM_lpage">2575</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2016.04.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=27102162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmtlegur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2567-2575&author=P.+Jainauthor=P.+K.+Wadhwaauthor=S.+Gunapatiauthor=H.+R.+Jadhav&title=Design%2C+synthesis+and+in+vitro+evaluation+studies+of+sulfonyl-amino-acetamides+as+small+molecule+BACE-1+inhibitors&doi=10.1016%2Fj.bmc.2016.04.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors</span></div><div class="casAuthors">Jain, Priti; Wadhwa, Pankaj K.; Gunapati, Sinduri; Jadhav, Hemant R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2567-2575</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of a series of sulfonyl-amino-acetamides as BACE-1 (β-secretase) inhibitors for the treatment of Alzheimer's disease is reported.  The derivs. were designed based on the docking simulation study, synthesized and assessed for BACE-1 inhibition in vitro.  The designed ligands revealed desired binding interactions with the catalytic aspartate dyad and occupancy of S1 and S2' active site regions.  These in silico results correlated well with in vitro activity.  Out of 33 compds. synthesized, 12 compds. showed significant inhibition at 10 μM concn.  The most active compd. I had IC50 of 7.90 μM against BACE-1, which was concomitant with results of in silico docking study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfyzGhzRcSZbVg90H21EOLACvtfcHk0lj-IP_Buc5SBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmtlegur4%253D&md5=a56bc59e8476f0e13d82632052654e06</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.023%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DP.%26aulast%3DWadhwa%26aufirst%3DP.%2BK.%26aulast%3DGunapati%26aufirst%3DS.%26aulast%3DJadhav%26aufirst%3DH.%2BR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520studies%2520of%2520sulfonyl-amino-acetamides%2520as%2520small%2520molecule%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2567%26epage%3D2575%26doi%3D10.1016%2Fj.bmc.2016.04.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">De Tran, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bepary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H. J.</span><span> </span><span class="NLM_article-title">Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.11.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=51-54&author=Q.+De+Tranauthor=S.+Beparyauthor=G.+H.+Leeauthor=H.+Choauthor=W.+K.+Parkauthor=H.+J.+Lim&title=Synthesis+of+%283S%2C4S%29-4-aminopyrrolidine-3-ol+derivatives+and+biological+evaluation+for+their+BACE1+inhibitory+activities&doi=10.1016%2Fj.bmcl.2015.11.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BTran%26aufirst%3DQ.%26aulast%3DBepary%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DW.%2BK.%26aulast%3DLim%26aufirst%3DH.%2BJ.%26atitle%3DSynthesis%2520of%2520%25283S%252C4S%2529-4-aminopyrrolidine-3-ol%2520derivatives%2520and%2520biological%2520evaluation%2520for%2520their%2520BACE1%2520inhibitory%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D51%26epage%3D54%26doi%3D10.1016%2Fj.bmcl.2015.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Kacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Computational methods in the discovery and design of BACE-1 inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6095</span><span class="NLM_x">–</span> <span class="NLM_lpage">6111</span><span class="refDoi"> DOI: 10.2174/0929867311209066095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.2174%2F0929867311209066095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=23072352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1yrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=6095-6111&author=P.+Kackerauthor=G.+Bottegoniauthor=A.+Cavalli&title=Computational+methods+in+the+discovery+and+design+of+BACE-1+inhibitors&doi=10.2174%2F0929867311209066095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Computational methods in the discovery and design of BACE-1 inhibitors</span></div><div class="casAuthors">Kacker, P.; Bottegoni, G.; Cavalli, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">6095-6111</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  BACE-1 is a membrane assocd. aspartyl protease and is one of the enzymes responsible for the hydrolysis of the amyloid precursor protein.  Due to its central role in the generation of the amyloid-β peptide, it is considered as a primary drug target for Alzheimer's disease.  BACE-1 has been the focus of many drug discovery programs aimed at identifying inhibitors that effectively block this enzyme and trigger the sought therapeutic effects.  Thanks to the availability of a large no. of crystal structures of the catalytic domain of this enzyme, computational methods, ranging from mol. dynamics simulations, quantum mech. calcns. and ligand docking, have played a fundamental role in almost every hit discovery and hit optimization campaign performed on this target.  The present article reviews the latest computational modeling and drug discovery efforts that have been carried out on this target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi36YRvXfbJrVg90H21EOLACvtfcHk0liUJFHpiGJ3kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1yrsw%253D%253D&md5=73247b810fb9e673d360309ba68f6dc2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.2174%2F0929867311209066095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311209066095%26sid%3Dliteratum%253Aachs%26aulast%3DKacker%26aufirst%3DP.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DComputational%2520methods%2520in%2520the%2520discovery%2520and%2520design%2520of%2520BACE-1%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D6095%26epage%3D6111%26doi%3D10.2174%2F0929867311209066095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Hernández-Rodríguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa-Basurto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutiérrez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitorica, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosales-Hernández, M. C.</span><span> </span><span class="NLM_article-title">Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.ejmech.2016.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=27639619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFams7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=1142-1154&author=M.+Hern%C3%A1ndez-Rodr%C3%ADguezauthor=J.+Correa-Basurtoauthor=A.+Guti%C3%A9rrezauthor=J.+Vitoricaauthor=M.+C.+Rosales-Hern%C3%A1ndez&title=Asp32+and+Asp228+determine+the+selective+inhibition+of+BACE1+as+shown+by+docking+and+molecular+dynamics+simulations&doi=10.1016%2Fj.ejmech.2016.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations</span></div><div class="casAuthors">Hernandez-Rodriguez, Maricarmen; Correa-Basurto, Jose; Gutierrez, Antonia; Vitorica, Javier; Rosales-Hernandez, Martha C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1142-1154</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Inhibition of β-site amyloid-β-protein precursor cleaving enzyme 1 (BACE1) represents a promising approach for the treatment of Alzheimer's disease (AD).  However, the development of a selective BACE1 inhibitor is difficult due to its highly flexible catalytic site and homol. to other aspartic proteases, including BACE2 and Cathepsin D (CTSD).  Aiming to better understand the structural factors responsible for selective BACE1 inhibition, the authors performed alignment studies, mol. dynamics (MD) simulations and docking studies to explore the recognition of four selective BACE1 inhibitors by aspartyl proteases.  The results show that selective BACE1 inhibition may be due to the formation of strong electrostatic interactions with Asp32 and Asp228 and a large no. of hydrogen bonds, π-π and Van der Waals interactions with the amino acid residues located inside the catalytic cavity, which has different vol. and shape compared to BACE2 and CTSD.  Hindrance effects avoid the accommodation of ligands in the small catalytic site of BACE2, resulting in a lower affinity and the high cavity of CTSD results in the formation of a small no. of interactions with the ligands, although they show a similar binding mode with BACE1.  These results might help to rationalize the design of selective BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr79HaKwP_JxLVg90H21EOLACvtfcHk0liUJFHpiGJ3kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFams7nL&md5=4be6466e1222ef971bca4e3b5bd7affe</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez-Rodr%25C3%25ADguez%26aufirst%3DM.%26aulast%3DCorrea-Basurto%26aufirst%3DJ.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DA.%26aulast%3DVitorica%26aufirst%3DJ.%26aulast%3DRosales-Hern%25C3%25A1ndez%26aufirst%3DM.%2BC.%26atitle%3DAsp32%2520and%2520Asp228%2520determine%2520the%2520selective%2520inhibition%2520of%2520BACE1%2520as%2520shown%2520by%2520docking%2520and%2520molecular%2520dynamics%2520simulations%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D1142%26epage%3D1154%26doi%3D10.1016%2Fj.ejmech.2016.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span>Protein Data Bank. <a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a> (accessed February 1,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Data+Bank.+www.rcsb.org+%28accessed+February+1%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totrov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span> </span><span class="NLM_article-title">Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1021/jm8009958</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8009958" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=397-406&author=G.+Bottegoniauthor=I.+Kufarevaauthor=M.+Totrovauthor=R.+Abagyan&title=Four-dimensional+docking%3A+a+fast+and+accurate+account+of+discrete+receptor+flexibility+in+ligand+docking&doi=10.1021%2Fjm8009958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm8009958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8009958%26sid%3Dliteratum%253Aachs%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DFour-dimensional%2520docking%253A%2520a%2520fast%2520and%2520accurate%2520account%2520of%2520discrete%2520receptor%2520flexibility%2520in%2520ligand%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D397%26epage%3D406%26doi%3D10.1021%2Fjm8009958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Craig, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essex, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, K.</span><span> </span><span class="NLM_article-title">Ensemble docking into multiple crystallographically derived protein structures: an evaluation based on the statistical analysis of enrichments</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span><span class="refDoi"> DOI: 10.1021/ci900407c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci900407c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVChtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=511-524&author=I.+R.+Craigauthor=J.+W.+Essexauthor=K.+Spiegel&title=Ensemble+docking+into+multiple+crystallographically+derived+protein+structures%3A+an+evaluation+based+on+the+statistical+analysis+of+enrichments&doi=10.1021%2Fci900407c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Ensemble Docking into Multiple Crystallographically Derived Protein Structures: An Evaluation Based on the Statistical Analysis of Enrichments</span></div><div class="casAuthors">Craig, Ian R.; Essex, Jonathan W.; Spiegel, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-524</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Docking into multiple receptor conformations ("ensemble docking") has been proposed, and employed, in the hope that it may account for receptor flexibility in virtual screening and thus provide higher enrichments than docking into single rigid receptor structures.  The statistical analyses presented in this paper provide quant. evidence that in some cases docking into a crystallog. derived conformational ensemble does indeed yield better enrichment than docking into any of the individual members of the ensemble.  However, these "successful" ensembles account for only a minority of those examd. and it would not have been possible to prospectively predict their identity using only protein structural information.  A more frequently obsd. outcome is that the ensemble enrichment is higher than the mean of the enrichments provided by its individual members.  An addnl. and promising finding is that, if a set of known active compds. is available, an approach based on induced-fit docking appears to be a reliable way to construct ensembles which provide relatively high enrichments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsZjWjOe3d4rVg90H21EOLACvtfcHk0lgsaarsc8oRTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVChtr8%253D&md5=4d83a7d8b4f4ad1b961a85e6b9e0ccb2</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fci900407c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900407c%26sid%3Dliteratum%253Aachs%26aulast%3DCraig%26aufirst%3DI.%2BR.%26aulast%3DEssex%26aufirst%3DJ.%2BW.%26aulast%3DSpiegel%26aufirst%3DK.%26atitle%3DEnsemble%2520docking%2520into%2520multiple%2520crystallographically%2520derived%2520protein%2520structures%253A%2520an%2520evaluation%2520based%2520on%2520the%2520statistical%2520analysis%2520of%2520enrichments%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D511%26epage%3D524%26doi%3D10.1021%2Fci900407c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Limongelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span> </span><span class="NLM_article-title">Ensemble-docking approach on BACE-1: pharmacophore perception and guidelines for drug design</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1002/cmdc.200600314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fcmdc.200600314" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=667-678&author=V.+Limongelliauthor=L.+Marinelliauthor=S.+Cosconatiauthor=H.+A.+Braunauthor=B.+Schmidtauthor=E.+Novellino&title=Ensemble-docking+approach+on+BACE-1%3A+pharmacophore+perception+and+guidelines+for+drug+design&doi=10.1002%2Fcmdc.200600314"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200600314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200600314%26sid%3Dliteratum%253Aachs%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DBraun%26aufirst%3DH.%2BA.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DNovellino%26aufirst%3DE.%26atitle%3DEnsemble-docking%2520approach%2520on%2520BACE-1%253A%2520pharmacophore%2520perception%2520and%2520guidelines%2520for%2520drug%2520design%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D667%26epage%3D678%26doi%3D10.1002%2Fcmdc.200600314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Leva, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Protein flexibility in virtual screening: the BACE-1 case study</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2697</span><span class="NLM_x">–</span> <span class="NLM_lpage">2704</span><span class="refDoi"> DOI: 10.1021/ci300390h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300390h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2nsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2697-2704&author=S.+Cosconatiauthor=L.+Marinelliauthor=F.+S.+Di+Levaauthor=V.+La+Pietraauthor=A.+De+Simoneauthor=F.+Manciniauthor=V.+Andrisanoauthor=E.+Novellinoauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=Protein+flexibility+in+virtual+screening%3A+the+BACE-1+case+study&doi=10.1021%2Fci300390h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Flexibility in Virtual Screening: The BACE-1 Case Study</span></div><div class="casAuthors">Cosconati, Sandro; Marinelli, Luciana; Di Leva, Francesco Saverio; La Pietra, Valeria; De Simone, Angela; Mancini, Francesca; Andrisano, Vincenza; Novellino, Ettore; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2697-2704</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Simulating protein flexibility is a major issue in the docking-based drug-design process for which a single methodol. soln. does not exist.  In our search of new anti-Alzheimer ligands, we were faced with the challenge of including receptor plasticity in a virtual screening campaign aimed at finding new β-secretase inhibitors.  To this aim, we incorporated protein flexibility in our simulations by using an ensemble of static x-ray enzyme structures to screen the National Cancer Institute database.  A unified description of the protein motion was also generated by computing and combining a set of grid maps using an energy weighting scheme.  Such a description was used in an energy-weighted virtual screening expt. on the same mol. database.  Assessment of the enrichment factors from these two virtual screening approaches demonstrated comparable predictive powers, with the energy-weighted method being faster than the ensemble method.  The in vitro evaluation demonstrated that out of the 32 tested ligands, 17 featured the predicted enzyme inhibiting property.  Such an impressive success rate (53.1%) demonstrates the enhanced power of the two methodologies and suggests that energy-weighted virtual screening is a more than valid alternative to ensemble virtual screening given its reduced computational demands and comparable performance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot7N2e88apQrVg90H21EOLACvtfcHk0lgsaarsc8oRTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2nsLfJ&md5=531464b7df392cc788caf01e9c7f6c48</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fci300390h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300390h%26sid%3Dliteratum%253Aachs%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DDi%2BLeva%26aufirst%3DF.%2BS.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DProtein%2520flexibility%2520in%2520virtual%2520screening%253A%2520the%2520BACE-1%2520case%2520study%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D2697%26epage%3D2704%26doi%3D10.1021%2Fci300390h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Dominguez, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopeit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villaverde, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otero, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nystrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraznenok, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, F.</span><span> </span><span class="NLM_article-title">Effect of the protonation state of the titratable residues on the inhibitor affinity to BACE-1</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7263</span><span class="refDoi"> DOI: 10.1021/bi100637n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi100637n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslKjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=7255-7263&author=J.+L.+Dominguezauthor=T.+Christopeitauthor=M.+C.+Villaverdeauthor=T.+Gossasauthor=J.+M.+Oteroauthor=S.+Nystromauthor=V.+Baraznenokauthor=E.+Lindstromauthor=U.+H.+Danielsonauthor=F.+Sussman&title=Effect+of+the+protonation+state+of+the+titratable+residues+on+the+inhibitor+affinity+to+BACE-1&doi=10.1021%2Fbi100637n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the Protonation State of the Titratable Residues on the Inhibitor Affinity to BACE-1</span></div><div class="casAuthors">Dominguez, Jose L.; Christopeit, Tony; Villaverde, M. Carmen; Gossas, Thomas; Otero, Jose M.; Nystrom, Susanne; Baraznenok, Vera; Lindstrom, Erik; Danielson, U. Helena; Sussman, Fredy</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7255-7263</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE-1 is one of the aspartic proteases involved in the cleavage of β amyloid peptide, an initial step in the formation of amyloid plaques whose toxicity induces neuron death in Alzheimer's disease patients.  One of the central issues in the search of novel BACE-1 inhibitors is the optimum pH for the binding of inhibitors to the enzyme.  It is known that the enzyme has optimal catalytic activity at acidic pH, while cell active inhibitors may bind optimally at higher pH.  In this work we det. the effect of the pH on the affinities of a set of inhibitors, with a variety of chem. motifs, for the ectodomain region of BACE-1 by a surface plasmon resonance (SPR) biosensor based assay.  In order to understand the mol. interactions that underlie the diverse optimum pH for the binding of the various inhibitors as obsd. exptl., we have calcd. the titrn. curves for a set of BACE-1 ligand complexes.  The results indicate that the pKa values of the titratable residues of the protein depend on the nature of the ligand involved, in disagreement with previous work.  The enzyme-inhibitor structures with the resulting protonation states at pH values 4.5 and 7.4 served as the starting point for the prediction of the pH-dependent binding ranking.  Our calcns. reproduced the entire affinity ranking obsd. upon pH increase and most of the binding trends among inhibitors, esp. at low pH.  Finally, our cell-based assays indicate a possible correlation between high inhibitor affinity at both acidic and neutral pH values, with optimal cell response, a result that may open new venues for the search of potent BACE-1 inhibitors that are active at the cellular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprMAi9258abLVg90H21EOLACvtfcHk0lgsaarsc8oRTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslKjsro%253D&md5=17d462cc2666acaa43f6e48f3d757847</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fbi100637n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi100637n%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DJ.%2BL.%26aulast%3DChristopeit%26aufirst%3DT.%26aulast%3DVillaverde%26aufirst%3DM.%2BC.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DOtero%26aufirst%3DJ.%2BM.%26aulast%3DNystrom%26aufirst%3DS.%26aulast%3DBaraznenok%26aufirst%3DV.%26aulast%3DLindstrom%26aufirst%3DE.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSussman%26aufirst%3DF.%26atitle%3DEffect%2520of%2520the%2520protonation%2520state%2520of%2520the%2520titratable%2520residues%2520on%2520the%2520inhibitor%2520affinity%2520to%2520BACE-1%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D7255%26epage%3D7263%26doi%3D10.1021%2Fbi100637n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Polgar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Virtual screening for beta-secretase (BACE1) inhibitors reveals the importance of protonation states at Asp32 and Asp228</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3749</span><span class="NLM_x">–</span> <span class="NLM_lpage">3755</span><span class="refDoi"> DOI: 10.1021/jm049133b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049133b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3749-3755&author=T.+Polgarauthor=G.+M.+Keseru&title=Virtual+screening+for+beta-secretase+%28BACE1%29+inhibitors+reveals+the+importance+of+protonation+states+at+Asp32+and+Asp228&doi=10.1021%2Fjm049133b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm049133b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049133b%26sid%3Dliteratum%253Aachs%26aulast%3DPolgar%26aufirst%3DT.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DVirtual%2520screening%2520for%2520beta-secretase%2520%2528BACE1%2529%2520inhibitors%2520reveals%2520the%2520importance%2520of%2520protonation%2520states%2520at%2520Asp32%2520and%2520Asp228%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3749%26epage%3D3755%26doi%3D10.1021%2Fjm049133b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Barman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, R.</span><span> </span><span class="NLM_article-title">Protonation states of the catalytic dyad of beta-secretase (BACE1) in the presence of chemically diverse inhibitors: a molecular docking study</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span><span class="refDoi"> DOI: 10.1021/ci200611t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200611t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1OqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1275-1287&author=A.+Barmanauthor=R.+Prabhakar&title=Protonation+states+of+the+catalytic+dyad+of+beta-secretase+%28BACE1%29+in+the+presence+of+chemically+diverse+inhibitors%3A+a+molecular+docking+study&doi=10.1021%2Fci200611t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Protonation States of the Catalytic Dyad of β-Secretase (BACE1) in the Presence of Chemically Diverse Inhibitors: A Molecular Docking Study</span></div><div class="casAuthors">Barman, Arghya; Prabhakar, Rajeev</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1275-1287</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this mol. docking study, the protonation states of the catalytic Asp dyad of the beta-secretase (BACE1) enzyme in the presence of eight chem. diverse inhibitors have been predicted.  BACE1 catalyzes the rate-detg. step in the generation of Alzheimer amyloid beta peptides and is widely considered as a promising therapeutic target.  All the inhibitors were redocked into their corresponding x-ray structures using a combination of eight different protonation states of the Asp dyad for each inhibitor.  Five inhibitors were primarily found to favor two different monoprotonated states, and the remaining three favor a dideprotonated state.  In addn., five of them exhibited secondary preference for a diprotonated state.  These results show that the knowledge of a single protonation state of the Asp dyad is not sufficient to search for the novel inhibitors of BACE1 and the most plausible state for each inhibitor must be detd. prior to conducting in-silico screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ324QbyXbT7Vg90H21EOLACvtfcHk0lhEDMwG7afFkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1OqtL0%253D&md5=6a18e71bfe8af60e73b8a4e4775f317f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fci200611t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200611t%26sid%3Dliteratum%253Aachs%26aulast%3DBarman%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DR.%26atitle%3DProtonation%2520states%2520of%2520the%2520catalytic%2520dyad%2520of%2520beta-secretase%2520%2528BACE1%2529%2520in%2520the%2520presence%2520of%2520chemically%2520diverse%2520inhibitors%253A%2520a%2520molecular%2520docking%2520study%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1275%26epage%3D1287%26doi%3D10.1021%2Fci200611t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Dominguez, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villaverde, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, F.</span><span> </span><span class="NLM_article-title">Effect of pH and ligand charge state on BACE-1 fragment docking performance</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span><span class="refDoi"> DOI: 10.1007/s10822-013-9653-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1007%2Fs10822-013-9653-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=403-417&author=J.+L.+Dominguezauthor=M.+C.+Villaverdeauthor=F.+Sussman&title=Effect+of+pH+and+ligand+charge+state+on+BACE-1+fragment+docking+performance&doi=10.1007%2Fs10822-013-9653-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9653-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9653-7%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DJ.%2BL.%26aulast%3DVillaverde%26aufirst%3DM.%2BC.%26aulast%3DSussman%26aufirst%3DF.%26atitle%3DEffect%2520of%2520pH%2520and%2520ligand%2520charge%2520state%2520on%2520BACE-1%2520fragment%2520docking%2520performance%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D403%26epage%3D417%26doi%3D10.1007%2Fs10822-013-9653-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veronesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Development and application of a virtual screening protocol for the identification of multitarget fragments</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1263</span><span class="refDoi"> DOI: 10.1002/cmdc.201500521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fcmdc.201500521" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1259-1263&author=G.+Bottegoniauthor=M.+Veronesiauthor=P.+Bisignanoauthor=P.+Kackerauthor=A.+D.+Faviaauthor=A.+Cavalli&title=Development+and+application+of+a+virtual+screening+protocol+for+the+identification+of+multitarget+fragments&doi=10.1002%2Fcmdc.201500521"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500521%26sid%3Dliteratum%253Aachs%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DKacker%26aufirst%3DP.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DDevelopment%2520and%2520application%2520of%2520a%2520virtual%2520screening%2520protocol%2520for%2520the%2520identification%2520of%2520multitarget%2520fragments%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1259%26epage%3D1263%26doi%3D10.1002%2Fcmdc.201500521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Kacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Combining dyad protonation and active site plasticity in BACE-1 structure-based drug design</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1085</span><span class="refDoi"> DOI: 10.1021/ci200366z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200366z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVOjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1079-1085&author=P.+Kackerauthor=M.+Masettiauthor=M.+Mangoldauthor=G.+Bottegoniauthor=A.+Cavalli&title=Combining+dyad+protonation+and+active+site+plasticity+in+BACE-1+structure-based+drug+design&doi=10.1021%2Fci200366z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Dyad Protonation and Active Site Plasticity in BACE-1 Structure-Based Drug Design</span></div><div class="casAuthors">Kacker, Puneet; Masetti, Matteo; Mangold, Martina; Bottegoni, Giovanni; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1079-1085</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ability of the BACE-1 catalytic dyad to adopt multiple protonation states and the conformational flexibility of the active site have hampered the reliability of computational screening campaigns carried out on this drug target for Alzheimer's disease.  Here, we propose a protocol that, for the first time, combining quantum mech. calcns., mol. dynamics, and conformational ensemble virtual ligand screening addresses these issues simultaneously.  The encouraging results prefigure this approach as a valuable tool for future drug discovery campaigns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKRhdkbh-ZUbVg90H21EOLACvtfcHk0lh10Q4lkeYQ1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVOjtro%253D&md5=6e718d38ed3c4fa24820b33161183b78</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fci200366z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200366z%26sid%3Dliteratum%253Aachs%26aulast%3DKacker%26aufirst%3DP.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DMangold%26aufirst%3DM.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DCombining%2520dyad%2520protonation%2520and%2520active%2520site%2520plasticity%2520in%2520BACE-1%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1079%26epage%3D1085%26doi%3D10.1021%2Fci200366z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.1002/med.20132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fmed.20132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=18651582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=295-338&author=R.+Silvestri&title=Boom+in+the+development+of+non-peptidic+beta-secretase+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fmed.20132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-338</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  β-Amyloid cleaving enzyme-1 (BACE1) has become a significant target for the therapy of Alzheimer's disease.  After the discovery of the first non-peptidomimetic β-secretase inhibitors by Takeda Chems. in 2001, several research teams focused on SAR development of these agents.  The non-peptidic BACE1 inhibitors may potentially overcome the classical problems assocd. with the peptide structure of first generation, such as blood-brain barrier crossing, poor oral bioavailability and susceptibility to P-glycoprotein transport.  In the past 6 years a boom in research of non-peptidic BACE1 inhibitors has disseminated findings over hundreds of publications and patents.  The rapidly growing literature has been reviewed with particular emphasis on literature of pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpbmzl8ONz3LVg90H21EOLACvtfcHk0lh10Q4lkeYQ1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D&md5=1e92f25f055def1c1c56b3650f4cc40a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1002%2Fmed.20132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20132%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DBoom%2520in%2520the%2520development%2520of%2520non-peptidic%2520beta-secretase%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D295%26epage%3D338%26doi%3D10.1002%2Fmed.20132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span> </span><span class="NLM_article-title">Determination of the active site protonation state of beta-secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">16416</span><span class="NLM_x">–</span> <span class="NLM_lpage">16422</span><span class="refDoi"> DOI: 10.1021/ja0304493</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0304493" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=16416-16422&author=H.+Parkauthor=S.+Lee&title=Determination+of+the+active+site+protonation+state+of+beta-secretase+from+molecular+dynamics+simulation+and+docking+experiment%3A+implications+for+structure-based+inhibitor+design&doi=10.1021%2Fja0304493"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fja0304493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0304493%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DDetermination%2520of%2520the%2520active%2520site%2520protonation%2520state%2520of%2520beta-secretase%2520from%2520molecular%2520dynamics%2520simulation%2520and%2520docking%2520experiment%253A%2520implications%2520for%2520structure-based%2520inhibitor%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D16416%26epage%3D16422%26doi%3D10.1021%2Fja0304493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Mongan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span> </span><span class="NLM_article-title">Constant pH molecular dynamics in generalized Born implicit solvent</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2038</span><span class="NLM_x">–</span> <span class="NLM_lpage">2048</span><span class="refDoi"> DOI: 10.1002/jcc.20139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fjcc.20139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=15481090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVylsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=2038-2048&author=J.+Monganauthor=D.+A.+Caseauthor=J.+A.+McCammon&title=Constant+pH+molecular+dynamics+in+generalized+Born+implicit+solvent&doi=10.1002%2Fjcc.20139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Constant pH molecular dynamics in generalized Born implicit solvent</span></div><div class="casAuthors">Mongan, John; Case, David A.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2038-2048</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A new method is proposed for const. pH mol. dynamics (MD), employing generalized Born (GB) electrostatics.  Protonation states are modeled with different charge sets, and titrating residues sample a Boltzmann distribution of protonation states as the simulation progresses, using Monte Carlo sampling based on GB-derived energies.  The method is applied to four different crystal structures of hen egg-white lysozyme (HEWL).  PKa predictions derived from the simulations have root-mean-square (RMS) error of 0.82 relative to exptl. values.  Similarity of results between the four crystal structures shows the method to be independent of starting crystal structure; this is in contrast to most electrostatics-only models.  A strong correlation between conformation and protonation state is noted and quant. analyzed, emphasizing the importance of sampling protonation states in conjunction with dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25O2HS8zlebVg90H21EOLACvtfcHk0lgQw8WHx8dTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVylsb0%253D&md5=d59be32638bb1c3def2cefdf594df47b</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20139%26sid%3Dliteratum%253Aachs%26aulast%3DMongan%26aufirst%3DJ.%26aulast%3DCase%26aufirst%3DD.%2BA.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DConstant%2520pH%2520molecular%2520dynamics%2520in%2520generalized%2520Born%2520implicit%2520solvent%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D2038%26epage%3D2048%26doi%3D10.1002%2Fjcc.20139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Itoh, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damjanović, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, B. R.</span><span> </span><span class="NLM_article-title">pH replica-exchange method based on discrete protonation states</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">3420</span><span class="NLM_x">–</span> <span class="NLM_lpage">3436</span><span class="refDoi"> DOI: 10.1002/prot.23176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fprot.23176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22002801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVektrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=3420-3436&author=S.+G.+Itohauthor=A.+Damjanovi%C4%87author=B.+R.+Brooks&title=pH+replica-exchange+method+based+on+discrete+protonation+states&doi=10.1002%2Fprot.23176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">pH replica-exchange method based on discrete protonation states</span></div><div class="casAuthors">Itoh, Satoru G.; Damjanovic, Ana; Brooks, Bernard R.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3420-3436</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The authors propose a new algorithm for obtaining proton titrn. curves of ionizable residues.  The algorithm is a pH replica-exchange method (PHREM), which is based on the const. pH algorithm of J. Mongan et al. (2004).  In the original replica-exchange method, simulations of different replicas are performed at different temps., and the temps. are exchanged between the replicas.  In the authors' PHREM, simulations of different replicas are performed at different pH values, and the pHs are exchanged between the replicas.  The PHREM was applied to a blocked amino acid and to two protein systems (snake cardiotoxin and turkey ovomucoid third domain), in conjunction with a generalized Born implicit solvent.  The performance and accuracy of this algorithm and the original const. pH method (PHMD) were compared.  For a single set of simulations at different pHs, the use of PHREM yields more accurate Hill coeffs. of titratable residues.  By performing multiple sets of const. pH simulations started with different initial states, the accuracy of predicted pKa values and Hill coeffs. obtained with PHREM and PHMD methods becomes comparable.  However, the PHREM algorithm exhibits better samplings of the protonation states of titratable residues and less scatter of the titrn. points and thus better precision of measured pKa values and Hill coeffs.  In addn., PHREM exhibits faster convergence of individual simulations than the original const. pH algorithm.  Proteins 2011; © 2011 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFZWUDme4fTrVg90H21EOLACvtfcHk0lgQw8WHx8dTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVektrvM&md5=35718b888a8b98b999af0d4a34c824bf</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fprot.23176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.23176%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DS.%2BG.%26aulast%3DDamjanovi%25C4%2587%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DB.%2BR.%26atitle%3DpH%2520replica-exchange%2520method%2520based%2520on%2520discrete%2520protonation%2520states%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2011%26volume%3D79%26spage%3D3420%26epage%3D3436%26doi%3D10.1002%2Fprot.23176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Swails, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roitberg, A. E.</span><span> </span><span class="NLM_article-title">Enhancing conformation and protonation state sampling of hen egg white lysozyme using pH replica exchange molecular dynamics</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">4393</span><span class="NLM_x">–</span> <span class="NLM_lpage">4404</span><span class="refDoi"> DOI: 10.1021/ct300512h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300512h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OksL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=4393-4404&author=J.+M.+Swailsauthor=A.+E.+Roitberg&title=Enhancing+conformation+and+protonation+state+sampling+of+hen+egg+white+lysozyme+using+pH+replica+exchange+molecular+dynamics&doi=10.1021%2Fct300512h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing Conformation and Protonation State Sampling of Hen Egg White Lysozyme Using pH Replica Exchange Molecular Dynamics</span></div><div class="casAuthors">Swails, Jason M.; Roitberg, Adrian E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4393-4404</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We evaluate the efficiency of the pH replica exchange mol. dynamics (pH-REMD) method proposed by Itoh et al. (Proteins 2011, 79, 3420-3436) by using it to predict the pKa values of the titratable residues in hen egg white lysozyme (HEWL).  PKa values predicted using pH-REMD converge significantly faster than those calcd. using const. pH mol. dynamics (CpHMD).  Furthermore, increasing the frequency between exchange attempts in pH-REMD simulations improves protonation and conformational state sampling.  By enabling the simulation to sample both conformational and protonation states more rapidly, pH-REMD simulations provide valuable insight into the pH-dependence of HEWL that the CpHMD simulations failed to capture.  We present an efficient and highly scalable implementation of pH-REMD as an attractive enhancement to traditional CpHMD methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqclVg3r5a-ubVg90H21EOLACvtfcHk0lgQw8WHx8dTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OksL3E&md5=ed9dd8ac07eaa488cd069c226091bef3</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fct300512h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300512h%26sid%3Dliteratum%253Aachs%26aulast%3DSwails%26aufirst%3DJ.%2BM.%26aulast%3DRoitberg%26aufirst%3DA.%2BE.%26atitle%3DEnhancing%2520conformation%2520and%2520protonation%2520state%2520sampling%2520of%2520hen%2520egg%2520white%2520lysozyme%2520using%2520pH%2520replica%2520exchange%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D4393%26epage%3D4404%26doi%3D10.1021%2Fct300512h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Ellis, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">pH-dependent population shift regulates BACE1 activity and inhibition</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">9543</span><span class="NLM_x">–</span> <span class="NLM_lpage">9546</span><span class="refDoi"> DOI: 10.1021/jacs.5b05891</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b05891" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyqsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=9543-9546&author=C.+R.+Ellisauthor=J.+Shen&title=pH-dependent+population+shift+regulates+BACE1+activity+and+inhibition&doi=10.1021%2Fjacs.5b05891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Dependent Population Shift Regulates BACE1 Activity and Inhibition</span></div><div class="casAuthors">Ellis, Christopher R.; Shen, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9543-9546</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1, a major therapeutic target for treatment of Alzheimer's disease, functions within a narrow pH range.  Despite tremendous effort and progress in the development of BACE1 inhibitors, details of the underlying pH-dependent regulatory mechanism remain unclear.  Here the authors elucidate the pH-dependent conformational mechanism that regulates BACE1 activity using continuous const.-pH mol. dynamics (MD).  The simulations reveal that BACE1 mainly occupies three conformational states and that the relative populations of the states shift according to pH.  At intermediate pH, when the catalytic dyad is monoprotonated, a binding-competent state is highly populated, while at low and high pH a Tyr-inhibited state is dominant.  The authors' data provide strong evidence supporting conformational selection as a major mechanism for substrate and peptide-inhibitor binding.  These new insights, while consistent with expt., greatly extend the knowledge of BACE1 and have implications for further optimization of inhibitors and understanding potential side effects of targeting BACE1.  Finally, the work highlights the importance of properly modeling protonation states in MD simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCblGrLaicdLVg90H21EOLACvtfcHk0lgQw8WHx8dTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyqsL%252FM&md5=a7d2efc129a95da28e647bcaad8c857e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b05891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b05891%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DC.%2BR.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DpH-dependent%2520population%2520shift%2520regulates%2520BACE1%2520activity%2520and%2520inhibition%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D9543%26epage%3D9546%26doi%3D10.1021%2Fjacs.5b05891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Kim, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blachly, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span> </span><span class="NLM_article-title">Conformational dynamics and binding free energies of inhibitors of BACE-1: from the perspective of protonation equilibria</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1004341</span><span class="refDoi"> DOI: 10.1371/journal.pcbi.1004341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1371%2Fjournal.pcbi.1004341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1004341&author=M.+O.+Kimauthor=P.+G.+Blachlyauthor=J.+A.+McCammon&title=Conformational+dynamics+and+binding+free+energies+of+inhibitors+of+BACE-1%3A+from+the+perspective+of+protonation+equilibria&doi=10.1371%2Fjournal.pcbi.1004341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1004341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1004341%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BO.%26aulast%3DBlachly%26aufirst%3DP.%2BG.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DConformational%2520dynamics%2520and%2520binding%2520free%2520energies%2520of%2520inhibitors%2520of%2520BACE-1%253A%2520from%2520the%2520perspective%2520of%2520protonation%2520equilibria%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3De1004341%26doi%3D10.1371%2Fjournal.pcbi.1004341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Ellis, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Constant pH molecular dynamics reveals pH-modulated binding of two small-molecule BACE1 inhibitors</span> <span class="citation_source-journal">J. Phys. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">944</span><span class="NLM_x">–</span> <span class="NLM_lpage">949</span><span class="refDoi"> DOI: 10.1021/acs.jpclett.6b00137</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jpclett.6b00137" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFOltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=944-949&author=C.+R.+Ellisauthor=C.-C.+Tsaiauthor=X.+Houauthor=J.+Shen&title=Constant+pH+molecular+dynamics+reveals+pH-modulated+binding+of+two+small-molecule+BACE1+inhibitors&doi=10.1021%2Facs.jpclett.6b00137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Constant pH Molecular Dynamics Reveals pH-Modulated Binding of Two Small-Molecule BACE1 Inhibitors</span></div><div class="casAuthors">Ellis, Christopher R.; Tsai, Cheng-Chieh; Hou, Xinjun; Shen, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">944-949</span>CODEN:
                <span class="NLM_cas:coden">JPCLCD</span>;
        ISSN:<span class="NLM_cas:issn">1948-7185</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeting β-secretase (BACE1) with small-mol. inhibitors offers a promising route for treatment of Alzheimer's disease.  However, the intricate pH dependence of BACE1 function and inhibitor efficacy has posed major challenges for structure-based drug design.  Here we investigate two structurally similar BACE1 inhibitors that have dramatically different inhibitory activity using continuous const. pH mol. dynamics (CpHMD).  At high pH, both inhibitors are stably bound to BACE1; however, within the enzyme active pH range, only the iminopyrimidinone-based inhibitor remains bound, while the aminothiazine-based inhibitor becomes partially dissocd. following the loss of hydrogen bonding with the active site and change of the 10s loop conformation.  The drastically lower activity of the second inhibitor is due to the protonation of a catalytic aspartate and the lack of a propyne tail.  This work demonstrates that CpHMD can be used for screening pH-dependent binding profiles of small-mol. inhibitors, providing a new tool for structure-based drug design and optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvwJYDdO8MHrVg90H21EOLACvtfcHk0ljlUDYx7kP1zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFOltrY%253D&md5=7305c7884d26f2c841c2bd47e5c8032d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facs.jpclett.6b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jpclett.6b00137%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DC.%2BR.%26aulast%3DTsai%26aufirst%3DC.-C.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DConstant%2520pH%2520molecular%2520dynamics%2520reveals%2520pH-modulated%2520binding%2520of%2520two%2520small-molecule%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Phys.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D944%26epage%3D949%26doi%3D10.1021%2Facs.jpclett.6b00137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Chodera, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirts, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pande, V. S.</span><span> </span><span class="NLM_article-title">Alchemical free energy methods for drug discovery: progress and challenges</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span><span class="refDoi"> DOI: 10.1016/j.sbi.2011.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.sbi.2011.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=21349700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Kisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=150-160&author=J.+D.+Choderaauthor=D.+L.+Mobleyauthor=M.+R.+Shirtsauthor=R.+W.+Dixonauthor=K.+Bransonauthor=V.+S.+Pande&title=Alchemical+free+energy+methods+for+drug+discovery%3A+progress+and+challenges&doi=10.1016%2Fj.sbi.2011.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Alchemical free energy methods for drug discovery: Progress and challenges</span></div><div class="casAuthors">Chodera, John D.; Mobley, David L.; Shirts, Michael R.; Dixon, Richard W.; Branson, Kim; Pande, Vijay S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-160</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Improved rational drug design methods are needed to lower the cost and increase the success rate of drug discovery and development.  Alchem. binding free energy calcns., one potential tool for rational design, have progressed rapidly over the past decade, but still fall short of providing robust tools for pharmaceutical engineering.  Recent studies, esp. on model receptor systems, have clarified many of the challenges that must be overcome for robust predictions of binding affinity to be useful in rational design.  In this review, inspired by a recent joint academic/industry meeting organized by the authors, we discuss these challenges and suggest a no. of promising approaches for overcoming them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobUBHsGUCIWLVg90H21EOLACvtfcHk0ljlUDYx7kP1zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Kisrk%253D&md5=fa17c0982d921cd1c32cd095fd34420e</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2011.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2011.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DChodera%26aufirst%3DJ.%2BD.%26aulast%3DMobley%26aufirst%3DD.%2BL.%26aulast%3DShirts%26aufirst%3DM.%2BR.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DBranson%26aufirst%3DK.%26aulast%3DPande%26aufirst%3DV.%2BS.%26atitle%3DAlchemical%2520free%2520energy%2520methods%2520for%2520drug%2520discovery%253A%2520progress%2520and%2520challenges%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D150%26epage%3D160%26doi%3D10.1016%2Fj.sbi.2011.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Ciordia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Benito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Application of free energy perturbation for the design of BACE1 inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1871</span><span class="refDoi"> DOI: 10.1021/acs.jcim.6b00220</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00220" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12mu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1856-1871&author=M.+Ciordiaauthor=L.+P%C3%A9rez-Benitoauthor=F.+Delgadoauthor=A.+A.+Trabancoauthor=G.+Tresadern&title=Application+of+free+energy+perturbation+for+the+design+of+BACE1+inhibitors&doi=10.1021%2Facs.jcim.6b00220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Free Energy Perturbation for the Design of BACE1 Inhibitors</span></div><div class="casAuthors">Ciordia, Myriam; Perez-Benito, Laura; Delgado, Francisca; Trabanco, Andres A.; Tresadern, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1856-1871</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel spiroaminodihydropyrroles probing for optimized interactions at the P3 pocket of β-secretase 1 (BACE1) were designed with the use of free energy perturbation (FEP) calcns.  The resulting mols. showed pIC50 potencies in enzymic BACE1 inhibition assays ranging from approx. 5 to 7.  Good correlation was obsd. between the predicted activity from the FEP calcns. and exptl. activity.  Simulations run with a default 5 ns approach delivered a mean unsigned error (MUE) between prediction and expt. of 0.58 and 0.91 kcal/mol for retrospective and prospective applications, resp.  With longer simulations of 10 and 20 ns, the MUE was in both cases 0.57 kcal/mol for the retrospective application, and 0.69 and 0.59 kcal/mol for the prospective application.  Other considerations that impact the quality of the calcns. are discussed.  This work provides an example of the value of FEP as a computational tool for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqpi-OiII-FrVg90H21EOLACvtfcHk0lgz0qhuGeiQmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12mu7%252FK&md5=b7577a89492867fc334cb1ec937a4eb6</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00220%26sid%3Dliteratum%253Aachs%26aulast%3DCiordia%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez-Benito%26aufirst%3DL.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DApplication%2520of%2520free%2520energy%2520perturbation%2520for%2520the%2520design%2520of%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2016%26volume%3D56%26spage%3D1856%26epage%3D1871%26doi%3D10.1021%2Facs.jcim.6b00220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Keranen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Benito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciordia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbrecher, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Vlijmen, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Acylguanidine beta secretase 1 inhibitors: a combined experimental and free energy perturbation study</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1439</span><span class="NLM_x">–</span> <span class="NLM_lpage">1453</span><span class="refDoi"> DOI: 10.1021/acs.jctc.6b01141</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.6b01141" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1ehsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=1439-1453&author=H.+Keranenauthor=L.+Perez-Benitoauthor=M.+Ciordiaauthor=F.+Delgadoauthor=T.+B.+Steinbrecherauthor=D.+Oehlrichauthor=H.+W.+van+Vlijmenauthor=A.+A.+Trabancoauthor=G.+Tresadern&title=Acylguanidine+beta+secretase+1+inhibitors%3A+a+combined+experimental+and+free+energy+perturbation+study&doi=10.1021%2Facs.jctc.6b01141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Acylguanidine Beta Secretase 1 Inhibitors: A Combined Experimental and Free Energy Perturbation Study</span></div><div class="casAuthors">Keranen, Henrik; Perez-Benito, Laura; Ciordia, Myriam; Delgado, Francisca; Steinbrecher, Thomas B.; Oehlrich, Daniel; van Vlijmen, Herman W. T.; Trabanco, Andres A.; Tresadern, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1439-1453</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acylguanidine beta secretase 1 (BACE1) inhibitors with modified scaffold and P3 pocket substituent was synthesized and studied with Free Energy Perturbation (FEP) calcns.  The resulting mols. showed potencies in enzymic BACE1 inhibition assays up to 1 nM.  The correlation between the predicted activity from the FEP calcns. and the exptl. activity was good for the P3 pocket substituents.  The av. mean unsigned error (MUE) between prediction and expt. was 0.68±0.17 kcal/mol for the default 5 ns lambda window simulation time improving to 0.35±0.13 kcal/mol for 40 ns.  FEP calcns. for the P2' pocket substituents on the same acylguanidine scaffold also showed good agreement with expt. and the results remained stable with repeated simulations and increased simulation time.  It proved more difficult to use FEP calcns. to study the scaffold modification from increasing 5 to 6 and 7 membered-rings.  Although prediction and expt. were in agreement for short 2 ns simulations, as the simulation time increased the results diverged.  This was improved by the use of a newly developed 'Core Hopping FEP+' approach, which also showed improved stability in repeat calcns.  The origins of these differences along with the value of repeat and longer simulation times are discussed.  This work provides a further example of the use of FEP as a computational tool for mol. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmHZjygsk_PbVg90H21EOLACvtfcHk0lgz0qhuGeiQmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1ehsrg%253D&md5=987ab8fc475670d0ba19aa086519a4ba</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.6b01141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.6b01141%26sid%3Dliteratum%253Aachs%26aulast%3DKeranen%26aufirst%3DH.%26aulast%3DPerez-Benito%26aufirst%3DL.%26aulast%3DCiordia%26aufirst%3DM.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DSteinbrecher%26aufirst%3DT.%2BB.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3Dvan%2BVlijmen%26aufirst%3DH.%2BW.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DAcylguanidine%2520beta%2520secretase%25201%2520inhibitors%253A%2520a%2520combined%2520experimental%2520and%2520free%2520energy%2520perturbation%2520study%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2017%26volume%3D13%26spage%3D1439%26epage%3D1453%26doi%3D10.1021%2Facs.jctc.6b01141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">De Vivo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Role of molecular dynamics and related methods in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4035</span><span class="NLM_x">–</span> <span class="NLM_lpage">4061</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4035-4061&author=M.+De+Vivoauthor=M.+Masettiauthor=G.+Bottegoniauthor=A.+Cavalli&title=Role+of+molecular+dynamics+and+related+methods+in+drug+discovery&doi=10.1021%2Facs.jmedchem.5b01684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Molecular Dynamics and Related Methods in Drug Discovery</span></div><div class="casAuthors">De Vivo, Marco; Masetti, Matteo; Bottegoni, Giovanni; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4035-4061</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. dynamics (MD) and related methods are close to becoming routine computational tools for drug discovery.  Their main advantage is in explicitly treating structural flexibility and entropic effects.  This allows a more accurate est. of the thermodn. and kinetics assocd. with drug-target recognition and binding, as better algorithms and hardware architectures increase their use.  Here, we review the theor. background of MD and enhanced sampling methods, focusing on free-energy perturbation, metadynamics, steered MD, and other methods most consistently used to study drug-target binding.  We discuss unbiased MD simulations that nowadays allow the observation of unsupervised ligand-target binding, assessing how these approaches help optimizing target affinity and drug residence time toward improved drug efficacy.  Further issues discussed include allosteric modulation and the role of water mols. in ligand binding and optimization.  We conclude by calling for more prospective studies to attest to these methods' utility in discovering novel drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQb_02a7Nmh7Vg90H21EOLACvtfcHk0lgz0qhuGeiQmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWksLs%253D&md5=b3d8a4fb5705a3555c2bb2a962420396</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01684%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DRole%2520of%2520molecular%2520dynamics%2520and%2520related%2520methods%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4035%26epage%3D4061%26doi%3D10.1021%2Facs.jmedchem.5b01684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krilov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupyan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbrecher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span> </span><span class="NLM_article-title">Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">2695</span><span class="NLM_x">–</span> <span class="NLM_lpage">2703</span><span class="refDoi"> DOI: 10.1021/ja512751q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja512751q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2iuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=2695-2703&author=L.+Wangauthor=Y.+Wuauthor=Y.+Dengauthor=B.+Kimauthor=L.+Pierceauthor=G.+Krilovauthor=D.+Lupyanauthor=S.+Robinsonauthor=M.+K.+Dahlgrenauthor=J.+Greenwoodauthor=D.+L.+Romeroauthor=C.+Masseauthor=J.+L.+Knightauthor=T.+Steinbrecherauthor=T.+Beumingauthor=W.+Dammauthor=E.+Harderauthor=W.+Shermanauthor=M.+Brewerauthor=R.+Westerauthor=M.+Murckoauthor=L.+Fryeauthor=R.+Faridauthor=T.+Linauthor=D.+L.+Mobleyauthor=W.+L.+Jorgensenauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=R.+Abel&title=Accurate+and+reliable+prediction+of+relative+ligand+binding+potency+in+prospective+drug+discovery+by+way+of+a+modern+free-energy+calculation+protocol+and+force+field&doi=10.1021%2Fja512751q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field</span></div><div class="casAuthors">Wang, Lingle; Wu, Yujie; Deng, Yuqing; Kim, Byungchan; Pierce, Levi; Krilov, Goran; Lupyan, Dmitry; Robinson, Shaughnessy; Dahlgren, Markus K.; Greenwood, Jeremy; Romero, Donna L.; Masse, Craig; Knight, Jennifer L.; Steinbrecher, Thomas; Beuming, Thijs; Damm, Wolfgang; Harder, Ed; Sherman, Woody; Brewer, Mark; Wester, Ron; Murcko, Mark; Frye, Leah; Farid, Ramy; Lin, Teng; Mobley, David L.; Jorgensen, William L.; Berne, Bruce J.; Friesner, Richard A.; Abel, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2695-2703</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designing tight-binding ligands is a primary objective of small-mol. drug discovery.  Over the past few decades, free-energy calcns. have benefited from improved force fields and sampling algorithms, as well as the advent of low-cost parallel computing.  However, it has proven to be challenging to reliably achieve the level of accuracy that would be needed to guide lead optimization (∼5× in binding affinity) for a wide range of ligands and protein targets.  Not surprisingly, widespread com. application of free-energy simulations has been limited due to the lack of large-scale validation coupled with the tech. challenges traditionally assocd. with running these types of calcns.  Here, we report an approach that achieves an unprecedented level of accuracy across a broad range of target classes and ligands, with retrospective results encompassing 200 ligands and a wide variety of chem. perturbations, many of which involve significant changes in ligand chem. structures.  In addn., we have applied the method in prospective drug discovery projects and found a significant improvement in the quality of the compds. synthesized that have been predicted to be potent.  Compds. predicted to be potent by this approach have a substantial redn. in false positives relative to compds. synthesized on the basis of other computational or medicinal chem. approaches.  Furthermore, the results are consistent with those obtained from our retrospective studies, demonstrating the robustness and broad range of applicability of this approach, which can be used to drive decisions in lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9UtXEyLPpLVg90H21EOLACvtfcHk0lj3YwaOOD6KDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2iuro%253D&md5=37a4f4a6c085f47ed531342643b6c33b</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fja512751q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja512751q%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DPierce%26aufirst%3DL.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DGreenwood%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DD.%2BL.%26aulast%3DMasse%26aufirst%3DC.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DSteinbrecher%26aufirst%3DT.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DBrewer%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DR.%26aulast%3DMurcko%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DL.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DMobley%26aufirst%3DD.%2BL.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DAbel%26aufirst%3DR.%26atitle%3DAccurate%2520and%2520reliable%2520prediction%2520of%2520relative%2520ligand%2520binding%2520potency%2520in%2520prospective%2520drug%2520discovery%2520by%2520way%2520of%2520a%2520modern%2520free-energy%2520calculation%2520protocol%2520and%2520force%2520field%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D2695%26epage%3D2703%26doi%3D10.1021%2Fja512751q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitaleri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saladino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gervasio, F. L.</span><span> </span><span class="NLM_article-title">Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span><span class="refDoi"> DOI: 10.1021/ar500356n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar500356n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2nt7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=277-285&author=A.+Cavalliauthor=A.+Spitaleriauthor=G.+Saladinoauthor=F.+L.+Gervasio&title=Investigating+drug-target+association+and+dissociation+mechanisms+using+metadynamics-based+algorithms&doi=10.1021%2Far500356n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating Drug-Target Association and Dissociation Mechanisms Using Metadynamics-Based Algorithms</span></div><div class="casAuthors">Cavalli, Andrea; Spitaleri, Andrea; Saladino, Giorgio; Gervasio, Francesco L.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Account highlights recent advances and discusses major challenges in the field of drug-target recognition, binding, and unbinding studied using metadynamics-based approaches, with particular emphasis on their role in structure-based design.  Computational chem. has significantly contributed to drug design and optimization in an extremely broad range of areas, including prediction of target druggability and drug likeness, de novo design, fragment screening, ligand docking, estn. of binding affinity, and modulation of ADMET (absorption, distribution, metab., excretion, toxicity) properties.  Computationally driven drug discovery must continuously adapt to keep pace with the evolving knowledge of the factors that modulate the pharmacol. action of drugs.  There is thus an urgent need for novel computational approaches that integrate the vast amt. of complex information currently available for small (bio)org. compds., biol. relevant targets and their complexes, while also accounting accurately for the thermodn. and kinetics of drug-target assocn., the intrinsic dynamical behavior of biomol. systems, and the complexity of protein-protein networks.  Understanding the mechanism of drug binding to and unbinding from biol. targets is fundamental for optimizing lead compds. and designing novel biol. active ones.  One major challenge is the accurate description of the conformational complexity prior to and upon formation of drug-target complexes.  Recently, enhanced sampling methods, including metadynamics and related approaches, have been successfully applied to investigate complex mechanisms of drugs binding to flexible targets.  Metadynamics is a family of enhanced sampling techniques aimed at enhancing the rare events and reconstructing the underlying free energy landscape as a function of a set of order parameters, usually referred to as collective variables.  Studies of drug binding mechanisms have predicted the most probable assocn. and dissocn. pathways and the related binding free energy profile.  In addn., the availability of an efficient open-source implementation, running on cost-effective GPU (i.e., graphical processor unit) architectures, has considerably decreased the learning curve and the computational costs of the methods, and increased their adoption by the community.  Here, we review the recent contributions of metadynamics and other enhanced sampling methods to the field of drug-target recognition and binding.  We discuss how metadynamics has been used to search for transition states, to predict binding and unbinding paths, to treat conformational flexibility, and to compute free energy profiles.  We highlight the importance of such predictions in drug discovery.  Major challenges in the field and possible solns. will finally be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-_m41iVArELVg90H21EOLACvtfcHk0lj3YwaOOD6KDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2nt7zL&md5=e3b79a23aca3a58914eb0bbf4d73306e</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Far500356n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far500356n%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DSpitaleri%26aufirst%3DA.%26aulast%3DSaladino%26aufirst%3DG.%26aulast%3DGervasio%26aufirst%3DF.%2BL.%26atitle%3DInvestigating%2520drug-target%2520association%2520and%2520dissociation%2520mechanisms%2520using%2520metadynamics-based%2520algorithms%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26spage%3D277%26epage%3D285%26doi%3D10.1021%2Far500356n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4186</span><span class="NLM_x">–</span> <span class="NLM_lpage">4189</span><span class="refDoi"> DOI: 10.1021/jm9810452</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9810452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4186-4189&author=C.+Melchiorreauthor=V.+Andrisanoauthor=M.+L.+Bolognesiauthor=R.+Budriesiauthor=A.+Cavalliauthor=V.+Cavriniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatini&title=Acetylcholinesterase+noncovalent+inhibitors+based+on+a+polyamine+backbone+for+potential+use+against+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm9810452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fjm9810452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9810452%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520noncovalent%2520inhibitors%2520based%2520on%2520a%2520polyamine%2520backbone%2520for%2520potential%2520use%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4186%26epage%3D4189%26doi%3D10.1021%2Fjm9810452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massenzio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Multitarget drug discovery for Alzheimer’s disease: triazinones as BACE-1 and GSK-3beta inhibitors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1002/anie.201410456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fanie.201410456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1578-1582&author=F.+Pratiauthor=A.+De+Simoneauthor=P.+Bisignanoauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=A.+D.+Faviaauthor=G.+Bottegoniauthor=A.+Martinezauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=Multitarget+drug+discovery+for+Alzheimer%E2%80%99s+disease%3A+triazinones+as+BACE-1+and+GSK-3beta+inhibitors&doi=10.1002%2Fanie.201410456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410456%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DMultitarget%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520triazinones%2520as%2520BACE-1%2520and%2520GSK-3beta%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1578%26epage%3D1582%26doi%3D10.1002%2Fanie.201410456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massenzio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatino, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the first dual BACE-1/GSK-3beta fragment hits against Alzheimer’s disease</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1665</span><span class="NLM_x">–</span> <span class="NLM_lpage">1682</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00121</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00121" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKkt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1665-1682&author=F.+Pratiauthor=A.+De+Simoneauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=S.+M.+Bertozziauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=P.+Sabatinoauthor=G.+Bottegoniauthor=A.+Martinezauthor=A.+Cavalliauthor=M.+L.+Bolognesi&title=3%2C4-Dihydro-1%2C3%2C5-triazin-2%281H%29-ones+as+the+first+dual+BACE-1%2FGSK-3beta+fragment+hits+against+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.5b00121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease</span></div><div class="casAuthors">Prati, Federica; De Simone, Angela; Armirotti, Andrea; Summa, Maria; Pizzirani, Daniela; Scarpelli, Rita; Bertozzi, Sine Mandrup; Perez, Daniel I.; Andrisano, Vincenza; Perez-Castillo, Ana; Monti, Barbara; Massenzio, Francesca; Polito, Letizia; Racchi, Marco; Sabatino, Piera; Bottegoni, Giovanni; Martinez, Ana; Cavalli, Andrea; Bolognesi, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1665-1682</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the main obstacles toward the discovery of effective anti-Alzheimer drugs is the multifactorial nature of its etiopathol.  Therefore, the use of multitarget-directed ligands has emerged as particularly suitable.  Such ligands, able to modulate different neurodegenerative pathways, for example, amyloid and tau cascades, as well as cognitive and neurogenic functions, are fostered to come.  In this respect, we report herein on the first class of BACE-1/GSK-3β dual inhibitors based on a 3,4-dihydro-1,3,5-triazin-2(1H)-one skeleton, whose hit compd. 1 showed interesting properties in a preliminary investigation.  Notably, compd. 2, endowed with well-balanced potencies against the two isolated enzymes (IC50 of 16 and 7 μM against BACE-1 and GSK-3β, resp.), displayed effective neuroprotective and neurogenic activities and no neurotoxicity in cell-based assays.  It also showed good brain permeability in a pharmacokinetic assessment in mice.  Overall, triazinone derivs., thanks to the simultaneous modulation of multiple points of the diseased network, might emerge as suitable candidates to be tested in in vivo Alzheimer's disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9gpkNszZOQ7Vg90H21EOLACvtfcHk0lgr2EDaDFQgEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKkt73O&md5=5d02342f3164a73e41eb17c4f87fb4fa</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00121%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DSabatino%26aufirst%3DP.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3D3%252C4-Dihydro-1%252C3%252C5-triazin-2%25281H%2529-ones%2520as%2520the%2520first%2520dual%2520BACE-1%252FGSK-3beta%2520fragment%2520hits%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1665%26epage%3D1682%26doi%3D10.1021%2Facschemneuro.5b00121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Di Martino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span> </span><span class="NLM_article-title">Versatility of the curcumin scaffold: discovery of potent and balanced dual BACE-1 and GSK-3beta inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00894</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00894" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=531-544&author=R.+M.+Di+Martinoauthor=A.+De+Simoneauthor=V.+Andrisanoauthor=P.+Bisignanoauthor=A.+Bisiauthor=S.+Gobbiauthor=A.+Rampaauthor=R.+Fatoauthor=C.+Bergaminiauthor=D.+I.+Perezauthor=A.+Martinezauthor=G.+Bottegoniauthor=A.+Cavalliauthor=F.+Belluti&title=Versatility+of+the+curcumin+scaffold%3A+discovery+of+potent+and+balanced+dual+BACE-1+and+GSK-3beta+inhibitors&doi=10.1021%2Facs.jmedchem.5b00894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors</span></div><div class="casAuthors">Di Martino, Rita Maria Concetta; De Simone, Angela; Andrisano, Vincenza; Bisignano, Paola; Bisi, Alessandra; Gobbi, Silvia; Rampa, Angela; Fato, Romana; Bergamini, Christian; Perez, Daniel I.; Martinez, Ana; Bottegoni, Giovanni; Cavalli, Andrea; Belluti, Federica</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">531-544</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multitarget approach has gained increasing acceptance as a useful tool to address complex and multifactorial maladies such as Alzheimer's disease (AD).  The concurrent inhibition of the validated AD targets β-secretase (BACE-1) and glycogen synthase kinase-3β (GSK-3β) by attacking both β-amyloid and tau protein cascades has been identified as a promising AD therapeutic strategy.  In our study, curcumin was identified as a lead compd. for the simultaneous inhibition of both targets; therefore, synthetic efforts were dedicated to obtaining a small library of novel curcumin-based analogs, and a no. of potent and balanced dual-target inhibitors were obtained.  In particular, 2, 6, and 7 emerged as promising drug candidates endowed with neuroprotective potential and brain permeability.  Notably, for some new compds. the sym. diketo and the β-keto-enol tautomeric forms were purposely isolated and tested in vitro, allowing us to gain insight into the key requirements for BACE-1 and GSK-3β inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw1HaZGRzvJbVg90H21EOLACvtfcHk0lgr2EDaDFQgEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrsLrJ&md5=349916a940c9cc8d87ca817c689756f1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00894%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMartino%26aufirst%3DR.%2BM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DFato%26aufirst%3DR.%26aulast%3DBergamini%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26atitle%3DVersatility%2520of%2520the%2520curcumin%2520scaffold%253A%2520discovery%2520of%2520potent%2520and%2520balanced%2520dual%2520BACE-1%2520and%2520GSK-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D531%26epage%3D544%26doi%3D10.1021%2Facs.jmedchem.5b00894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">Feeling nature’s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span><span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=616-628&author=J.+B.+Baell&title=Feeling+nature%E2%80%99s+PAINS%3A+natural+products%2C+natural+product+drugs%2C+and+pan+assay+interference+compounds+%28PAINS%29&doi=10.1021%2Facs.jnatprod.5b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-628</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We have previously reported on classes of compds. that can interfere with bioassays via a no. of different mechanisms and termed such compds. Pan Assay INterference compds., or PAINS.  These compds. were defined on the basis of high-throughput data derived from vendor-supplied synthetics.  The question therefore arises whether the concept of PAINS is relevant to compds. of natural origin.  Here, it is shown that this is indeed the case, but that the context of the biol. readout is an important factor that must be brought into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFy3lN9vzSbVg90H21EOLACvtfcHk0lgcO1B0KIbKUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D&md5=199b040b1f6f3d636521879acae0114d</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00947%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DFeeling%2520nature%25E2%2580%2599s%2520PAINS%253A%2520natural%2520products%252C%2520natural%2520product%2520drugs%252C%2520and%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D616%26epage%3D628%26doi%3D10.1021%2Facs.jnatprod.5b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Leinonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koponen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartikainen, S.</span><span> </span><span class="NLM_article-title">Systematic review: representativeness of participants in RCTs of acetylcholinesterase inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0124500</span><span class="refDoi"> DOI: 10.1371/journal.pone.0124500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1371%2Fjournal.pone.0124500" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0124500&author=A.+Leinonenauthor=M.+Koponenauthor=S.+Hartikainen&title=Systematic+review%3A+representativeness+of+participants+in+RCTs+of+acetylcholinesterase+inhibitors&doi=10.1371%2Fjournal.pone.0124500"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0124500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0124500%26sid%3Dliteratum%253Aachs%26aulast%3DLeinonen%26aufirst%3DA.%26aulast%3DKoponen%26aufirst%3DM.%26aulast%3DHartikainen%26aufirst%3DS.%26atitle%3DSystematic%2520review%253A%2520representativeness%2520of%2520participants%2520in%2520RCTs%2520of%2520acetylcholinesterase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0124500%26doi%3D10.1371%2Fjournal.pone.0124500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colizzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2007.09.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=17998161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1WgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=423-426&author=L.+Piazziauthor=A.+Cavalliauthor=F.+Colizziauthor=F.+Bellutiauthor=M.+Bartoliniauthor=F.+Manciniauthor=M.+Recanatiniauthor=V.+Andrisanoauthor=A.+Rampa&title=Multi-target-directed+coumarin+derivatives%3A+hAChE+and+BACE1+inhibitors+as+potential+anti-Alzheimer+compounds&doi=10.1016%2Fj.bmcl.2007.09.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds</span></div><div class="casAuthors">Piazzi, Lorna; Cavalli, Andrea; Colizzi, Francesco; Belluti, Federica; Bartolini, Manuela; Mancini, Francesca; Recanatini, Maurizio; Andrisano, Vincenza; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">423-426</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The complex etiol. of Alzheimer's disease (AD) prompts scientists to develop multifunctional compds. to combat causes and symptoms of such neurodegeneration.  A series of compds., e.g., I, has been designed, synthesized, and tested by introducing halophenylalkylamidic functions on the scaffold of AP2238 (II), which is a dual binding site acetylcholinesterase inhibitor.  The inhibitory activity was successfully extended to the beta-site amyloid precursor protein cleavage enzyme, leading to the discovery of a potent inhibitor of this enzyme and affording multifunctional compds. for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQZP5TwhQKrVg90H21EOLACvtfcHk0lgcO1B0KIbKUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1WgtA%253D%253D&md5=f97fcfe0199fced046a876d98ed481bc</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.100%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DColizzi%26aufirst%3DF.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DMulti-target-directed%2520coumarin%2520derivatives%253A%2520hAChE%2520and%2520BACE1%2520inhibitors%2520as%2520potential%2520anti-Alzheimer%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D423%26epage%3D426%26doi%3D10.1016%2Fj.bmcl.2007.09.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer’s disease therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2282</span><span class="refDoi"> DOI: 10.1021/jm0340602</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0340602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2279-2282&author=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Cavalliauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=P.+Valentiauthor=M.+Recanatini&title=3-%284-%5B%5BBenzyl%28methyl%29amino%5Dmethyl%5Dphenyl%29-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+inhibits+both+acetylcholinesterase+and+acetylcholinesterase-induced+beta-amyloid+aggregation%3A+a+dual+function+lead+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1021%2Fjm0340602"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm0340602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340602%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3D3-%25284-%255B%255BBenzyl%2528methyl%2529amino%255Dmethyl%255Dphenyl%2529-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520inhibits%2520both%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%253A%2520a%2520dual%2520function%2520lead%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2279%26epage%3D2282%26doi%3D10.1021%2Fjm0340602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djemil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.ejmech.2014.03.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=157-166&author=F.+Bellutiauthor=A.+De+Simoneauthor=A.+Tarozziauthor=M.+Bartoliniauthor=A.+Djemilauthor=A.+Bisiauthor=S.+Gobbiauthor=S.+Montanariauthor=A.+Cavalliauthor=V.+Andrisanoauthor=G.+Bottegoniauthor=A.+Rampa&title=Fluorinated+benzophenone+derivatives%3A+balanced+multipotent+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2014.03.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDjemil%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DMontanari%26aufirst%3DS.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFluorinated%2520benzophenone%2520derivatives%253A%2520balanced%2520multipotent%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D78%26spage%3D157%26epage%3D166%26doi%3D10.1016%2Fj.ejmech.2014.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Martino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span> </span><span class="NLM_article-title">From AChE to BACE1 inhibitors: the role of the amine on the indanone scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2804</span><span class="NLM_x">–</span> <span class="NLM_lpage">2808</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmcl.2015.05.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2804-2808&author=A.+Rampaauthor=F.+Manciniauthor=A.+De+Simoneauthor=F.+Falchiauthor=F.+Bellutiauthor=R.+M.+Di+Martinoauthor=S.+Gobbiauthor=V.+Andrisanoauthor=A.+Tarozziauthor=M.+Bartoliniauthor=A.+Cavalliauthor=A.+Bisi&title=From+AChE+to+BACE1+inhibitors%3A+the+role+of+the+amine+on+the+indanone+scaffold&doi=10.1016%2Fj.bmcl.2015.05.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DFalchi%26aufirst%3DF.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DDi%2BMartino%26aufirst%3DR.%2BM.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26atitle%3DFrom%2520AChE%2520to%2520BACE1%2520inhibitors%253A%2520the%2520role%2520of%2520the%2520amine%2520on%2520the%2520indanone%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2804%26epage%3D2808%26doi%3D10.1016%2Fj.bmcl.2015.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Zha, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesaresi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span> </span><span class="NLM_article-title">Novel tacrine-benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer’s disease: design, synthesis, biological evaluation, and X-ray crystallography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01119</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01119" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=114-131&author=X.+Zhaauthor=D.+Lambaauthor=L.+Zhangauthor=Y.+Louauthor=C.+Xuauthor=D.+Kangauthor=L.+Chenauthor=Y.+Xuauthor=L.+Zhangauthor=A.+De+Simoneauthor=S.+Samezauthor=A.+Pesaresiauthor=J.+Stojanauthor=M.+G.+Lopezauthor=J.+Egeaauthor=V.+Andrisanoauthor=M.+Bartolini&title=Novel+tacrine-benzofuran+hybrids+as+potent+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+design%2C+synthesis%2C+biological+evaluation%2C+and+X-ray+crystallography&doi=10.1021%2Facs.jmedchem.5b01119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography</span></div><div class="casAuthors">Zha, Xiaoming; Lamba, Doriano; Zhang, Lili; Lou, Yinghan; Xu, Changxu; Kang, Di; Chen, Li; Xu, Yungen; Zhang, Luyong; De Simone, Angela; Samez, Sarah; Pesaresi, Alessandro; Stojan, Jure; Lopez, Manuela G.; Egea, Javier; Andrisano, Vincenza; Bartolini, Manuela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-131</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Twenty-six new tacrine-benzofuran hybrids, I [R = H, OMe, X = (CH2)m, Y= (CH2)n, m = 1-3, n = 6, 7], II [R = H, OMe, X = CH2, Y = (CH2)6; R = OMe, X = (CH2)2, Y = (CH2)6; R = H, X = (CH2)m, m = 1, 2, Y = (CH2)7; R = H, X = (CH2)2, Y = (CH2)7; R = OMe, X = (CH2)3, Y = (CH2)7] and III [R = H, OMe, X = CH2, Y = (CH2)6; R = OMe, X = (CH2)m, m = 2, 3, Y = (CH2)6; R = H, X = (CH2)m, m = 1-3, Y = (CH2)7; R = OMe, X = (CH2)3, Y = (CH2)7] were designed, synthesized, and evaluated in vitro on key mol. targets for Alzheimer's disease.  Most hybrids exhibited good inhibitory activities on cholinesterases and β-amyloid self-aggregation.  Selected compds. displayed significant inhibition of human β-secretase-1 (hBACE-1).  Among the 26 hybrids, II [R = H, X = (CH2)2, Y = (CH2)7] (IV) showed the most interesting profile as a subnanomolar selective inhibitor of human acetylcholinesterase (hAChE) (IC50 = 0.86 nM) and a good inhibitor of both β-amyloid aggregation (hAChE- and self-induced, 61.3% and 58.4%, resp.) and hBACE-1 activity (IC50 = 1.35 μM).  Kinetic studies showed that IV acted as a slow, tight-binding, mixed-type inhibitor, while X-ray crystallog. studies highlighted the ability of IV to induce large-scale structural changes in the active-site gorge of Torpedo californica AChE (TcAChE), with significant implications for structure-based drug design.  In vivo studies confirmed that IV significantly ameliorates performances of scopolamine-treated ICR mice.  Finally, IV administration did not exhibit significant hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdWlshOsJO7Vg90H21EOLACvtfcHk0lgG8R7D1ZAQ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGnsr%252FJ&md5=809e7be0412644a990920590f8a31125</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01119%26sid%3Dliteratum%253Aachs%26aulast%3DZha%26aufirst%3DX.%26aulast%3DLamba%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DSamez%26aufirst%3DS.%26aulast%3DPesaresi%26aufirst%3DA.%26aulast%3DStojan%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26atitle%3DNovel%2520tacrine-benzofuran%2520hybrids%2520as%2520potent%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520design%252C%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520X-ray%2520crystallography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D114%26epage%3D131%26doi%3D10.1021%2Facs.jmedchem.5b01119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Costanzo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cariati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desiderio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgammato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamberti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masullo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliverio, M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of donepezil-like compounds as AChE and BACE-1 inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=470-475&author=P.+Costanzoauthor=L.+Cariatiauthor=D.+Desiderioauthor=R.+Sgammatoauthor=A.+Lambertiauthor=R.+Arconeauthor=R.+Salernoauthor=M.+Nardiauthor=M.+Masulloauthor=M.+Oliverio&title=Design%2C+synthesis%2C+and+evaluation+of+donepezil-like+compounds+as+AChE+and+BACE-1+inhibitors&doi=10.1021%2Facsmedchemlett.5b00483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors</span></div><div class="casAuthors">Costanzo, Paola; Cariati, Luca; Desiderio, Doriana; Sgammato, Roberta; Lamberti, Anna; Arcone, Rosaria; Salerno, Raffaele; Nardi, Monica; Masullo, Mariorosario; Oliverio, Manuela</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">470-475</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylmethylpiperidinylmethyleneindanone donepezil analogs I (R, R1, R2 = H, HO, MeO; R3 = Ph, 3-MeOC6H4, 1,3-benzodioxole-5-yl) were prepd. as dual acetylcholinesterase (AChE) and β-secretase (BACE-1) inhibitors for potential use in the treatment of Alzheimer's disease.  I were prepd. by a green synthesis by Friedel-Crafts reaction of arylpropanoic acids in the presence of triflic acid using microwave irradn. followed by diastereoselective aldol condensation using Amberlyst A-26 as base and ultrasound as the energy source at 40-50°; for selected compds., demethylation was performed using iodocyclohexane in DMF.  The selectivities of I for inhibition of acetylcholinesterase over butyrylcholinesterase and their toxicities to neuroblastoma cells were detd.  I (R = H; R1 = R2 = MeO; R3 = Ph) and I (R = R1 = H; R2 = MeO; R3 = Ph) were identified as potential new lead compds. for a dual therapeutic strategy against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWJM9pEJTfmbVg90H21EOLACvtfcHk0lhYDWnj_EwuLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCks7o%253D&md5=994095d9e45508b6c6494d6f482bd217</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00483%26sid%3Dliteratum%253Aachs%26aulast%3DCostanzo%26aufirst%3DP.%26aulast%3DCariati%26aufirst%3DL.%26aulast%3DDesiderio%26aufirst%3DD.%26aulast%3DSgammato%26aufirst%3DR.%26aulast%3DLamberti%26aufirst%3DA.%26aulast%3DArcone%26aufirst%3DR.%26aulast%3DSalerno%26aufirst%3DR.%26aulast%3DNardi%26aufirst%3DM.%26aulast%3DMasullo%26aufirst%3DM.%26aulast%3DOliverio%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520donepezil-like%2520compounds%2520as%2520AChE%2520and%2520BACE-1%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D470%26epage%3D475%26doi%3D10.1021%2Facsmedchemlett.5b00483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1600</span><span class="NLM_x">–</span> <span class="NLM_lpage">1613</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.12.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2008.12.067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1600-1613&author=Y.+Zhuauthor=K.+Xiaoauthor=L.+Maauthor=B.+Xiongauthor=Y.+Fuauthor=H.+Yuauthor=W.+Wangauthor=X.+Wangauthor=D.+Huauthor=H.+Pengauthor=J.+Liauthor=Q.+Gongauthor=Q.+Chaiauthor=X.+Tangauthor=H.+Zhangauthor=J.+Liauthor=J.+Shen&title=Design%2C+synthesis+and+biological+evaluation+of+novel+dual+inhibitors+of+acetylcholinesterase+and+beta-secretase&doi=10.1016%2Fj.bmc.2008.12.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.12.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.12.067%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DChai%26aufirst%3DQ.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520beta-secretase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D1600%26epage%3D1613%26doi%3D10.1016%2Fj.bmc.2008.12.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dafni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5365</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span><span class="refDoi"> DOI: 10.1021/jm900859q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Munoz-Torreroauthor=L.+Ramirezauthor=E.+Gomezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodriguez-Francoauthor=O.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline-6-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+beta-amyloid-directed+anti-Alzheimer+compounds&doi=10.1021%2Fjm900859q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26aulast%3DRamirez%26aufirst%3DL.%26aulast%3DGomez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline-6-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520beta-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379%26doi%3D10.1021%2Fjm900859q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span> </span><span class="NLM_article-title">Searching for the multi-target-directed ligands against Alzheimer’s disease: discovery of quinoxaline-based hybrid compounds with AChE, H(3)R and BACE 1 inhibitory activities</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7158</span><span class="NLM_x">–</span> <span class="NLM_lpage">7167</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.09.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1016%2Fj.bmc.2011.09.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=7158-7167&author=W.+Huangauthor=L.+Tangauthor=Y.+Shiauthor=S.+Huangauthor=L.+Xuauthor=R.+Shengauthor=P.+Wuauthor=J.+Liauthor=N.+Zhouauthor=Y.+Hu&title=Searching+for+the+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease%3A+discovery+of+quinoxaline-based+hybrid+compounds+with+AChE%2C+H%283%29R+and+BACE+1+inhibitory+activities&doi=10.1016%2Fj.bmc.2011.09.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.09.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.09.061%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DSearching%2520for%2520the%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520discovery%2520of%2520quinoxaline-based%2520hybrid%2520compounds%2520with%2520AChE%252C%2520H%25283%2529R%2520and%2520BACE%25201%2520inhibitory%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D7158%26epage%3D7167%26doi%3D10.1016%2Fj.bmc.2011.09.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia-Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juarez-Jimenez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabateauthor=J.+Juarez-Jimenezauthor=B.+Perezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Munoz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lj-e1oM24noDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DJuarez-Jimenez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Oudin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolfsson, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modig, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolfsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L. G.</span><span> </span><span class="NLM_article-title">Traffic-related air pollution and dementia incidence in northern sweden: a longitudinal study</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1289/ehp.1408322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1289%2Fehp.1408322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtFyhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=306-312&author=A.+Oudinauthor=B.+Forsbergauthor=A.+N.+Adolfssonauthor=N.+Lindauthor=L.+Modigauthor=M.+Nordinauthor=S.+Nordinauthor=R.+Adolfssonauthor=L.+G.+Nilsson&title=Traffic-related+air+pollution+and+dementia+incidence+in+northern+sweden%3A+a+longitudinal+study&doi=10.1289%2Fehp.1408322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Traffic-related air pollution and dementia incidence in northern Sweden: a longitudinal study</span></div><div class="casAuthors">Oudin, Anna; Forsberg, Bertil; Adolfsson, Annelie Nordin; Lind, Nina; Modig, Lars; Nordin, Maria; Nordin, Steven; Adolfsson, Rolf; Nilsson, Lars-Goeran</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Health Perspectives</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-312</span>CODEN:
                <span class="NLM_cas:coden">EVHPAZ</span>;
        ISSN:<span class="NLM_cas:issn">1552-9924</span>.
    
            (<span class="NLM_cas:orgname">U. S. Department of Health and Human Services, National Institutes of Health</span>)
        </div><div class="casAbstract">Background: Exposure to ambient air pollution is suspected to cause cognitive effects, but a prospective cohort is needed to study exposure to air pollution at the home address and the incidence of dementia.  Objectives: We aimed to assess the assocn. between long-term exposure to traffic-related air pollution and dementia incidence in a major city in northern Sweden.  Methods: Data on dementia incidence over a 15-yr period were obtained from the longitudinal Betula study.  Traffic air pollution exposure was assessed using a land-use regression model with a spatial resoln. of 50 m × 50 m.  Annual mean nitrogen oxide levels at the residential address of the participants at baseline (the start of follow-up) were used as markers for long-term exposure to air pollution.  Results: Out of 1,806 participants at baseline, 191 were diagnosed with Alzheimer's disease during follow-up, and 111 were diagnosed with vascular dementia.  Participants in the group with the highest exposure were more likely than those in the group with the lowest exposure to be diagnosed with dementia (Alzheimer's disease or vascular dementia), with a hazard ratio (HR) of 1.43 (95% CI: 0.998, 2.05 for the highest vs. the lowest quartile).  The ests. were similar for Alzheimer's disease (HR 1.38) and vascular dementia (HR 1.47).  The HR for dementia assocd. with the third quartile vs. the lowest quartile was 1.48 (95% CI: 1.03, 2.11).  A subanal. that excluded a younger sample that had been retested after only 5 years of follow-up suggested stronger assocns. with exposure than were present in the full cohort (HR = 1.71; 95% CI: 1.08, 2.73 for the highest vs. the lowest quartile).  Conclusions: If the assocns. we obsd. are causal, then air pollution from traffic might be an important risk factor for vascular dementia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGXyUJFPkxI7Vg90H21EOLACvtfcHk0lj-e1oM24noDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtFyhsro%253D&md5=a6c7f631f214658c7fbdeb9a6cec55f9</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1289%2Fehp.1408322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.1408322%26sid%3Dliteratum%253Aachs%26aulast%3DOudin%26aufirst%3DA.%26aulast%3DForsberg%26aufirst%3DB.%26aulast%3DAdolfsson%26aufirst%3DA.%2BN.%26aulast%3DLind%26aufirst%3DN.%26aulast%3DModig%26aufirst%3DL.%26aulast%3DNordin%26aufirst%3DM.%26aulast%3DNordin%26aufirst%3DS.%26aulast%3DAdolfsson%26aufirst%3DR.%26aulast%3DNilsson%26aufirst%3DL.%2BG.%26atitle%3DTraffic-related%2520air%2520pollution%2520and%2520dementia%2520incidence%2520in%2520northern%2520sweden%253A%2520a%2520longitudinal%2520study%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2016%26volume%3D124%26spage%3D306%26epage%3D312%26doi%3D10.1289%2Fehp.1408322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Moulton, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span> </span><span class="NLM_article-title">Air pollution, oxidative stress, and Alzheimer’s disease</span> <span class="citation_source-journal">J. Environ. Public Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">472751</span><span class="refDoi"> DOI: 10.1155/2012/472751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1155%2F2012%2F472751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=22523504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A280%3ADC%252BC38rntVaktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=472751&author=P.+V.+Moultonauthor=W.+Yang&title=Air+pollution%2C+oxidative+stress%2C+and+Alzheimer%E2%80%99s+disease&doi=10.1155%2F2012%2F472751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Air pollution, oxidative stress, and Alzheimer's disease</span></div><div class="casAuthors">Moulton Paula Valencia; Yang Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of environmental and public health</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">472751</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the most common form of dementia affecting millions of people worldwide and will continue to affect millions more with population aging on the rise.  AD causality is multifactorial.  Known causal factors include genetic predisposition, age, and sex.  Environmental toxins such as air pollution (AP) have also been implicated in AD causation.  Exposure to AP can lead to chronic oxidative stress (OS), which is involved in the pathogenesis of AD.  Whereas AP plays a role in AD pathology, the epidemiological evidence for this association is limited.  Given the significant prevalence of AP exposure combined with increased population aging, epidemiological evidence for this link is important to consider.  In this paper, we examine the existing evidence supporting the relationship between AP, OS, and AD and provide recommendations for future research on the population level, which will provide evidence in support of public health interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS3_M1KFAjW5IkFb3mqPUYDfW6udTcc2eZyKU3CmodF6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rntVaktw%253D%253D&md5=bcdeacb748355673d975ae93fa56300f</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1155%2F2012%2F472751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F472751%26sid%3Dliteratum%253Aachs%26aulast%3DMoulton%26aufirst%3DP.%2BV.%26aulast%3DYang%26aufirst%3DW.%26atitle%3DAir%2520pollution%252C%2520oxidative%2520stress%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Environ.%2520Public%2520Health%26date%3D2012%26volume%3D2012%26spage%3D472751%26doi%3D10.1155%2F2012%2F472751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">A small molecule targeting the multifactorial nature of Alzheimer’s disease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span><span class="refDoi"> DOI: 10.1002/anie.200700256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1002%2Fanie.200700256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvFOns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3689-3692&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=S.+Capsoniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Margottiauthor=A.+Cattaneoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=A+small+molecule+targeting+the+multifactorial+nature+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fanie.200700256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule targeting the multifactorial nature of Alzheimer's disease</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Capsoni, Simona; Andrisano, Vincenza; Bartolini, Manuela; Margotti, Elisa; Cattaneo, Antonino; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3689-3692</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sights set on a cure: Memoquin (1) affects several mechanisms relevant to Alzheimer's disease (AD): the formation of reactive oxygen species, the processing and aggregation of amyloid β (Aβ) peptides, and acetylcholinesterase activity.  In animal models, 1 causes a remarkable decrease in the formation of AD neuro-degenerative hallmarks and a significant reversal of behavioral deficits.  HAChE, BACE-1, and NQO1 are enzymes targeted by 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDjj0kTvqp_bVg90H21EOLACvtfcHk0lj-e1oM24noDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvFOns78%253D&md5=249751815672fbdb88d73debf79518ed</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Fanie.200700256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200700256%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMargotti%26aufirst%3DE.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DA%2520small%2520molecule%2520targeting%2520the%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3689%26epage%3D3692%26doi%3D10.1002%2Fanie.200700256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Capurro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busquet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56870</span><span class="refDoi"> DOI: 10.1371/journal.pone.0056870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=10.1371%2Fjournal.pone.0056870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=23441223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFShsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56870&author=V.+Capurroauthor=P.+Busquetauthor=J.+P.+Lopesauthor=R.+Bertorelliauthor=G.+Tarozzoauthor=M.+L.+Bolognesiauthor=D.+Piomelliauthor=A.+Reggianiauthor=A.+Cavalli&title=Pharmacological+characterization+of+memoquin%2C+a+multi-target+compound+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0056870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of Memoquin, a multi-target compound for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Capurro, Valeria; Busquet, Perrine; Lopes, Joao Pedro; Bertorelli, Rosalia; Tarozzo, Glauco; Bolognesi, Maria Laura; Piomelli, Daniele; Reggiani, Angelo; Cavalli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e56870</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by progressive loss of cognitive function, dementia and altered behavior.  Over 30 million people worldwide suffer from AD and available therapies are still palliative rather than curative.  Recently, Memoquin (MQ), a quinone-bearing polyamine compd., has emerged as a promising anti-AD lead candidate, mainly thanks to its multi-target profile.  MQ acts as an acetylcholinesterase and β-secretase-1 inhibitor, and also possesses anti-amyloid and anti-oxidant properties.  Despite this potential interest, in vivo behavioral studies with MQ have been limited.  Here, we report on in vivo studies with MQ (acute and sub-chronic treatments; 7-15 mg/kg per os) carried out using two different mouse models: i) scopolamine- and ii) beta-amyloid peptide- (Aβ-) induced amnesia.  Several aspects related to memory were examd. using the T-maze, the Morris water maze, the novel object recognition, and the passive avoidance tasks.  At the dose of 15 mg/kg, MQ was able to rescue all tested aspects of cognitive impairment including spatial, episodic, aversive, short and long-term memory in both scopolamine- and Aβ-induced amnesia models.  Furthermore, when tested in primary cortical neurons, MQ was able to fully prevent the Aβ-induced neurotoxicity mediated by oxidative stress.  The results support the effectiveness of MQ as a cognitive enhancer, and highlight the value of a multi-target strategy to address the complex nature of cognitive dysfunction in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9fRuR1K2KrrVg90H21EOLACvtfcHk0lhPPIxduRdpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFShsr8%253D&md5=8873f950c61e58ae5ad2e66f4c40e584</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0056870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0056870%26sid%3Dliteratum%253Aachs%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DLopes%26aufirst%3DJ.%2BP.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DPharmacological%2520characterization%2520of%2520memoquin%252C%2520a%2520multi-target%2520compound%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56870%26doi%3D10.1371%2Fjournal.pone.0056870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhPPIxduRdpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Nelson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauli, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, M. A.</span><span> </span><span class="NLM_article-title">The essential medicinal chemistry of curcumin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1620</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00975</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00975" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1620-1637&author=K.+M.+Nelsonauthor=J.+L.+Dahlinauthor=J.+Bissonauthor=J.+Grahamauthor=G.+F.+Pauliauthor=M.+A.+Walters&title=The+essential+medicinal+chemistry+of+curcumin&doi=10.1021%2Facs.jmedchem.6b00975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">The Essential Medicinal Chemistry of Curcumin</span></div><div class="casAuthors">Nelson, Kathryn M.; Dahlin, Jayme L.; Bisson, Jonathan; Graham, James; Pauli, Guido F.; Walters, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1620-1637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Curcumin is a constituent (3-5%) of the traditional medicine known as turmeric.  Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation.  Curcumin has recently been classified as both a PAINS (pan-assay interference compds.) and an IMPS (invalid metabolic panaceas) candidate.  The likely false activity of curcumin in vitro and in vivo has resulted in >120 clin. trials of curcuminoids against several diseases.  No double-blinded, placebo controlled clin. trial of curcumin has been successful.  This Perspective reviews the essential medicinal chem. of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compd. and, therefore, a highly improbable lead.  Based on this in-depth evaluation, potential new directions for research on curcuminoids are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSvgRUG-0XoLVg90H21EOLACvtfcHk0lhPPIxduRdpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsFKjsA%253D%253D&md5=dfb16371e0ef27d4111628203c6acc09</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00975%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DK.%2BM.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DBisson%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DJ.%26aulast%3DPauli%26aufirst%3DG.%2BF.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26atitle%3DThe%2520essential%2520medicinal%2520chemistry%2520of%2520curcumin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1620%26epage%3D1637%26doi%3D10.1021%2Facs.jmedchem.6b00975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span>Alzheimer’s Drug Fails in Another Crushing Disappointment. <a href="https://www.scientificamerican.com/article/alzheimer-rsquo-s-drug-fails-in-another-crushing-disappointment/" class="extLink">https://www.scientificamerican.com/article/alzheimer-rsquo-s-drug-fails-in-another-crushing-disappointment/</a>. (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Drug+Fails+in+Another+Crushing+Disappointment.+https%3A%2F%2Fwww.scientificamerican.com%2Farticle%2Falzheimer-rsquo-s-drug-fails-in-another-crushing-disappointment%2F.+%28accessed+June+7%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00393&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00393%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-3%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00393" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799840afef73d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
